# Gmt database for MulEA software (http://www.mulea.org/)
# taxon_name: Homo sapiens
# taxid: 9606 
# ID_type: Gene symbol
# source_URL: www.pathwaycommons.org/
# source_PMID: 21071392
# source_version: Version 12 
# source_last_update: 18-09-2019
# gmt_download_date: 24-09-2020
# gmt_file_version: 2 
# gmt_entry_names: Pathway ID
# Pathway ID	Pathway	Gene set (Gene symbol)
# Pathway ID	Pathway	Gene set (Gene symbol)
PC_1	Glycolysis / Gluconeogenesis	55902	83440	10327	218	224	230	669	1737	1738	2023	2026	2027	2203	57818	130589	2597	2645	2821	3098	3099	3101	80201	160287	8382	4967	55753	5106	5162	5214	5232	5236	55276	5313	5315	7167
PC_2	Citrate cycle (TCA cycle)	47	48	50	1431	1737	1738	1743	2271	3417	3418	3419	3420	3421	4190	4967	55753	5091	5106	5162	6389	8803	8802	8801
PC_3	Pentose phosphate pathway	230	51071	2203	2539	2821	9563	5214	5226	25796	5236	55276	5634	64080	9104	729020	22934	6888	84076
PC_4	Pentose and glucuronate interconversions	231	224	51084	51181	27294	2990	729020	7358	7360	9942
PC_5	Fructose and mannose metabolism	231	57016	230	2203	197258	8790	2762	29925	3098	3099	3101	80201	3795	4351	8776	8898	9107	9108	5210	5214	29085	5372	6652	7167	7264
PC_6	Galactose metabolism	231	2683	57818	2582	2584	2585	2592	2595	2645	2717	2720	3098	3099	3101	80201	3938	5214	5236	55276	6476	7360
PC_7	Ascorbate and aldarate metabolism	224	55586	9104	7358
PC_8	Fatty acid biosynthesis	31	54898	79071	2194	27349	55301	54995
PC_9	Fatty acid elongation	10449	34	36	37	38	10965	2182	570	1892	1962	3030	3030	3028	51102	5538	51807
PC_10	Fatty acid degradation	10449	33	34	35	36	37	38	8310	2182	218	224	1374	1375	126129	1376	284541	1892	10455	1962	2639	3030	3030	3028	51807
PC_11	Synthesis and degradation of ketone bodies	38	622	3155	3157	3158	64064
PC_12	Steroid biosynthesis	1594	120227	1595	1718	1717	10682	10826	2222	51478	3988	4047	50814	6309	6646	6713	7108
PC_13	Primary bile acid biosynthesis	8309	1109	6718	23600	570	9023	1593	51302	10858	1581	9420	1582	3295	80270	10106	10998
PC_14	Ubiquinone and other terpenoid-quinone biosynthesis	27235	51805	84274	51004	10229	2805	2806	3242	6898
PC_15	Steroid hormone biosynthesis	1109	6718	1312	1583	1584	1585	1586	1588	1543	1545	1589	64816	1581	9420	3291	3293	8630	3283	79644	412	6783	6822	6820
PC_16	Purine metabolism	100	109	132	56985	158	159	205	55821	270	353	471	10380	1633	1716	5167	954	956	957	2272	2618	8034	2766	51292	8833	3000	2987	3251	3614	3615	3704	8382	30833	84284	131870	318	11164	53343	10606	10914	9060	5198	5236	55276	5313	5315	4860	87178	5426	51728	5471	5634	58497	6240	1890	646625	7498
PC_17	Caffeine metabolism	1544	64816	9	10	7498
PC_18	Pyrimidine metabolism	205	1677	978	51727	1503	1633	1635	1723	1806	1807	1841	1854	956	957	3704	8382	30833	318	4860	87178	5426	51728	6240	7083	7084	23318	7296	10587	114112	1890	7298	83549	7372	51733	151531	139596
PC_19	Alanine, aspartate and glutamate metabolism	18	158	159	189	8659	7915	435	440	443	445	1677	1373	8528	2673	2744	2747	2752	132789	2806	84706	259307	56954	5471	6898
PC_20	Glycine, serine and threonine metabolism	189	501	275	314	8639	635	102724560	55349	1491	1610	1738	29958	2593	2628	23464	2731	132158	27232	4128	4129	26227	51268	29968	5723	1757	10993	6470	63826
PC_21	Cysteine and methionine metabolism	55256	10768	262	51074	635	102724560	1036	1491	29947	58478	2806	259307	160287	27430	4357	84245	4507	4548	10993	6611	6723	6898
PC_22	Valine, leucine and isoleucine degradation	18	10449	27034	34	35	36	38	224	4329	316	549	587	593	594	1629	1738	1892	1962	3030	11112	26275	3155	3157	3158	3028	259307	3712	64087	84693	4594	4967	55753	64064	5095	51807
PC_23	Valine, leucine and isoleucine biosynthesis	587	3376	55699	23395	5162	7407
PC_24	Lysine biosynthesis	51166	10157	501
PC_25	Lysine degradation	51166	10157	38	224	501	223	8424	1743	1892	1962	2639	3030	3028	51111	4967	55753	51268	5351	5352	8985	55217	51807
PC_26	Arginine and proline metabolism	95	79814	5832	224	8659	262	26	314	8639	383	435	445	113451	57571	1160	1373	1610	2593	2628	2744	2747	2752	2806	51056	4128	4129	162417	4846	4942	4953	5009	5033	8974	283208	5625	5625	65263	112483	6611	6723
PC_27	Histidine metabolism	218	224	144193	26	314	8639	443	57571	84735	55748	1644	10841	3034	3067	3176	4128	4129	131965	131669
PC_28	Tyrosine metabolism	218	314	8639	316	1312	1621	1638	1644	2184	2805	2806	2954	3081	3242	259307	4128	4129	131965	268	5409	6898	7054	7173	7299	7306
PC_29	Phenylalanine metabolism	218	314	8639	1644	2806	3242	259307	4128	4129	268	5053	9588	6898
PC_30	Tryptophan metabolism	15	38	130013	125061	224	26	314	8639	316	438	847	1544	1644	1738	1743	1892	1962	2639	23498	3030	3028	169355	259307	11185	8564	883	8942	4128	4129	4967	55753	6999	7166	121278	51807	10352
PC_31	Phenylalanine, tyrosine and tryptophan biosynthesis	2805	2806	259307	5053	6898
PC_32	beta-Alanine metabolism	18	34	218	224	26	8639	57571	84735	1806	1807	1892	26275	23417	6611	6723	51733
PC_33	Taurine and hypotaurine metabolism	84890	570	1036	51380	2571	2572	2687
PC_34	Selenocompound metabolism	1491	11185	883	56267	4141	4548	9060	118672	51540	22929	51091	7296	10587	114112
PC_35	Cyanoamino acid metabolism	57733	2687	6470
PC_36	D-Glutamine and D-glutamate metabolism	2744	2747
PC_37	D-Arginine and D-ornithine metabolism	1610
PC_38	Glutathione metabolism	290	2539	2730	79017	2687	2879	257202	2936	2937	9563	3417	3418	3419	3420	3421	51056	4953	26873	5226	6240	6611	6723	51060
PC_39	Starch and sucrose metabolism	178	276	276	276	279	280	5167	57818	2595	57733	2632	2645	2821	2990	2998	3098	3099	3101	80201	8972	256281	5236	55276	283209	5837	6476	11181	7358	7360	80146
PC_40	N-Glycan biosynthesis	56052	84920	440138	79087	79868	199857	10016	10195	29880	29929	79053	79796	8703	1603	22845	57171	1798	8813	8818	54344	2530	23193	11253	4122	4245	4247	4248	11282	25834	4249	7841	6480	201595
PC_41	Mucin type O-Glycan biosynthesis	11041	9334	56913	100528030	2650	9245	6482	55808
PC_42	Other types of O-glycan biosynthesis	145173	8703	283464	3955	146664	8473	8985	23509	56983	55624	10585	6480
PC_43	Amino sugar and nucleotide sugar metabolism	51005	1116	27159	1118	55907	51706	197258	8790	2582	2584	2585	2592	2645	2673	2762	29925	10020	132789	64841	2821	3073	3098	3099	3101	80201	4351	55577	140838	54187	80896	5236	55276	5238	5372	5973	7264	6675	7358	7360	80146
PC_44	Butirosin and neomycin biosynthesis	2645	3098	3099	3101	80201
PC_45	Glycosaminoglycan degradation	411	2588	2720	2799	2990	3073	138050	10855	60495	3373	3423	3425	4669	6448
PC_46	Glycosaminoglycan biosynthesis - chondroitin sulfate	126792	135152	11285	54480	22856	55454	64131	64132
PC_47	Glycosaminoglycan biosynthesis - heparan sulfate	126792	135152	11285	2131	2134	2137	64131	64132
PC_48	Glycerolipid metabolism	55750	10554	10327	231	224	2585	2717	132158	84803	4023	11343	346606	8613	5408	26007
PC_49	Inositol phosphate metabolism	4329	10423	3613	3628	8821	3633	27124	253430	64768	51477	3705	3707	9562	55586	5298	5286	5287	5288	5289	5290	5291	5293	5294	200576	5305	8396	79837	8395	51196	5728	8871	7167
PC_50	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	8818	2822	5277	9488	5279	5281	54872	5283	9487	93183	23556	84720	51227	9091	55650	284098	54965	84992	80235
PC_51	Glycerophospholipid metabolism	43	56985	10554	590	10423	11200	10390	1103	1119	56994	54675	8443	84803	23171	2820	3931	10162	9926	154141	79143	5130	5833	10400	9489	162466	23761	5337	8613	9791	81490	85465	6901
PC_52	Ether lipid metabolism	8540	10390	56994	5168	133121	54947	254531	5051	5320	5337	8613	85465
PC_53	Arachidonic acid metabolism	8644	239	242	247	240	873	874	1562	1557	1558	1559	1571	1573	113612	1579	284541	4051	2053	2687	257202	27306	4048	4056	9536	5740	5743	6916
PC_54	Linoleic acid metabolism	57016	246	64816
PC_55	alpha-Linolenic acid metabolism	8310	9415
PC_56	Sphingolipid metabolism	55331	439	427	9331	64781	8560	9514	2581	2629	2717	2720	2531	3938	4758	4759	129807	8613	259230	166929	8879	81537	6609	56848	10558	7357	7368
PC_57	Glycosphingolipid biosynthesis - lacto and neolacto series	28	8708	8707	10317	10331	84002	2683	8704	8703	8702	11041	2523	2524	2525	2526	2527	2529	10690	2651	6487	6484	10402	6489
PC_58	Glycosphingolipid biosynthesis - globo series	53947	8706	10317	2523	2524	10690	26301	2717	3073	4668	6482
PC_59	Glycosphingolipid biosynthesis - ganglio series	8705	2583	2720	3073	6482	8869	256435	27090	81849	30815	6489	29906
PC_60	Pyruvate metabolism	31	38	134526	55902	98	231	218	224	1737	1738	2739	9380	3029	160287	197257	4190	4199	4200	10873	8382	4967	55753	5091	5106	5162	5313	5315
PC_61	Glyoxylate and dicarboxylate metabolism	38	47	48	50	125061	1431	132158	9380	51179	81888	84693	4190	4594	5095	283871
PC_62	Propanoate metabolism	18	31	34	38	55902	79611	224	4329	1892	26275	160287	84693	23417	4594	5095	8803	8802	8801
PC_63	Butanoate metabolism	65985	18	35	36	38	54988	57016	7915	622	1892	1962	3030	3155	3157	3158	3028	79944	64064	5162	51807
PC_64	One carbon pool by folate	160428	275	471	635	1719	10841	2618	123263	4522	25902	441024	4524	10588	4548	6470	7298
PC_65	Thiamine metabolism	9054	84284	79178	27010
PC_66	Riboflavin metabolism	51205	645	5167	80308	55312	7299
PC_67	Vitamin B6 metabolism	316	8566	57026	55163	29968
PC_68	Nicotinate and nicotinamide metabolism	316	952	5167	65220	55191	10135	93100	349565	54981	4837	23530	30833	83594	4860	23475
PC_69	Pantothenate and CoA biosynthesis	60496	587	80347	1806	1807	5167	53354	80025	79646	55229	60490	79717	51733	8875
PC_70	Biotin metabolism	686	3141
PC_71	Lipoic acid metabolism	11019	51601	387787
PC_72	Folate biosynthesis	248	1719	2356	2643	8836	4337	4338	5805	5860	6697
PC_73	Retinol metabolism	216	158835	53630	1543	1544	340665	1553	64816	284541	9249	10901	10170	9227	8228	51109	54884	6121	195814
PC_74	Porphyrin and chlorophyll metabolism	210	645	1352	1355	1371	124454	2235	94033	2990	3052	3145	3162	3163	326625	3060	7389	7390
PC_75	Terpenoid backbone biosynthesis	38	79947	2224	9453	3156	3157	3158	3422	4597	4598	23590	10654
PC_76	Nitrogen metabolism	275	440	759	1373	1491	1738	2731	2744	2747	2752	3034
PC_77	Sulfur metabolism	10380	50515	9060	445329	445329	6783	6820	6821
PC_78	Aminoacyl-tRNA biosynthesis	57505	79587	1615	124454	2193	2617	23438	3376	55699	3735	23395	4141	123263	4677	25973	118672	2058	5917	57038	6301	54938	51091	80222	7407	10352	51067
PC_79	Metabolism of xenobiotics by cytochrome P450	1109	218	1544	1571	64816	2052
PC_80	Drug metabolism - cytochrome P450	218	314	8639	316	1544	1553	1555	1562	1557	1558	1559	1565	1571	1573	64816	2329	4128	4129
PC_81	Drug metabolism - other enzymes	978	8824	221223	1553	64816	1806	1807	8833	2990	3251	3614	3615	3704	9	10	7083	7084	7172	1890	83549	7372	51733	151531	7498
PC_82	Biosynthesis of unsaturated fatty acids	30	10965	122970	8310	2182	570	54898	79071	9415	9200	3030	51144	54995	5538	79966	9524
PC_83	Metabolic pathways	53947	51166	15	10157	18	28	10449	31	27034	33	34	35	36	37	38	47	130013	48	50	10965	8309	8310	2182	54988	55902	79611	95	100	128	55256	132	84890	83440	158	159	125061	55750	178	79814	10554	8540	189	10768	205	10327	231	57016	1109	6718	210	5832	216	218	224	8659	7915	4329	501	230	56052	84920	440138	79087	79868	199857	10016	10195	29880	29929	79053	79796	55821	239	242	246	247	240	248	23600	262	144193	270	275	276	276	276	279	280	290	314	8639	316	51074	353	383	411	427	435	438	440	374569	445	471	549	113451	8706	8708	8707	8705	10317	126792	135152	10331	84002	11041	2583	2683	8704	8703	8702	9331	11285	11041	570	587	593	594	53630	622	635	669	10380	686	56913	1677	873	874	102724560	952	978	10423	1036	11200	10390	10715	8824	221223	1119	54480	56994	22856	1160	55907	134147	51727	84735	55748	80347	1312	27235	51805	84274	51004	10229	1371	1373	54675	51084	1431	51380	55454	1491	1503	1583	1584	1585	1586	1588	1543	1544	1589	1593	1594	1562	1557	1558	1559	1571	1573	120227	113612	64816	1579	284541	4051	1595	1581	1582	1603	1610	1621	1629	1633	1638	1635	51181	1644	8560	1716	1718	1717	1719	1723	9249	10901	10170	1738	1743	29958	29947	22845	1798	8813	8818	54344	1806	1807	1841	1854	124454	10682	1892	1962	2023	2026	2027	5167	2053	2131	2134	2137	2184	2194	10826	2203	197258	2222	2224	2235	2271	80308	2356	8790	10841	2523	2524	2525	2526	2527	2529	2530	10690	57818	2539	2571	2572	9514	2581	2582	2584	2585	2588	100528030	2592	2593	23193	2595	2597	2618	2628	2629	2632	26301	2639	2643	2645	2730	2650	2651	9245	8034	2673	9453	2687	2585	2720	2731	2744	2747	2752	132158	2762	29925	8833	10020	132789	2799	2805	2806	84803	2821	84706	9380	2937	2954	2987	2990	9563	23498	3030	3030	3034	51179	3067	3073	3081	138050	11112	26275	3098	3099	3101	80201	3141	3145	3155	3156	3157	3158	3242	27306	3251	10855	60495	3291	3028	3293	3295	8630	51478	3283	80270	3373	81888	3417	3418	3419	3420	3421	3422	169355	3423	3425	259307	3613	3614	3615	3628	8821	3633	27124	64768	51477	3704	3705	3707	3712	2531	3795	8564	883	8942	51056	3938	160287	11019	51601	387787	54947	254531	4047	4048	4056	11253	4122	4128	4129	27430	27349	64087	84693	4190	4199	4200	10873	51102	8972	4245	4247	4248	11282	25834	4249	11343	23417	326625	4594	4337	4338	346606	7841	4351	4357	84245	4507	4522	25902	441024	4524	10588	4534	4548	4597	4598	65220	55191	4669	162417	140838	54187	93100	9	10	8382	349565	4837	23530	4846	50814	30833	84284	4942	4953	4967	55753	55301	5009	54995	5033	8974	283208	5051	5053	10606	53354	80025	79646	55229	10914	9060	5091	5095	5106	5130	5833	5162	8566	57026	10400	5198	5214	5226	5232	25796	5236	55276	283871	9489	26227	162466	5298	5277	9488	5279	5281	5283	9487	93183	23556	84720	51227	9091	55650	284098	54965	84992	5286	5287	5288	5289	8395	51268	23761	5313	5315	5320	11145	51196	5337	8613	5372	10654	5408	5409	4860	55163	5426	51728	5444	5471	60490	79717	3060	5538	10549	9588	5625	5625	5634	29968	5723	9791	81490	9536	5740	5743	5805	65263	2058	5860	23475	51109	55312	9104	729020	22934	6240	1757	112483	6309	51540	10106	6389	195814	10993	85465	22929	259230	166929	8879	6448	6470	6476	10998	6609	6611	6652	56848	6697	10558	6713	6723	6482	6487	6484	8869	10402	6480	55808	256435	27090	81849	30815	6489	29906	201595	8803	8802	8801	8871	6888	6898	6916	6999	23483	7054	79178	7083	7084	26007	84076	7108	7166	121278	7167	27010	7173	54802	7264	51807	23318	1890	7298	7299	7306	6675	83549	7357	7358	7360	7368	7372	51733	151531	139596	646625	131669	7389	7390	80146	7498	9942	64131	64132
PC_84	Adrenaline and noradrenaline biosynthesis	1312	1621	1644	11185	4128	4129	4837	5409	6570	6571	55117	28968	388662	348932	340024	6530	54716	6531	8773	6616	9342	23673	8417	7054	6843	6844	10490
PC_85	Alpha adrenergic receptor signaling pathway	146	147	150	151	152	2767	3708	23236	5330	5331	5332	51196	5578	5580	5581	5582	8773	6616	8677	10228	6843	6844	9341
PC_86	Alzheimer disease-amyloid secretase pathway	102	6868	8754	320	321	9546	83464	351	23621	25825	775	776	778	779	782	783	89832	1128	1129	1131	1132	1133	1139	5045	10524	3831	147700	147700	89953	5594	5602	5600	6300	5603	1432	225689	5595	5596	5597	5598	5599	5601	23385	5122	5126	54760	5046	9159	5585	5586	29941	5578	5579	5580	5581	5582	5584	5588	5590	5663	5664	55851
PC_87	Alzheimer disease-presenilin pathway	58	59	60	345651	70	71	72	10097	6868	4301	323	10307	83464	351	23621	25825	960	999	1001	1499	1855	1856	1857	2066	2081	11167	5045	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	2932	3728	10524	11143	51176	4035	53353	4036	4037	4038	4041	4040	4312	4322	4323	4325	4326	4327	4313	9313	8510	8510	79148	64066	4316	4317	4318	23385	5818	4851	4853	4854	4855	5122	5126	54760	5046	9159	5663	5664	55851	3516	11317	83439	6934	23321	10612	7220	7223	7224	7225	7226	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484
PC_88	Angiogenesis	207	208	10000	284	285	324	10297	369	392	23779	8312	332	673	842	1398	1399	102724652	1410	1499	8788	28514	10683	54567	420	9046	79930	1855	1856	1857	1947	1948	2042	2047	2048	2049	2113	2149	2152	2155	2246	2260	2353	10818	10817	8321	2535	8326	7855	10750	2888	2886	2932	3091	3265	3315	182	3714	3716	3725	3791	9404	5604	5605	6416	4214	5594	1432	5595	5599	9261	7867	4690	8440	4846	4851	4853	4855	4893	5058	5062	5063	5154	5155	56034	80310	5156	5159	5286	5287	5289	5290	5291	5293	5294	5295	5296	8503	5321	100137049	8605	283748	5335	5336	5337	5338	5578	5579	5580	5581	5582	5584	5588	5590	5587	25865	23683	55615	5747	5787	5829	5894	5921	3516	11317	387	388	389	9047	6464	25759	6654	6655	8877	56848	6714	6772	6774	6932	6934	7010	7041	7422	7471	80326	7480	7472	7482	7474	81029	7476	7477
PC_89	Apoptosis signaling pathway	9131	207	208	10000	317	466	1386	467	468	22926	1388	11016	9531	9530	578	581	596	598	10017	10018	599	638	329	330	666	843	836	840	841	842	8837	1147	8738	1390	54205	1616	56616	5610	1965	2021	8772	355	356	2353	3002	2999	3303	3303	3305	3306	3309	3310	3312	3482	3551	122953	3725	4049	4050	8567	5606	6416	5609	4214	9020	4217	5871	8491	9448	5594	5602	5595	5599	5601	4170	4790	4791	4792	5290	5291	5293	5294	5578	5579	5580	5581	5582	5588	8575	5966	5970	5971	8737	7009	7124	8797	8795	8794	8793	7132	7133	8743	7157	8717	7186	331
PC_90	Axon guidance mediated by semaphorins	9138	1020	1400	1807	1808	10570	56896	2242	2444	2534	8829	5058	5361	5364	5879	5880	387	10371	10507
PC_91	Axon guidance mediated by Slit/Robo	25	998	6387	7852	1630	9423	4917	59277	22854	84628	5879	5880	389	6091	6585	9353	6586	57522
PC_92	Axon guidance mediated by netrin	3983	998	1630	4773	4775	4776	9423	4917	59277	22854	84628	5286	5287	5290	5291	5293	5294	5295	5296	8503	23533	5335	5336	5879	5880	58480	219699	8633	137970	7408
PC_93	B cell activation	369	29760	695	801	930	933	973	974	1147	2353	2885	3265	3551	3708	3709	3710	3725	4067	5604	5605	10746	4215	5594	5602	5600	6300	5603	1432	5595	5599	5601	4792	4795	4893	5290	5291	5293	5294	5336	5530	5532	5579	5580	5777	5788	5879	5880	5894	6654	6655	6850	7409	7410	10451
PC_94	Blood coagulation	351	2159	2161	2165	2147	2149	9002	2152	2155	2157	2158	2243	2244	2266	2811	2812	2814	2815	3674	3818	3827	5327	5328	5329	5340	5624	10544	5627	8858	5265	51156	5055	462	5054	5345	7035	7056	7450
PC_95	Cadherin signaling pathway	58	59	60	345651	70	71	72	10097	999	1008	1009	1010	1012	1013	1014	1015	1016	8642	1000	28316	64405	64072	64403	1001	1002	1003	1004	1005	1006	1007	92211	54825	9620	1952	1951	1459	283106	1460	1499	1500	1501	8642	1956	2064	2065	2066	2195	2196	120114	2241	2444	11167	2534	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	2932	51176	4067	5097	57575	27328	83259	51294	65217	54510	57526	64881	5099	5100	5101	56147	56139	56138	56137	56136	56146	56145	56144	56143	56142	56141	56140	9752	56135	56134	29930	56126	56125	56124	56123	56122	56121	57717	56133	56132	56131	26167	56130	56129	56128	56114	56106	56105	26025	56113	56112	56110	56109	56108	9708	56104	56103	8641	56100	56099	5098	56098	56097	5770	6714	83439	6934	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484	7525
PC_96	Cell cycle	894	896	898	9134	51550	5717	5718	5719	10213	5709	5710	5713	10197	6119
PC_97	Cholesterol biosynthesis	2222	2224	9453	3156	3157	91734	4047	4597	4598	23590	10654	6713
PC_98	Circadian clock system	406	9575	1407	1408	1453	102800317	5187	8864	8863
PC_99	Cytoskeletal regulation by Rho GTPase	58	59	60	345651	70	71	72	392	23779	9138	10552	10095	10109	10094	10093	10092	998	1072	1073	1729	1730	55740	3984	4619	4628	4629	8735	79784	4620	4621	4622	4624	4625	57644	4626	4627	4638	85366	91807	53904	140469	5058	5062	5063	10298	106821730	106821730	5216	5217	345456	5879	5880	389	58480	6093	9475	54434	3925	81551	203068	81027	7280	347733	10381	10382	10383	84617	347688	7408	8976
PC_100	DNA replication	1763	440093	8290	5111	5422	5424	5425	5557	5981	5982	5983	5984	5985	246243	6118	7150	7153	7155
PC_101	EGF receptor signaling pathway	207	208	10000	369	374	673	685	867	868	23624	153090	1950	1956	2064	2065	2066	2069	2549	9846	139716	10750	1839	3265	5604	5605	5606	6416	5608	5609	10746	4215	4216	4217	5594	5602	5600	6300	5603	1432	5595	5599	5601	22808	4763	4893	3084	9542	10718	145957	5037	157310	90102	5286	5287	5289	5290	5291	5293	5294	23533	5335	5336	5515	5516	5525	5526	5527	5528	5529	5578	5579	5580	5581	5582	5584	5588	5590	5587	25865	23683	5879	5880	5894	5921	5922	10156	9462	6237	22800	2810	6464	25759	53358	6654	6655	10252	10253	10251	81848	6772	6773	6774	6775	6776	6777	6778	7039	7529	7531	7532	7533	10971	7534
PC_102	untitled	107	55811	108	109	196883	111	112	113	114	115	207	208	10000	369	1889	110599583	9427	1906	1907	1908	1909	1910	5045	2767	9630	2774	2776	2778	2982	2977	2983	3708	3709	3710	5604	5605	5594	5595	4846	5122	5321	23236	5330	5331	5332	5578	5567	5568	5573	5575	5576	5577	5578	5579	5580	5581	5582	5584	5588	5590	5592	5593	5743	5894	23478	90701
PC_103	FAS signaling pathway	317	822	843	836	839	840	841	842	8837	1537	1616	1677	1956	2064	2065	2066	8772	11124	355	356	2735	2737	2934	3725	4000	4001	84823	6416	4217	5602	5599	5601	142	10038	10039	143	85477
PC_104	FGF signaling pathway	207	208	10000	369	2246	2255	2256	2257	2258	2259	8822	8817	26281	27006	2248	2249	2250	2251	2252	2253	2254	2260	2263	2261	2264	10818	10817	10750	3265	5604	5605	5606	6416	5608	5609	10746	4215	4216	4217	9064	5594	5602	5600	6300	5603	1432	5595	5599	5601	4893	5037	5286	5287	5289	5290	5291	5293	5294	5335	5336	5515	5516	5518	5519	5520	5521	5522	55844	5525	5526	5527	5528	5529	5578	5579	5580	5581	5582	5584	5588	5590	5777	5879	5880	5894	5921	5922	10156	2810	6464	53358	6654	6655	10252	10253	10251	81848	7529	7531	7532	10971	7534
PC_105	General transcription by RNA polymerase I	284119	84172	51082	5440	29893	54700	9015	9014	9013	129685	6908	9519	387332	7080	7343
PC_106	General transcription regulation	677	55290	29105	2957	11036	2958	2959	2960	2961	2962	2963	2965	2967	2968	80298	5432	5435	5437	6882	6883	9013	6873	6874	6878	6879	129685	6880	51616	9519	7080
PC_107	Glycolysis	226	669	2023	2026	2597	2821	3098	3099	80201	5211	5213	5224	441531	5230	5313	5315	7167
PC_108	Hedgehog signaling pathway	8945	1387	1452	122011	102800317	23291	2735	2737	2932	5573	5575	5576	5577	5727	6469	6608	27148	51684	51366
PC_109	Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway	107	108	109	196883	111	112	113	114	115	134	135	136	140	146	147	146	151	152	153	154	155	801	1128	1129	1131	1132	1133	1211	1212	1213	8218	1385	10488	90993	64764	84699	148327	9586	1387	1390	1812	1813	1815	1816	2033	2770	2771	2773	2774	2782	2783	2790	55970	54331	2785	2786	2787	2788	2793	2792	2793	2798	9248	26086	29899	6011	156	157	2868	2869	2870	131890	2911	2912	2913	2914	2915	2916	2917	2918	2931	2932	2997	2998	3269	3274	11255	59340	3350	3351	3352	3354	3355	3356	3357	3358	3360	3361	3362	3363	3760	3762	3763	3765	4543	4544	4985	4986	4987	4988	5255	5256	5257	5260	5261	5578	5567	5568	5573	5575	5576	5577	5834	5836	5837	5906	5908	5996	6001	8786	6002	6003	10636	6004	26575	64407	10287	5997	5998	5999	8490	9628	6000	85397	8787	6751	6752	6753	6754	6755
PC_110	Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway	134	135	136	140	9138	623	624	773	774	777	1128	1129	1131	1132	1133	1211	1212	1213	8218	51277	1812	1813	1815	1816	84253	2767	9630	2769	2775	2776	2782	2783	2784	59345	2790	55970	51764	54331	2785	2786	2787	2788	2793	2792	2793	2798	11250	26086	29899	156	157	2868	2869	2870	131890	2911	2912	2913	2914	2915	2916	2917	2918	3708	3709	3710	3760	3762	3763	3765	4985	4986	4987	4988	23236	5330	5331	5332	5578	5579	5580	5581	5582	5584	5588	5590	5906	5908	5909	10125	10235	25780	115727	5996	6001	8786	6002	6003	10636	6004	26575	64407	10287	5997	5998	5999	8490	9628	6000	85397	8787	387	6751	6752	6753	6754	6755
PC_111	Heterotrimeric G-protein signaling pathway-rod outer segment phototransduction	801	810	1259	1261	1258	54714	2779	2782	2783	59345	10681	2790	55970	51764	54331	2785	2786	2787	2788	2793	2792	2793	6011	5132	5145	5158	5148	5578	5567	5568	5957	8787	6010
PC_112	Huntington disease	58	59	60	345651	70	71	72	10097	207	208	10000	160	161	317	375	377	378	381	382	23647	400	10124	10123	379	10552	10095	10092	81873	627	823	11132	11131	147968	824	825	726	827	23473	10753	826	84290	836	841	998	1212	1387	1537	23191	26999	1639	1742	55567	1767	56171	1769	64446	10126	1778	1780	1781	51143	1783	79659	8655	140735	2033	2353	2597	26330	2897	2898	2899	2900	2901	2902	2903	2904	2905	2906	116443	328	3092	9026	6532	55081	3725	8997	6416	5609	4294	5601	10133	29993	4218	5879	5880	391	57381	23433	6457	6667	8867	6874	6908	25816	7157	8626	7161	203068	81027	7280	347733	10381	10382	10383	84617	347688	8976
PC_113	Hypoxia response via HIF activation	207	208	10000	405	1387	54583	112398	112399	2861	9283	3091	2475	5071	5728	6097	7179	7295	25828	7428
PC_114	Inflammation mediated by chemokine and cytokine signaling pathway	58	59	60	345651	70	71	72	108	111	112	207	208	10000	239	246	241	369	10552	10095	10109	10094	10093	10092	81873	728	815	817	8573	6356	6357	6362	6347	6364	6366	6367	10344	10850	6348	414062	414062	388372	388372	388372	6352	6354	6355	1230	1238	729230	1232	1233	1234	9034	1236	1237	10803	9034	998	1147	1303	7373	57642	1291	1292	1293	6376	1524	3627	3576	3577	3579	2833	7852	643	10663	2357	2359	2767	9630	2769	2770	2771	2773	2775	2776	2784	2790	55970	54331	2785	2786	2787	2788	2793	10750	2870	3454	3458	3551	3636	3683	3688	3695	3708	3709	3710	3717	3725	3726	3727	3845	56413	5594	5595	4619	4628	4629	8735	79784	4620	4621	4622	4624	4625	57644	4626	4627	4638	85366	91807	53904	140469	10725	4772	4773	4775	4776	4791	4893	5058	5062	5063	10298	106821730	106821730	5170	5196	5197	5290	5291	5293	5294	5321	23236	5330	5331	5332	5333	84812	51196	5335	5336	5334	89869	57580	5578	5567	5568	5579	5581	5590	5613	5728	5742	5743	2185	5879	5880	5894	5970	5971	6003	5999	387	389	391	6093	6237	6464	9306	9655	30837	30837	6654	6774	7409	7450	2829
PC_115	Insulin/IGF pathway-mitogen activated protein kinase kinase/MAP kinase cascade	2002	2353	3479	3480	3481	3482	3630	3643	3645	3667	8660	8471	5604	5605	5606	5594	5595	5894	5921	6195	6196	6197	8986	9252	27330	6198	6199	6654	6655
PC_116	Insulin/IGF pathway-protein kinase B signaling cascade	2308	2309	2931	2932	3479	3480	3481	3482	3636	3630	3643	3645	3667	8660	8471	4193	4194	5170	5290	5728	7179	7248	7249
PC_117	Integrin signalling pathway	60	345651	71	87	88	81	369	375	382	55738	79658	23092	400	10552	10095	10109	10094	10092	81873	50807	9564	673	857	998	1300	1301	1302	1303	1305	7373	1306	1307	1308	1277	1278	57642	85301	1280	1281	1282	1284	1285	1286	1287	1288	1289	1290	50509	1291	1292	1293	1295	1296	1297	1298	1299	1398	1399	1445	1755	51277	1793	9844	63916	2316	2317	2335	2534	3265	3611	3672	8515	22801	3673	3674	3675	3676	3678	3655	3679	8516	3680	3681	3682	3683	3684	3685	3687	3688	3689	3691	3693	3694	3695	3696	9358	284217	3908	3909	3910	3911	3912	3915	3914	22798	3915	3918	10319	3987	55679	5604	5605	5606	6416	10746	4215	4216	4217	5602	5603	5595	5597	5599	5601	85377	4893	59277	55742	29780	5286	5287	5289	5290	5291	5293	5294	5295	5296	8503	5747	2185	5782	5829	5879	5880	5894	5906	5908	5911	5912	57826	2889	387	388	389	27289	8153	390	6237	6464	6654	6655	6714	7094	7408	7414
PC_118	Interferon-gamma signaling pathway	1154	3458	3459	3460	3716	3717	5594	5602	5600	6300	5603	1432	225689	5595	5599	5601	8554	9063	10401	51588	5777	8835	9021	9306	9655	30837	30837	6772
PC_119	Interleukin signaling pathway	207	208	10000	369	673	1026	1027	1147	3576	3577	3579	2002	2004	2005	2353	2309	2932	3551	3587	3588	3589	3590	3594	3595	3597	3598	3600	3601	3552	53832	59067	51561	3559	3560	3563	3565	3566	3568	3569	3570	3572	3578	3667	8660	3718	5594	225689	5595	5597	5598	9261	8569	2872	2475	4609	4846	4893	5170	5290	5291	5894	5921	6195	6196	6197	27330	6464	84174	6654	6655	6688	121599	6722	6772	6773	6774	6775	6776	6777	6778
PC_120	Ionotropic glutamate receptor pathway	10369	27091	815	816	817	2890	2891	2892	2893	2897	2898	2899	2900	2901	2902	2903	2904	2905	2906	116443	2912	2913	4905	9463	50944	57084	246213	6505	6506	6507	6511	6512	8773	6616	9342	8676	415117	6843	6844	9341	8673
PC_121	JAK/STAT signaling pathway	3716	3717	3718	1432	8554	9063	10401	5788	8651	6772	6774	6775	6776	6777	6778
PC_122	Metabotropic glutamate receptor group III pathway	55811	773	774	777	782	2770	2771	2773	2782	2783	2784	59345	10681	2790	2785	2786	2787	2788	2793	2793	2890	2891	2892	2893	2897	2898	2899	2900	2901	2902	2903	2904	2905	2906	116443	2911	2914	2915	2916	2917	2918	5578	5567	5568	5573	5575	5576	5577	5613	57030	6505	6506	6507	6511	6512	8773	6616	9342	6804	112755	6843	6844	9341	8673	143187
PC_123	Metabotropic glutamate receptor group II pathway	55811	773	774	777	782	2770	2771	2773	2775	2780	2782	2783	2784	59345	10681	2790	2791	2785	2786	2787	2788	2793	2793	2912	2913	5578	5567	5568	5573	5575	5576	5577	5613	8773	6616	9342	6804	112755	6843	6844	9341	8673
PC_124	Metabotropic glutamate receptor group I pathway	2767	2769	2776	2897	2901	2902	2903	2904	2905	2906	116443	2907	2911	2915	9456	3708	5332	5578	5567	5568	5573	5575	5579	5613
PC_125	Muscarinic acetylcholine receptor 1 and 3 signaling pathway	43	590	1103	1128	1131	2767	9630	2776	2782	2783	2784	59345	10681	2790	2791	2785	2786	2787	2788	2793	2793	2902	2903	2904	2905	2906	116443	3708	3709	3710	5585	5586	29941	5332	5578	5579	5580	5581	5582	5584	5588	5590	6572	60482	8773	6616	9342	6804	112755	6843	6844	9341	8673
PC_126	Muscarinic acetylcholine receptor 2 and 4 signaling pathway	43	55811	590	1103	1129	1132	2770	2771	2773	2775	2779	2780	2782	2783	2784	59345	10681	2790	2791	2785	2786	2787	2788	2793	2793	3760	3762	3763	3765	5578	5567	5568	5573	5575	5576	5577	5613	6572	60482	6535	8773	6616	9342	8676	8675	415117	6804	112755	6810	6843	6844	9341	8673
PC_127	Nicotinic acetylcholine receptor signaling pathway	43	58	59	60	345651	70	71	72	10121	10120	590	1103	89832	1134	57053	1135	1136	1137	1138	8973	1139	55584	1140	1141	1142	1143	1144	1145	1146	441294	100128553	643854	4619	4628	4629	8735	79784	22989	4620	4621	4622	4624	4625	57644	4626	4627	4651	51168	23026	399687	84700	80179	4640	4430	4641	4642	4643	4542	64005	53904	140469	4644	4645	55930	4646	4647	4648	4649	79990	6572	126969	60482	6535	8773	6616	9342	8676	8675	415117	6804	112755	6810	6843	6844	9341	8673
PC_128	Notch signaling pathway	102	6868	9541	8788	10683	54567	55294	2530	182	3714	3955	84708	222484	9794	4242	9612	23385	9148	140825	84461	4851	4853	4854	4855	8650	23509	5663	3516	11317
PC_129	Oxidative stress response	596	338599	1843	11221	11266	51207	11072	128853	80824	150290	142679	1844	63904	56940	78986	92235	1845	1846	1847	1848	1849	1850	1852	29904	2002	3725	5606	6416	5608	5600	6300	5603	1432	5599	5601	4149	4208	8569	2872	4609	5321	6772	6815	7295
PC_130	PDGF signaling pathway	208	369	392	79658	94134	55843	23092	393	143872	394	395	23779	64333	673	1147	26298	1997	1998	1999	2000	2001	2002	2005	8518	2077	2078	2113	2117	54738	2313	2353	2549	9846	2551	10750	9402	2885	2931	2932	3265	3551	3708	3709	3710	3716	3717	3718	3725	5604	5605	10746	4216	5594	5602	225689	5595	5597	5598	5599	9261	8569	2872	4609	26292	4690	8440	51199	22981	4893	4983	5154	5155	5156	5159	5157	5170	5289	5290	5291	5293	5294	5295	5296	8503	23533	5586	5335	5336	5578	9230	5894	5921	5922	10156	85004	6195	6196	6197	8986	9252	27330	6198	6199	26750	6464	25759	53358	6654	6655	25803	6722	57522	9901	6772	6773	6774	6775	6776	6777	6778	7392	7409	7410	10451
PC_131	PI3 kinase pathway	207	208	10000	842	2308	2309	4303	2767	9630	2770	2771	2773	2776	2780	2782	2783	2784	59345	10681	2792	2793	2932	3632	3636	3643	3667	3717	4846	4893	5170	5290	5291	5295	5296	8503	23533	5728	5731	6198	6199	6654	6655	7534
PC_132	Parkinson disease	640	8573	898	9134	1445	1452	122011	1453	102800317	1455	1456	1459	283106	1460	8454	2002	23291	55294	2268	2444	2534	2861	9283	156	157	3055	3091	3303	3303	3305	3306	3309	3310	3312	3313	3932	4067	5594	5602	6300	1432	225689	5595	5598	5599	5601	4729	5338	5071	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	5691	5695	1731	4735	5414	5413	2810	6531	6622	9627	6620	6623	6714	10273	23673	8417	7054	1861	27433	118424	7332	9246	7345	7525	7529	7531	7532	7533	10971	7534
PC_133	Plasminogen activating cascade	1361	2243	2244	2266	4018	4312	4322	4314	4318	5327	5328	5329	5340	5055	5054	5345
PC_134	TCA cycle	50	1431	2271	4190	4967	5160	5161	5164	6391	8802
PC_135	TGF-beta signaling pathway	90	91	130399	92	93	94	269	1386	25805	649	27302	9210	650	651	652	653	654	655	353500	656	657	658	659	4435	10370	1387	196513	2033	2280	2281	2286	8061	8928	2657	2662	10220	9518	2658	9573	8200	392255	151449	2661	2668	3265	3624	3625	3626	83729	3725	3726	3727	10637	7044	6885	56911	5594	5602	5600	6300	5603	1432	5595	5599	5601	2660	4838	4893	6237	6497	6498	4086	4087	4088	4089	4090	4091	4092	4093	57154	64750	79753	10454	7042	7043	7046	7048	7092	7093	9765	9372
PC_136	T cell activation	207	208	10000	369	673	801	919	940	915	916	917	941	942	998	1147	1445	2353	9402	3265	3551	3708	3725	27040	3932	3937	5604	5605	4214	5594	5595	5599	5601	4690	8440	4792	4893	5058	5062	5063	5289	5290	5291	5293	5294	5295	5296	8503	5335	5530	5532	5533	5588	5788	5879	5894	6654	6655	7409	7410	10451	7454	7535
PC_137	Toll receptor signaling pathway	929	1147	51295	2002	3551	9641	3654	11213	51135	3661	3725	23643	5604	5605	5606	6885	1326	1432	5595	5599	5601	4615	4792	4794	10454	10010	29110	148022	100302736	114609	81793	7097	7098	7099	10333	51284	51311	54106	7128	54472	7189	7334	389898	387522
PC_138	Transcription regulation by bZIP transcription factor	677	55290	29105	90993	64764	84699	148327	9586	1387	2033	2957	11036	2958	2959	2960	2961	2962	2963	2965	2967	2968	80298	5432	5434	5435	5437	5441	5573	5575	5576	5577	29893	6882	6883	9013	6873	6874	6878	6879	129685	6880	51616	6908	9519	387332	7080	2304
PC_139	VEGF signaling pathway	207	369	392	23779	673	842	102724652	1410	2113	3091	3265	3315	3791	9404	5604	5605	5594	1432	5595	9261	7867	4846	4893	5286	5287	5289	5290	5291	5293	5294	5295	5296	8503	5321	5335	5336	5578	5579	5580	5581	5582	5584	5588	5590	5587	25865	23683	55615	5747	5829	5879	5880	5881	5894	9047	25759	8877	56848	7041	7422
PC_140	Wnt signaling pathway	91	130399	22881	8289	407	408	409	8312	607	657	658	8945	999	1008	1009	1010	1012	1013	1014	1015	1016	8642	1000	28316	64405	64072	64403	1001	1002	1003	1004	1005	1006	1007	92211	54825	9620	1952	1951	9350	9557	1387	1452	122011	1453	102800317	1455	1456	1459	283106	1460	1487	1488	1495	1496	29119	8727	1499	51339	8642	1855	1856	1857	2033	57634	2195	2196	120114	23291	2487	11167	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	2767	9630	2769	2776	2782	2783	2784	59345	2790	55970	51764	54331	2785	2786	2787	2788	2793	2932	3065	3066	8841	55869	3070	6596	54617	3708	3709	3710	83999	79412	51176	4041	4040	6885	56911	4772	4773	4775	4776	85407	85409	51701	5097	57575	27328	83259	51294	65217	54510	57526	64881	5099	5100	5101	56147	56139	56138	56137	56136	56146	56145	56144	56143	56142	56141	56140	9752	56135	56134	29930	56126	56125	56124	56123	56122	56121	57717	56133	56132	56131	26167	56130	56129	56128	56114	56106	56105	26025	56113	56112	56110	56109	56108	9708	56104	56103	8641	56100	56099	5098	56098	56097	23236	5330	5331	5332	5515	5516	5525	5526	5527	5528	5529	5530	5532	5533	5534	5535	5578	5579	5580	5581	5582	5584	5588	5590	26108	90780	6295	6422	6423	6424	6425	6477	6478	4086	4089	4090	6594	6595	6597	8467	50485	6598	6599	6601	6602	6603	6604	6605	10847	6907	79718	90665	83439	6934	7046	7088	7089	7090	7091	166	79816	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484
PC_141	mRNA splicing	9129	9410	6626	6629	8233
PC_142	p53 pathway	207	208	10000	472	390502	891	898	995	983	1017	1026	11200	1387	2033	1647	4616	10912	51512	3065	3146	8850	23522	4193	4194	9219	5170	5290	5371	5515	5516	5728	2810	25942	23411	7341	6613	6612	7157	8626	7161	7179	7186	7486
PC_143	Ubiquitin proteasome pathway	10533	83737	4193	5704	5707	5719	10213	5708	5710	5713	10055	57154	64750	11219	7317	10054	9039	55236	7318	7319	7320	11065	7321	7322	7323	51619	7324	7325	10477	7326	7327	3093	7332	9246	7334	389898	27338	29089	7336	7337	89910	9690	11059	11060
PC_144	ATP synthesis	506	509
PC_145	Acetate utilization	84532	55902	79611
PC_146	Adenine and hypoxanthine salvage pathway	100	353	3251	4860	56952	7498
PC_147	Alanine biosynthesis	586	587
PC_148	Allantoin degradation	55821
PC_149	Aminobutyrate degradation	18
PC_150	Androgen/estrogene/progesterone biosynthesis	1588	3292	3294	3293	8630	51478	3988	6646	8435
PC_151	Arginine biosynthesis	435	445	1677	1373	162417	5009
PC_152	Ascorbate degradation	6120
PC_153	Asparagine and aspartate biosynthesis	440
PC_154	Coenzyme A biosynthesis	79877	53354	80025	79646	55229	79717
PC_155	Cysteine biosynthesis	102724560
PC_156	De novo purine biosynthesis	158	159	122622	203	204	205	205	26289	158067	471	57453	2618	8833	2987	3615	4830	4831	4832	4833	8382	10201	29922	5471	6240	6241	50484
PC_157	De novo pyrimidine deoxyribonucleotide biosynthesis	134637	57453	1841	1854	4830	4831	4832	4833	6240	6241	50484	7298
PC_158	De novo pyrimidine ribonucleotides biosythesis	1677	1373	1503	56474	1723	57453	4830	4831	4832	4833
PC_159	Flavin biosynthesis	80308	55312
PC_160	Tetrahydrofolate biosynthesis	1719	200895	2356	2643	7298
PC_161	Formyltetrahydroformate biosynthesis	1719	200895	25902	10797	4548	7298
PC_162	Fructose galactose metabolism	226	229	230	2582	2592	3098	3099	80201	3795
PC_163	Glutamine glutamate conversion	2746	2747	2752	51557
PC_164	Heme biosynthesis	210	1352	1371	124454	2058	2235	3145	3060	2058	55316	7389
PC_165	Isoleucine biosynthesis	586	587	10994
PC_166	Leucine biosynthesis	586	587
PC_167	Lipoate_biosynthesis	11019
PC_168	Mannose metabolism	2762	29926	29925	4351	5372	5373
PC_169	Methionine biosynthesis	4548
PC_170	Methylcitrate cycle	48	3658
PC_171	Methylmalonyl pathway	84693	4594	5095	5096
PC_172	N-acetylglucosamine metabolism	51005	2673	9945	10007	132789	80896
PC_173	O-antigen biosynthesis	2673	9945	23483
PC_174	Ornithine degradation	51582	113451	4953
PC_175	Pyridoxal-5-phosphate biosynthesis	55163	29968
PC_176	Pentose phosphate pathway	2821	3098	3099	80201	5226	22934	6888	7086
PC_177	Phenylethylamine degradation	26	314	8639
PC_178	Purine metabolism	272	8034	4907	7498
PC_179	Pyridoxal phosphate salvage pathway	8566	55163
PC_180	Pyrimidine Metabolism	18	4329	978	1806	1807	1808	1809	56896	4907	51733
PC_181	Pyruvate metabolism	47	171425	1431	4199	5091	5105	5160	5161	5313	5315
PC_182	S-adenosylmethionine biosynthesis	4143	4144	4548
PC_183	Salvage pyrimidine deoxyribonucleotides	134637	978	7083
PC_184	Salvage pyrimidine ribonucleotides	134637	4831	4832	4833	83549	7371	54963	7378	151531
PC_185	Serine glycine biosynthesis	26227	29968	5723
PC_186	Succinate to proprionate conversion	55862	4594	5096
PC_187	Thiamine metabolism	79178	27010
PC_188	Threonine biosynthesis	79896
PC_189	Triacylglycerol metabolism	3990	3991
PC_190	Valine biosynthesis	586	587	10994
PC_191	Vitamin B6 metabolism	8566	55163	29968
PC_192	Xanthine and guanine salvage pathway	8034	3251	4860	56952
PC_193	5-Hydroxytryptamine biosynthesis	1644	7166	121278
PC_194	5-Hydroxytryptamine degredation	126133	216	8854	220	219	10840	160428	217	218	224	8659	501	64577	223	259307	4128	4129
PC_195	5HT1 type receptor mediated signaling pathway	108	113	2770	2771	2773	2775	2782	2783	2784	59345	10681	2790	2791	55970	54331	2785	2786	2787	2788	2793	2793	3350	3351	3352	3354	3355	3777	51305	5578	5567	5568	5576	5577	5613	6532	8773	6616	9342	6809	6843	6844	9341
PC_196	5HT2 type receptor mediated signaling pathway	2767	9630	2776	2782	2783	2784	59345	10681	2790	2791	55970	54331	2785	2786	2787	2788	2793	2793	3356	3357	3358	3777	51305	23236	5330	5331	5332	5333	84812	51196	5335	5336	5334	89869	5578	5579	5580	5581	5582	5584	5588	5590	6570	6571	6532
PC_197	5HT3 type receptor mediated signaling pathway	3777	51305	6570	6571	6532	8773	6616	9342	6809	6843	6844	9341	8673
PC_198	5HT4 type receptor mediated signaling pathway	108	113	2774	2782	2783	2784	59345	10681	2790	55970	54331	2785	2786	2787	2788	2793	2793	3360	3777	51305	6570	6571	6532	8773	6616	9342	6809	6843	6844	9341	8673
PC_199	Beta1 adrenergic receptor signaling pathway	108	113	153	2774	2782	2783	2784	59345	10681	2790	55970	54331	2785	2786	2787	2788	2793	2793	5578	5567	5568	5576	5577	5613	8773	6616	9342	6809	6843	6844	9341	8673
PC_200	Beta2 adrenergic receptor signaling pathway	108	113	154	2774	2782	2783	2784	59345	10681	2790	55970	54331	2785	2786	2787	2788	2793	2793	5578	5567	5568	5576	5577	5613
PC_201	Beta3 adrenergic receptor signaling pathway	108	113	155	2774	2782	2783	2784	59345	10681	2790	55970	54331	2785	2786	2787	2788	2793	2793	8773	6616	9342	6809	6843	6844	9341	8673
PC_202	Cortocotropin releasing factor receptor signaling pathway	1392	104909134	1395	2767	9630	2774	2776	2782	2783	2784	59345	10681	2790	55970	54331	2785	2786	2787	2788	2793	2793	5443	8773	6616	9342	6809	6843	6844	9341	8673
PC_203	Gamma-aminobutyric acid synthesis	18	7915	51380	2571	2572
PC_204	Histamine H1 receptor mediated signaling pathway	2767	9630	2776	2782	2783	2784	59345	10681	2790	55970	54331	2785	2786	2787	2788	2793	2793	3269	3708	3709	3710	23236	5330	5331	5332	5333	84812	51196	5335	5336	5334	89869	5578	5579	5580	5581	5582	5584	5588	5590
PC_205	Histamine H2 receptor mediated signaling pathway	108	113	2774	2782	2783	2784	59345	10681	2790	55970	54331	2785	2786	2787	2788	2793	2793	3274	5578	5567	5568	5576	5577	5613
PC_206	Histamine synthesis	3067
PC_207	Oxytocin receptor mediated signaling pathway	2767	9630	2776	2782	2783	2784	59345	10681	2790	55970	54331	2785	2786	2787	2788	2793	2793	5021	23236	5330	5331	5332	5333	84812	51196	5335	5336	5334	89869	5578	5579	5580	5581	5582	5584	5588	5590	8773	6616	9342	6809	6843	6844	9341	8673
PC_208	P53 pathway feedback loops 1	114769	4193	4194	7157	8626	7161
PC_209	Ras Pathway	207	10000	369	1386	673	998	2002	2113	55770	2885	2931	2932	3265	3725	3845	5604	5605	5606	6416	5608	5609	4214	4216	56911	5594	5602	5600	6300	5603	1432	5595	5599	5601	9261	7867	4893	5058	5062	5063	5170	5289	5290	5291	5293	5294	5337	5338	5879	5880	5881	5894	5898	5899	5900	23179	5863	387	388	389	6195	6196	6197	27330	6464	6654	6655	6722	6772	6774	7074
PC_210	Thyrotropin-releasing hormone receptor signaling pathway	773	774	777	782	783	784	785	1081	2767	9630	2776	2782	2783	2784	59345	10681	2790	55970	54331	2785	2786	2787	2788	2793	2793	23236	5330	5331	5332	5333	84812	51196	5335	5336	5334	89869	5578	5579	5580	5581	5582	5584	5588	5590	8773	6616	9342	6809	7200	7201	7252	6843	6844	9341	8673
PC_211	Vasopressin synthesis	551	1363	387921	5020	23077	5550	9581	23478	90701	9789	60559
PC_212	Vitamin D metabolism and pathway	1593	1594	339761	2165	2638	5914	6256	7421
PC_213	p53 pathway by glucose deprivation	207	208	10000	1978	3476	5515	5516	5562	5563	5564	5565	5571	6009	6198	6199	6794	7157	8626	7161	7248	7249
PC_214	p53 pathway feedback loops 2	207	208	10000	472	390502	8900	890	898	900	1017	1026	1499	3265	3845	5600	6300	5603	1432	4609	4893	5170	5286	5287	5288	5289	5290	5291	5293	5294	5295	5296	8503	23533	5515	5516	5728	5925	5933	6477	7157	8626	7161	7179
PC_215	5-arachidonylglycerol_biosynthesis	747	200879	4023	51365	23236	5330	5331
PC_216	Anandamide_degradation	2166
PC_217	Bupropion_degradation	1555
PC_218	Endogenous_cannabinoid_signaling	773	774	8913	1268	2770	2773	2775	2782	2783	2784	59345	2791	2785	2786	2787	2788	2793	2793	2911	2915	4792	23236	5330	5331
PC_219	GABA-B_receptor_II_signaling	107	108	196883	111	112	113	114	115	773	774	8913	2550	9568	2770	2773	2775	2782	2783	2784	59345	2791	2785	2786	2787	2788	2793	2793	3760	5578	5567	5568	5573	5575	5576	5577
PC_220	Synaptic_vesicle_trafficking	4905	5864	22999	6616	6804	112755	2054	6812	6857	23208	91683	102724488	127833	84258	6861	148281	9066	10497	440279	201294	6843
PC_221	Angiotensin_II-stimulated_signaling_through_G_proteins_and_beta-arrestin	183	185	408	409	1958	2002	2776	2782	2783	2784	59345	10681	2790	2791	2785	2786	2788	2793	2793	156	157	2869	2870	3708	3709	3710	5604	5605	5594	5595	23236	5330	5331	5578	5894
PC_222	PNAT	108	113	54102	1312	1621	1644	1812	1813	1815	1816	2035	2036	2037	23136	2316	2770	2771	2773	2781	2782	2783	2784	59345	2791	2785	2786	2793	3777	51305	4128	4129	5499	5501	84152	5578	5567	5568	5576	5577	5613	6571	6531	8773	6616	9342	6809	7054	6843	6844	9341	8673
PC_223	Enkephalin release	108	113	1385	1390	2770	2771	2773	2774	2775	2782	2783	2784	59345	10681	2790	55970	54331	2785	2786	2787	2788	2793	2793	4985	4988	5173	5179	5578	5567	5568	5576	5577	5613
PC_224	Nicotine_degradation	1553	1548	1549	2328	11185
PC_225	Opioid proenkephalin pathway	108	113	2770	2771	2773	2782	2783	2784	59345	10681	2790	55970	54331	2785	2786	2787	2788	2793	2793	4985	5173	5179	8773	6616	9342	6809	6843	6844	9341	8673
PC_226	untitled	108	113	551	2770	2771	2773	2775	2782	2783	2784	59345	10681	2790	55970	54331	2785	2786	2787	2788	2793	2793	4986	5020	5173	8773	6616	9342	6809	6843	6844	9341	8673
PC_227	Opioid proopiomelanocortin pathway	108	113	2770	2771	2773	2775	2782	2783	2784	59345	10681	2790	55970	54331	2785	2786	2787	2788	2793	2793	4985	5443	8773	6616	9342	6809	6843	6844	9341	8673
PC_228	p38 MAPK pathway	466	1843	11221	29904	1977	2002	1647	3315	3554	6416	5608	4294	4216	4217	6885	5600	6300	5603	1432	9261	7867	100271849	4208	4209	8569	2872	8986	9252	6722	10454	23118	7189
PC_229	Nicotine pharmacodynamics pathway	108	775	8913	1136	1137	1138	8973	1141	1142	1143	54102	1644	1813	1815	2035	2036	2037	2316	2770	2782	54331	3777	51305	5499	84152	5578	6571	7054
PC_230	untitled	5970	6498	7050
PC_231	Gastrin_CCK2R_240212	107	8165	207	84335	1173	369	393	64283	409	1386	572	581	9564	596	598	673	801	814	84254	836	885	887	952	998	999	1071	1191	10256	1363	1385	1390	1398	1445	1452	1453	102800317	1499	3576	1759	1958	1977	1978	1994	2002	2005	2353	2308	2309	2520	2782	54331	2885	2932	3000	1839	51564	3315	8870	3667	3685	3688	3708	3717	3725	9314	4067	5604	5605	6416	5607	5608	4296	9020	5594	5602	1432	5595	5598	5599	5601	100271849	4208	4209	4221	4314	4773	4792	4842	7182	4953	5058	5136	5170	5291	5295	5321	5328	5335	5468	5530	5578	5567	5568	5578	5579	5580	5581	5588	5587	25865	5592	5728	5743	5747	2185	5781	5829	5879	5894	5997	6009	387	6093	6194	6195	6197	6198	6261	6262	6263	6464	6571	6615	6654	6667	6670	6714	6722	6774	6925	53373	219931	8460	7189	7525	7529
PC_232	Interleukin-6 signaling	867	3569	3570	3572	3716	3717	5781	9021	6772	6774	7297
PC_233	PI3K Cascade	2246	2255	8823	8822	8817	9965	2247	26281	27006	8074	2248	2249	2250	2251	2252	2253	2254	2260	2263	2261	2264	2322	2323	10818	2549	9846	2885	3667	8660	9365	152831	5289	5290	5291	5295	5296	30849	5781	54106
PC_234	MAPK3 (ERK1) activation	983	3569	3570	3572	3716	3717	5604	5595	5781	7297
PC_235	Translesion synthesis by REV1	10459	5111	51455	5980	5981	5982	5983	5984	5985	6117	6118	6119	6233	7311	7314	7316
PC_236	Recognition of DNA damage by PCNA-containing replication complex	8451	8450	1642	51514	5111	5424	5425	10714	57804	5426	5427	54107	56655	56852	9978	5981	5982	5983	5984	5985	6117	6118	6119	6233	7311	7314	7316	7320	7398	57599
PC_237	Translesion Synthesis by POLH	55666	5111	10721	25898	5981	5982	5983	5984	5985	6117	6118	6119	6233	83932	7311	7314	7316	7353	7415
PC_238	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	65057	474382	55766	94239	3014	3015	102724334	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	121504	121504	128312	8290	121504	8930	79661	252969	55247	4913	4968	25913	23583	6996	7013	7014	54386	26277	7374
PC_239	Cleavage of the damaged pyrimidine	65057	474382	55766	94239	3014	3015	102724334	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	121504	121504	128312	8290	121504	8930	79661	252969	55247	4913	4968	25913	23583	6996	7013	7014	54386	26277	7374
PC_240	Recognition and association of DNA glycosylase with site containing an affected purine	65057	474382	55766	94239	3014	3015	102724334	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	121504	121504	128312	8290	121504	4350	4595	55247	4968	25913	7013	7014	54386	26277
PC_241	Cleavage of the damaged purine	65057	474382	55766	94239	3014	3015	102724334	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	121504	121504	128312	8290	121504	4350	4595	55247	4968	25913	7013	7014	54386	26277
PC_242	Displacement of DNA glycosylase by APEX1	328	8930	4350	4595	4913	4968	23583	6996	7374
PC_243	POLB-Dependent Long Patch Base Excision Repair	54936	328	2237	3978	670	142	10038	5423
PC_244	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	328	5423
PC_245	Resolution of AP sites via the single-nucleotide replacement pathway	3980	5423	7515
PC_246	SLBP independent Processing of Histone Pre-mRNAs	84967	134353	4686	22916	6628	6634	6635	6636	6637	25888
PC_247	Activation of BIM and translocation to mitochondria	10018	8655	5599
PC_248	Activation of BAD and translocation to mitochondria	207	208	10000	572	596	637	5533	5534	2810	7529	7531	7532	7533	10971	7534
PC_249	Activation of NOXA and translocation to mitochondria	1869	5366	7027	7029	7157
PC_250	Activation and oligomerization of BAK protein	578	637
PC_251	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	572	27113	596	598	10018	637	90427	5366	6774
PC_252	Release of apoptotic factors from the mitochondria	578	581	54205	56616	5414
PC_253	Formation of apoptosome	317	51074	57099	22900	842	54205
PC_254	Activation of caspases through apoptosome-mediated cleavage	317	836	840	842	54205	331
PC_255	SMAC (DIABLO) binds to IAPs	317	836	840	842	54205	56616	331
PC_256	SMAC(DIABLO)-mediated dissociation of IAP	317	836	840	842	54205	56616	331
PC_257	Apoptotic cleavage of cellular proteins	22985	324	10134	329	660	836	839	840	841	63967	2339	5580	5588	5747	6093	6304	8428	51765
PC_258	SMAC, XIAP-regulated apoptotic response	836	840	56616	5414	331
PC_259	Opioid Signalling	4988	5173	5443
PC_260	PKA-mediated phosphorylation of CREB	1385	5578	5567	5568	5613
PC_261	CaMK IV-mediated phosphorylation of CREB	801	815	816	817	818	814	84254	10645	1385	3838
PC_262	Calmodulin induced events	801	156	5578	5580	5582
PC_263	Cam-PDE 1 activation	801	5136	5153	5137
PC_264	phospho-PLA2 pathway	5594	5321
PC_265	CaM pathway	801
PC_266	PLC beta mediated events	10768	2770	2771	2773	2775	2779	2780	346562	2781	3708	3709	3710	23236	5330	5331	5332
PC_267	ALKBH2 mediated reversal of alkylation damage	121642
PC_268	ALKBH3 mediated reversal of alkylation damage	221120	51008	84164	10973
PC_269	Electric Transmission Across Gap Junctions	81025	10052	57369	24145	56666
PC_270	Presynaptic depolarization and calcium channel opening	11094	773	774	777	9254	55799	782	783	784	785	10369	27092
PC_271	Neurotransmitter release cycle	27163
PC_272	Neurotransmitter clearance	43	590	6580	6582
PC_273	Neurotransmitter receptors and postsynaptic signal transmission	2741	2742	8001	2743	3359	9177	170572	200909	285242
PC_274	Formation of RNA Pol II elongation complex	27125	902	8812	904	905	79577	1022	1025	9150	9646	85403	55840	8178	6924	51224	6923	6921	2068	2071	2962	2963	2965	2966	2967	2968	404672	55677	123169	4298	4300	4331	4686	22916	7469	25920	51497	7936	5828	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	23168	6749	11198	6827	6829	6830	6917	80349
PC_275	IRS-mediated signalling	3667	8660	5290	5291	5295	5296
PC_276	RAF-independent MAPK1/3 activation	1843	11221	80824	1844	1846	1847	1848	1849	1850	1852	5594	5595	8682
PC_277	MAPK1 (ERK2) activation	3569	3570	3572	3716	3717	5605	5594	5781	7297
PC_278	SOS-mediated signalling	2885	3265	3667	8660	3845	4893	6654
PC_279	Formation of the Early Elongation Complex	902	1022	9150	2068	2071	2962	2963	2965	2966	2967	2968	404672	4331	4686	22916	7469	25920	51497	7936	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	6827	6829
PC_280	Inhibition of replication initiation of damaged DNA by RB1/E2F1	1869	5422	23649	5515	5516	5518	5519	28227	5557	5558	5925	7027	7029
PC_281	E2F-enabled inhibition of pre-replication complex formation	891	983	84515	4998	4999	23595	5000	5001	23594
PC_282	Activation, translocation and oligomerization of BAX	581	637
PC_283	Effects of PIP2 hydrolysis	1606	1607	8527	8526	1608	160851	9162	139189	1609	8525	3708	3709	3710	5580	5581	5588	10125	10235	7222	7225	7226
PC_284	Disinhibition of SNARE formation	5578	5579	5582	6810	6814
PC_285	GPVI-mediated activation cascade	998	51266	2207	2534	51206	27040	3932	3937	4067	80739	5170	10630	5290	5291	5294	5295	5296	8503	23533	146850	5336	5590	5781	5777	5879	5880	387	388	391	6850	7409	7410	10451
PC_286	Platelet degranulation	1	2	10257	87	88	81	197	213	226	308	334	335	350	139322	351	27154	801	813	10487	135228	948	967	928	55664	1675	1072	66005	7123	1191	1521	51706	1893	1950	23052	2162	2153	2157	10447	51571	83706	2243	2244	2266	2316	2335	2621	54676	22927	3082	3273	3309	3479	3481	3671	3674	3690	3699	3700	3827	3920	7044	3959	10184	259215	10916	7873	22915	374354	29789	5004	5005	5099	78991	5154	5155	5175	5196	5216	9749	5341	5340	5473	5478	5627	5660	5768	5874	5919	51097	29106	6414	6403	5265	12	5267	5054	5345	710	6647	6678	6694	5552	6813	94121	8407	51368	7018	7040	7042	7043	7057	7076	7078	7094	7114	54495	54863	7273	7277	7414	7422	7423	7424	2277	10490	7450	9948
PC_287	Activation of NF-kappaB in B cells	8915	8945	84433	1147	8454	23291	3551	8517	10892	6885	4790	4792	4793	4794	5579	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	5966	5970	6233	7979	6500	7311	7314	7316
PC_288	Activation of RAS in B cells	3265	3845	4893	10125	25780
PC_289	ISG15 antiviral mechanism	8086	25820	23586	5610	1973	1974	9775	1977	9470	317649	1981	1982	8672	2317	51191	3434	3661	9636	3716	3836	3838	3839	3840	3841	402569	3837	5595	4599	4600	55706	4734	57122	55746	9972	9631	23279	23511	23165	23225	8021	129401	79023	11097	348995	10762	53371	9818	23636	79902	4927	9688	4928	5300	5335	9883	5495	8480	5903	6233	6396	81929	6772	7175	7706	7311	7318	7314	7316	7324	9246	7334	11274
PC_290	Prolactin receptor signaling	8945	1442	8454	2688	2689	2690	3717	5617	5618	5781	9978	25970	6500	6776	6777
PC_291	Signaling by NODAL	91	130399	92	93	9350	55997	199699	10589	8928	2309	5045	2657	10637	7044	4838	5046	4087	4088	4089	6997
PC_292	Meiotic synapsis	65057	390502	672	11083	8468	474382	55766	94239	3014	3015	102724334	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	121504	121504	128312	8290	121504	3306	4000	4001	25913	5885	9985	8243	27127	9126	10274	10735	10734	23353	25777	93426	256126	644186	6847	10388	50511	23345	23224	7013	7014	54386	56158	26277	7329
PC_293	Mtb iron assimilation by chelation	4057
PC_294	ROS and RNS production in phagocytes	535	23545	50617	533	527	9114	245972	8992	155066	523	525	526	528	245973	51382	529	90423	9296	9550	534	127124	51606	1535	1536	84329	653361	4688	4689	4842	4843	4846	5880	6556	10312
PC_295	Signaling by ERBB2	685	11140	1950	1956	2064	2065	2066	55914	2069	2534	1839	3320	3084	9542	10718	145957	6714	7525
PC_296	Regulation of gene expression by Hypoxia-inducible Factor	405	768	10370	1387	2033	2034	2056	3091	64344	25994	7422
PC_297	Cellular response to hypoxia	2034	3091	55662
PC_298	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	84962	8453	54583	112398	112399	6923	6921	2034	3091	64344	8994	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	9978	6233	7979	7311	7314	7316	7321	7322	7323	7428	126374
PC_299	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	867	11140	1950	1956	2549	2885	3265	3320	3845	4893	5290	5295	5335	6233	6464	6654	7311	7314	7316
PC_300	Signaling by ERBB4	685	1742	1950	1956	2065	2066	2069	2554	2560	2561	2562	2566	2567	55879	1839	3084	9542	10718	145957
PC_301	Cross-presentation of particulate exogenous antigens (phagosomes)	948	1535	1536	3685	3693	653361	4688	4689
PC_302	ER-Phagosome pathway	567	695	811	929	948	1147	3105	3106	3107	3133	3134	3135	3551	8517	23643	4615	2923	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	6233	9554	29927	55176	10952	23480	7979	8773	6810	6890	6891	6892	114609	7096	7097	7099	10333	7311	7314	7316	9341	8673
PC_303	Endosomal/Vacuolar pathway	567	1514	1520	1515	3105	3106	3107	3133	3134	3135	4012
PC_304	Cross-presentation of soluble exogenous antigens (endosomes)	50489	2209	4360	9902	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	7979
PC_305	Erythrocytes take up carbon dioxide and release oxygen	358	759	760	762	51706	51700	51167	606495	3039	3039	3043	6005	6521
PC_306	Methionine salvage pathway	55256	51074	58478	2805	84245	4507
PC_307	Erythrocytes take up oxygen and release carbon dioxide	358	759	760	762	3039	3039	3043	6005	6521
PC_308	SHC1 events in ERBB2 signaling	685	1950	1956	2064	2065	2066	2069	2885	1839	3265	3845	4893	3084	9542	10718	145957	5578	5580	5581	5782	6464	6654
PC_309	PI3K events in ERBB4 signaling	685	2066	2069	1839	3084	9542	10718	145957	5290	5295
PC_310	SHC1 events in ERBB4 signaling	685	2066	2069	2885	1839	3265	3845	4893	3084	9542	10718	145957	6464	6654
PC_311	PLCG1 events in ERBB2 signaling	1950	1956	2064	5335
PC_312	Nuclear signaling by ERBB4	6868	11033	51107	83464	348	685	1447	6387	2066	2069	2099	2670	1839	10608	9611	23385	3084	9542	10718	145957	5241	5663	5664	55851	6285	6678	6714	6776	3925	23118	51741	10413
PC_313	Downregulation of ERBB4 signaling	2066	83737	4734	6233	6714	7311	7314	7316	11059
PC_314	PI3K/AKT Signaling	207	208	10000	374	685	930	940	941	942	1950	1956	255324	2064	2065	2066	2069	2099	2100	2246	2255	8823	8822	8817	9965	2247	26281	27006	8074	2248	2249	2250	2251	2252	2253	2254	2260	2263	2261	2264	10818	2534	2549	2885	1839	3082	29851	3556	9173	90865	3654	51135	3667	8660	3815	4254	9365	152831	3932	79109	4233	64223	2475	4615	3084	9542	10718	145957	5154	5155	5156	5159	5170	118788	5290	5291	5293	5295	5296	8503	55615	5781	5879	5880	391	253260	6714	6801	7039	117145	7189	50852	57761	7409
PC_315	Interleukin-7 signaling	54014	1154	64109	3082	8350	8350	8350	8350	8350	8350	8350	8350	8350	126961	126961	126961	3561	3574	3575	3667	8660	3716	3718	5295	5296	8503	5896	5897	6597	8651	8835	6774	6776	6777	85480
PC_316	Mitochondrial protein import	50	498	506	516	617	400916	51142	54927	131474	84269	79145	56942	100272147	51287	388753	27235	10063	90639	1431	1537	131118	2395	2671	80273	134266	150274	3313	3329	3421	197257	4580	10651	4714	5009	51025	10531	23203	9512	25813	8604	10165	291	293	6901	26519	26515	26517	10440	10245	29090	29928	100287932	10469	92609	1678	26521	26520	9804	56993	10452	401505	100188893	54543	9868	7416
PC_317	Spry regulation of FGF signaling	673	867	2885	5594	5595	8569	5515	5516	5518	5781	6233	10253	6714	7311	7314	7316
PC_318	ATP sensitive Potassium channels	6833	10060	3767	3764
PC_319	Activation of G protein gated Potassium channels	2550	9568	2782	2783	2784	2790	55970	54331	2785	2786	2787	2788	2793	2792	2793	3766	3768	3772	3773	3759	3760	3761	3762	3763	3765
PC_320	Ca activated K+ channels	3778	3779	27094	27094	27345	3780	3781	3782	3783
PC_321	Classical Kir channels	3768	3772	3759	3761
PC_322	HCN channels	348980	610	57657	10021
PC_323	Potassium transport channels	3758	3766	3773
PC_324	Voltage gated Potassium channels	3736	3744	3737	3738	3739	3741	3742	3743	7881	8514	9196	3745	9312	3746	3747	3748	3749	3750	3751	3752	3754	3755	26251	170850	93107	3756	3757	23416	23415	27133	81033	90134	131096	3784	3785	3786	9132	56479	3787	3788	3790	27012	169522
PC_325	Tandem pore domain halothane-inhibited K+ channel (THIK)	56659
PC_326	Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)	3775	9424	10089
PC_327	TWIK-releated acid-sensitive K+ channel (TASK)	3777	51305
PC_328	TWIK-related spinal cord K+ channel (TRESK)	338567
PC_329	TWIK-related alkaline pH activated K+ channel (TALK)	83795	89822
PC_330	TWIK related potassium channel (TREK)	54207	3776	50801
PC_331	Sperm Motility And Taxes	117144	117155	347732	378807	79820	257062	57828	84329	157855
PC_332	Acrosome Reaction and Sperm	49	928	284359	126123	113177
PC_333	GRB7 events in ERBB2 signaling	2064	2065	2886	3084	9542
PC_334	betaKlotho-mediated ligand binding	9965	2264	152831
PC_335	Downregulation of ERBB2	207	208	10000	2064	2065	3084	9542	10193	6233	7311	7314	7316	9101
PC_336	Transcription of E2F targets under negative control by DREAM complex	993	990	1869	1874	1875	3065	55957	91750	132660	286826	4149	4609	5111	5928	5933	5934	7027	7029	7153
PC_337	Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1	890	983	1869	1874	1875	3065	55957	91750	132660	286826	4605	5928	5933	5934	7027	7029
PC_338	Mitochondrial iron-sulfur cluster biogenesis	2230	112812	2395	51218	150274	81689	122961	23479	57128	9054	81894	51312
PC_339	NR1D1 (REV-ERBA) represses gene expression	83401	8841	9611	9572
PC_340	RORA activates gene expression	10498	80205	1374	1387	2033	85441	8930	8648	10499	23054	5465	6095	6256	6604	6720	6907	79718	96764
PC_341	BMAL1	406	56938	551	8553	79365	10498	80205	9575	1387	1628	2155	85441	28999	8930	10135	8648	10499	23054	25819	4862	5465	6256	5054	6604	6907	79718	96764
PC_342	Mitochondrial ABC transporters	23456	10058	22	11194
PC_343	ABC transporters in lipid homeostasis	10349	26154	20	21	23461	23460	10347	10350	215	225	5825	9619	64137	64240	64241	335	5824	8504
PC_344	Elevation of cytosolic Ca2+ levels	3708	3709	3710	84876	80228	5023	22953	5024	5025	5026	9127	5027	6786	7222	7225	7226
PC_345	Activation of BMF and translocation to mitochondria	90427	140735	5599
PC_346	Activation of PUMA and translocation to mitochondria	27113	1869	23368	7027	7029	7157	7159	8626	7161
PC_347	COX reactions	5742
PC_348	Apoptosis induced DNA fragmentation	836	1676	1677	3005	3024	3009	3006	3007	3008	3146	3148	3836	3837
PC_349	Ligand-dependent caspase activation	841	929	8772	355	356	23643	8737	148022	100302736	7099	8797	8795	8743	8717	7186
PC_350	Extrinsic Pathway of Fibrin Clot Formation	2159	2152	2155	2158	7035
PC_351	Intrinsic Pathway of Fibrin Clot Formation	2	708	2159	2160	2161	2147	2157	2158	2811	2812	2814	2815	3818	3827	5547	5624	5104	462	3053	5270	710	6469	6470	7450
PC_352	Common Pathway of Fibrin Clot Formation	57126	2159	2162	2165	2147	2149	2153	2157	2243	2244	2266	5196	5197	5624	10544	5627	5657	5104	462	3053	5270	6469	6470	7056
PC_353	Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB	4128	4129
PC_354	PAOs oxidise polyamines to amines	196743	54498
PC_355	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	991	4085
PC_356	Inactivation of APC/C via direct inhibition of the APC/C complex	64682	10393	51529	25906	119504	29882	29945	51433	51434	701	9184	8881	991	8697	246184	996	4085	11065	7321	7324
PC_357	Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal	25909	9212	80776	332	699	701	9184	991	55143	1058	1060	1062	1063	64946	2491	64105	91687	79019	55839	79172	401541	55166	100526739	80152	79682	9793	23332	23122	6249	79980	1778	1780	1781	51143	1783	8655	140735	54821	3619	23421	81930	3796	84643	11004	57082	9735	8379	4085	22919	79003	10403	54820	81565	284058	10726	83540	57122	55746	23279	79023	348995	79902	4928	5048	5347	100527963	5501	5515	5516	5518	5519	5525	5526	5527	5528	5529	5903	5905	55920	6232	6396	81929	151648	151246	220134	348235	147841	9789	54908	57551	7514	9183	55055	11130
PC_358	Signaling by SCF-KIT	1111	1215	2241	2242	2534	9846	10750	9402	2887	2885	2886	3265	3717	3815	4254	3845	3932	4067	4318	4893	5290	5295	5296	8503	5578	5781	10076	5879	6654	6714	6772	6774	6776	6777	7006	7409	7525
PC_359	Regulation of KIT signaling	867	2534	2885	3815	4254	3932	4067	5578	5777	10603	10019	8651	30837	6654	6714	7525
PC_360	Regulation of signaling by NODAL	91	130399	92	93	9350	55997	199699	10637	7044	4838	6997
PC_361	Collagen degradation	102	6868	8754	1303	1305	7373	1306	1307	1308	80781	1310	91522	84570	136227	1297	1298	1299	1508	1509	1513	1514	1991	5045	4312	4319	4320	4321	4322	4323	4327	4313	9313	4314	4316	4317	4318	85007	5645	164656
PC_362	Translocation of SLC2A4 (GLUT4) to the plasma membrane	207	208	79058	9847	801	55763	55770	11336	60412	10640	54536	23265	149371	11127	9371	22920	4012	4627	4641	4644	5563	5564	5565	5571	51422	53632	10890	8766	5872	51552	5867	4218	5879	5898	57186	57148	23433	2810	6517	8773	6810	6814	23216	9882	6844	7529	7531	7532	7533	10971	7534
PC_363	Beta defensins	729230	9034	1672	414325	414325	140596	140596	245908	245908	245909	245909	245910	245910	245911	245913	245927	245928	245929	245930	117285	245932	245934	245936	245937	245938	81623	140850	245939	140881	100133267	100133267	644414	400830	613211	613209	613210	100289462	100289462	7096	7097
PC_364	Defensins	1667	1667	1668	1669	1670	1671	1672	414325	414325	140596	140596	245908	245908	245909	245909	245910	245910	245911	245913	245927	245928	245929	245930	117285	245932	245934	245936	245937	245938	81623	140850	245939	140881	100133267	100133267	644414	400830	613211	613209	613210	100289462	100289462
PC_365	Alpha-defensins	417	920	1667	1667	1668	1669	1670	1671	5645	5646
PC_366	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	207	801	1719	2643	2644	3320	4846	5593	5805	6697
PC_367	Degradation of the extracellular matrix	2	176	102	8751	101	9510	170690	170692	9507	11096	11095	56999	63827	649	682	823	11132	11131	147968	92291	440854	6650	824	825	726	827	23473	388743	10753	826	84290	836	10849	960	999	1511	1513	1514	1520	1515	1634	1991	3339	5654	5650	3909	3911	3912	3914	3915	3918	4312	4319	4320	4321	4322	4323	4327	4313	9313	4314	4316	4317	4318	23385	4811	26254	5340	5663	80274	222663	6696	7092	7093	164656
PC_368	Extracellular matrix organization	2335
PC_369	Reversible hydration of carbon dioxide	759	771	377677	23632	760	761	762	763	765	766	768
PC_370	Acyl chain remodelling of PC	79888	54947	10162	254531	129642	8399	81579	5319	5320	26279	30814	64600	50487	5321	100137049	8605	283748	123745	255189	5322	8398	22925	11145	151056	79887	50640	255043
PC_371	Acyl chain remodeling of CL	3030	3032	253558	5321	8398	6901
PC_372	Acyl chain remodelling of PS	10162	254531	154141	114884	114879	114882	51365	8399	81579	5319	5320	26279	30814	64600	5321	100137049	283748	123745	255189	5322	22925	11145
PC_373	Acyl chain remodelling of PE	63874	10162	254531	154141	129642	8399	81579	5319	5320	26279	30814	64600	50487	5321	100137049	8605	283748	123745	255189	5322	8398	22925	57110	54979	11145	5920	117245	79887	50640
PC_374	Acyl chain remodeling of DAG and TAG	158835	8694	84649	347516	11343	57104	80339
PC_375	Acyl chain remodelling of PI	79143	8399	81579	5319	5320	26279	30814	64600	5321	8605	283748	123745	255189	5322	22925	11145	79887
PC_376	Acyl chain remodelling of PG	54675	79888	254531	9926	8399	81579	5319	5320	26279	30814	64600	50487	5321	100137049	283748	255189	5322	22925
PC_377	Synthesis of CL	54675
PC_378	Synthesis of PS	9791	81490
PC_379	Hydrolysis of LPC	56261	23659	5321	100137049	8605	283748	123745	255189	79887
PC_380	Synthesis of PG	9489	5337	5338	23646	122618	201164	114971
PC_381	Hydrolysis of LPE	56261	8605
PC_382	Synthesis of PA	51205	10554	10555	56894	56895	55326	248	80821	23259	8443	57678	150763	84803	137964	2819	23171	2820	253558	200879	149998	79888	254531	374986	84895	8399	81579	5319	5320	26279	30814	64600	5321	100137049	283748	5322	22925	5337	5338	201164
PC_383	Synthesis of PC	171586	43	590	10390	1103	1119	1120	56994	1457	1459	1460	79888	23175	9663	64900	84879	58488	5130	9468	10400	162466	23446	57153	126969	80736	204962	10809	56910
PC_384	PI and PC transport between ER and Golgi membranes	23760
PC_385	Glycerophospholipid biosynthesis	55750	8904	8895	9362	27132
PC_386	Synthesis of PE	10390	1119	1120	55500	55224	64850	23175	9663	64900	5833	162466	23761	85465
PC_387	Synthesis of PI	10423	11200	9600	57605	83394
PC_388	Synthesis of PIPs at the ER membrane	8898	55300	5297	22908	6305
PC_389	PI Metabolism	25816	126282	79626	388121
PC_390	DAG and IP3 signaling	10768	3708	3709	3710	5335	5580	5581
PC_391	Signaling by Activin	91	130399	92	93	10589	8928	3624	3625	4087	4088	4089
PC_392	G0 and Early G1	8900	890	898	9134	1017	1859	1874	1875	3065	55957	91750	132660	286826	5928	5933	5934	7027	7029
PC_393	Methylation	191	57412	1312	1544	9446	4143	4144	27430	4548	4552	29104	4837	7172	51504
PC_394	Acetylation	9	10
PC_395	Cytosolic sulfonation of small molecules	84836	10380	54928	50512	6817	6799	445329	445329	27284	6819	27233	6783	6822	6820	25830	391365	8460	8459
PC_396	Glucuronidation	55347	54658	54575	54659	54657	54579	54578	54577	54576	54600	10941	574537	79799	7365	10720	7366	7367	54490	7363	7364	133688	167127
PC_397	Glutathione conjugation	10327	2098	2938	2939	2940	2941	221357	373156	2944	2946	2947	2948	2949	9446	119391	2950	2952	2953	653689	2954	27306	4257	4258	4259
PC_398	Elastic fibre formation	2006	10516	2200	2201	84467	5045	3678	3685	3688	3690	3694	4015	4016	4017	84695	84171	4237	8076
PC_399	Fibronectin matrix formation	634	4680	1088	2335	3678	3688
PC_400	Polo-like kinase mediated events	891	9133	993	995	1063	2033	2305	55957	91750	132660	286826	4605	9088	5347	5928	7465
PC_401	L13a-mediated translational silencing of Ceruloplasmin expression	1356	1964	1965	8894	1968	3692	8662	8663	8664	3646	8665	8666	8667	8668	8669	27335	51386	10480	1973	1974	1975	1977	1981	7458	2197	26986	6134	4736	140801	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	200916	9349	6147	6152	6154	51121	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6166	6167	6168	6169	6170	116832	6123	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6233	51065	6234	6235	6188	6189	6191	6192	140032	6193	6194	6201	6202	6203	3921	7311
PC_402	Eukaryotic Translation Elongation	1915	1917	1933	1936	1937
PC_403	Peptide chain elongation	1915	1938	2197	6134	4736	140801	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	200916	9349	6147	6152	6154	51121	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6166	6167	6168	6169	6170	116832	6123	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6233	51065	6234	6235	6188	6189	6191	6192	140032	6193	6194	6201	6202	6203	3921	7311
PC_404	Transport of the SLBP independent Mature mRNA	8086	10189	1977	4686	22916	55706	57122	55746	9972	9631	23279	23511	23165	23225	8021	129401	79023	11097	348995	10762	53371	9818	23636	79902	4927	9688	4928	10482	9883	8480	5903	6396	81929	7175
PC_405	Transport of the SLBP Dependant Mature mRNA	8086	10189	1977	4686	22916	55706	57122	55746	9972	9631	23279	23511	23165	23225	8021	129401	79023	11097	348995	10762	53371	9818	23636	79902	4927	9688	4928	10482	9883	8480	5903	6396	81929	7884	7175
PC_406	Transport of Mature mRNA Derived from an Intronless Transcript	8086	10189	29894	53981	51692	10898	1977	81608	4686	22916	55706	57122	55746	9972	9631	23279	23511	23165	23225	8021	129401	79023	11097	348995	10762	53371	9818	23636	79902	4927	9688	4928	10482	9883	8480	5903	6396	81929	8189	7175	55339
PC_407	Transport of Mature mRNA derived from an Intron-Containing Transcript	8086	10189	22794	51362	26097	10212	7919	9785	9775	84248	2733	51213	4116	55110	4686	22916	55706	57122	55746	9972	9631	23279	23511	23165	23225	8021	129401	79023	11097	348995	10762	53371	9818	23636	79902	4927	9688	4928	10482	56001	56001	29107	84271	9883	8480	5903	9939	10921	84324	6396	81929	10569	10250	6426	9295	6427	6428	6429	6430	6431	6432	8683	9984	57187	84321	8563	79228	80145	7175	102724594	199746	11338	65109	9877
PC_408	Activation of Matrix Metalloproteinases	1215	80781	1504	440387	1511	1513	1515	1991	5045	3817	3818	4312	4319	4320	4322	4323	4325	4326	4313	79148	4314	4316	4317	4318	5340	5644	5645	50859	7076	7077	7177
PC_409	Recycling of bile acids and salts	8647	8714	213	570	2172	8648	10499	9971	6256	6554	6555	10998	6579	10599	28234	80765
PC_410	Gamma-carboxylation of protein precursors	632	2159	2147	2155	2158	2621	2677	5624	5627	8858
PC_411	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	632	2159	2147	2155	2158	2621	5624	5627	8858
PC_412	Removal of aminoterminal propeptides from gamma-carboxylated proteins	632	2159	2147	2155	2158	5045	2621	5624	5627	8858
PC_413	ZBP1(DAI) mediated induction of type I IFNs	81030
PC_414	IRF3 mediated activation of type 1 IFN	23220	3661	147945	29110	81030
PC_415	Sulfide oxidation to sulfate	23474	1468	58472	6821	7263	100131187
PC_416	Degradation of cysteine and homocysteine	84890	1036	51380	1491	339896	2806	4357	7263	25828
PC_417	Cysteine formation from homocysteine	102724560	1491
PC_418	Sulfur amino acid metabolism	191	635	23743	4143	4548	4552
PC_419	Uncoating of the HIV Virion	5478
PC_420	Budding and maturation of HIV virion	27243	25978	100526767	29082	128866	92421	51510	79643	91782	93343	89853	23327	10015	5478	6233	7251	7311	51271	7314	7316	51160	137492	79720	55048	155382	27183	9525	51534
PC_421	Integration of provirus	8815	3159	3836	5478	11168
PC_422	Early Phase of HIV Life Cycle	2237	3978	5478
PC_423	Late Phase of HIV Life Cycle	4836
PC_424	Golgi Cisternae Pericentriolar Stack Reorganization	8548	891	9133	983	2801	64689	26003	5594	5595	5347	5861	81876	5862	8615
PC_425	Synthesis of dolichyl-phosphate mannose	8813	8818	54344
PC_426	Synthesis of glycosylphosphatidylinositol (GPI)	8818	5277	9488	5279	5281	54872	5283	9487	93183	23556	84720	51227	9091	55650	284098	54965	84992	80235
PC_427	Attachment of GPI anchor to uPAR	8733	80055	10026	94005	51604	128869	5329
PC_428	Post-translational modification	251	248	249	419	420	683	135228	1043	1048	1087	5067	152330	53942	1368	2215	2350	2813	338328	2822	390243	4045	8581	4061	80740	58530	4062	54742	116372	137797	27076	147719	284348	130576	646627	266727	161357	4241	10232	257194	51299	123904	50863	22854	84628	4978	146183	349633	23627	10942	8000	353091	154064	8434	146760	349667	171169	503542	7007	6975	83639	7070	80328	8876	8875	7512
PC_429	Formation of ATP by chemiosmotic coupling	498	506	509	513	514	516	517	518	521	9551	10632	515	10476	522	539	27109	4508	4509
PC_430	Mitochondrial transcription initiation	5442	7019	64216
PC_431	Macroautophagy	55626	83734	60673	9140	9776	22863	55054	64422	115201	23192	84938	84971	9474	10533	79065	285973	8678	27243	25978	100526767	29082	128866	92421	79643	91782	8655	140735	11337	23710	11345	55004	28956	8649	389541	10542	84557	81631	440738	64223	64419	8897	2475	5289	30849	5562	5563	5564	5565	5571	51422	53632	9821	6009	57521	10670	10325	58528	153129	7248	7249	8408	7405	11152	56270	55062	26100
PC_432	Mitochondrial transcription termination	7978
PC_433	PKA-mediated phosphorylation of key metabolic factors	51085	5207	5578	5567	5568
PC_434	Glucagon signaling in metabolic regulation	107	108	109	196883	111	112	113	114	115	2641	2642	2778	2782	2783	2784	59345	2790	2791	55970	51764	54331	2785	2786	2787	2788	2793
PC_435	Triglyceride catabolism	51099	857	2168	646486	2169	2170	2167	2171	2172	2173	646480	2820	3991	11343	5346	10226	8228	150379	5499	5500	5501	5578	5567	5568
PC_436	PKA activation	107	108	109	196883	111	112	113	114	115	801	5578	5567	5568	5573	5575	5576	5577
PC_437	AMPK inhibits chREBP transcriptional activation activity	9370	51094	79602	51085	5563	5565	51422	6794
PC_438	Integration of energy metabolism	5515	5516	5518	5519	5528
PC_439	Insulin effects increased synthesis of Xylulose-5-Phosphate	6888	7086
PC_440	ChREBP activates metabolic gene expression	31	32	47	10554	2194	6945	51085	5313
PC_441	PP2A-mediated dephosphorylation of key metabolic factors	51085	5207	5515	5516	5518	5519	5528
PC_442	Gamma carboxylation, hypusine formation and arylsulfatase activation	64122	79672	23463
PC_443	PKA activation in glucagon signalling	107	108	109	196883	111	112	113	114	115	2778	5578	5567	5568	5573	5575	5576	5577
PC_444	Minus-strand DNA synthesis	5478
PC_445	Plus-strand DNA synthesis	5478
PC_446	2-LTR circle formation	8815	3159	3981	11168	7518	7520	2547
PC_447	Nef mediated downregulation of CD28 cell surface expression	1173	940
PC_448	Nef mediated downregulation of MHC class I complex cell surface expression	162	164	8907	10053	1174	8905	130340	567	3105	55690
PC_449	Nef and signal transduction	919	1794	9844	2534	3055	3932	5062	5879
PC_450	Rev-mediated nuclear export of HIV RNA	8086	55706	57122	55746	9972	9631	23279	23511	23165	23225	8021	129401	79023	11097	348995	10762	53371	9818	23636	79902	4927	9688	4928	9883	8480	5901	5902	5903	5905	1104	6396	81929	7175	7514
PC_451	Collagen biosynthesis and modifying enzymes	140766	9509	9508	649	1300	1301	1302	1303	1305	7373	1306	1307	1308	80781	1310	1277	1278	57642	81578	169044	91522	255631	84570	136227	85301	340267	1280	1281	1282	1284	1285	1286	1287	1288	1289	1290	50509	1291	1292	1293	256076	131873	1294	1295	1296	1297	1298	1299	79709	23127	10491	64175	55214	10536	5033	8974	283208	5034	5118	26577	5351	5352	8985	5479	871	7092	7093
PC_452	Activation of PKB	208	5170	117145	57761
PC_453	mTOR signalling	207	84335	55004	28956	8649	389541	10542	64223	2475	6009	57521	10670	10325	58528	153129	7529
PC_454	PDE3B signalling	208	5140
PC_455	Inhibition of TSC complex formation by PKB	208	7248	7249
PC_456	Regulation of cholesterol biosynthesis by SREBP (SREBF)	3638	51141	3837	8720	51360	5901	51128	22937	10484	10802	10427	9632	9871	6720	6721
PC_457	Toll Like Receptor 4 (TLR4) Cascade	671	929	4064	1759	1785	26052	3684	3689	3929	9450	23643	5336	5775	100302736	7099
PC_458	Transfer of LPS from LBP carrier to CD14	929	3929
PC_459	Synthesis of PIPs at the plasma membrane	375	660	3631	8821	3635	27124	51763	3636	4534	8776	64419	8898	8897	9107	55613	66036	4952	55361	55300	5286	5287	5288	5290	5291	5293	5294	5295	5296	8503	23533	146850	5305	8396	79837	8394	8395	23396	59338	59339	65977	57664	54477	22874	84725	5728	5783	51552	5867	5868	80230	81846	8867	8871
PC_460	Synthesis of PIPs at the Golgi membrane	375	377	9896	23203	4952	55361	55300	5297	5298	5286	5288	5289	30849	200576	22908	7179	93492	55697
PC_461	Synthesis of PIPs at the early endosome membrane	9896	3631	8821	22876	4534	54893	54545	8898	9110	55361	55300	5286	5289	30849	200576	55697
PC_462	Synthesis of PIPs at the late endosome membrane	9896	4534	8898	9110	9108	66036	5286	5289	30849	200576	55697
PC_463	MyD88	695	929	948	51295	3654	3656	11213	51135	23643	4214	4615	59307	8651	114609	7096	7097	7099	10333	7189
PC_464	Sphingolipid de novo biosynthesis	125981	340485	55331	224	221	10715	29956	204219	79603	91012	253782	10087	1455	8560	123099	79152	2531	94101	29095	94103	5007	8611	8612	8613	151742	5587	25865	23683	142891	259230	166929	8879	81537	130367	8877	56848	10558	9517	55304	171546	165679	9218	9217
PC_465	Glycosphingolipid metabolism	439	411	414	415	416	22901	347527	340075	79642	153642	427	56624	8706	2583	64781	80772	5476	339221	23344	57488	83850	2581	2629	57704	57733	2717	2720	79411	51228	2760	3073	3074	4758	4759	10825	129807	5660	6609	6610	55512	55627	412	285362	25870	7357	7368
PC_466	MyD88-independent TLR4 cascade	929	23643	23098	148022	100302736	7099
PC_467	mTORC1-mediated signalling	84335	29904	1975	1977	1978	1981	55004	28956	8649	389541	10542	64223	2475	6009	6194	6198	57521	10670	10325	58528	153129	7529
PC_468	The activation of arylsulfatases	439	411	414	415	416	22901	347527	340075	79642	153642	412	285362	25870
PC_469	Lectin pathway of complement activation	10584	78989	2219	2220	8547	5648	10747	4153
PC_470	Initial triggering of complement	712	713	714	715	716	717	720	100293534	100293534	10584	78989	2219	2220	8547	5648	10747	4153
PC_471	Terminal pathway of complement	727	729	730	731	732	733	735	1191
PC_472	PLC-gamma1 signalling	4803	4914	5335
PC_473	Signalling to RAS	2885	3265	3845	4803	4893	4914	6464	25759	53358	6654
PC_474	NGF processing	5045	4803	5125	5046
PC_475	Formation of HIV elongation complex in the absence of HIV Tat	902	8812	904	905	1022	1025	9150	8178	6924	51224	6923	6921	2068	2071	2962	2963	2965	2966	2967	2968	404672	4331	4686	22916	7469	25920	51497	7936	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	6749	11198	6827	6829	6917
PC_476	Formation of the HIV-1 Early Elongation Complex	902	1022	9150	2068	2071	2962	2963	2965	2966	2967	2968	404672	4331	4686	22916	7469	25920	51497	7936	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	6827	6829
PC_477	RNA Pol II CTD phosphorylation and interaction with CE during HIV infection	902	1022	2068	2071	2962	2963	2965	2966	2967	2968	404672	4331	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	8732	8731	6829
PC_478	HIV Transcription Initiation	902	1022	2068	2071	2957	2958	2959	2960	2961	2962	2963	2965	2966	2967	2968	404672	4331	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	6872	6881	6882	6883	6884	6883	138474	6873	83860	6874	6875	6877	6878	6879	54457	6880	51616	6908
PC_479	RNA Polymerase II HIV Promoter Escape	902	1022	2068	2071	2957	2958	2959	2960	2961	2962	2963	2965	2966	2967	2968	404672	4331	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	6872	6881	6882	6883	6884	6883	138474	6873	83860	6874	6875	6877	6878	6879	54457	6880	51616	6908
PC_480	Transcription of the HIV genome	902	1022	2068	2071	2957	2958	2959	2960	2961	2962	2963	2965	2966	2967	2968	404672	4331	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	6872	6881	6882	6883	6884	6883	138474	6873	83860	6874	6875	6877	6878	6879	54457	6880	51616	6908
PC_481	Formation of HIV-1 elongation complex containing HIV-1 Tat	902	904	1022	1025	9150	8178	6924	51224	6923	6921	2068	2071	2962	2963	2965	2966	2967	2968	404672	4331	4686	22916	7469	25920	51497	7936	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	6749	11198	6827	6829	6917
PC_482	Pausing and recovery of Tat-mediated HIV elongation	904	1025	9150	8178	6924	51224	6923	6921	2962	2963	7469	25920	51497	7936	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	6749	11198	6827	6829	6917
PC_483	Abortive elongation of HIV-1 transcript in the absence of Tat	9150	2962	2963	4686	22916	7469	25920	51497	7936	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	6827	6829
PC_484	Tat-mediated HIV elongation arrest and recovery	904	1025	9150	8178	6924	51224	6923	6921	2962	2963	7469	25920	51497	7936	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	6749	11198	6827	6829	6917
PC_485	Tat-mediated elongation of the HIV-1 transcript	902	904	1022	1025	9150	8178	6924	51224	6923	6921	2068	2071	2962	2963	2965	2966	2967	2968	404672	4331	7469	25920	51497	7936	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	6749	11198	6827	6829	6917
PC_486	HIV elongation arrest and recovery	8812	904	905	1025	9150	8178	6924	51224	6923	6921	2962	2963	7469	25920	51497	7936	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	6749	11198	6827	6829	6917
PC_487	Pausing and recovery of HIV elongation	8812	904	905	1025	9150	8178	6924	51224	6923	6921	2962	2963	7469	25920	51497	7936	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	6749	11198	6827	6829	6917
PC_488	Nef Mediated CD4 Down-regulation	160	161	163	1173	1175	375	51606	920	3932
PC_489	The fatty acid cycling model	9016	9481	7350	7351	7352
PC_490	The proton buffering model	9016	9481	7350	7351	7352
PC_491	Trafficking and processing of endosomal TLR	10695	1508	1513	1514	1520	1515	7184	5641	7098	51284	51311	54106	81622
PC_492	Toll Like Receptor 9 (TLR9) Cascade	8411	5289	30849	64145	54106
PC_493	Toll Like Receptor 10 (TLR10) Cascade	81793
PC_494	Toll Like Receptor 3 (TLR3) Cascade	23098	148022	7098
PC_495	Toll Like Receptor 5 (TLR5) Cascade	7100
PC_496	Toll Like Receptor TLR1	929	7096	7097
PC_497	Toll Like Receptor 7/8 (TLR7/8) Cascade	51284	51311
PC_498	Toll Like Receptor TLR6	929	948	7097	10333
PC_499	Transport of Ribonucleoproteins into the Host Nucleus	8086	3836	3837	55706	57122	55746	9972	9631	23279	23511	23165	23225	8021	129401	79023	11097	348995	10762	53371	9818	23636	79902	4927	9688	4928	9883	8480	5903	6396	81929	7175
PC_500	Entry of Influenza Virion into Host Cell via Endocytosis	1211	1213
PC_501	NS1 Mediated Effects on Host Pathways	8086	9636	3836	3838	3839	3840	3841	402569	3837	55706	57122	55746	9972	9631	23279	23511	23165	23225	8021	129401	79023	11097	348995	10762	53371	9818	23636	79902	4927	9688	4928	9883	8480	5903	6396	81929	7175
PC_502	Influenza Virus Induced Apoptosis	293	7040
PC_503	Inhibition of Host mRNA Processing and RNA Silencing	10898	8106
PC_504	Assembly of Viral Components at the Budding Site	811	821
PC_505	Viral Messenger RNA Synthesis	8086	2962	2963	55706	57122	55746	9972	9631	23279	23511	23165	23225	8021	129401	79023	11097	348995	10762	53371	9818	23636	79902	4927	9688	4928	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	9883	8480	5903	6396	81929	7175
PC_506	Viral RNP Complexes in the Host Cell Nucleus	3303
PC_507	NEP/NS2 Interacts with the Cellular Export Machinery	8086	55706	57122	55746	9972	9631	23279	23511	23165	23225	8021	129401	79023	11097	348995	10762	53371	9818	23636	79902	4927	9688	4928	9883	8480	5901	5903	6396	81929	7175	7514
PC_508	NOD1/2 Signaling Pathway	329	330	64170	834	835	837	841	842	1147	1540	3551	8517	3654	3656	83737	5608	6885	5600	6300	5603	1432	10392	64127	8767	10454	23118	257397	7128	7189	7334	387522
PC_509	TICAM1, RIP1-mediated IKK complex recruitment	329	330	1147	3551	8517	8737	11035	6233	148022	7098	7189	7311	7314	7316	7321	7322	7323	7334	387522
PC_510	DDX58/IFIH1-mediated induction of interferon-alpha/beta	23586	79132	51191	64135	9636	57506	84166	79671	84282	26007	7706	7318	9246
PC_511	Inhibition of PKR	5610
PC_512	Regulation of Apoptosis	115209	4976
PC_513	Phosphorylation of proteins involved in the G2/M transition by Cyclin A	8900	890	983
PC_514	Adenylate cyclase activating pathway	107	108	109	196883	111	112	113	114	115	2774
PC_515	Adenylate cyclase inhibitory pathway	107	108	109	196883	111	112	113	114	115	2770	2771	2773	2774	346562
PC_516	Regulation of Glucokinase by Glucokinase Regulatory Protein	8086	2645	2646	55706	57122	55746	9972	9631	23279	23511	23165	23225	8021	129401	79023	11097	348995	10762	53371	9818	23636	79902	4927	9688	4928	9883	8480	5903	6396	81929	7175
PC_517	Frs2-mediated activation	673	1399	10818	5594	5595	4803	4914	5906	2889	7529
PC_518	ARMS-mediated activation	673	1398	57498	4803	4914	5906	7529
PC_519	p38MAPK events	3265	3845	5600	6300	5603	1432	9261	7867	4893	5898	5899	5900	6714
PC_520	Synthesis and processing of ENV and VPU	5045
PC_521	Packaging Of Telomere Ends	65057	474382	55766	94239	3014	3015	102724334	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	121504	121504	128312	8290	121504	25913	7013	7014	54386	26277
PC_522	Telomere Extension By Telomerase	1736	8607	10856	7015	55135
PC_523	Binding and entry of HIV virion	1234	920	7852	5478
PC_524	Formation of the active cofactor, UDP-glucuronate	23169	7358	7360
PC_525	Classical antibody-mediated complement activation	712	713	714	715	716	1401
PC_526	Alternative complement activation	718	629	1675	3004
PC_527	APC/C	64682	10393	51529	25906	119504	29882	29945	51433	51434	891	8881	991	8697	246184	996	983	6233	7311	7314	7316	11065	7321	7324
PC_528	Autodegradation of Cdh1 by Cdh1	64682	10393	51529	25906	119504	29882	29945	51433	51434	8881	8697	246184	996	51343	5682	5683	5684	5685	5686	5687	5688	5689	5699	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	9491	6233	7979	7311	7314	7316	11065	7321	7324
PC_529	SCF-beta-TrCP mediated degradation of Emi1	8945	991	8454	26271	51343	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	6233	7979	6500	7311	7314	7316
PC_530	APC/C	64682	10393	51529	25906	119504	29882	29945	51433	51434	8881	991	8697	246184	996	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	9232	6233	7979	7311	7314	7316	11065	7321	7324
PC_531	APC/C	64682	10393	51529	25906	119504	29882	29945	51433	51434	6790	9212	8881	991	8697	246184	996	51343	5347	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	9232	6233	7979	6502	7311	7314	7316	11065	7321	7324
PC_532	Cdc20	64682	10393	51529	25906	119504	29882	29945	51433	51434	701	9184	8900	890	8881	991	8697	246184	996	983	4085	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	6233	7979	7311	7314	7316	11065	7321	7324
PC_533	Transport and synthesis of PAPS	9061	9060	10861	1836	347734	51000
PC_534	Glutathione synthesis and recycling	79094	494143	55748	2729	2730	79017	2678	2687	124975	2686	2937	26873
PC_535	Polymerase switching on the C-strand of the telomere	5111	5422	23649	5424	5425	10714	57804	5557	5558	5981	5982	5983	5984	5985
PC_536	Processive synthesis on the C-strand of the telomere	3978	5111	5424	5425	10714	57804
PC_537	Telomere C-strand (Lagging Strand) Synthesis	5111	5424	5425	10714	57804
PC_538	Telomere C-strand synthesis initiation	5422	23649	5426	5427	54107	56655	5557	5558
PC_539	Removal of the Flap Intermediate from the C-strand	1763	2237	5111	5424	5425	10714	57804	6117	6118	6119
PC_540	Membrane binding and targetting of GAG proteins	93343	89853	9397	6233	7251	7311	51271	7314	7316	51160	137492	79720	55048	155382
PC_541	Activation of C3 and C5	717	718	720	100293534	100293534	727	629
PC_542	Assembly Of The HIV Virion	5478	6233	7311	7314	7316
PC_543	Integration of viral DNA into host genomic DNA	8815	3159	11168
PC_544	Interactions of Tat with host cellular proteins	904	1025
PC_545	Activation of ATR in response to replication stress	390502	84126	993	995	8318	990	8317	1017	1111	63967	10926	3364	55388	4176	4172	4173	4174	4175	4176	84515	4998	4999	23595	5000	5001	23594	5810	5884	5883	144715	5982	5983	5984	5985	6117	6118	6119
PC_546	Conversion from APC/C	64682	10393	51529	25906	119504	29882	29945	51433	51434	8556	8881	991	8697	246184	996	51343	11065	7321	7324
PC_547	Regulation of APC/C activators between G1/S and early anaphase	64682	10393	51529	25906	119504	29882	29945	51433	51434	8900	890	891	8881	991	8697	246184	996	983	1017	26271	51343	11065	7321	7324
PC_548	APC/C	64682	10393	51529	25906	119504	29882	29945	51433	51434	701	9184	8881	991	8697	246184	996	4085	11065	7321	7324
PC_549	Phosphorylation of the APC/C	64682	10393	51529	25906	119504	29882	29945	51433	51434	891	8881	8697	246184	996	983	5347	11065	7321	7324
PC_550	Phosphorylation of Emi1	891	991	983	26271	51343	5347
PC_551	Unwinding of DNA	8318	9837	51659	64785	84296	4176	4172	4173	4174	4175	4176	84515
PC_552	Conjugation of salicylate with glycine	123876	348158	341392	54988	10249	92292	219970	389396
PC_553	Conjugation of benzoate with glycine	116285	348158	10249	92292	219970	389396
PC_554	Conjugation of phenylacetate with glutamine	116285	348158
PC_555	Retrograde neurotrophin signalling	160	161	163	1173	1175	1211	1213	10126	1759	1785	26052	4803	4914	6456
PC_556	Autointegration results in viral DNA circles	8815	3159	11168
PC_557	Signaling by EGFR	102	8038	6868	374	685	1950	1956	255324	2069	1839	26018	6714	7039
PC_558	APC-Cdc20 mediated degradation of Nek2A	64682	10393	51529	25906	119504	29882	29945	51433	51434	701	9184	8881	991	8697	246184	996	4085	4751	6233	7311	7314	7316	11065	7321	7324
PC_559	GRB2 events in EGFR signaling	374	685	1950	1956	255324	2069	2885	1839	3265	3845	4893	6654	7039
PC_560	SRP-dependent cotranslational protein targeting to membrane	1650	2197	6134	4736	140801	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	200916	9349	6147	6152	6154	51121	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6166	6167	6168	6169	6170	116832	6123	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6184	6185	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6233	51065	6234	6235	6188	6189	6191	6192	140032	6193	6194	6201	6202	6203	3921	23478	90701	29927	55176	10952	23480	28972	9789	60559	6727	6728	6729	6730	6731	6726	6734	58477	6745	6746	6747	6748	23471	7311
PC_561	DARPP-32 events	801	1020	5141	5142	5143	5144	5499	84152	5515	5516	5518	5519	5528	5530	5532	5533	5534	5578	5567	5568	5573	5575	5576	5577
PC_562	GAB1 signalosome	374	685	1445	1950	1956	255324	2069	2549	2885	1839	55824	5290	5295	5781	5829	6714	7039
PC_563	SHC1 events in EGFR signaling	374	685	1950	1956	255324	2069	2885	1839	3265	3845	4893	6464	6654	7039
PC_564	Vpu mediated degradation of CD4	8945	920	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	6233	7979	6500	7311	7314	7316
PC_565	Vif-mediated degradation of APOBEC3G	60489	8065	6923	6921	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	9978	6233	7979	7311	7314	7316
PC_566	APOBEC3G mediated resistance to HIV-1 infection	60489	8815	3159	5478	11168
PC_567	Nuclear import of Rev protein	8086	3837	55706	4869	57122	55746	9972	9631	23279	23511	23165	23225	8021	129401	79023	11097	348995	10762	53371	9818	23636	79902	4927	9688	4928	9883	8480	5901	5903	1104	6396	81929	7175
PC_568	Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization	291	292	293
PC_569	Vpr-mediated nuclear import of PICs	8086	8815	3159	3836	55706	57122	55746	9972	9631	23279	23511	23165	23225	8021	129401	79023	11097	348995	10762	53371	9818	23636	79902	4927	9688	4928	9883	11168	8480	5903	6396	81929	7175
PC_570	RIP-mediated NFkB activation via ZBP1	1147	1660	3551	8517	4615	4790	4791	4792	4793	28512	28511	5970	8737	11035	148022	7098	81030
PC_571	Serotonin Neurotransmitter Release Cycle	10815	8500	8499	8541	8497	5864	22999	6571	6616	6804	6812	6853	6854	8224	6857	9256	10497	6844
PC_572	Norepinephrine Neurotransmitter Release Cycle	10815	4128	8500	8499	8541	8497	5864	22999	6571	6580	6582	6616	6804	6812	6857	9256	10497	6844
PC_573	Nef Mediated CD8 Down-regulation	160	161	163	1173	1175	51606	926
PC_574	EGFR downregulation	374	8874	685	867	998	1950	1956	255324	29924	2060	58513	2069	2885	1839	9146	5782	5774	5796	6233	6455	6456	6457	30011	10252	10253	8027	10254	7039	7311	7314	7316
PC_575	STING mediated induction of host immune responses	115004	51428	3428	340061	6737
PC_576	Cytosolic sensors of pathogen-associated DNA	27297	4361	9533	51082	5434	5435	5437	5440	5441	11128	55703	10623	661	55718	10621	10622	84265	171568	51728	5591	7520	2547
PC_577	Signaling by cytosolic FGFR1 fusion mutants	613	11064	11052	1523	11116	26127	9846	2885	9208	399687	5290	5295	6772	6774	6776	6777	8805	7750
PC_578	Signaling by FGFR1 amplification mutants	2260
PC_579	Signaling by activated point mutants of FGFR1	2246	8822	2247	26281	8074	2249	2250	2251	2253	2254	2260
PC_580	FGFR4 mutant receptor activation	2264
PC_581	Signaling by activated point mutants of FGFR3	2246	8823	8822	8817	2247	26281	8074	2249	2250	2253	2254	2261
PC_582	Synthesis of pyrophosphates in the cytosol	9807	117283	64768	3705	170685	55190	11165	11163	9677	23262
PC_583	Synthesis of IP2, IP, and Ins in the cytosol	3612	3613	3628	3631	8821	3632	3633	27124	51477	55586	9108	66036	4952	8867
PC_584	Synthesis of IPs in the nucleus	9807	51447	253430	64768
PC_585	Synthesis of IP3 and IP4 in the cytosol	801	3633	3635	27124	3636	3705	3706	3707	80271	4952	23236	5330	5331	5332	5333	113026	84812	51196	5335	5336	23007	9651	89869	122618	5728	8867
PC_586	Synthesis of IPs in the ER lumen	9562
PC_587	Downstream signal transduction	9564	1398	1399	2885	2886	3265	3845	4690	8440	4893	5154	5155	5156	5159	5290	5291	5295	5296	5335	5781	2889	5921	6654	6714	6772	6774	6776	6777	6778
PC_588	Signaling by PDGF	1282	1284	1285	1286	1287	1291	1292	1293	256076	131873	1297	1298	1299	5045	5154	5155	56034	80310	5156	5159	5327	5340	5782	6696	7057	7058	7059	7060
PC_589	NGF-independant TRKA activation	116	117	135	4914	4915
PC_590	TRKA activation by NGF	4803	4914
PC_591	SCF(Skp2)-mediated degradation of p27/p21	8900	890	595	898	9134	1017	1019	1026	1027	1163	8454	5682	5683	5684	5685	5686	5687	5688	5689	5699	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	9491	5753	6233	7979	6500	6502	7311	7314	7316
PC_592	Signalling to p38 via RIT and RIN	673	4803	4914	6016	6014
PC_593	Digestion of dietary carbohydrate	276	276	276	279	280	27159	1118	3938	8972	6476	11181
PC_594	Cellular hexose transport	26291	91749	6513	81031	66035	154091	144195	6514	6515	6517	11182	155184	29988	56606	85414	55974	6523	125206	6524	6527	200010
PC_595	Heme biosynthesis	210	211	212	1352	1355	1371	2235	3145	3060	7389	7390
PC_596	Heme degradation	644	645	3162	3163	54657
PC_597	FGFR4 ligand binding and activation	2246	8823	8822	8817	9965	2247	26281	8074	2249	2251	2253	2254	2264
PC_598	FGFR1b ligand binding and activation	2246	2255	2247	27006	2248	2260
PC_599	FGFR3b ligand binding and activation	2246	8822	8817	26281	2253	2254	2261
PC_600	FGFR3c ligand binding and activation	2246	8823	8822	8817	2247	26281	8074	2249	2250	2253	2254	2261	2591
PC_601	FGFR1c ligand binding and activation	3730	2246	8822	2247	26281	8074	2249	2250	2251	2253	2254	2260
PC_602	FGFR1c and Klotho ligand binding and activation	8074	2260	9365
PC_603	FGFR2c ligand binding and activation	2246	8823	8822	8817	2247	26281	8074	2249	2250	2251	2253	2254	2263
PC_604	FGFR2b ligand binding and activation	2246	2255	2247	27006	2248	2252	9982	83888	143282	2263
PC_605	Oligomerization of connexins into connexons	2697	2705	2706
PC_606	Transport of connexins along the secretory pathway	2697	2705	2706
PC_607	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	2697
PC_608	Gap junction assembly	2697	81025	2700	2701	2702	2703	81025	2705	2706	2707	127534	2709	10804	375519	10052	57165	57369	125111	219770
PC_609	Transport of connexons to the plasma membrane	2706
PC_610	Gap junction degradation	1173	1211	1212	1213	8218	1601	1759	1785	2697	4646
PC_611	Pre-NOTCH Processing in the Endoplasmic Reticulum	4851	4853	4854	4855	23509	56983
PC_612	Pre-NOTCH Transcription and Translation	26523	27161	192669	192670	595	1387	1869	1871	1999	2033	474382	55766	94239	3014	3015	102724334	3020	3020	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	8350	8350	8350	8350	8350	8350	8350	8350	8350	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	126961	126961	126961	121504	121504	128312	121504	3725	2648	8850	9794	84441	55534	10046	4343	4851	4853	4854	4855	5584	3516	861	51548	22938	7027	7029	27327	23112	57690	7157
PC_613	Pre-NOTCH Processing in Golgi	487	488	489	2683	5045	3955	4242	4851	4853	4854	4855	5870	5986	6400	6487	6484	10402	10959
PC_614	Cholesterol biosynthesis	8435	64801	1595	2222	2224	9453	3156	3157	51478	3422	91734	3930	4047	6307	4597	4598	50814	403313	10654	6713	7108
PC_615	Regulation of gap junction activity	2697	6714	7082
PC_616	snRNP Assembly	8086	1207	11218	8487	50628	25929	79833	79760	54960	4686	22916	55706	57122	55746	9972	9631	23279	23511	23165	23225	8021	129401	79023	11097	348995	10762	53371	9818	23636	79902	4927	9688	4928	51808	9883	10419	8480	5903	6396	81929	6606	6606	6628	6632	6633	6634	6635	6636	6637	10073	96764	7175	79084
PC_617	Synthesis of bile acids and bile salts	9023	1581	9420	8648	10499	9971	5007	114876	9885	26031	114880	114881	114883	6256
PC_618	Digestion of dietary lipid	1208	8513	5406	5407	5408	119548
PC_619	Viral mRNA Translation	5611	2197	2926	6134	4736	140801	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	200916	9349	6147	6152	6154	51121	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6166	6167	6168	6169	6170	116832	6123	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6233	51065	6234	6235	6188	6189	6191	6192	140032	6193	6194	6201	6202	6203	3921	7311
PC_620	vRNP Assembly	3320	3843
PC_621	Androgen biosynthesis	1081	1586	51144	3293	3283	3284	3972	5443	6715	6716	79644
PC_622	Estrogen biosynthesis	441282	1588	3292	51170	51171	3294
PC_623	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	8647	10005	8309	1645	1646	8644	1109	6718	23600	570	1593	1581	9420	1582	3295	80270	8648	10499	9971	5740	6256	10106	11001	10998
PC_624	Axonal growth inhibition (RHOA activation)	396	84894	4099	4168	4804	4974	387	57142
PC_625	NRAGE signals death through JNK	26574	29	11214	9138	9639	55160	9826	23365	22899	27237	9828	23370	128272	9181	26084	50650	100271715	445328	389337	54848	84904	50649	55701	7984	9459	8874	23229	572	10018	1894	2245	221472	89846	121512	10672	6453	8997	9500	5599	4168	23263	6530	25791	4803	4804	84033	64857	57449	57580	5879	5924	6654	6655	7074	26230	7204	7409	7410	10451
PC_626	p75NTR negatively regulates cell cycle via SC1	3065	3066	8841	4803	4804	11108
PC_627	Ceramide signalling	4803	4804	6610
PC_628	Regulated proteolysis of p75NTR	6868	51107	83464	23385	4790	4804	5663	5664	55851	5970	7189
PC_629	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	1645	1646	8644	1109	6718	23600	1593	51302	10858	1582	80270	5740	11001	10998
PC_630	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	1645	1646	8644	1109	6718	1593	1581	9420	1582	80270	8648	10499	9971	5740	6256
PC_631	Mineralocorticoid biosynthesis	1081	1585	1589	3283	3284	3972
PC_632	Glucocorticoid biosynthesis	1584	1585	1586	1589	3290	3291	3283	3284	5443
PC_633	Neurophilin interactions with VEGF and VEGFR	2321	3791	8829	8828
PC_634	VEGF ligand-receptor interactions	5228	7422	7423	7424	2277
PC_635	Rho GTPase cycle	2	29	11214	116985	116984	64411	392	79658	9824	89839	94134	55843	55114	93663	84986	57569	57584	58504	57636	83478	9938	23092	201176	9411	257106	57514	9743	115703	2909	158763	80728	393	143872	9912	23526	394	395	23779	64333	396	397	398	9138	9639	55160	9826	23365	22899	27237	9828	23370	128272	9181	26084	50650	100271715	445328	389337	54848	84904	50649	55701	7984	9459	8874	23229	613	998	1123	1124	55789	91614	8655	1894	10144	51306	2245	221472	89846	121512	2664	2665	51291	10672	3633	6453	8997	4168	23263	4649	4650	6530	25791	84033	4952	4983	5296	64857	57449	57580	5879	5880	5881	29127	10928	5924	387	388	9886	23221	389	29984	54509	391	399	57381	23433	55288	89941	58480	171177	6654	6655	57522	9901	9901	90627	9754	85360	84144	117289	7074	26230	7204	9322	7409	7410	10451
PC_636	Degradation of beta-catenin by the destruction complex	139285	324	8312	8945	1452	1499	8454	2932	5515	5516	5518	5519	5525	5526	5527	5528	5529	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	9978	6233	7979	6500	7311	7314	7316
PC_637	VEGF binds to VEGFR leading to receptor dimerization	2321	2324	3791	5228	7422	7423	7424	2277
PC_638	Formation of annular gap junctions	1173	1211	1212	1213	8218	1601	1759	1785	2697
PC_639	Pregnenolone biosynthesis	231	1583	2230	112812	2232	2984	10948	83930	134429	147323	9256
PC_640	Beta-catenin phosphorylation cascade	139285	324	8312	1452	1499	10023	23401	2932	5515	5516	5518	5519	5525	5526	5527	5528	5529
PC_641	GRB2 events in ERBB2 signaling	685	1950	1956	2064	2066	2069	2885	1839	3265	3845	4893	3084	9542	10718	145957	6654
PC_642	PI3K events in ERBB2 signaling	685	1950	1956	2064	2065	2066	2069	2549	2885	1839	3084	9542	10718	145957	5290	5295
PC_643	Cobalamin (Cbl, vitamin B12) transport and metabolism	4363	5826	81693	2694	51293	1504	440387	11330	8029	55788	166785	326625	25974	27249	4594	4548	4552	5644	5646	6947	6948
PC_644	Metabolism of folate and pterines	10840	160428	1719	200895	2350	2356	4522	25902	10797	441024	4524	10588	6470	6472	6573	81034	113235
PC_645	Biotin transport and metabolism	31	32	686	3141	56922	64087	5091	5095	5096	51248	8884
PC_646	Coenzyme A biosynthesis	80347	53354	80025	79646	55229	60490	79717	8034
PC_647	Vitamin D (calciferol) metabolism	8029	1591	1594	120227	2638	5641	4036	51588	6613	7329	7421
PC_648	Nicotinate metabolism	683	952	65220	133686	55191	64802	23057	349565	54981	27231	4907	23475
PC_649	Vitamin B1 (thiamin) metabolism	10560	80704	60386	79178	27010
PC_650	Vitamin C (ascorbate) metabolism	1528	1727	9446	119391	9962	9962	6513	6515
PC_651	Vitamin B2 (riboflavin) metabolism	54	5167	80308	55312	55065	79581	113278
PC_652	A tetrasaccharide linker sequence is required for GAG synthesis	375790	126792	27087	135152	26229	11285	63827	633	1464	10675	1634	2817	221914	2719	2239	2262	10082	3339	1463	6382	6383	9672	6385	1462	64131	64132
PC_653	Nicotinamide salvaging	1582	10135	93100	55739	128240	4837	83594	84875	54625	54956	143	56965	79668	83666	5740	5743	55328	9390	160728
PC_654	PI3K/AKT activation	3667	8660	4803	4914	5290	5291	5295	5296	387
PC_655	AKT phosphorylates targets in the cytosol	207	84335	208	10000	572	842	1026	1027	1147	2931	2932	4193	23608	7249
PC_656	AKT phosphorylates targets in the nucleus	207	208	10000	1385	2308	2309	4303	3164	6199
PC_657	Signalling to STAT3	4803	4914	6774
PC_658	ERK/MAPK targets	2002	5594	5600	1432	5595	5598	4205	4208	5515	5516	5518	5519	5528	6195	6196	6197	9252
PC_659	Signalling to ERK5	5607	5598
PC_660	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	567	718	11126	930	909	910	911	912	4345	131450	933	10666	919	11314	10871	342510	124599	100131439	146722	146894	945	947	915	916	917	958	959	975	925	926	10225	4267	999	9976	29121	339390	81035	56253	1525	2209	2213	2214	10870	3105	3106	3107	3133	3134	3135	3383	3384	3385	3386	7087	8519	3676	3683	3688	3689	3695	120425	3802	3803	3804	3805	3806	100132285	3811	3812	3820	3821	3824	51348	10219	100528032	3903	3904	11024	11027	11026	23547	353514	10859	10288	102725035	11006	10990	8174	100507436	4277	9437	9436	259197	374383	5819	56654	126014	196500	29992	29990	5817	135250	6402	4068	117157	6614	89790	114132	89858	8778	946	27036	27181	27180	114836	57823	54210	54209	340205	79865	285852	7305	80329	79465	7412
PC_661	PPARA activates gene expression	19	5244	34	51	2180	183	196	57491	211	51129	27063	335	336	116519	405	9915	406	10498	892	948	23097	1024	80205	9575	1374	1376	1387	1543	1579	1581	2033	2101	2168	3992	84498	2222	2274	50486	11010	2874	29841	8841	85441	3156	3157	3158	4199	8930	84246	400569	9968	9969	23389	9282	51586	10025	9440	54797	219541	9477	9412	6837	9439	9862	81857	9441	9442	80306	55588	90390	51003	29079	10001	9443	112950	55090	4661	8648	10499	8202	23054	9611	9612	4800	4801	4802	4862	9572	7376	10062	9971	4779	8800	123	5465	5468	10891	133522	23179	6095	6256	6257	376497	6604	6667	6720	6721	6822	6907	79718	96764	9967	26230	27242	57761	7296	54600
PC_662	Vitamin B5 (pantothenate) metabolism	60496	5167	5168	5169	2194	51248	8884	8876	8875
PC_663	Negative regulation of the PI3K/AKT network	207	208	10000	23239	23035	5728	117145	57761
PC_664	CREB phosphorylation	466	1385	9261	6195	6196	6197	9252
PC_665	trans-Golgi Network Vesicle Budding	375	8729	8773	6810	6844	6845	8673
PC_666	Import of palmitoyl-CoA into the mitochondrial matrix	1374	1375	1376	58526	5467	5563	5565	51422	6256	6584	788	7069
PC_667	Signaling by BMP	92	93	94	268	269	27302	650	657	658	659	9350	91851	11167	2658	64388	9241	6497	4086	4089	4090	4091	4092	4093	57154	64750	7321	7323	9765
PC_668	TCF dependent signaling in response to WNT	8312	8313	1499	22943	27123	27121	1855	1856	1857	8321	2535	83999	79412	4041	4040	81847	6233	6259	6422	6423	50964	8658	80351	7311	7314	7316	9736	11197	7471	7473	89780	54361	7474	7478	7479	7483
PC_669	WNT mediated activation of DVL	102800317	1457	1459	1460	1855	1856	1857	8395
PC_670	Formation of the beta-catenin	9070	607	283149	79577	1387	1499	2033	474382	55766	94239	3014	3015	102724334	3020	3020	3065	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	8350	8350	8350	8350	8350	8350	8350	8350	8350	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	126961	126961	126961	121504	121504	128312	8290	121504	10524	8085	51176	123169	4221	4609	26108	90780	5929	8607	6597	6925	6932	83439	6934	7015	7088	7089	7090	7091	8295
PC_671	G-protein activation	2770	2771	2773	2775	2779	2780	346562	2781	2782	2783	2784	59345	10681	2790	2791	55970	51764	54331	2785	2786	2787	2788	2793	2792	2793	4988	5173	5443
PC_672	Assembly of collagen fibrils and other multimeric structures	977	1300	1301	1302	1306	80781	1277	1278	255631	85301	1280	1281	1282	1284	1285	1286	1287	1289	1290	50509	1291	1292	1293	256076	131873	1295	1296	1297	1298	1299	1508	1514	1520	1515	667	3655	3691	3909	3914	3918	4322	9313	4314	4316	4318	5339
PC_673	Metabolism of Angiotensinogen to Angiotensins	1636	59272	183	290	84909	10159	4502	1215	1359	1360	1361	1509	1511	1522	2028	2999	4311	5972
PC_674	Keratan sulfate biosynthesis	176	10678	10331	79369	93010	2683	8704	8703	8702	9334	9331	11041	8534	9435	23563	4166	2331	11081	4060	4969	4958	5549	11046	6482	6483	6487	6484	10402
PC_675	Keratan sulfate degradation	176	2331	2720	79411	2799	3073	3074	11081	4060	4969	4958	5549
PC_676	Chondroitin sulfate biosynthesis	63827	633	79586	54480	50515	55501	166012	51363	9469	56548	83539	22856	337876	55790	55454	1464	10675	1634	1463	1462
PC_677	Dermatan sulfate biosynthesis	63827	633	113189	1464	10675	1634	29940	92126	1463	10090	1462
PC_678	HS-GAG biosynthesis	375790	2131	2132	26035	2817	221914	2719	2239	2262	10082	9653	9957	9956	9955	9953	9951	222537	64711	9394	90161	266722	3339	3340	8509	9348	64579	6382	6383	9672	6385	11046
PC_679	Signaling by FGFR2 amplification mutants	2263
PC_680	HS-GAG degradation	375790	2720	79411	2817	221914	2719	2239	2262	10082	2990	10855	60495	3339	3423	3425	4669	6382	6383	9672	6385	6448
PC_681	CS/DS degradation	411	63827	633	1464	10675	1634	3073	3074	3373	8372	3423	3425	1463	1462
PC_682	Downstream TCR signaling	8915	8945	84433	919	915	916	917	920	997	1147	8454	23291	3113	3115	3117	3118	3119	3120	3122	3123	3125	3126	3127	3551	8517	3635	3932	10892	6885	4790	4792	5170	5290	5291	5295	5296	5588	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	5728	5970	8767	6233	7979	6500	23118	7189	50852	7311	7314	7316	7321	7322	7334	387522
PC_683	Phosphorylation of CD3 and TCR zeta chains	919	915	916	917	920	1445	3113	3115	3117	3118	3119	3120	3122	3123	3125	3126	3127	3932	55824	26191	5788	5795
PC_684	Translocation of ZAP-70 to Immunological synapse	919	915	916	917	920	3113	3115	3117	3118	3119	3120	3122	3123	3125	3126	3127	3932	26191	7535
PC_685	Generation of second messenger molecules	9398	919	915	916	917	920	55740	51466	2533	9402	3113	3115	3117	3118	3119	3120	3122	3123	3125	3126	3127	3702	27040	3932	3937	4690	5058	5062	5063	5335	7408	7454	7535
PC_686	Calcineurin activates NFAT	801	2280	4772	4773	4775	5478	5530	5532	5534
PC_687	ERKs are inactivated	1845	1846	1848	1849	5594	5595	5598	5515	5516	5518	5519	5528	51231
PC_688	Cell surface interactions at the vascular wall	338	57126	914	51744	960	961	962	965	972	8832	4267	83692	634	1084	1048	4680	1088	1525	4072	90952	50848	2147	83953	2207	2335	2534	2621	2734	51206	2817	2993	2994	2995	3543	3676	3678	3683	3684	3687	3688	3689	58494	83700	120425	3512	4067	10461	268	4973	5175	5196	5197	9463	5624	10544	5627	5669	5678	5670	5671	5672	5673	5675	5676	440533	5678	6382	6383	9672	6385	6401	6402	6403	6404	140885	55423	10522	7040	7056	8797	8795	8793	54210	7102	7441	29802
PC_689	Signaling by Hippo	154796	154810	51421	836	1856	9113	26524	55233	92597	261734	60485	6788	6789	7082	9414	23286	25937	10413	7529	7531
PC_690	FCGR activation	919	917	2209	2212	2214	2268	2534	3055	4067	6714	6850	7525
PC_691	Regulation of actin dynamics for phagocytic cup formation	10006	10152	25	60	71	10097	10096	10552	10095	10109	10094	10093	10092	10458	55845	695	919	917	998	1072	1398	23191	26999	1793	9844	63916	2209	2212	2214	2885	3320	3326	3984	5594	5595	4620	4627	4651	4641	4644	4650	4690	10787	3071	51517	4771	5058	5747	5879	6850	7409	7410	10451	7454	8936	10163	10810	8976	7456	147179	644150
PC_692	Role of phospholipids in phagocytosis	10768	919	917	2209	2212	2214	3708	3709	3710	5290	5291	5295	5296	8398	5335	5336	5337	5338	23646	122618	196051	84513	5580	5581	6850
PC_693	YAP1- and WWTR1 (TAZ)-stimulated gene expression	1490	2626	204851	28996	8850	1482	4878	860	6910	7003	8463	7005	7004	25937	10413
PC_694	FGFR3 mutant receptor activation	2246	8823	8822	8817	2247	26281	8074	2249	2250	2253	2254	2261
PC_695	t(4	2261
PC_696	Activated point mutants of FGFR2	2246	2255	8823	8822	8817	2247	26281	27006	8074	2248	2249	2250	2251	2252	2253	2254	2263
PC_697	eNOS activation	207	801	857	114757	23576	23564	3320	10434	4846	6697	340481
PC_698	NOSTRIN mediated eNOS trafficking	857	1785	4846	115677	8976
PC_699	NOSIP mediated eNOS trafficking	4846	51070
PC_700	MicroRNA (miRNA) biogenesis	26523	27161	192669	192670	144233	54487	23405	29102	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	8575	5901	6895	57510
PC_701	COPII-mediated vesicle transport	23243	374	10282	966	10175	254263	149111	1294	1453	1075	1522	2153	2157	2348	2801	64689	9570	2890	3998	79748	10960	81562	90411	9476	63908	8774	4905	5537	22870	55291	10113	5861	81876	51128	23256	6396	9919	89866	26984	9554	9117	10484	11196	10802	10427	9632	9871	22872	5265	55014	6811	128637	10342	7039	10972	10959	58485	7109	6399	51693	27095	51399	126003	79090	122553	83696	8615	10652
PC_702	Regulation of pyruvate dehydrogenase (PDH) complex	1737	1738	2954	5160	5161	5162	8050	5170	5164	5165	5166	403313	57546	55066	5467	6256
PC_703	Linoleic acid (LA) metabolism	215	2180	64834	54898	83401	60481	3992	9415
PC_704	alpha-linolenic acid (ALA) metabolism	215	30	10005	51	2180	64834	54898	83401	60481	3992	9415	3295	10106
PC_705	Hypusinylation	1725	83475	1984	56648
PC_706	NFG and proNGF binds to p75NTR	4803	4804
PC_707	NADE modulates death signalling	27018	835	836	4803	4804	7531
PC_708	NRIF signals cell death from the nucleus	51107	83464	23421	5599	23385	4803	4804	5663	5664	55851	6233	8878	7189	7311	7314	7316
PC_709	p75NTR recruits signalling complexes	3551	3654	4615	4803	4804	5584	8767	6233	8878	7189	7311	7314	7316
PC_710	NF-kB is activated and signals survival	3551	3654	4790	4792	4803	4804	5970	6233	8878	7189	7311	7314	7316
PC_711	Axonal growth stimulation	396	4803	4804	387
PC_712	Glycoprotein hormones	1081	1082	1082	1082	2488	3623	3624	3625	3626	83729	3972	7252
PC_713	Catecholamine biosynthesis	1621	1644	5409	7054
PC_714	Serotonin and melatonin biosynthesis	15	438	1644	7166	121278
PC_715	Peptide hormone biosynthesis	5122	5443
PC_716	Thyroxine biosynthesis	1081	53905	50506	389434	6528	7173	7252
PC_717	Astrocytic Glutamate-Glutamine Uptake And Metabolism	2752	6506	6507	81539
PC_718	Glutamate Neurotransmitter Release Cycle	10550	10815	2744	27165	8500	8499	8541	8497	5864	22999	57030	6505	6506	6507	6511	6512	54407	6616	6804	6812	6857	9256	10497	6844
PC_719	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	1387	2033	8209	6928	2648	8850	9794	84441	55534	10046	50674	4851	3175	390874	3516	22938
PC_720	Regulation of gene expression in beta cells	3170	3171	2308	2645	6927	3172	3174	3375	3630	389692	4760	4821	4825	5080	8050	5313	222546	6514
PC_721	Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells	3642	4760	50674	4821
PC_722	Regulation of gene expression in early pancreatic precursor cells	2255	6928	4825	2494	3175	390874	8050	256297
PC_723	PECAM1 interactions	2534	3635	3685	3690	3932	4067	5175	5335	5781	5777	6714	7525
PC_724	Basigin interactions	481	482	483	682	857	3675	3655	3688	3897	4099	4312	5478	23759	6566	9123	23539	6520	56301	23657	8140	9057	9056	23428	11136	10522
PC_725	Tie2 Signaling	284	285	51378	9046	2888	2885	2886	3265	3845	4893	5290	5291	5295	5296	5781	6464	6654	7010
PC_726	AKT-mediated inactivation of FOXO1A	207	208	10000	2308
PC_727	Regulation of PAK-2p34 activity by PS-GAP/RHG10	79658	5062
PC_728	Regulation of activated PAK-2p34 by proteasome mediated degradation	5062	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	6233	7979	7311	7314	7316
PC_729	Stimulation of the cell death response by PAK-2p34	836	5062
PC_730	Cytochrome P450 - arranged by substrate type	5447
PC_731	Vitamins	1591	1592	56603	340665	1594	120227
PC_732	Fatty acids	1553	1549	1555	1565	1572	1573	1579	284541	1580	57834	66002	8529	126410	4051	11283
PC_733	Phase I - Functionalization of compounds	13	196	57491	218	26	314	8639	405	9915	670	874	4502	8824	23491	134147	80777	1727	2052	64757	54996	4835
PC_734	Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2	1544
PC_735	Miscellaneous substrates	1565	29785	113612	54905	64816	1579	284541	1580	57834	8529	126410	4051
PC_736	Endogenous sterols	196	57491	405	9915	1583	1584	1585	1588	1545	1589	1593	51302	10858	285440	1595	1581	9420	2230	112812	2232	8648	10499	9971	5443	6256
PC_737	Eicosanoids	1579	284541	1580	57834	66002	8529	126410	4051	11283	1582	5740	6916
PC_738	Xenobiotics	196	57491	405	9915	1543	1553	1548	1549	1555	1562	1557	1558	1559	1565	1571	1572	1573	29785	54905	1576	64816	1577	100861540
PC_739	Sterols are 12-hydroxylated by CYP8B1	1582	5740
PC_740	CYP2E1 reactions	1553	1548	1549	1555	1557	1558	1559	1565	1571	1572	29785
PC_741	NOTCH1 Intracellular Domain Regulates Transcription	892	1024	1387	8454	2033	55294	3065	83933	79885	3066	8841	9759	10014	10013	51564	55869	9734	8209	388585	23462	23493	26508	3091	2648	8850	9794	84441	55534	10046	4609	9611	9612	4851	3516	9978	6233	6500	22938	6907	79718	7088	7089	7090	7091	7311	7314	7316
PC_742	Activated NOTCH1 Transmits Signal to the Nucleus	102	6868	51107	83464	408	409	1272	8788	28514	54567	92737	1840	113878	23220	83737	182	3714	57534	142678	23385	9148	54492	4851	8650	5663	5664	55851	6233	7311	7314	7316
PC_743	PRC2 methylates histones and DNA	121536	1786	1788	1789	8726	2146	474382	55766	94239	3014	3015	102724334	3020	3020	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	8350	8350	8350	8350	8350	8350	8350	8350	8350	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	126961	126961	126961	121504	121504	128312	121504	3720	22823	5252	26147	5928	5931	23512
PC_744	Generic Transcription Pathway	892	1024	84626	55634	8930	84246	9968	9969	9282	51586	10025	9440	9477	9439	9862	81857	9441	9442	90390	51003	29079	10001	9443	112950	11105	10155	162239	57677	80108	140612	22835	7539	339559	65243	146198	284307	23619	114026	7586	80317	387032	23660	55888	7745	7556	163227	94039	7771	163071	7559	7678	7692	7694	7695	7697	7561	7699	7700	7710	7711	7712	90338	169841	7565	7728	7566	7733	7738	7743	7567	7748	10168	7549	7568	7752	7753	7755	7757	10520	7988	7760	7761	7762	7638	7673	7766	7767	1958	7769	7770	7571	50862	353355	10780	9310	57209	219749	58500	56242	9534	10172	113835	7574	10127	9422	10781	10308	10795	10793	10782	7576	8427	26974	57335	57336	7551	90075	91975	55900	57343	282890	57693	162967	25799	388569	55422	84449	55713	26152	7581	7582	80778	79175	84671	59348	6940	117608	30832	7587	84911	163087	84124	57541	7592	55786	55659	147687	147686	79744	147923	155054	79088	353088	7594	80264	170959	9668	163059	80818	90594	126070	126068	79973	10224	353274	55663	7596	285676	10794	92283	90333	388566	57573	25888	90827	147657	158399	83744	220992	90649	57474	57615	284443	84838	26048	440515	22869	84874	340385	162655	84436	57711	348327	163255	125919	27300	339327	284306	147694	256051	162972	90233	79818	115196	148254	80032	79230	148156	84527	147741	93134	54811	147837	163050	147929	84924	163081	374900	148266	148268	51276	126231	84765	147948	147949	201514	199704	92285	54807	84914	51385	152687	169270	146434	148103	162966	100289635	80095	84775	162963	81856	79898	80110	284370	90317	285267	253639	285268	57547	90589	199777	199692	121274	65251	79027	26149	285349	389114	144348	79788	63934	79759	79862	93474	79891	171392	163223	342926	168417	340252	148213	91120	127396	146542	51058	55657	79943	90874	374879	7621	90592	55762	80139	619279	440077	728957	100131539	100131980	51123	286075	7562	163051	58491	374655	7552	349075	148206	441234	100131827	255403	124411	170960	730087	442319	100287226	100129543	654254	730291	728927	100129842	7625	283337	155061	65988	388567	79755	7627	7626	388561	92595	58492	54989	51333	400720	374928	342132	285971	284309	27153	197320	158431	146540	136051	7633	388536	163049	126375	390927	90576	219578	55778	344787	284459	168374	7652	221785	54925
PC_745	Dopamine Neurotransmitter Release Cycle	320	8573	10815	8825	64130	55327	8500	8499	8541	8497	5864	22999	6571	6616	6804	6812	6853	6854	8224	6857	9256	10497	6844
PC_746	EGFR interacts with phospholipase C-gamma	374	685	1950	1956	255324	2069	1839	5335	7039
PC_747	Molecules associated with elastic fibres	27302	650	652	655	2202	30008	2192	2199	10516	8200	8516	3685	3688	3690	3693	3694	3696	4052	4053	4053	8425	4236	4237	4238	4239	8076	7040	7042	7043	7448
PC_748	MHC class II antigen presentation	55860	10121	10120	162	164	8907	10053	1174	8905	130340	160	161	163	1173	1175	375	821	829	830	93661	832	972	1062	1211	1213	5476	1508	1075	1509	1510	8722	1512	1513	1514	1519	1520	1515	1639	10540	11258	51164	84516	10671	1759	1785	26052	1778	1780	1781	51143	1783	8655	140735	3109	3111	3112	3113	3115	3117	3118	3119	3120	3122	3123	3125	3126	3127	10437	3832	56992	81930	10112	3835	9493	26153	3796	84643	11004	11127	9371	3797	24137	285643	3798	3799	22920	3831	147700	147700	89953	3902	5641	114876	7879	29127	144165	51128	6396	10484	10802	10427	9632	9871	22872	6456	6712
PC_749	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	1543	1544	1545	1557	1558	1559	1573	2053
PC_750	Synthesis of 5-eicosatetraenoic acids	240	241	2876	2877	2879	4056	5444	5445	5446
PC_751	Synthesis of Leukotrienes (LT) and Eoxins (EX)	4363	246	240	241	1579	284541	1580	57834	8529	126410	4051	11283	1800	64174	64180	2678	2687	4048	4056	9261	22949
PC_752	Synthesis of Hepoxilins (HX) and Trioxilins (TrX)	239
PC_753	Synthesis of Lipoxins (LX)	239	240	241	3248	4056	22949
PC_754	Synthesis of 12-eicosatetraenoic acid derivatives	239	242	246	59344	2876	2877	2879
PC_755	Arachidonic acid metabolism	158833	2166	158584	5321
PC_756	Synthesis of 15-eicosatetraenoic acid derivatives	246	247	2876	2877	2879	5743
PC_757	Ubiquinol biosynthesis	27235	51805	84274	51004	10229	57017	23590	57107
PC_758	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	1543	1544	1545	1557	1558	1559	113612	1579	8529
PC_759	Hyaluronan biosynthesis and export	10057	57214	3036	3037	3038
PC_760	Transcriptional activation of mitochondrial biogenesis	55902	211	1386	506	801	814	10498	80205	1385	1387	23373	200186	64784	54205	2101	2551	2553	2746	2747	3054	8841	85441	3418	8930	4208	4209	7978	8648	10499	23054	9611	9572	4779	84808	11232	5442	5465	10891	133522	23082	6256	23410	23409	23408	6604	6648	6742	6907	79718	7019	51106	64216	96764	56652	64854
PC_761	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	5600	6300	1432	10891	5563	5564	5565	5571	51422	53632
PC_762	Phenylketonuria	5053
PC_763	Integrin cell surface interactions	375790	682	960	961	999	1305	1307	80781	91522	1282	1284	1285	1286	1297	1298	1299	1311	50848	2200	2243	2244	2266	2335	3339	3381	3383	3384	3385	3386	7087	3672	8515	22801	3673	3674	3675	3676	3678	3655	3679	8516	3680	3681	3682	3683	3684	3685	3687	3688	3689	3690	3693	3694	3695	3696	58494	83700	3791	4060	8174	5175	6696	7057	3371	7412	7448
PC_764	Hyaluronan uptake and degradation	960	11261	2990	3073	3074	3161	3373	8692	8372	10894	6548	55576
PC_765	Abacavir transmembrane transport	5243	9429	6580	6582	6581
PC_766	Abacavir metabolism	161823	124	2987	22978	5105
PC_767	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	8644	873	1582	3248	27306	127281	5730	9536	80142	10728	5740	145482	5742	5743	6916
PC_768	Scavenging of heme from plasma	213	259	335	8542	9332	3039	3039	3043	3240	3250	3263	3512	4035
PC_769	DAP12 interactions	567	342510	124599	23601	3106	3107	3133	100132285	3809	3810	3813	3822	3824	100528032	9436	100049587	284266	10326	54210	54209	7305
PC_770	FMO oxidises nucleophiles	2326	2329	2328
PC_771	Downregulation of TGF-beta receptor signaling	25805	9110	23327	56937	5499	5500	5501	23645	6233	4087	4088	4092	57154	64750	11171	10273	7040	7046	7048	7311	7314	7316	51377	9958	7514	9372
PC_772	TGF-beta receptor signaling activates SMADs	867	2280	5045	4738	4087	4088	4089	7040	7046	7048	9040	9372
PC_773	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	23370	57530	50848	2280	56288	50855	5590	387	6233	57154	7040	7046	7048	7311	7314	7316
PC_774	Downregulation of SMAD2/3	3065	9611	9612	23327	142	5494	54778	6233	6497	6498	4087	4088	4089	64750	7050	60436	51592	7311	7314	7316	7321	7323	8239
PC_775	SMAD2/SMAD3	23439	892	8812	904	905	1024	1025	1030	1874	1875	3065	3726	4221	4609	5933	54778	6233	5054	4087	4088	4089	4092	22938	6667	7027	7029	7050	60436	7311	7314	7316	25937
PC_776	EGFR Transactivation by Gastrin	1956	2885	1839	3265	3845	4314	4893	5578	6654
PC_777	The retinoid cycle in cones (daylight vision)	158835	9249	5956	101060233	611	5949	6017
PC_778	NOTCH2 intracellular domain regulates transcription	1385	2033	2208	3002	8209	388585	9794	84441	55534	10046	4853	3516
PC_779	MPS IX - Natowicz syndrome	3373
PC_780	MPS IIIB - Sanfilippo syndrome B	4669
PC_781	MPS VI - Maroteaux-Lamy syndrome	411
PC_782	MPS IV - Morquio syndrome A	2588
PC_783	MPS IIIC - Sanfilippo syndrome C	138050
PC_784	MPS VII - Sly syndrome	2990
PC_785	MPS II - Hunter syndrome	3423
PC_786	MPS I - Hurler syndrome	3425
PC_787	MPS IIID - Sanfilippo syndrome D	2799
PC_788	MPS IIIA - Sanfilippo syndrome A	6448
PC_789	MPS IV - Morquio syndrome B	2720
PC_790	Anchoring fibril formation	649	1294	3909	3914	3918	7092	7093
PC_791	Constitutive Signaling by Aberrant PI3K in Cancer	374	685	930	940	941	942	1950	1956	255324	2064	2065	2066	2069	2099	2100	2246	2255	8823	8822	8817	9965	2247	26281	27006	8074	2248	2249	2250	2251	2252	2253	2254	2260	2263	2261	2264	10818	2534	2549	2885	1839	3082	29851	3667	8660	3815	4254	9365	152831	3932	4233	3084	9542	10718	145957	5154	5155	5156	5159	118788	5290	5291	5293	5295	5296	8503	5781	5879	5880	391	6714	6801	7039	50852	7409
PC_792	Crosslinking of collagen fibrils	649	4015	4016	4017	84695	84171	5118	7837	7092	7093
PC_793	Condensation of Prophase Chromosomes	891	983	474382	55766	94239	3014	3015	102724334	3020	3020	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	8350	8350	8350	8350	8350	8350	8350	8350	8350	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	126961	126961	126961	121504	121504	128312	8290	121504	387893	79648	23310	54892	29781	23133	5347	5925	6418	10592	10051
PC_794	Phosphate bond hydrolysis by NUDT proteins	56985	4521	55270	131870	79873	11164	53343
PC_795	Electron transport from NADPH to Ferredoxin	2230	112812	2232
PC_796	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	8483	3479	3480	3481
PC_797	Metabolism of ingested SeMet, Sec, MeSec into H2Se	191	102724560	1491	27232	3176	4143	4837	51540
PC_798	Selenoamino acid metabolism	9255	7965	1615	9521	2058	3376	3735	51520	4141	2058	5917
PC_799	Metabolism of ingested H2SeO4 and H2SeO3 into H2Se	2936	9061	9060	7296
PC_800	Methylation of MeSeH for excretion	11185
PC_801	Selenocysteine synthesis	60678	2197	118672	6134	4736	140801	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	200916	9349	6147	6152	6154	51121	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6166	6167	6168	6169	6170	116832	6123	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6233	51065	6234	6235	6188	6189	6191	6192	140032	6193	6194	6201	6202	6203	3921	6301	79048	22928	51091	7311
PC_802	DAP12 signaling	567	695	2534	9402	2885	3133	3265	3822	3824	100528032	3845	27040	3932	3937	4893	5290	5291	5295	5296	5335	5336	5879	6464	6654	6850	54209	7305	7410	10451
PC_803	Activation of gene expression by SREBF (SREBP)	31	32	10498	80205	1387	1595	1717	79071	2194	2222	2224	9453	57678	85441	3156	3157	3422	4047	8930	4661	4597	4598	8648	10499	23054	4800	4801	4802	10654	5465	6256	6309	6319	6604	6667	6713	6720	6721	6907	79718	96764	7108
PC_804	IRS-related events triggered by IGF1R	3479	3480	3481	3667	8660	8471
PC_805	SHC-related events triggered by IGF1R	2885	3265	3479	3480	3481	3845	4893	6464	6654
PC_806	Retinoid cycle disease events	24	9227	5956	101060233	611	9256	5950	145226	5959	6017	64220	7276
PC_807	The canonical retinoid cycle in rods (twilight vision)	24	285440	10170	3292	8630	9227	4647	9256	5949	5950	157506	51109	145226	8608	5959	50700	6010	6017	6121	121214	64220	7276
PC_808	Fc epsilon receptor (FCERI) signaling	2205	2207	27040	4067	2206	6850
PC_809	MASTL Facilitates Mitotic Progression	10776	891	983	2029	84930	5515	5516	5518	5519	55844
PC_810	Biosynthesis of A2E, implicated in retinal degradation	222236
PC_811	Separation of Sister Chromatids	25909	64682	10393	51529	25906	119504	29882	29945	51433	51434	9212	80776	332	699	701	9184	8881	991	8697	246184	996	113130	55143	1058	1060	1062	1063	64946	2491	64105	91687	79019	55839	79172	401541	55166	100526739	80152	79682	9793	23332	23122	6249	79980	1778	1780	1781	51143	1783	8655	140735	54821	9700	55869	3619	23421	81930	3796	84643	11004	57082	9735	8379	4085	22919	79003	10403	54820	81565	284058	10726	83540	57122	55746	23279	79023	348995	79902	4928	5048	23244	23047	5347	100527963	5501	5515	5516	5518	5519	5525	5526	5527	5528	5529	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	9232	5885	5903	5905	55920	6232	6233	6396	81929	7979	151648	151246	220134	348235	8243	9126	147841	9789	54908	10274	10735	57551	7311	7314	7316	11065	7321	7324	23063	7514	9183	55055	11130
PC_812	Establishment of Sister Chromatid Cohesion	113130	114799	157570	23244	23047	5885	8243	9126	10274	10735	23063
PC_813	Cohesin Loading onto Chromatin	23383	25836	23244	23047	5885	8243	9126	10274	10735	23063
PC_814	Antagonism of Activin by Follistatin	10468	10272	3624	3625
PC_815	Activation of the phototransduction cascade	1259	1258	2779	2782	2792	5145	5158	5148	6010	6295	9187
PC_816	Resolution of Sister Chromatid Cohesion	25909	9212	80776	332	699	701	9184	891	9133	991	113130	55143	983	1058	1060	1062	1063	64946	2491	64105	91687	79019	55839	79172	401541	55166	100526739	80152	79682	9793	23332	23122	6249	79980	1778	1780	1781	51143	1783	8655	140735	54821	55869	3619	23421	81930	3796	84643	11004	57082	9735	8379	4085	22919	79003	10403	54820	81565	284058	10726	83540	57122	55746	23279	79023	348995	79902	4928	5048	23244	23047	5347	100527963	5501	5515	5516	5518	5519	5525	5526	5527	5528	5529	5885	5903	5905	55920	6232	6396	81929	151648	151246	220134	348235	8243	9126	147841	9789	54908	10274	10735	57551	23063	7514	9183	55055	11130
PC_817	Condensation of Prometaphase Chromosomes	891	9133	983	1457	1459	1460	9918	64151	23397	10592	10051
PC_818	Inactivation, recovery and regulation of the phototransduction cascade	801	79823	1259	1258	2339	100529261	2779	2782	10681	2792	6011	2868	131890	118142757	2979	9626	3000	2986	23173	10988	4836	9397	5145	5158	5148	5475	5578	5588	5957	8787	388531	6010	6295
PC_819	Interaction With Cumulus Cells And The Zona Pellucida	2515	8748	8747	11085	2683	5016	6677	22917	7783	7784	57829
PC_820	Oxidative Stress Induced Senescence	26523	192669	192670	100532731	84733	8535	23466	57332	1019	1021	1029	1030	1031	1032	1869	1870	1871	8726	2146	2353	474382	55766	94239	3014	3015	102724334	3020	3020	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	8350	8350	8350	8350	8350	8350	8350	8350	8350	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	126961	126961	126961	121504	121504	128312	121504	3456	3725	23135	5606	6416	5608	5609	4217	9448	5594	5602	5600	1432	5595	5599	5601	9261	7867	8550	4193	4194	50488	4343	1911	1912	80012	5928	5931	6015	6045	6233	22955	23512	7027	7029	23043	27327	23112	57690	7157	7295	7311	7314	7316
PC_821	Senescence-Associated Secretory Phenotype (SASP)	64682	10393	51529	25906	119504	29882	29945	51433	51434	8900	890	8881	8697	246184	996	1017	1019	1021	1026	1027	1029	1030	1031	1032	1051	3576	79813	10919	2353	51343	474382	55766	94239	3014	3015	102724334	3020	3020	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	8350	8350	8350	8350	8350	8350	8350	8350	8350	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	126961	126961	126961	121504	121504	128312	121504	3490	3552	3569	3725	5594	5595	5598	4790	5970	6233	6195	6196	6197	6774	7311	7314	7316	11065	7321	7324
PC_822	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	25842	23523	1026	57634	3005	7290	3024	3009	3006	3007	3008	3159	8091	4001	5925	7157	29855
PC_823	Oncogene Induced Senescence	26523	192669	192670	1019	1021	1029	1030	1031	1032	1869	1870	1871	2077	2113	2114	3397	5594	5595	4193	4194	4343	5925	6233	6667	7027	7029	27327	23112	57690	7157	7311	7314	7316
PC_824	DNA Damage/Telomere Stress Induced Senescence	65057	472	8900	890	898	9134	1017	1026	1027	57634	474382	55766	94239	3014	3015	102724334	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	121504	121504	128312	8290	121504	10524	4361	4683	25913	10111	7013	7014	54386	26277	7157
PC_825	TRIF-mediated programmed cell death	841	929	8772	23643	8737	11035	148022	100302736	7099
PC_826	Cytosolic iron-sulfur cluster assembly	22	83990	9391	51647	64428	57019	2068	64210	27158	4682	10101	5424	51750
PC_827	Regulation of PLK1 Activity at G2/M Transition	10121	84962	10142	7840	6790	79866	8945	891	9133	9738	983	55755	55835	22994	9662	22995	22897	55125	11190	80184	95681	9702	80254	80321	55722	79959	84131	1069	9793	23332	11064	1453	102800317	8454	1639	10540	11258	1778	1781	8655	23291	11116	115106	55142	79441	54930	23354	54801	55559	93323	3320	22919	54820	121441	4751	22981	4957	8481	10133	5048	5108	5116	5347	10733	5500	4659	4660	5518	5578	5577	4218	6233	10806	9814	6500	8636	7846	7277	203068	10382	10383	7283	7311	7314	7316	7531	7532
PC_828	Signaling by Leptin	3667	8660	3717	3952	54741	5781	25970	9021	6774	6776	6777
PC_829	Constitutive Signaling by NOTCH1 PEST Domain Mutants	102	6868	51107	83464	892	1024	1387	8454	28514	54567	2033	55294	3065	83933	79885	3066	8841	9759	10014	10013	51564	55869	9734	8209	388585	23462	23493	26508	182	3714	2648	8850	9794	84441	55534	10046	57534	142678	4609	9611	9612	23385	9148	54492	4851	5663	5664	55851	3516	9978	6233	6500	22938	6907	79718	7311	7314	7316
PC_830	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	8454	55294	4851	9978	6500
PC_831	Acetylcholine Neurotransmitter Release Cycle	1103	10815	8500	8499	8541	8497	5864	22999	6572	60482	6616	6804	6812	6857	9256	10497	6844
PC_832	Caspase-mediated cleavage of cytoskeletal proteins	118	836	839	840	841	28988	2620	2934	4137	5339	6709	7431
PC_833	Insulin processing	57393	1363	30001	56605	55763	55770	11336	60412	10640	54536	23265	149371	3630	3798	3799	3800	4644	25924	5122	5126	5873	64924	55676	148867	169026	6804	6844
PC_834	Constitutive Signaling by NOTCH1 t(7	102	6868	28514	54567	182	3714	4851
PC_835	Stimuli-sensing channels	55107	55129	57101	63982	121601	203859	196527	50636	57719	338440	41	40	9311	55515	51802	444	7439	54831	144453	266675	7809	801	1179	9635	22802	1180	1181	1182	1183	1184	1185	1186	1187	1188	1193	2281	259232	23327	28962	5894	6233	6261	6262	6263	6337	6338	6339	6340	6446	10110	100533105	10786	150159	133308	285335	284525	6717	2040	161003	53373	219931	10345	1831	57348	94015	80727	7311	7314	7316	57578	285175	65125	65268	65267	65266	11059
PC_836	EPH-Ephrin signaling	1942	1943	1944	1945	1946	1947	1948	1949	2041	284656	1969	2042	2043	2044	285220	2045	2046	2047	2048	2049	2050	2051	2534	4067	6714	7525
PC_837	Constitutive Signaling by NOTCH1 HD Domain Mutants	102	6868	28514	54567	182	3714	57534	142678	9148	54492	4851	6233	7311	7314	7316
PC_838	Role of LAT2/NTAL/LAB on calcium mobilization	2534	9846	2885	7462	4067	5170	5290	5291	5295	5296	6464	6654	6850
PC_839	Ficolins bind to repetitive carbohydrate structures on the target cell surface	2219	2220	8547	5648	10747
PC_840	FCERI mediated MAPK activation	2353	9402	2885	3265	3725	3845	27040	3937	4067	6416	5609	4214	5594	5602	5595	5599	5601	4893	5058	5062	5335	5336	5879	6464	6654	6850	7409	7410	10451
PC_841	FCERI mediated Ca+2 mobilization	10768	695	801	9402	2885	3702	3708	3709	3710	27040	3937	4067	4772	4773	4775	5335	5336	5530	5532	5534	6464	6654	6850	7006	7294	7409	7410	10451
PC_842	FCERI mediated NF-kB activation	8915	8945	84433	997	1147	8454	23291	3551	8517	4067	10892	6885	4790	4792	5170	5588	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	10125	10235	115727	5970	6233	7979	6500	10454	23118	257397	7189	7311	7314	7316	7321	7322	7334	387522
PC_843	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	1045	22943	8320	2627	145258	3087	79923	5460	6657	8848
PC_844	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	55211	2041	2247	27022	79923	2649	5460	6299	57167	6657	6774	6997	7547
PC_845	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	102	6868	51107	83464	892	1024	1387	8454	28514	54567	2033	55294	3065	83933	79885	3066	8841	9759	10014	10013	51564	55869	9734	8209	388585	23462	23493	26508	182	3714	2648	8850	9794	84441	55534	10046	57534	142678	4609	9611	9612	23385	9148	54492	4851	5663	5664	55851	3516	9978	6233	6500	22938	6907	79718	7311	7314	7316
PC_846	Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate	3417
PC_847	NOTCH2 Activation and Transmission of Signal to the Nucleus	102	51107	83464	1272	28514	54567	182	3714	4192	57534	142678	23385	9148	54492	4853	5663	5664	55851	6233	7311	7314	7316
PC_848	Nuclear Envelope Breakdown	8815	2010	221496	23592	7112	7443	7444
PC_849	Activation of NIMA Kinases NEK9, NEK6, NEK7	891	9133	983	10783	140609	91754	5347
PC_850	Initiation of Nuclear Envelope Reformation	23141	8815	2010	221496	23592	4000	4001	5515	5518	5520	7112	7443	7444
PC_851	Laminin interactions	80781	3339	3672	3673	3675	3655	3679	3685	3688	3691	284217	3908	3909	3910	3911	3912	3915	3914	3915	3918	10319	4811	22795
PC_852	Syndecan interactions	87	8573	2247	3673	3655	3685	3688	3690	3691	3693	5578	6382	6383	9672	6385	7040	7057	3371	51399	7448
PC_853	Non-integrin membrane-ECM interactions	375790	1605	780	4921	1756	2247	3339	284217	3908	3909	3910	3911	3912	3915	3914	3915	3918	10319	9378	59277	5154	5155	7276
PC_854	ECM proteoglycans	176	375790	54829	63827	633	1297	1298	1299	1311	1605	1634	1758	1834	2331	1404	3339	3381	3673	3674	3679	8516	3680	3685	3687	3688	3690	3693	3694	284217	3908	3909	3910	3911	3912	3915	3915	4038	4060	4146	4148	8785	4593	4684	1463	5802	5054	6678	7040	7042	7043	3371	63923	7143	7148	1462	7448
PC_855	Scavenging by Class B Receptors	335	338	948	6288	949	284297
PC_856	Scavenging by Class A Receptors	335	338	348	811	1277	1278	1281	1282	1284	78989	81035	2495	2512	7184	8685	5648	4481	286133	117156
PC_857	Scavenging by Class F Receptors	338	811	3320	10808	10525	8578
PC_858	Scavenging by Class H Receptors	338	6678	23166	55576
PC_859	SUMO is conjugated to E1 (UBA2	10055	7341	6613	6612	10054
PC_860	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	25950	10055	7341	6613	6612	10054	7329
PC_861	SUMO is proteolytically processed	29843	59343	205564	7341	6613	6612
PC_862	SUMOylation of DNA damage response and repair proteins	8086	641	100532731	672	84733	8535	57332	1029	1069	493861	51564	8924	9656	55706	197370	286053	56160	54780	57122	55746	9972	9631	23279	23511	23165	23225	8021	129401	79023	11097	348995	10762	53371	9818	23636	79902	4927	9688	4928	142	7703	1911	1912	80012	8554	9063	51588	5371	9883	5885	5893	8480	5903	6015	165918	6045	6117	22955	6396	81929	8243	9126	23137	79677	6672	10274	10735	7341	6613	6612	6996	7175	7329	7486	7508	7518
PC_863	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	170506	1660	3665	4615	4790	4791	5970
PC_864	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	1387	1499	2033	3661	9208
PC_865	Regulation of innate immune responses to cytosolic DNA	51428	23220	3661	147945	6233	29110	340061	6737	22954	81844	7311	7314	7316	81030
PC_866	HDACs deacetylate histones	5926	51742	25855	1107	1108	54815	57459	2874	3065	83933	3066	8841	55869	221613	3012	8334	3013	3012	8329	85235	8329	8331	8329	8329	8329	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	8350	8350	8350	8350	8350	8350	8350	8350	8350	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	317772	8338	8349	440689	126961	126961	126961	121504	121504	92815	128312	121504	10362	23028	53615	9112	9219	57504	9611	9612	51317	5928	5931	23186	5978	10284	8819	79685	64426	6907	79718
PC_867	PKMTs methylate histone lysines	121536	55870	9070	55729	84444	84661	8726	79813	10919	2146	8350	8350	8350	8350	8350	8350	8350	8350	8350	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	126961	126961	126961	121504	121504	121504	4297	9757	58508	8085	55904	387893	51111	84787	2122	4790	4791	64324	7468	54904	63976	56979	5928	5929	5931	5970	9739	23067	29072	84193	79918	80854	9869	83852	56950	64754	6839	79723	23512	11091
PC_868	HDMs demethylate histones	84159	8350	8350	8350	8350	8350	8350	8350	8350	8350	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	126961	126961	126961	121504	121504	121504	23210	23028	221656	22992	84678	55818	51780	9682	23030	23081	55693	5927	10765	8242	8284	7403	23135	80853	5253	23133	84864	7404
PC_869	HATs acetylate histones	60	86	1386	6314	56970	23774	10902	7862	27154	9575	1387	55929	1810	8518	55250	55140	26610	23587	54859	56943	2033	57634	80314	8520	3054	221613	3012	8334	3013	3012	8329	85235	8329	8331	8329	8329	8329	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	8350	8350	8350	8350	8350	8350	8350	8350	8350	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	317772	8338	8349	440689	126961	126961	126961	121504	121504	92815	128312	121504	54556	51147	84289	79960	23338	9767	284058	54934	55683	57325	2648	8850	10524	7994	23522	11143	84148	51562	10445	64769	10933	9643	55257	339287	55167	10943	8648	10499	8473	5077	51230	5931	8607	10856	23450	112869	55578	8464	9913	117143	6871	93624	10474	6881	6883	27097	10629	6880	8295	23326	6944	11091	55689	8089	26009
PC_870	RMTs methylate histone arginines	86	51412	8289	57492	196528	10498	595	1019	55352	1788	474382	55766	94239	3014	3015	221613	3012	8334	3013	3012	8329	85235	8329	8331	8329	8329	8329	8350	8350	8350	8350	8350	8350	8350	8350	8350	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	317772	8338	126961	126961	126961	121504	121504	92815	121504	3717	55193	3276	10196	10419	55170	54496	5931	6187	6595	6597	6598	6599	6601	6602	6603	6604	6605	11091	79084
PC_871	GSD Ib	2542
PC_872	SUMOylation of transcription factors	1029	668	3090	4193	4286	9112	8554	9063	10401	51588	6670	7341	6613	6612	7020	7021	7022	7157	7158	7329
PC_873	SUMOylation of ubiquitinylation proteins	8086	4193	55706	57122	55746	9972	9631	23279	23511	23165	23225	8021	129401	79023	11097	348995	10762	53371	9818	23636	79902	4927	9688	4928	8554	9063	51588	5371	9883	8480	5903	6396	81929	7341	7175	5987	7329	7428
PC_874	WNT ligand biogenesis and trafficking	64840	8724	50999	9559	51699	55737	79971	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484
PC_875	Chromatin modifying enzymes	54014	8350	8350	8350	8350	8350	8350	8350	8350	8350	126961	126961	126961	29943	11240	51702	23569	353238	6597
PC_876	Regulation by TREX1	11277
PC_877	STAT6-mediated induction of chemokines	6778	29110	340061
PC_878	IRF3-mediated induction of type I IFN	51428	23220	3428	3661	4361	197358	147945	5591	29110	340061	11277	7520	2547
PC_879	GSD Ia	2538
PC_880	SCN4	92579
PC_881	TRP channels	57192	255231	55283	8989	7220	7222	7223	26133	7224	7225	7226	4308	7226	80036	54795	29850	140803	54822	79054	7442	51393	162514	59341	56302	55503
PC_882	Hydroxycarboxylic acid-binding receptors	27198	338442	8843
PC_883	Detoxification of Reactive Oxygen Species	343	475	538	847	9973	1535	1536	54205	30001	2876	2877	2878	2880	257202	2882	493869	2936	2950	653361	4688	4689	50507	79400	318	5034	5052	7001	10935	25824	9588	6647	6648	6649	7295	25828	7296	10587
PC_884	Nuclear Pore Complex (NPC) Disassembly	8086	891	9133	983	55706	10783	140609	91754	57122	55746	9972	9631	23279	23511	23165	23225	8021	129401	79023	11097	348995	10762	53371	9818	23636	79902	4927	9688	4928	9883	8480	5903	6396	81929	7175
PC_885	SMAD2/3 Phosphorylation Motif Mutants in Cancer	4087	4088	7040	7046	7048	9372
PC_886	SMAD4 MH2 Domain Mutants in Cancer	4087	4088	4089
PC_887	SMAD2/3 MH2 Domain Mutants in Cancer	4087	4088	4089
PC_888	Glycogen synthesis	2632	2992	8908	2997	2998	378884	5236	55276	283209	5507	6233	7311	7314	7316	7360
PC_889	Defective TCN2 causes hereditary megaloblastic anemia	6948
PC_890	Defective GIF causes intrinsic factor deficiency	2694
PC_891	Defective LMBRD1 causes methylmalonic aciduria and homocystinuria type cblF	55788
PC_892	Defective AMN causes hereditary megaloblastic anemia 1	81693	2694	8029
PC_893	Defective CUBN causes hereditary megaloblastic anemia 1	81693	2694	8029
PC_894	Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE	4548	4552
PC_895	Defective MTR causes methylmalonic aciduria and homocystinuria type cblG	4548	4552
PC_896	Defective MMAB causes methylmalonic aciduria type cblB	326625
PC_897	Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD	25974	27249
PC_898	Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC	25974
PC_899	Defective MMAA causes methylmalonic aciduria type cblA	166785	4594
PC_900	Defective MUT causes methylmalonic aciduria mut type	166785	4594
PC_901	Defective CD320 causes methylmalonic aciduria	51293	6948
PC_902	Regulation by c-FLIP	841	8837	8772	355	356	8737	8797	8795	8743	8717	7186
PC_903	Regulation of HSF1-mediated heat shock response	8086	472	390502	573	9532	9531	9530	9529	57805	1288	1413	162989	3337	10049	27000	7266	2288	2765	2932	51501	3297	259217	116835	6782	51182	3303	3303	3305	3306	3308	22824	3309	3310	3312	3313	3315	3316	10808	5594	5595	9261	55706	57122	55746	9972	9631	23279	23511	23165	23225	8021	129401	79023	11097	348995	10762	53371	9818	23636	79902	4927	9688	4928	9883	8480	5903	6013	6117	6118	6119	91582	6396	81929	871	23411	6767	27242	7175	7314	7531
PC_904	HSP90 chaperone cycle for SHRs	55860	10121	367	829	830	93661	832	1639	10540	11258	51164	84516	10671	3301	10294	55466	3337	1778	1780	1781	51143	1783	8655	140735	2288	2289	3320	3326	3303	3303	3305	3306	3312	2908	4306	5241	10728	10963
PC_905	HSF1 activation	1288	1413	162989	3337	10049	1915	2288	2765	10013	3281	3297	3320	3326	3303	3303	3305	3310	3315	3316	10808	10728	6013	6117	6118	6119	871	27242	7314	7415	7531
PC_906	Attenuation phase	1288	1387	1413	162989	3337	10049	2033	2288	2765	3281	3297	3320	3326	3303	3303	3305	3306	3310	3312	3315	3316	10808	10728	6013	871	27242	7314
PC_907	HSF1-dependent transactivation	84335	815	816	817	818	1288	1410	1413	162989	3337	10049	2288	2765	3281	3297	3320	3326	3303	3303	3305	3310	3312	3315	3316	26353	10808	64223	2475	6013	57521	871	27242	7314
PC_908	Defective BTD causes biotidinase deficiency	686
PC_909	Defective HLCS causes multiple carboxylase deficiency	31	3141	56922	64087	5091	5095	5096
PC_910	Autodegradation of the E3 ubiquitin ligase COP1	472	114769	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	6233	7979	7157	7311	7314	7316
PC_911	Notch-HLH transcription pathway	1387	3065	83933	79885	3066	8841	9759	10014	10013	51564	55869	9734	2648	8850	9794	84441	55534	10046	9611	9612	4851	4853	4854	4855	3516	22938	6907	79718
PC_912	Regulation of ornithine decarboxylase (ODC)	51582	1728	4946	4947	51686	4953	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	7979
PC_913	Regulation of thyroid hormone activity	1733	1734	1735
PC_914	Agmatine biosynthesis	79814	113451
PC_915	Interconversion of polyamines	196743	6303	54498
PC_916	Metabolism of polyamines	262	4953	6611	6723
PC_917	Apoptotic cleavage of cell adhesion proteins	836	999	1499	1828	1829	1830	1832	100506658	5317	7082	9414
PC_918	Amino acid transport across the plasma membrane	117247	6509	6510	123096	206358	153201	120103	81539	54407	10991	55089	92745	6519	6520	8501	124935	6539	11254	55117	348932	340024	54716	6533	6541	56301	23657	6542	84889	8140	9057	9056	23428	11136
PC_919	Breakdown of the nuclear lamina	839	4000	4001
PC_920	Integrin alphaIIb beta3 signaling	207	54518	1445	2243	2244	2266	2335	3674	3690	5170	5747	5770	5906	5908	10411	11069	10125	10235	6464	6714	6850	7094	7450
PC_921	GRB2	54518	2243	2244	2266	2335	2885	3674	3690	5747	5906	5908	6654	6714	7094	7450
PC_922	Defective B4GALT7 causes EDS, progeroid type	375790	11285	63827	633	1464	10675	1634	2817	221914	2719	2239	2262	10082	3339	1463	6382	6383	9672	6385	1462
PC_923	Defective SLC26A2 causes chondrodysplasias	1836
PC_924	Defective PAPSS2 causes SEMD-PA	9060
PC_925	Defective B3GAT3 causes JDSSDHD	375790	26229	63827	633	1464	10675	1634	2817	221914	2719	2239	2262	10082	3339	1463	6382	6383	9672	6385	1462
PC_926	Defective CHST3 causes SEDCJD	63827	633	9469	1464	10675	1634	1463	1462
PC_927	Defective CHST14 causes EDS, musculocontractural type	63827	633	113189	1464	10675	1634	1463	1462
PC_928	Defective CHSY1 causes TPBS	63827	633	22856	1464	10675	1634	1463	1462
PC_929	TGFBR2 MSI Frameshift Mutants in Cancer	7040	7048
PC_930	TGFBR2 Kinase Domain Mutants in Cancer	7040	7046	7048
PC_931	Defective CHST6 causes MCDC1	176	4166	2331	11081	4060	4969	4958	5549
PC_932	Defective HEXA causes GM2G1	3073
PC_933	Defective EXT2 causes exostoses 2	375790	2131	2132	2817	221914	2719	2239	2262	10082	3339	6382	6383	9672	6385
PC_934	Defective ST3GAL3 causes MCT12 and EIEE15	176	2331	11081	4060	4969	4958	5549	6487
PC_935	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	176	2683	2331	11081	4060	4969	4958	5549
PC_936	Defective HEXB causes GM2G2	3074
PC_937	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	375790	2131	2132	2817	221914	2719	2239	2262	10082	3339	6382	6383	9672	6385
PC_938	TGFBR1 KD Mutants in Cancer	4087	4088	7040	7046	7048	9372
PC_939	TGFBR1 LBD Mutants in Cancer	2280	7040	7046	7048
PC_940	p130Cas linkage to MAPK signaling for integrins	54518	9564	1398	2243	2244	2266	2335	3674	3690	5747	5906	5908	6714	7094	7450
PC_941	Class A/1 (Rhodopsin-like receptors)	1240	1268	1269	151306	29933	2841	1880	2859	2863	2828	9290	8477	8111	338442	4543	4544	27199	5724	56670
PC_942	Class B/2 (Secretin family receptors)	2015	30817	84658	1604	976	1392	1393	104909134	1395	50846	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	3549	5727	8643	5741	5745	113091	5746	5744	6469	6608	7349	90226	114131	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	7475	7476	7477	7478	7479	7483	7484
PC_943	Netrin-1 signaling	116986	1630	7430	148738	4651	4756	9423	59277	5588	56963	285704	6091	6477	6478	6585	9353	6586	90249	219699
PC_944	Nephrin family interactions	87	88	89	81	8573	23607	2534	8826	55243	84063	84623	9863	4690	8440	4868	5290	5291	5295	5296	6709	6711	8976
PC_945	SDK interactions	221935	54549
PC_946	L1CAM interactions	214	100133941	1272	6900	2048	2596	3897	284217	3912	3915	11313	1463	55705
PC_947	NCAM signaling for neurite out-growth	1385	2260	2534	2885	3265	3845	5594	5595	4684	4893	5747	5786	9252	6654	6708	6709	6710	6711	6712	57731	51332	6714
PC_948	Peptide ligand-binding receptors	2532	183	185	186	8862	187	623	624	680	718	719	727	728	27202	885	886	887	1325	3576	1889	110599583	1906	1907	1908	1909	1910	2147	2149	2150	2151	9002	51083	2587	8811	8484	51738	2693	2852	2861	9283	2922	2925	3792	3814	84634	3827	4157	4158	4159	4160	4161	2847	84539	100507027	2862	57486	4828	4829	129521	10874	10316	56923	256933	2831	2832	594857	387129	283869	4852	4886	4887	100996758	4889	4922	4923	23620	4985	4986	4987	4988	5173	5179	5367	5368	5443	5539	51052	2834	84432	60675	10887	128674	5660	5697	6750	6751	6752	6753	6754	6755	7200	7201	10911	257313	2837	7504
PC_949	Amine ligand-binding receptors	4935	134864	9287	9038	319100	83551	134860
PC_950	Hormone ligand-binding receptors	1081	2488	2492	2796	2797	2798	170589	122876	3972	3973	7252	7253
PC_951	DSCAM interactions	1630	1826	57453	5600	6300	5603	1432	5599	9423	5058	5879
PC_952	Signaling by ROBO receptors	6387	7852	55740	51466	23767	2817	8829	5216	5217	6091	6092	6585	9353	6586	7408
PC_953	Deactivation of the beta-catenin transactivating complex	207	208	324	9070	607	283149	8945	25776	57680	1487	1499	56998	3065	8085	51176	4221	26108	90780	5929	6233	9580	64321	6657	6658	6659	55553	83595	6662	6736	6932	83439	6934	7088	7089	7090	7091	7311	7314	7316	331	7514	7534
PC_954	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	22943	27123	27121	83999	79412	4041	4040	6422	6423	50964	11197	89780	54361	7474	7483
PC_955	Myoclonic epilepsy of Lafora	2992	2997	378884	5507	6233	7311	7314	7316
PC_956	Enzymatic degradation of dopamine by COMT	1312	220074	4128
PC_957	Enzymatic degradation of Dopamine by monoamine oxidase	1312	4128
PC_958	Clearance of dopamine	6531
PC_959	Cytosolic tRNA aminoacylation	16	9255	7965	833	1615	9521	2058	2193	10056	2617	3035	3376	3735	51520	4141	4677	5464	2058	5917	6301	6897	7407	7453	8565
PC_960	Mitochondrial tRNA aminoacylation	57505	79587	55157	124454	10667	2617	23438	55699	3735	23395	92935	79731	25973	27068	2058	57038	54938	80222	7407	10352	51067
PC_961	Tachykinin receptors bind tachykinins	6863	6866	6869	6865	6870
PC_962	Chemokine receptors bind chemokines	57007	51554	6346	6357	6360	6363	6364	6366	6370	10850	56477	6352	1230	1238	729230	1232	1233	1234	9034	1236	1237	10803	9034	6376	1524	2919	3627	6373	6387	10563	58191	2920	2921	6374	6372	3576	4283	3577	3579	2833	7852	643	10663	5196	5473	6375	6846	2829
PC_963	Loss of Nlp from mitotic centrosomes	10121	10142	7840	9738	983	55755	55835	22994	9662	22995	22897	55125	11190	80184	95681	9702	80254	80321	55722	79959	84131	1069	9793	23332	11064	1453	102800317	1639	10540	11258	1778	1781	8655	11116	115106	55142	79441	54930	23354	54801	55559	93323	3320	22919	54820	121441	4751	22981	4957	8481	5048	5108	5116	5347	10733	5518	5578	5577	10806	9814	8636	7846	7277	203068	10382	10383	7283	7531	7532
PC_964	Recruitment of mitotic centrosome proteins and complexes	10121	10142	7840	9738	983	728642	984	55755	55835	22994	9662	22995	22897	55125	11190	80184	95681	9702	80254	80321	55722	79959	84131	1069	9793	23332	11064	1453	102800317	1639	10540	11258	1778	1781	8655	11116	115106	55142	79441	54930	23354	54801	55559	93323	3320	22919	440145	653784	80097	54820	121441	4751	22981	29922	4957	8481	5048	5108	5116	5347	10733	5518	5578	5577	10806	9814	8636	7846	7277	203068	10382	10383	7283	27175	10844	10426	27229	114791	85378	7531	7532
PC_965	Loss of proteins required for interphase microtubule organization from the centrosome	10121	10142	7840	9738	983	55755	55835	22994	9662	22995	22897	55125	11190	80184	95681	9702	80254	80321	55722	79959	84131	1069	9793	23332	11064	1453	102800317	1639	10540	11258	1778	1781	8655	11116	115106	55142	79441	54930	23354	54801	55559	93323	3320	22919	54820	121441	4751	22981	4957	8481	5048	5108	5116	5347	10733	5518	5578	5577	10806	9814	8636	7846	7277	203068	10382	10383	7283	7531	7532
PC_966	Recruitment of NuMA to mitotic centrosomes	10121	10142	7840	9738	983	55755	55835	22994	9662	22995	22897	55125	11190	80184	95681	9702	80254	80321	55722	79959	84131	1069	9793	23332	11064	1453	102800317	1639	10540	11258	1778	1781	8655	11116	115106	55142	79441	54930	23354	54801	55559	93323	3320	22919	440145	653784	80097	54820	121441	4751	22981	29922	4926	4957	8481	5048	5108	5116	5347	10733	5518	5578	5577	10806	9814	8636	7846	7277	203068	10382	10383	7283	27175	10844	10426	27229	114791	85378	7531	7532
PC_967	Metabolism of serotonin	217	4128
PC_968	Clearance of seratonin	6532
PC_969	Energy dependent regulation of mTOR by LKB1-AMPK	51719	81617	55004	28956	8649	389541	10542	64223	2475	5494	5562	5563	5564	5565	5571	51422	53632	6009	57521	10670	10325	58528	153129	6794	92335	55437	7248	7249
PC_970	ATF4 activates genes in response to endoplasmic reticulum stress	440	467	468	22926	6347	1054	3576	167227	22894	51013	23404	51010	54512	56915	118460	23016	11340	5393	9709	3484	8570	4800	4801	4802	5073
PC_971	ATF6 (ATF6-alpha) activates chaperones	22926	3309	8720	51360
PC_972	XBP1(S) activates chaperone genes	37	118	55738	9114	10106	9820	30827	1639	1663	51726	4189	5611	9695	2134	2135	2137	55033	2673	9570	2931	3068	10525	11015	116138	4000	56005	10954	10130	100137049	5526	10113	22872	27230	6464	6734	58477	6745	445329	84447	9797	7094	1200	64061	7466	55062	7494	10897	7709
PC_973	PERK regulates gene expression	468	9451	1965	8894	1968	3309
PC_974	IRE1alpha activates chaperones	2081	3309	7494
PC_975	ATF6 (ATF6-alpha) activates chaperone genes	468	22926	811	7184	3309	4800	4801	4802	7494
PC_976	Transcriptional regulation of white adipocyte differentiation	9370	10974	51129	10498	892	896	948	23097	1019	1024	1050	1051	1052	80205	1387	1879	1959	2033	2167	84498	8841	85441	9314	688	3952	4023	8930	84246	400569	9968	9969	23389	9282	51586	10025	9440	54797	219541	9477	9412	6837	9439	9862	81857	9441	9442	80306	55588	90390	51003	29079	10001	9443	112950	55090	8648	10499	8202	23054	9611	9612	4790	7026	5105	5346	5465	5468	10891	5970	6256	6517	6604	6720	6721	6907	79718	7040	96764	9967	7124	7471	7480	168544	27332
PC_977	Regulation of IGF Activity by IGFBP	102	174	197	213	258	265	401138	57719	334	335	336	116519	338	348	8542	351	9210	652	80341	718	720	813	3491	1000	1114	91851	10970	1356	1435	1471	1511	1758	5611	10117	84141	2147	2153	54757	56975	2200	2243	8074	2266	2335	11167	10272	2519	2621	51280	2719	2999	3270	7184	3479	3481	3483	3484	3485	3486	3487	3488	3489	3490	3569	3698	3816	26085	3817	3818	3827	3895	3912	3915	3915	3956	4052	4148	8720	4241	4221	56955	4240	11320	375056	4312	4313	10232	54587	147111	4924	5034	5069	60676	255738	10130	5179	5340	57104	5589	5624	11098	5768	5954	4221	29106	6383	5265	51156	462	3053	51246	8404	6696	6694	8614	7018	10618	7076	54972	3371	1462	7425	64856	7466
PC_978	GSD XV	2992	2997
PC_979	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	111	112	114	9495	2641	2740	2778	2782	2783	2784	59345	10681	2790	2791	55970	51764	54331	2785	2786	2787	2788	2793	2792	2793	8826	3708	3709	3710	3745	3747	26251	3790	5578	5567	5568	5573	5575	5576	5577	5906	10411	11069
PC_980	Olfactory Signaling Pathway	2774	2782	2792	341276	26496	283297	144124	390093	121364	121275	282770	442194	26534	26533	390264	390265	219869	219870	26539	26538	26532	126541	284433	26476	441911	127385	391109	391107	121130	219960	343406	219873	128360	390201	81341	128367	128368	26531	390439	81061	79334	390442	122748	390441	391189	26529	81797	79290	392376	138803	138804	138799	138802	286362	286365	138805	441933	347468	392309	284532	127066	401994	442191	8383	26189	347169	26188	4991	8386	8387	8388	4992	8390	126370	347168	26740	26219	392392	26737	26735	254973	392390	138881	125963	138883	138882	158131	219959	219958	346528	346525	135941	442361	392138	79541	346528	393046	401427	81392	144125	338755	391191	121129	341152	127623	81697	442184	26212	4993	81472	120776	120775	26211	135948	81470	81469	391211	26716	7932	442185	26707	442186	26248	284521	26246	391192	81466	391190	391194	127062	26245	127059	391196	56656	26696	127069	127077	127064	401992	403239	343563	343173	391195	127068	403244	127074	401993	254879	343172	26693	285659	26692	343171	441932	134083	284383	4994	4995	8392	81328	81327	403253	81318	119765	219429	283093	283092	81309	219428	256144	403257	119749	79346	219432	26689	390197	219986	124538	219875	219983	390199	26687	390649	26683	81099	441308	26683	26683	26682	79501	390648	79544	390433	122740	81127	390436	390431	79317	122742	441670	390538	390429	102723532	390437	81300	441669	256148	219431	390113	119764	401667	401666	119687	79345	79339	282763	390058	390038	143503	81285	119694	79324	81282	401663	390063	390064	79470	119682	390059	390061	119692	401665	283111	23538	390054	255725	340980	390066	79296	119678	390081	390078	390079	390067	390037	143502	119679	390036	119774	338751	119772	79473	390077	390072	390075	119695	120787	283110	120796	390083	120793	390084	387748	196335	219982	219981	81050	390181	79482	390195	338675	219493	219447	390445	390191	219965	390190	219968	441608	392391	390142	219436	390144	219438	338674	26341	403273	403274	79310	79295	10798	282775	26339	402135	403277	403278	219437	26338	390168	390167	219487	219482	219484	390162	120065	120066	219479	390155	219464	390154	81696	390148	8590	135946	389090	150681	390321	341416	254786	341418	283365	403282	403284	390327	254783	390323	390326	343169	81448	391114	128371	390261	128372	81442	128366	219952	341799	219874	346517	390260	391112	390892	26333	26659	26664	26658	162998	125958	26648	125962	390882	390883	390275	219858	26595	390271	283162	26493	283159	283160	338662	26494	26492	219865	219469	390151	390152	120586	219477	81168	390157	219473	219453	341568	219417	504189	504190	135924	130075	390174	283189	219954	441639	219956	219957	65055	51308	221035	80346	7905	92840	132112	344892	83597	64108	285093
PC_981	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	1045	1499	1803	2864	338557	2641	346562	2784	51764	139760	2922	3952	5080	5122	23478	90701	28972	9789	60559	6934
PC_982	ABC-family proteins mediated transport	24	10351	5243	5244	340273	23457	4363	89845	85320	1244	8714	10257	10057	368	10060	23	1080	79139	51009	91319	1965	8894	1968	27248	10613	11160	3767	10956	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	91445	6048	6233	6400	7979	7311	7314	7316	7415
PC_983	GSD 0 (muscle)	2992	2997
PC_984	Nuclear Receptor transcription pathway	367	2099	2100	2101	2103	2104	3172	3174	8930	9611	9612	190	8431	9572	9975	7376	10062	9971	8856	9970	7181	7182	126382	7101	10002	7025	2063	2908	4306	3164	4929	8013	2516	2494	2649	29982	29959	5241	5465	5467	5468	5914	5915	5916	6095	6097	6256	6257	6258	7067	7068	7421
PC_985	GSD 0	8908	2998
PC_986	GSD IV	2632	8908	2998
PC_987	Vasopressin-like receptors	551	552	553	554	5020	5021
PC_988	Costimulation by the CD28 family	151888	2885	29851	23308	5290	5295	5296	8503	5781	5777	8764
PC_989	Receptor-type tyrosine-protein phosphatases	3556	11141	26280	94030	4916	8500	8499	8541	8497	8496	8495	5789	5792	5802	114798	84631	22865	139065	26050	84189
PC_990	CD28 co-stimulation	940	941	942	2534	9402	3932	4067	6714	7525
PC_991	CD28 dependent PI3K/Akt signaling	207	208	10000	940	941	942	2534	3932	9020	1326	79109	64223	2475	5170	5290	5295	5296	8503	55615	253260	117145	57761
PC_992	CD28 dependent Vav1 pathway	940	941	942	998	2534	2885	3932	5058	5062	5063	5879	7409
PC_993	Orexin and neuropeptides FF and QRFP bind to their respective receptors	3060	3061	3062	8620	64106	10886	347148	84109
PC_994	CTLA4 inhibitory signaling	207	208	10000	941	942	1493	2534	3932	4067	5515	5516	5518	5519	5525	5526	5527	5528	5529	5781	6714	7525
PC_995	NADPH regeneration	3417
PC_996	Alpha-oxidation of phytanate	224	26061	55825	5264	10478	11001
PC_997	Glyoxylate metabolism and glycine degradation	189	64902	8659	593	594	1610	1629	8528	55526	1737	1738	1743	2653	27232	2806	9380	54363	112817	11019	51601	387787	4706	4967	5160	5161	5162	8050	5625	5827
PC_998	Beta-oxidation of pristanoyl-CoA	10005	8309	8310	55289	23600	1384	54677	3295	10106
PC_999	SUMOylation of transcription cofactors	100532731	9994	84733	8535	57332	1387	1487	1616	10521	1655	2033	28996	3622	4152	57591	8648	10499	9612	4869	8204	11315	7703	1911	1912	80012	8554	9063	10401	51588	10891	6015	6045	6294	22955	25942	7341	6613	6612	10210	10155	7329	115426	7690	59348
PC_1000	PD-1 signaling	919	29126	915	916	917	920	1445	3113	3115	3117	3118	3119	3120	3122	3123	3125	3126	3127	3932	5133	80380	5781	5777
PC_1001	Prefoldin mediated transfer of substrate to CCT/TriC	60	10576	7203	10575	22948	908	10693	10574	10694	5201	5202	5203	5204	10471	6950	7846	84790	7278	113457	7277	81027	7280	347733	10381	10382	10383	84617	7411
PC_1002	Formation of tubulin folding intermediates by CCT/TriC	10576	7203	10575	22948	908	10693	10574	10694	6950	7846	10376	84790	7278	113457	112714	7277	51807	79861	81027	7280	347733	10381	10382	10383	84617
PC_1003	Post-chaperonin tubulin folding pathway	402	6902	1155	6903	6904	6905	7846	10376	84790	7278	113457	112714	7277	51807	79861	81027	7280	347733	10381	10382	10383	84617
PC_1004	Beta-oxidation of very long chain fatty acids	215	30	122970	641372	10005	51	26063	10455	1962	3295	23417
PC_1005	Folding of actin by CCT/TriC	60	10576	7203	10575	22948	908	10693	10574	10694	6950
PC_1006	Association of TriC/CCT with target proteins during biosynthesis	26985	10564	898	9134	10576	7203	10575	22948	908	10693	10574	10694	10238	26224	26234	26272	26270	10517	26190	6468	54461	55294	84261	11328	26330	2629	8841	63971	3801	83752	10528	6499	8877	6774	6950	7157	8237	55135	22803
PC_1007	Striated Muscle Contraction	88	89	1674	1756	4604	4606	4607	4621	4624	4626	4632	4633	4634	4635	4703	8557	7111	29767	29766	29765	7137	7125	7135	7136	7137	7138	7139	7140	7168	7169	7170	7171	7273	7431
PC_1008	Muscarinic acetylcholine receptors	1128	1129	1131	1132	1133
PC_1009	Histamine receptors	3269	3274	11255	59340
PC_1010	Dopamine receptors	1812	1813	1814	1815	1816
PC_1011	Serotonin receptors	3350	3351	3352	3354	3355	3356	3357	3358	3360	3361	3362	3363
PC_1012	Adrenoceptors	146	147	146	150	151	152	153	154	155
PC_1013	Peroxisomal lipid metabolism	79777	91452	51179	390916	283927
PC_1014	Signal regulatory protein family interactions	961	2533	2885	5747	2185	5781	5777	140885	10326	55423	8935	6714	7305
PC_1015	Eicosanoid ligand-binding receptors	165140
PC_1016	Leukotriene receptors	10800	57105	2840	1241	56413
PC_1017	Prostanoid ligand receptors	5729	11251	5731	5734	5733	5734	5737	5739	6915
PC_1018	Adrenaline signalling through Alpha-2 adrenergic receptor	150	151	152
PC_1019	Nitric oxide stimulates guanylate cyclase	2982	2977	2983	4842	4843	4846
PC_1020	ADP signalling through P2Y purinoceptor 12	2770	2771	2773	346562	2782	2783	2784	59345	10681	2790	2791	55970	51764	54331	2785	2786	2787	2788	2793	2792	2793	64805
PC_1021	G beta	207	208	10000	2782	2783	2784	59345	10681	2790	2791	55970	51764	54331	2785	2786	2787	2788	2793	2792	2793	5170	5294	23533	146850	387
PC_1022	Rap1 signalling	5578	5567	5568	5592	5894	5906	5908	5909	23108	10411	11069	10125	10235	6494	7529	7534
PC_1023	Prostacyclin signalling through prostacyclin receptor	2778	2782	2783	2784	59345	10681	2790	2791	55970	51764	54331	2785	2786	2787	2788	2793	2792	2793	5739
PC_1024	EPHB-mediated forward signaling	60	71	10097	10096	64283	10552	10095	10109	10094	10093	10092	998	1072	2534	2902	2904	3265	6453	8997	3984	3985	4067	5058	5747	5879	5921	387	6093	9475	6383	6714	7074	8976	7525
PC_1025	EPHA-mediated growth cone collapse	2534	4067	4628	4629	79784	4627	103910	4637	10398	25791	387	6093	9475	6714	7525
PC_1026	Ephrin signaling	8874	1947	1948	1949	2047	2048	2049	2050	2051	2534	28964	10627	8440	5058	5062	5063	5879	6386	6714
PC_1027	EPH-ephrin mediated repulsion of cells	102	160	161	163	1173	1175	51107	83464	1211	1212	1213	8218	1759	1942	1943	1944	1945	1946	1947	1948	1949	2041	284656	1969	2042	2043	2044	285220	2045	2046	2047	2048	2049	2050	2051	2534	4067	4313	4318	23385	5663	5664	55851	5879	6714	7074	7410	10451	7525
PC_1028	Activation of AMPA receptors	2890	2891	2892	2893
PC_1029	Trafficking of AMPA receptors	9495	10369	10368	27092	59283	815	816	817	818	1739	1742	2036	2890	2892	2893	4193	4646
PC_1030	Sema3A PAK dependent Axon repulsion	1072	2242	2534	3320	3326	3984	8829	5058	5062	5063	5361	5362	55558	91584	5879	10371
PC_1031	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	9855	2242	2534	8829	23396	5361	5362	55558	91584	5879	27289	6237	10371	7094
PC_1032	CRMPs in Sema3A signaling	1020	8851	1400	1808	1809	10570	56896	2242	2534	2932	8829	5361	5362	55558	91584	10371
PC_1033	Acetylcholine regulates insulin secretion	1131	2767	9630	2769	2776	4082	23236	5330	5331	5578
PC_1034	Adrenaline,noradrenaline inhibits insulin secretion	111	112	150	152	775	776	9254	783	784	2770	2771	2782	2783	2784	59345	10681	2790	2791	55970	51764	54331	2785	2786	2787	2788	2793	2792	2793
PC_1035	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	10498	80205	1387	2168	8841	85441	8930	8648	10499	23054	9611	9612	5465	6256	25942	23309	6604	6907	79718	96764
PC_1036	Circadian Clock	406	1386	79365	8945	10498	80205	9575	1385	1387	1390	23373	200186	64784	1407	1408	1453	102800317	8454	2033	26224	8841	85441	3091	8930	4208	4209	8648	10499	23054	9611	4783	4862	9572	2908	8204	5187	8864	5465	10891	5499	5500	5501	10743	5936	6095	6233	6256	102724428	23411	6500	6604	6907	79718	96764	7311	7314	7316	64854
PC_1037	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	1803	2864	2626	2695	139760	3670	5080	5122	23478	90701	28972	9789	60559
PC_1038	Defective PMM2 causes PMM2-CDG (CDG-1a)	5373
PC_1039	Defective MPI causes MPI-CDG (CDG-1b)	4351
PC_1040	Sialic acid metabolism	55907	5476	2720	10020	140838	54187	4758	4759	10825	129807	80896	26503	10559	6482	6483	6487	6484	8869	10402	6480	84620	55808	10610	256435	27090	81849	30815	6489	8128	51046	7903	29906	338596
PC_1041	Defective GNE causes sialuria, Nonaka myopathy and inclusion body myopathy 2	10020
PC_1042	Defective GFPT1 causes CMSTA1	2673
PC_1043	SUMOylation of SUMOylation proteins	8086	55706	57122	55746	9972	9631	23279	23511	23165	23225	8021	129401	79023	11097	348995	10762	53371	9818	23636	79902	4927	9688	4928	51588	9883	8480	5903	6396	81929	7341	6613	10210	7175	7329
PC_1044	Ca2+ pathway	26523	27161	192669	192670	8313	801	815	1499	2535	8326	8322	7855	8323	2775	2780	2782	2783	2784	59345	10681	2790	2791	55970	51764	54331	2785	2786	2787	2788	2793	2792	2793	3708	3709	3710	51176	6885	4343	4609	4772	51701	5145	5158	5148	23236	5330	5331	5530	5532	5534	5578	5592	5593	6932	83439	6934	27327	23112	57690	7481	7474
PC_1045	PCP/CE pathway	23002	1855	1856	1857	8321	8326	8323	8324	5216	5879	5880	5881	387	4920	6259	57216	7471	7481	54361	7474	81029
PC_1046	SUMOylation of intracellular receptors	367	2099	9759	7376	10062	9971	8856	7181	2908	4306	4929	2516	2494	5241	8554	9063	10401	51588	5465	5468	5914	6095	6256	7341	6613	6612	7067	7068	7329	7421
PC_1047	G alpha (q) signalling events	146	147	146	183	185	301	351	115557	551	552	553	623	624	680	695	846	885	886	887	6368	1128	1131	1133	10800	57105	1906	1907	1908	1909	1910	2147	2149	2150	2151	9002	2864	2867	2865	338557	2358	2520	2641	2642	51738	2693	2767	9630	2769	2776	2782	2783	2784	59345	10681	2790	2791	55970	51764	54331	2785	2786	2787	2788	2793	2792	2793	2796	2797	2798	29933	4935	2840	2863	2828	8477	8111	222545	156	2869	2911	2915	2922	2925	3060	3061	3062	3269	3356	3357	3358	8997	3814	84634	3827	1902	9170	23566	2846	57121	10161	1241	56413	2847	84539	100507027	2862	4828	4829	129521	10874	10316	56923	8620	64106	10886	594857	387129	4922	4923	23620	94233	5020	5021	5028	27334	5032	5029	5031	5290	5295	5296	8503	23236	5330	5331	5332	5367	84432	60675	10887	128674	5724	5731	5737	347148	84109	5996	6003	6004	26575	64407	10287	5997	431704	5998	5999	8490	353299	6288	6863	6866	6869	6865	6870	6915	7200	7201	7204	10911	257313	2837	6375	6846	2829
PC_1048	G alpha (12/13) signalling events	29	146	147	146	11214	9138	9639	55160	9826	23365	22899	27237	9828	23370	128272	9181	26084	50650	100271715	445328	389337	54848	84904	50649	55701	7984	9459	8874	23229	695	1894	2245	221472	89846	121512	2768	10672	2782	2783	2784	59345	10681	2790	2791	55970	51764	54331	2785	2786	2787	2788	2793	2792	2793	6453	8997	4168	23263	6530	25791	84033	64857	57449	5364	57580	5924	387	388	389	6093	9475	6654	6655	6915	7074	26230	7204	7409	7410	10451
PC_1049	Sema4D mediated inhibition of cell attachment and migration	2909	4233	5364	5879	387	27289	6237	10507
PC_1050	Sema4D induced cell migration and growth-cone collapse	9826	23365	2064	3984	3985	4628	4629	79784	4627	103910	4637	10398	5364	387	388	389	27289	6093	9475	10507
PC_1051	Other semaphorin interactions	971	3672	3688	5361	5362	91584	5365	10154	23129	5788	9723	64218	10507	9037	57556	80031	8482	54209	7305
PC_1052	Trafficking of GluR2-containing AMPA receptors	160	161	163	1173	1175	2890	2891	2892	2893	85329	80852	4905	9463	5578	5579	5582	7102
PC_1053	P2Y receptors	2840	2846	10161	5028	27334	5032	64805	53829	9934	5029	5030	5031
PC_1054	Adenosine P1 receptors	134	135	136	140
PC_1055	G beta	2782	2783	2784	59345	10681	2790	2791	55970	51764	54331	2785	2786	2787	2788	2793	2792	2793	23236	5330	5331
PC_1056	Platelet homeostasis	5023	22953	5024	5025	5026	9127	5027	5051
PC_1057	Reduction of cytosolic Ca++ levels	487	488	489	490	493	492	493	801	6546	6543	6547	6717
PC_1058	cGMP effects	3708	3778	3779	27094	27094	27345	10335	10846	50940	5136	5153	5138	8654	5152	5592	5593
PC_1059	G alpha (s) signalling events	107	108	109	196883	111	112	113	114	115	116	117	133	79924	135	136	153	154	155	408	409	551	554	796	797	799	10203	1081	1392	104909134	1395	1812	1816	2488	2492	2641	2642	2691	2692	2695	2696	2740	9340	2770	2771	2773	2778	346562	2781	2782	2783	2784	59345	10681	2790	2791	55970	51764	54331	2785	2786	2787	2788	2793	2792	2793	151306	170589	122876	2838	285601	11245	2843	2848	2850	2854	2863	11250	10888	53831	156	157	2869	2870	3274	3360	3362	3363	3375	3640	3972	3973	4157	4158	4159	4160	4161	594857	387129	5032	10846	50940	5136	5153	5138	5139	5140	5141	5143	5144	5150	27115	5151	8622	5443	5729	5734	5734	5739	5741	5745	113091	5746	5744	10267	10266	10268	6019	117579	59350	122042	6343	6344	6714	134864	9287	9038	319100	83551	134860	7252	7253	7432	7433	7434
PC_1060	ADP signalling through P2Y purinoceptor 1	2767	9630	2769	2776	2782	2783	2784	59345	10681	2790	2791	55970	51764	54331	2785	2786	2787	2788	2793	2792	2793	1432	5028	5321	6714
PC_1061	G alpha (i) signalling events	57007	107	108	109	196883	111	112	113	114	115	134	140	150	151	152	183	186	301	8862	187	351	623	624	718	719	727	728	846	6346	6357	6360	6363	6364	6366	6368	6370	10850	56477	388372	388372	388372	6352	1230	1238	729230	1232	1233	1234	9034	1236	1237	10803	1129	1132	1268	1269	1325	6376	1524	2919	3627	6373	6387	10563	58191	2920	2921	6374	6372	3576	4283	3577	3579	2833	7852	643	10663	1813	1814	1815	2357	2358	2359	2550	9568	51083	2587	8811	8484	2770	2771	2773	2778	2779	2780	346562	2781	2782	2783	2784	59345	10681	2790	2791	55970	51764	54331	2785	2786	2787	2788	2793	2792	2793	2852	2840	2841	1880	2853	2861	9283	9290	26086	29899	63940	2912	2913	2914	2916	2917	2918	27198	338442	8843	50865	11255	59340	3350	3351	3352	3354	3355	3361	10022	3827	1902	9170	23566	57121	2847	84539	4543	4544	129521	10874	10316	56923	256933	2831	2832	283869	4852	4886	4887	100996758	4889	5956	101060233	611	23596	221391	4985	4986	4987	4988	165140	27199	64805	53829	9934	5030	126006	5173	5179	5196	5367	5368	5443	5473	5539	5660	11251	5733	5697	5995	5996	6001	8786	6002	6003	10636	6004	26575	64407	10287	8601	431704	26166	5998	5999	8490	9628	6000	85397	8787	353299	6010	117579	10692	51289	339403	1901	9294	1903	8698	53637	6288	6714	6750	6751	6752	6753	6754	6755	56670	80835	80834	83756	50834	50839	50838	50840	50833	259294	259295	50831	259293	259290	5726	259285	50832	259286	259287	259289	259292	54429	259296	338398	50837	50836	50835
PC_1062	G alpha (z) signalling events	107	108	109	196883	111	112	113	114	115	150	151	152	2770	2771	2773	2778	346562	2781	2782	2783	2784	59345	10681	2790	2791	55970	51764	54331	2785	2786	2787	2788	2793	2792	2793	5578	5579	5580	5581	5582	5588	6004	26575	10287	8601	5999	353299
PC_1063	DCC mediated attractive signaling	3983	84448	22885	998	1630	1793	2534	4690	9423	5747	5879	6714	7204	8976
PC_1064	Netrin mediated repulsion signals	1630	9423	5781	6714	90249	219699	8633	137970
PC_1065	Ligand-independent caspase activation via DCC	26060	836	842	1612	23604	1613	1630	9500	90249	219699
PC_1066	Role of second messengers in netrin-1 signaling	1630	9423	5306	5335	7220	7222	7223	7224	7225	7226
PC_1067	Adherens junctions interactions	4301	283	23705	253559	57863	999	1008	1009	1010	1012	1013	1015	1016	1000	64403	1001	1002	1003	1004	1005	1006	1007	1495	1499	1500	3728	5818	5819	25945	81607
PC_1068	NCAM1 interactions	375790	9048	775	776	8913	8912	8911	779	782	783	784	785	6900	1282	1284	1285	1286	1287	1291	1292	1293	256076	131873	1297	1298	1299	2668	2674	2675	64096	4684	1463	4902	5621	5623	8128	7903
PC_1069	Lysosphingolipid and LPA receptors	1902	9170	23566	57121	54886	64748	79948	9890	163404	1901	9294	1903	8698	53637
PC_1070	Opsins	5956	101060233	611	23596	94233	221391	5995	6010	10692
PC_1071	Calcitonin-like ligand receptors	133	79924	796	797	799	10203	3375	10267	10266	10268
PC_1072	Tight junction interactions	9076	9071	5010	9069	23562	24146	10686	26285	51208	149461	9075	49861	53842	137075	1365	1364	7122	9074	1366	9073	9080	92359	50848	64398	56288	50855	84612	84552	5584
PC_1073	Glucagon-type ligand receptors	116	117	2641	2642	2691	2692	2695	2696	2740	9340	2778	2782	2783	2784	59345	10681	2790	2791	55970	51764	54331	2785	2786	2787	2788	2793	2792	2793	6343	6344	7432	7433	7434
PC_1074	Class C/3 (Metabotropic glutamate/pheromone receptors)	846	2550	9568	222545	2911	2912	2913	2914	2915	2916	2917	2918	80835	80834	83756	50834	50839	50838	50840	50833	259294	259295	50831	259293	259290	5726	259285	50832	259286	259287	259289	259292	54429	259296	338398	50837	50836	50835
PC_1075	Nectin/Necl trans heterodimerization	23705	57863	5818	5819	25945	81607	5817
PC_1076	Synthesis, secretion, and deacylation of Ghrelin	43	590	1395	2641	2688	51738	3479	3630	9314	3952	619373	5122	7941	23478	90701	28972	9789	60559	7349
PC_1077	Regulation of insulin secretion	6833	10768	773	775	776	777	9254	783	784	2770	2771	3630	3708	3709	3710	3767	5578	5567	5568	10411	11069	6513	6514	6616	6804	6812	6861	6844
PC_1078	Transport of bile salts and organic acids, metal ions and amine compounds	345274	6563	8170	23446	57153	126969	80736	204962	55244	146802	60482
PC_1079	Bicarbonate transporters	23382	6521	57282	6522	6508	8671	57835	9497	9498	83697
PC_1080	Transport of inorganic cations/anions and amino acids/oligopeptides	1497	6505	6506	6507	6511	6512	115286	140679
PC_1081	Transport of vitamins, nucleosides, and related molecules	51248	9197	8884
PC_1082	Metal ion SLC transporters	1356	9843	6556	4891	55532	1317	30061	254428	84102
PC_1083	Sodium/Calcium exchangers	801	9187	25769	57419	123041	283652	6546	6543	6547	80024	6717
PC_1084	Sodium/Proton exchangers	6548	6549	6550	389015	6553	10479	84679	23315	285195
PC_1085	Arachidonate production from DAG	26090	57406	747	221955	11343
PC_1086	Cation-coupled Chloride cotransporters	6557	6558	6559	6560	57468	9990	10723
PC_1087	Small interfering RNA (siRNA) biogenesis	26523	27161	192669	192670	23405	8575	6895	7247	7257
PC_1088	Post-transcriptional silencing by small RNAs	26523	27161	192669	192670	27327	23112	57690
PC_1089	SIRT1 negatively regulates rRNA expression	474382	55766	94239	3014	3015	102724334	3020	3020	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	8350	8350	8350	8350	8350	8350	8350	8350	8350	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	126961	126961	126961	121504	121504	128312	121504	23378	23411	6839	9015	9014	9013	79101	6908
PC_1090	Activation of rRNA Expression by ERCC6 (CSB) and EHMT2 (G9a)	11335	1107	1108	10919	2074	54815	57459	474382	55766	94239	3014	3015	102724334	3020	3020	3065	3066	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	8350	8350	8350	8350	8350	8350	8350	8350	8350	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	126961	126961	126961	121504	121504	128312	121504	53615	9112	9219	57504	5928	5931	7080
PC_1091	NoRC negatively regulates rRNA expression	51742	11176	902	10849	1022	1786	1789	2068	2071	2965	2966	2967	2968	404672	474382	55766	94239	3014	3015	102724334	3020	3020	3065	3066	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	8350	8350	8350	8350	8350	8350	8350	8350	8350	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	126961	126961	126961	121504	121504	128312	121504	8932	4331	25885	84172	9533	51082	9533	5434	5435	5437	5440	5441	23450	10284	8819	29115	79685	25942	23309	8467	64426	9015	9014	9013	79101	6908	7080	221830	7343	30834
PC_1092	Type II Na+/Pi cotransporters	6569	10568	142680
PC_1093	Multifunctional anion exchangers	10861	284129	1836	1811	5172	65010	115111	115019	159963
PC_1094	Sodium-coupled phosphate cotransporters	6574	6575
PC_1095	Proton/oligopeptide cotransporters	6564	6565	51296	121260
PC_1096	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA	60	960	3481	10642	10644	10643	4609
PC_1097	Activation of RAC1	4690	8440	5058	5062	5063	10298	106821730	106821730	5879	6091	9353	6654	6655
PC_1098	Regulation of commissural axon pathfinding by SLIT and ROBO	1630	4753	9423	6091	6092	64221	6585	9353	6586	6714
PC_1099	Inactivation of CDC42 and RAC1	80728	998	5879	6091	9353	57522	9901	9901
PC_1100	Proton-coupled neutral amino acid transporters	206358	153201
PC_1101	Organic anion transporters	6568	26503	57084	57030	246213	1468	83733	79751	6528	160728
PC_1102	Role of ABL in ROBO-SLIT signaling	25	27	10487	10486	23332	23122	6091	9353
PC_1103	Thromboxane signalling through TP receptor	2767	10672	9630	2769	2776	2782	2783	2784	59345	10681	2790	2791	55970	51764	54331	2785	2786	2787	2788	2793	2792	2793	6915
PC_1104	Inositol transporters	114134	115584
PC_1105	Deadenylation of mRNA	23019	25904	55571	4848	4849	4850	246175	29883	9337	9125	1973	1974	9775	1975	1977	1981	26986	10605	9924	255967	5073	85456	23318	79670
PC_1106	mRNA decay by 3' to 5' exoribonuclease	28960	22894	51013	23404	51010	54512	56915	118460	23016	11340	5393	10767	115024	6499	9652	80349
PC_1107	mRNA decay by 5' to 3' exoribonuclease	55802	196513	167227	1656	80153	23644	27257	57819	27258	25804	23658	11157	51690	219988	54464
PC_1108	GP1b-IX-V activation signalling	2316	2811	2812	2814	2815	5295	5894	6714	7450	7534
PC_1109	Transport of glycerol from adipocytes to the liver by Aquaporins	364	364
PC_1110	Vasopressin regulates renal water homeostasis via Aquaporins	107	108	109	196883	111	112	113	114	115	358	359	360	361	551	554	2778	2782	2783	2784	59345	10681	2790	2791	55970	51764	54331	2785	2786	2787	2788	2793	2792	2793	4645	5578	5567	5568	5573	5575	5576	5577	8766	22841
PC_1111	Passive transport by Aquaporins	358	89872	282679	375318	359	360	361	362	363	364	343	364	4284
PC_1112	Platelet sensitization by LDL	338	2268	7804	1432	5175	5321	5515	5516	5518	5519	5525	5526	5527	5528	5529	5781	5777
PC_1113	Lysosome Vesicle Biogenesis	162	164	8906	8907	10053	1174	8905	130340	10717	23431	9179	11154	351	375	408	2647	27243	1211	1212	1213	157807	134829	1522	9829	1777	1785	2799	9146	3312	4074	6456	81567	6844	6845	8673
PC_1114	Golgi Associated Vesicle Biogenesis	64746	162	164	8907	10053	1174	8905	130340	8546	1176	10717	23431	375	408	2647	388552	55330	26258	9685	1211	1213	1362	9829	1785	84062	2495	2512	2580	2804	9026	3312	3482	9476	25977	4952	8301	5286	9698	5878	152503	6456	23557	6643	27131	51429	6272	54885	7037	10618	7163	7164	81567	6844	6845	8673	286451
PC_1115	Sodium-coupled sulphate, di- and tri-carboxylate transporters	6561	9058	64849	26266	284111
PC_1116	Proton-coupled monocarboxylate transport	682	133418	6566	9123	9194	23539
PC_1117	Defective NEU1 causes sialidosis	5476	2720	4758
PC_1118	Intracellular metabolism of fatty acids regulates insulin secretion	2181	2182	948
PC_1119	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	2864	2767	9630	2769	2776	23236	5330	5331
PC_1120	Zinc efflux and compartmentalization by the SLC30 family	7779	7780	7781	64924	55676	148867	169026
PC_1121	Recycling pathway of L1	160	161	163	1173	1175	1211	1213	1759	1785	26052	1808	7430	24137	285643	3897	5594	4478	8650	5962	6195	6196	6197	8986	9252	27330	6456	57698	6714
PC_1122	Unblocking of NMDA receptors, glutamate binding and activation	88	801	815	816	817	818	1739	4355	4356	1742	2890	2891	2892	2893	2902	2903	2904	2905	2906	4747
PC_1123	Binding of TCF/LEF	8313	1499	51176	4609	864	6932	83439	6934
PC_1124	Depolymerisation of the Nuclear Lamina	891	983	255919	23399	2010	221496	23592	4000	4001	23175	9663	64900	5578	5579	7112
PC_1125	VEGFA-VEGFR2 Pathway	10006	10152	558	10458	9564	55845	998	1398	1535	1536	23191	26999	1793	9844	63916	2534	3320	3315	3685	3690	3791	5600	6300	5603	1432	9261	7867	653361	4688	4689	4690	8440	10787	3071	5062	5290	5291	5295	5296	5578	5567	5568	5747	2185	5829	5879	387	6093	9475	9047	6461	25759	6714	7409	7410	10451	7422	8936	10163	10810
PC_1126	Defective B3GALT6 causes EDSP2 and SEMDJL1	375790	126792	63827	633	1464	10675	1634	2817	221914	2719	2239	2262	10082	3339	1463	6382	6383	9672	6385	1462
PC_1127	Zinc influx into cells by the SLC39 gene family	27173	57181	23516	29986	29985	55630	283375	25800	7922	64116
PC_1128	Na+/Cl- dependent neurotransmitter transporters	6570	6571	6580	6582	6529	6538	6539	6540	11254	55117	348932	340024	6530	54716	6531	6530	6533	6534	6536
PC_1129	CREB1 phosphorylation through the activation of Adenylate Cyclase	107	114	801	1385	5578	5567	5568	5573	5575	5576	5577	5613
PC_1130	CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde	801	816	818	814	84254	10645	1385	3838
PC_1131	CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling	1385	6195	6196	6197	27330
PC_1132	Ras activation upon Ca2+ influx through NMDA receptor	88	801	815	816	817	818	1739	4355	4356	1742	2902	2904	2906	3265	3845	4747	4893	5923	5924
PC_1133	Free fatty acid receptors	2864	2867	2865	338557	2853
PC_1134	RSK activation	5594	5595	5170	6195	6196	6197	27330
PC_1135	Rhesus glycoproteins mediate ammonium transport.	6005	57127	51458
PC_1136	Formyl peptide receptors bind formyl peptides and many other ligands	301	351	6368	2357	2358	2359	50865	6288
PC_1137	Relaxin receptors	3640	10022	6019	117579	59350	122042	51289	339403
PC_1138	Interaction between L1 and Ankyrins	286	287	288	3785	3786	3897	23114	4897	6336	11280	6323	6324	6326	6327	6328	55800	6329	6330	6331	6332	6334	6335	6708	6709	6710	6711	6712	57731	51332
PC_1139	Signal transduction by L1	1457	1459	1460	1956	2260	3674	3678	3680	3685	3688	3690	3897	5604	5605	5594	5595	4684	8829	5058	5879	7410
PC_1140	Smooth Muscle Contraction	59	72	301	302	309	800	801	859	8291	2982	2977	2983	3672	3693	25802	4629	93408	10627	103910	4636	4637	140465	58498	10398	4638	29895	5058	5062	5829	10580	10174	7094	7168	7169	7170	7171	493829	7414
PC_1141	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	177	351	1147	3146	3551	8517	3654	3656	6885	4790	4791	4792	4793	28512	28511	10392	64127	5970	8767	6283	6285	6288	10454	23118	257397	7189	7334	387522
PC_1142	Type I hemidesmosome assembly	977	1308	667	3655	3691	3909	3914	3918	5339
PC_1143	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	56052	84920	144245	440138	79087	79868	199857	10016	10195	29929	79053	79796	1798	9526	91869
PC_1144	Synthesis of Dolichyl-phosphate	79947	22845	57171	4597	116150	79644
PC_1145	Asparagine N-linked glycosylation	432	433	124872	1603	1650	84061	6184	6185	3703	7991	7369
PC_1146	Synthesis of GDP-mannose	29926	29925	4351	5372	5373
PC_1147	Synthesis of UDP-N-acetyl-glucosamine	51005	2673	9945	64841	55577	5238	5973	6675
PC_1148	Localization of the PINCH-ILK-PARVIN complex to focal adhesions	3611	3688	55742	5829
PC_1149	Cell-extracellular matrix interactions	54751	10979	2316	2318	3611	3987	55679	55742	29780	7408
PC_1150	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	87	9459	3987	55742	29780	5829	6251	7016
PC_1151	NrCAM interactions	286	6900	1739	4356	1742	4897	8828
PC_1152	CHL1 interactions	286	10752	27255	3312	3672	8515	3673	3688	8829
PC_1153	Neurofascin interactions	286	1272	8506	1641	23114	4897	6386
PC_1154	Interleukin-17 signaling	3605	27189	112744	23765	55540	84818	132014	64806
PC_1155	Interleukin-1 processing	834	1511	3606	3552	3553	4790	4791	5970
PC_1156	Other interleukin signaling	836	920	1435	1436	1440	1441	282618	163702	3588	3603	9235	146433	3716	5657	5803	6382	6616	6804	6809	6810	6813	200081	7297	6844
PC_1157	activated TAK1 mediates p38 MAPK activation	8517	3654	3656	5606	5608	6885	5600	1432	9261	7867	10392	64127	8767	10454	23118	257397	7189	7334	387522
PC_1158	JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1	8517	3654	3656	6416	5609	6885	5602	5599	5601	10392	64127	8767	10454	23118	257397	7189	7334	387522
PC_1159	Activation of the AP-1 family of transcription factors	1386	2353	3725	5594	5602	5600	1432	5595	5599	5601
PC_1160	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	207	55802	167227	22894	51013	23404	51010	54512	56915	118460	23016	11340	5393	9261	54464	7529	677
PC_1161	AUF1 (hnRNP D0) binds and destabilizes mRNA	1981	3184	3303	3312	3315	26986	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	6233	7979	7311	7314	7316
PC_1162	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	55802	167227	22894	51013	23404	51010	54512	56915	118460	23016	11340	5393	9261	3842	54464	7529	55552
PC_1163	HuR (ELAVL1) binds and stabilizes mRNA	8125	1994	9052	8021	5578	5580	6418	8741	7514
PC_1164	KSRP (KHSRP) binds and destabilizes mRNA	207	167227	22894	51013	23404	51010	54512	56915	118460	23016	11340	5393	8570	5600	1432	5073	7534
PC_1165	Activation of Na-permeable kainate receptors	2897	2898
PC_1166	Activation of Ca-permeable Kainate Receptor	801	1739	4356	1742	2897	2898	2899	2900	2901	83988
PC_1167	Interleukin-2 family signaling	84868	3965
PC_1168	Transcriptional regulation of pluripotent stem cells	2034	27086	64344	9314	79727	79923	2516	5087	5460	63978	57167	4087	4089	6657	6774	7547	84891
PC_1169	Defective ALG2 causes ALG2-CDG (CDG-1i)	10016
PC_1170	Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2	1798
PC_1171	Defective ALG1 causes ALG1-CDG (CDG-1k)	56052
PC_1172	Defective ALG11 causes ALG11-CDG (CDG-1p)	440138
PC_1173	SUMOylation of chromatin organization proteins	8086	100532731	84733	8535	23468	57332	1107	3065	3066	9759	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	83746	55706	57122	55746	9972	9631	23279	23511	23165	23225	8021	129401	79023	11097	348995	10762	53371	9818	23636	79902	4927	9688	4928	7703	1911	1912	80012	8554	9063	9883	8480	5903	6015	6045	6304	23314	22955	6396	81929	7341	6613	6612	23512	7175	7329	9189
PC_1174	Thrombin signalling through proteinase activated receptors (PARs)	408	409	2147	2149	2151	9002	2767	2768	10672	9630	2769	2776	2782	2783	2784	59345	10681	2790	2791	55970	51764	54331	2785	2786	2787	2788	2793	2792	2793	5594	5595	6714
PC_1175	SUMOylation of RNA binding proteins	8086	100532731	84733	8535	57332	3183	3190	55706	51602	57122	55746	9972	9631	23279	23511	23165	23225	8021	129401	79023	11097	348995	10762	53371	9818	23636	79902	4927	9688	4928	7703	1911	1912	80012	9883	8480	5903	6015	6045	22955	6396	81929	7341	6613	7175	7329
PC_1176	Defective RFT1 causes RFT1-CDG (CDG-1n)	91869
PC_1177	Asymmetric localization of PCP proteins	1856	8321	2535	8326	8322	7855	8324	8325	50855	144165	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	6233	7979	57154	64750	7311	7314	7316	57216	7474
PC_1178	SUMOylation of DNA replication proteins	8086	6790	9212	332	55143	3619	55706	57122	55746	9972	9631	23279	23511	23165	23225	8021	129401	79023	11097	348995	10762	53371	9818	23636	79902	4927	9688	4928	5111	10401	51588	9883	8480	5903	5905	6396	81929	7341	6613	6612	7150	7153	7155	7175	7329
PC_1179	Degradation of AXIN	8312	8313	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	81847	6233	7979	64750	8658	80351	7311	7314	7316
PC_1180	Degradation of DVL	8452	51339	1855	1856	1857	23072	59349	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	9978	6233	7979	7311	7314	7316
PC_1181	Disassembly of the destruction complex and recruitment of AXIN to the membrane	139285	324	8312	857	1452	1455	1499	1855	1856	1857	10023	23401	8321	2535	7855	2932	4041	4040	5515	5516	5518	5519	5525	5526	5527	5528	5529	7471	89780	7478	7479
PC_1182	Regulation of FZD by ubiquitination	8322	7855	8323	8325	55366	8549	59352	4041	4040	54894	6233	284654	340419	84870	343637	7311	7314	7316	9101	89780	84133
PC_1183	Repression of WNT target genes	8313	1487	1488	3065	51176	4609	6932	83439	6934	7088	7089	7090	7091	166
PC_1184	SUMOylation of DNA methylation proteins	100532731	84733	8535	57332	1786	1788	1789	7703	1911	1912	80012	6015	6045	22955	7341	7329
PC_1185	Defective MPDU1 causes MPDU1-CDG (CDG-1f)	9526
PC_1186	Defective DPM1 causes DPM1-CDG (CDG-1e)	8813	8818	54344
PC_1187	Defective DPM3 causes DPM3-CDG (CDG-1o)	8813	8818	54344
PC_1188	Defective DPM2 causes DPM2-CDG (CDG-1u)	8813	8818	54344
PC_1189	Defective ALG9 causes ALG9-CDG (CDG-1l)	79796
PC_1190	Defective ALG3 causes ALG3-CDG (CDG-1d)	10195
PC_1191	Defective ALG12 causes ALG12-CDG (CDG-1g)	79087
PC_1192	Defective ALG6 causes ALG6-CDG (CDG-1c)	29929
PC_1193	Defective ALG8 causes ALG8-CDG (CDG-1h)	79053
PC_1194	SUMOylation of immune response proteins	9641	8517	4791	4792	10401	51588	5970	7341	6612	10210	7329
PC_1195	Defective SRD5A3 causes SRD5A3-CDG (CDG-1q) and KHRZ	79644
PC_1196	Defective DOLK causes DOLK-CDG (CDG-1m)	22845
PC_1197	Defective DHDDS causes retinitis pigmentosa 59	79947	116150
PC_1198	Defective MAN1B1 causes MRT15	11253
PC_1199	Defective MGAT2 causes MGAT2-CDG (CDG-2a)	4247
PC_1200	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	2683
PC_1201	Defective MOGS causes MOGS-CDG (CDG-2b)	7841
PC_1202	Synthesis of dolichyl-phosphate-glucose	29880	256281
PC_1203	Interconversion of nucleotide di- and triphosphates	203	204	205	26289	50808	122481	158067	221264	51727	1503	56474	1635	79077	1841	1854	2745	2936	2987	4830	4831	4832	4833	25961	6240	6241	50484	7295	7296	7298
PC_1204	Presynaptic function of Kainate receptors	2782	2783	2784	59345	10681	2790	2791	55970	51764	54331	2785	2786	2787	2788	2793	2792	2793	2899	23236	5330	5331
PC_1205	Pyrimidine biosynthesis	1677	1723	7372
PC_1206	Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)	2591	4582	10071	56667	143662	94025	140453	283463	200958	394263	4584	4585	4586	727897	4588	4589	118430
PC_1207	Defective LARGE causes MDDGA6 and MDDGB6	11041	9215
PC_1208	Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3	1605	55624
PC_1209	Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2	1605	10585	29954
PC_1210	Defective LFNG causes SCDO3	3955	4851	4853	4854	4855
PC_1211	Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)	56913	29071	4582	10071	56667	143662	94025	140453	283463	200958	394263	4584	4585	4586	727897	4588	4589	118430
PC_1212	Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1	1605	10585	29954
PC_1213	Defective B3GALTL causes Peters-plus syndrome (PpS)	9510	81794	81792	11093	140766	170689	170690	170691	170692	171019	9509	80070	9508	9507	11096	11174	11173	11095	56999	92949	9719	57188	54507	339366	145173	5199	157869	9037	54437	10418	10417	7057	7058	55901	79875	221981	80731
PC_1214	Defective GALNT12 causes colorectal cancer 1 (CRCS1)	79695	4582	10071	56667	143662	94025	140453	283463	200958	394263	4584	4585	4586	727897	4588	4589	118430
PC_1215	WNT5A-dependent internalization of FZD4	160	161	163	1173	1175	409	1211	1212	1213	1856	8322	5578	5579	5582	7474
PC_1216	Interleukin-3, Interleukin-5 and GM-CSF signaling	1437	1438	1439	2885	3562	3563	3567	3568	3717	5290	5291	5293	5295	5296	8503	5578	5781	5777	6464	6776	6777	7006	7409	7534
PC_1217	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	160	161	163	1173	1175	1211	1212	1213	2535	7855	4919	4920	7474
PC_1218	O-linked glycosylation	148789	11041	1605	9215	120071	55624	84892	84197	10585	29954
PC_1219	O-glycosylation of TSR domain-containing proteins	9510	81794	81792	11093	140766	170689	170690	170691	170692	171019	9509	80070	9508	9507	11096	11174	11173	11095	56999	92949	9719	57188	54507	339366	145173	5199	23275	157869	9037	54437	10418	10417	7057	7058	55901	79875	221981	80731
PC_1220	Pink/Parkin Mediated Mitophagy	9140	9474	84557	81631	55669	9927	51001	65018	5071	6233	8878	9804	56993	10452	401505	100188893	54543	9868	7311	7314	7316	7416
PC_1221	Uptake and function of anthrax toxins	84168	118429	801	5045	5604	5605	5606	6416	5608	5609	10015
PC_1222	RIPK1-mediated regulated necrosis	329	330	841	8837	8772	355	356	197259	8737	11035	8797	8795	8743	8717	7186	331
PC_1223	CASP8 activity is inhibited	841	8837	8772	355	356	8737	8797	8795	8743	8717	7186
PC_1224	VEGFR2 mediated vascular permeability	207	208	10000	801	857	1003	1495	1499	1500	3320	3728	79109	64223	2475	4846	5058	5062	5063	5170	55615	5879	253260	117145	57761	7409	7410	10451
PC_1225	VEGFR2 mediated cell proliferation	10768	801	3265	3708	3709	3710	3791	3845	4893	5170	5335	5578	5579	5580	5590	5921	8877	6714	7422
PC_1226	Oxidative demethylation of DNA	6996	80312	54790	200424
PC_1227	Miscellaneous transport and binding events	118	119	120	56172	563	1497	2039	56262	23507	84230	55144	80131	84061	93380	57380	123606	81614	152519	79815	57185	348938	5304	54896	7991
PC_1228	B-WICH complex positively regulates rRNA expression	60	9031	10849	9188	7913	2033	2074	2932	474382	55766	94239	3014	3015	102724334	3020	3020	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	8350	8350	8350	8350	8350	8350	8350	8350	8350	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	126961	126961	126961	121504	121504	128312	121504	2648	8850	10514	4641	25885	84172	9533	51082	9533	5434	5435	5437	5440	5441	23451	8467	9015	9014	9013	79101	6908	221830	30834
PC_1229	Toxicity of botulinum toxin type D (BoNT/D)	9900	9899	22987	6843	6844
PC_1230	Toxicity of botulinum toxin type B (BoNT/B)	6857	127833	6844
PC_1231	Toxicity of botulinum toxin type A (BoNT/A)	6616	9900	9899	22987
PC_1232	Toxicity of botulinum toxin type C (BoNT/C)	6616	6804	112755
PC_1233	Toxicity of botulinum toxin type F (BoNT/F)	9900	9899	22987	6843	6844
PC_1234	Toxicity of tetanus toxin (TeNT)	6844
PC_1235	Toxicity of botulinum toxin type G (BoNT/G)	6857	6843	6844
PC_1236	Toxicity of botulinum toxin type E (BoNT/E)	6616	9900	9899
PC_1237	Myogenesis	25	663	91653	998	1013	1000	1002	50937	1495	1496	1499	5608	5600	6300	1432	4205	100271849	4208	4209	4617	4618	4654	4656	4756	4917	9043	6938	6929	6925
PC_1238	Metabolism of ingested MeSeO2H into MeSeH	7296
PC_1239	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	267	79139	64772	23193	9761	7841	55768	5589	5700	5887	6233	7311	7314	7316	51035	7415
PC_1240	DNA methylation	1786	1788	1789	29947	474382	55766	94239	3014	3015	102724334	3020	3020	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	8350	8350	8350	8350	8350	8350	8350	8350	8350	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	126961	126961	126961	121504	121504	128312	121504	29128
PC_1241	Uptake and function of diphtheria toxin	928	1938	1839	3320	3326	7296
PC_1242	TCF7L2 mutants don't bind CTBP	1487	1488	6934
PC_1243	Misspliced GSK3beta mutants stabilize beta-catenin	139285	324	8312	1452	1499	2932	5515	5516	5518	5519	5525	5526	5527	5528	5529
PC_1244	Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	22943	27123	27121	83999	79412	4041
PC_1245	WNT ligand secretion is abrogated by the PORCN inhibitor LGK974	64840
PC_1246	RNF mutants show enhanced WNT signaling and proliferation	8322	7855	8323	8325	4041	4040	54894	89780
PC_1247	GSD II	2548	2992
PC_1248	TNFR1-induced proapoptotic signaling	841	1540	8772	56957	8737	7124	7128	7132	8717	7186	9099	29761	7375
PC_1249	Regulation of TNFR1 signaling	329	330	841	1147	25999	1540	3551	8517	8567	56957	90268	10399	10616	8737	55072	6233	81858	84888	56928	8887	7124	7128	7132	8717	7185	7186	7311	7314	7316	9099	29761	7375	331
PC_1250	TNFR1-induced NFkappaB signaling pathway	329	330	1147	1540	3551	8517	6885	56957	10399	10616	8737	55072	81858	10454	23118	257397	7124	7128	7132	8717	7185	7186	9099	29761	7375	331
PC_1251	Hedgehog ligand biogenesis	51009	50846	27248	55733	3549	10956	5034	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	6233	6400	7979	6469	84447	7311	7314	7316	7415
PC_1252	Synthesis of diphthamide-EEF2	120526	1801	1802	285381	51611	89978	92715	1938
PC_1253	Mismatch repair (MMR) directed by MSH2	9156	3978	4292	4436	2956	5111	5395	5424	5425	10714	57804	6117	6118	6119
PC_1254	Mismatch repair (MMR) directed by MSH2	9156	3978	4292	4436	4437	5111	5395	5424	5425	10714	57804	6117	6118	6119
PC_1255	S33 mutants of beta-catenin aren't phosphorylated	139285	324	8312	1452	1499	2932	5515	5516	5518	5519	5525	5526	5527	5528	5529
PC_1256	S37 mutants of beta-catenin aren't phosphorylated	139285	324	8312	1452	1499	2932	5515	5516	5518	5519	5525	5526	5527	5528	5529
PC_1257	S45 mutants of beta-catenin aren't phosphorylated	139285	324	8312	1452	1499	2932	5515	5516	5518	5519	5525	5526	5527	5528	5529
PC_1258	T41 mutants of beta-catenin aren't phosphorylated	139285	324	8312	1452	1499	2932	5515	5516	5518	5519	5525	5526	5527	5528	5529
PC_1259	Signaling by Retinoic Acid	1374	1375	1382	1737	1738	2171	5160	5161	5162	8050	5170	5164	5165	5166	5467	5914	5915	5916	6256	6257	6258
PC_1260	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	51009	27248	10956	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	6233	6400	7979	6469	84447	7311	7314	7316	7415
PC_1261	Release of Hh-Np from the secreting cell	6868	50846	85455	2262	3549	147111	57758	6469
PC_1262	RA biosynthesis pathway	124	126	127	8644	216	8854	220	64577	1381	1592	56603	340665	9249	10901	10170	157506	51109	112724	57665	8608	5959	195814
PC_1263	Mitochondrial translation initiation	54998	118487	58512	26284	90480	65008	124995	65003	6182	28998	64928	9801	54948	63875	29074	9801	51069	55052	219927	29093	6150	79590	64975	10573	11222	51263	64928	9553	64981	51318	64979	51253	64978	54148	51073	64976	64975	28977	84545	65080	26589	57129	51642	740	54534	51258	122704	116540	116541	128308	78988	3396	65005	55173	64963	6183	63931	64960	51021	51373	55168	28973	51023	51116	54460	56945	51649	64951	64432	64949	23107	60488	10884	10240	51650	65993	60488	92259	64969	64968	51081	64965	123263	4528	219402	5018	55037
PC_1264	Negative regulation of TCF-dependent signaling by DVL-interacting proteins	440193	1855	1856	1857
PC_1265	Mitochondrial translation elongation	54998	118487	58512	26284	90480	85476	65008	124995	65003	6182	28998	64928	9801	54948	63875	29074	9801	51069	55052	219927	29093	6150	79590	64975	10573	11222	51263	64928	9553	64981	51318	64979	51253	64978	54148	51073	64976	64975	28977	84545	65080	26589	57129	51642	740	54534	51258	122704	116540	116541	128308	78988	3396	65005	55173	64963	6183	63931	64960	51021	51373	55168	28973	51023	51116	54460	56945	51649	64951	64432	64949	23107	60488	10884	10240	51650	65993	60488	92259	64969	64968	51081	64965	5018	55037	10102	7284
PC_1266	Mitochondrial translation termination	54998	118487	58512	26284	90480	84340	65008	124995	65003	6182	28998	64928	9801	54948	63875	29074	9801	51069	55052	219927	29093	6150	79590	64975	10573	11222	51263	64928	9553	64981	51318	64979	51253	64978	54148	51073	64976	64975	28977	84545	65080	26589	57129	51642	740	54534	51258	122704	116540	116541	128308	78988	3396	65005	55173	64963	6183	63931	64960	51021	51373	55168	28973	51023	51116	54460	56945	51649	64951	64432	64949	23107	60488	10884	10240	51650	65993	60488	92259	64969	64968	51081	64965	92399	54516	5018	55037
PC_1267	Aflatoxin activation and detoxification	95	91703	8574	22977	246181	1544	1553	1576	1577	1800	64174	64180	2678	2687	124975	2686	4257	4258	4259
PC_1268	APC truncation mutants are not K63 polyubiquitinated	324
PC_1269	APC truncation mutants have impaired AXIN binding	139285	324	8312	1452	2932	5515	5516	5518	5519	5525	5526	5527	5528	5529
PC_1270	AXIN missense mutants destabilize the destruction complex	139285	324	8312	1452	2932	5515	5516	5518	5519	5525	5526	5527	5528	5529
PC_1271	Deletions in the AMER1 gene destabilize the destruction complex	139285
PC_1272	Deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling	8312
PC_1273	Truncations of AMER1 destabilize the destruction complex	139285	324	8312	1452	2932	5515	5516	5518	5519	5525	5526	5527	5528	5529
PC_1274	Organic cation transport	6248	861	6580	55356	85413	5002	6582	6581	6583	6584
PC_1275	Defective Mismatch Repair Associated With MLH1	4292	5395
PC_1276	XAV939 inhibits tankyrase, stabilizing AXIN	8658	80351
PC_1277	Phase 4 - resting membrane potential	3768	3772	3759	3761	3775	54207	56660	56659	60598	83795	89822	338567	3776	3777	50801	8645	9424	10089	51305
PC_1278	Phase 3 - rapid repolarisation	10142	3753	9992	10008	23704	23630	3757	3784
PC_1279	Phase 0 - rapid depolarisation	775	776	778	779	781	9254	55799	93589	782	783	784	785	786	10369	10368	27092	27091	59283	59284	59283	801	815	816	817	818	2256	2257	2258	2259	29098	6336	11280	6323	6324	6326	6327	6328	55800	6329	6330	6331	6332	6334	6335
PC_1280	Phase 2 - plateau phase	10142	775	776	778	779	781	9254	55799	93589	782	783	784	785	786	10369	10368	27092	27091	59283	59284	59283	3753	9992	10008	23704	23630	3784
PC_1281	Phase 1 - inactivation of fast Na+ channels	3750	3751	3752	30820	30819	30818	80333
PC_1282	Transcriptional regulation by small RNAs	8086	26523	27161	474382	55766	94239	3014	3015	102724334	3020	3020	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	8350	8350	8350	8350	8350	8350	8350	8350	8350	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	126961	126961	126961	121504	121504	128312	121504	10526	55706	57122	55746	9972	9631	23279	23511	23165	23225	8021	129401	79023	11097	348995	10762	53371	9818	23636	79902	4927	9688	4928	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	9883	8480	5901	5903	6396	81929	27327	7175
PC_1283	Physiological factors	10699	2626	204851	28996	8850	1482	4878	4880	4881	4882	6910	25937
PC_1284	Ion homeostasis	10060	10768	444	476	477	478	480	481	482	483	487	488	489	490	493	492	493	801	815	816	817	818	1193	1760	2281	5348	486	5349	53828	53826	53822	3708	3709	3710	3767	4842	84876	80228	5350	5578	6261	6262	6263	6546	6543	6547	6588	6717	6786	7137	10345	7220
PC_1285	Defective TPMT causes Thiopurine S-methyltransferase deficiency (TPMT deficiency)	7172
PC_1286	Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX)	1593
PC_1287	Defective AHCY causes Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency (HMAHCHD)	191
PC_1288	Defective OPLAH causes 5-oxoprolinase deficiency (OPLAHD)	26873
PC_1289	Defective GCLC causes Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD)	2729	2730
PC_1290	Defective CYP1B1 causes Glaucoma	1545
PC_1291	Defective UGT1A1 causes hyperbilirubinemia	54658
PC_1292	Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4)	340665
PC_1293	Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)	126410
PC_1294	Defective GSS causes Glutathione synthetase deficiency (GSS deficiency)	2937
PC_1295	Defective ACY1 causes encephalopathy	95
PC_1296	Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency)	1585
PC_1297	Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)	1591
PC_1298	Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)	113612
PC_1299	Defective MAOA causes Brunner syndrome (BRUNS)	4128
PC_1300	Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)	9420
PC_1301	Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A)	1594
PC_1302	Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA)	56603
PC_1303	Defective UGT1A4 causes hyperbilirubinemia	54657
PC_1304	Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4)	1584
PC_1305	Defective FMO3 causes Trimethylaminuria (TMAU)	2328
PC_1306	Defective SLC35D1 causes Schneckenbecken dysplasia (SCHBCKD)	23169
PC_1307	Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3)	1589
PC_1308	Defective GGT1 causes Glutathionuria (GLUTH)	2678
PC_1309	Defective MAT1A causes Methionine adenosyltransferase deficiency (MATD)	4143
PC_1310	Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)	1583	2230	112812	2232
PC_1311	Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B)	120227
PC_1312	Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5)	1586
PC_1313	Defective CYP19A1 causes Aromatase excess syndrome (AEXS)	1588
PC_1314	Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)	4158	5443
PC_1315	Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD)	6916
PC_1316	PIWI-interacting RNA (piRNA) biogenesis	136991	54514	8468	113802	3320	84944	54456	4603	9271	55124	143689	201164	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	56165	91646	221400	122402	11022
PC_1317	TLR3 deficiency - HSE	7098
PC_1318	UNC93B1 deficiency - HSE	7098	81622
PC_1319	MyD88 deficiency (TLR2/4)	695	929	948	23643	4615	114609	7096	7097	7099	10333
PC_1320	TICAM1 deficiency - HSE	148022	7098
PC_1321	TRAF3 deficiency - HSE	148022	7098	7187
PC_1322	IKBKB deficiency causes SCID	1147	3551	8517
PC_1323	MyD88 deficiency (TLR5)	4615	7100
PC_1324	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	1147	3551	8517
PC_1325	IkBA variant leads to EDA-ID	1147	3551	8517	4790	4791	4792	5970
PC_1326	IRAK4 deficiency (TLR5)	51135	4615	81793	7100
PC_1327	IRAK4 deficiency (TLR2/4)	695	929	948	51135	23643	4615	114609	7096	7097	7099	10333
PC_1328	Dectin-1 mediated noncanonical NF-kB signaling	8945	6361	6367	1147	8454	23291	9020	4791	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	5970	5971	6233	7979	6500	9039	7311	7314	7316	9040
PC_1329	CLEC7A (Dectin-1) induces NFAT activation	10768	801	3708	3709	3710	4772	4773	4775	5530	5532	5534
PC_1330	CLEC7A (Dectin-1) signaling	8915	8945	84433	64170	997	1147	64581	8454	23291	3551	8517	10892	6885	4790	4792	5170	5336	5580	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	5970	6233	7979	6500	6714	6850	10454	23118	257397	7189	7311	7314	7316	7321	7322	7334	387522
PC_1331	Defective PGM1 causes PGM1-CDG (CDG1t)	5236
PC_1332	Defective GALK1 can cause Galactosemia II (GALCT2)	2584
PC_1333	Defective GALE can cause Epimerase-deficiency galactosemia (EDG)	2582
PC_1334	Defective GALT can cause Galactosemia	2592
PC_1335	Organic anion transport	55867	116085	9356	10864	9376
PC_1336	Degradation of GLI1 by the proteasome	8945	8454	2735	83737	8650	5578	5567	5568	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	9978	6233	7979	6500	51684	7311	7314	7316
PC_1337	Degradation of GLI2 by the proteasome	8945	1452	8454	2736	2932	5578	5567	5568	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	9978	6233	7979	6500	51684	7311	7314	7316
PC_1338	GLI3 is processed to GLI3R by the proteasome	8945	1452	8454	2737	2932	5578	5567	5568	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	9978	6233	7979	6500	51684	7311	7314	7316
PC_1339	Hedgehog 'off' state	107	55811	108	109	196883	111	112	113	114	115	79659	80199	2735	2736	2737	2778	23432	55764	9742	26160	51098	55081	8100	27152	11127	374654	54903	8481	5578	5567	5568	5573	5575	5576	5577	5727	23322	6608	51684	79809	7289	57728	57539
PC_1340	Activation of anterior HOX genes in hindbrain development during early embryogenesis	84962	9070	9125	1387	10664	8726	1959	2033	2146	474382	55766	94239	3014	3015	102724334	3020	3020	8841	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	8350	8350	8350	8350	8350	8350	8350	8350	8350	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	126961	126961	126961	121504	121504	128312	121504	3198	3199	3200	3201	3211	3212	3213	3214	3221	3231	3232	3233	3725	7403	58508	8085	9935	4211	8202	23054	9611	79447	5080	22976	5087	7703	9063	5316	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	5914	5915	5916	5928	5929	5931	6256	23512	11091	7528	63925
PC_1341	Cilium Assembly	79969	10013
PC_1342	Defective SLC17A5 causes Salla disease (SD) and ISSD	26503
PC_1343	Defective SLC24A5 causes oculocutaneous albinism 6 (OCA6)	283652
PC_1344	Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F)	10559
PC_1345	Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN)	9990
PC_1346	Defective SLC34A1 causes hypophosphatemic nephrolithiasis/osteoporosis 1 (NPHLOP1)	6569
PC_1347	Defective SLC36A2 causes iminoglycinuria (IG) and hyperglycinuria (HG)	153201
PC_1348	Defective RHAG causes regulator type Rh-null hemolytic anemia (RHN)	6005
PC_1349	Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1)	6513
PC_1350	Defective SLC6A19 causes Hartnup disorder (HND)	340024
PC_1351	Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM)	10568
PC_1352	Defective SLC26A4 causes Pendred syndrome (PDS)	5172
PC_1353	Defective SLC2A9 causes hypouricemia renal 2 (RHUC2)	56606
PC_1354	Defective SLC11A2 causes hypochromic microcytic anemia, with iron overload 1 (AHMIO1)	4891
PC_1355	Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages)	1356	30061
PC_1356	Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA)	6521
PC_1357	Defective SLC9A9 causes autism 16 (AUTS16)	285195
PC_1358	Defective SLC22A5 causes systemic primary carnitine deficiency (CDSP)	6584
PC_1359	Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA)	8671
PC_1360	Defective SLC24A4 causes hypomineralized amelogenesis imperfecta (AI)	123041
PC_1361	Defective HK1 causes hexokinase deficiency (HK deficiency)	3098
PC_1362	Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)	213	28234
PC_1363	Defective CP causes aceruloplasminemia (ACERULOP)	1356	30061
PC_1364	Defective SLC33A1 causes spastic paraplegia 42 (SPG42)	9197
PC_1365	Defective SLC1A3 causes episodic ataxia 6 (EA6)	6507
PC_1366	Defective SLC29A3 causes histiocytosis-lymphadenopathy plus syndrome (HLAS)	55315
PC_1367	Defective SLC22A18 causes lung cancer (LNCR) and embryonal rhabdomyosarcoma 1 (RMSE1)	5002
PC_1368	Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA)	6505
PC_1369	Defective SLC2A10 causes arterial tortuosity syndrome (ATS)	81031
PC_1370	Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT)	682	6566
PC_1371	Defective SLC22A12 causes renal hypouricemia 1 (RHUC1)	116085
PC_1372	Defective SLC35A2 causes congenital disorder of glycosylation 2M (CDG2M)	7355
PC_1373	Defective GCK causes maturity-onset diabetes of the young 2 (MODY2)	2645
PC_1374	Defective SLC17A8 causes autosomal dominant deafness 25 (DFNA25)	246213
PC_1375	Defective SLC24A1 causes congenital stationary night blindness 1D (CSNB1D)	9187
PC_1376	Defective SLC35C1 causes congenital disorder of glycosylation 2C (CDG2C)	55343
PC_1377	Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria	348932
PC_1378	Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)	6531
PC_1379	Defective SLC35A3 causes arthrogryposis, mental retardation, and seizures (AMRS)	23443
PC_1380	Defective SLC26A3 causes congenital secretory chloride diarrhea 1 (DIAR1)	1811
PC_1381	Defective SLC12A3 causes Gitelman syndrome (GS)	6559
PC_1382	Defective SLC39A4 causes acrodermatitis enteropathica, zinc-deficiency type (AEZ)	55630
PC_1383	Defective SLC6A5 causes hyperekplexia 3 (HKPX3)	6530
PC_1384	Defective SLC9A6 causes X-linked, syndromic mental retardation,, Christianson type (MRXSCH)	10479
PC_1385	Variant SLC6A14 may confer susceptibility towards obesity	11254
PC_1386	Defective SLCO2A1 causes primary, autosomal recessive hypertrophic osteoarthropathy 2 (PHOAR2)	6578
PC_1387	Defective SLC5A5 causes thyroid dyshormonogenesis 1 (TDH1)	6528
PC_1388	Defective SLC34A3 causes Hereditary hypophosphatemic rickets with hypercalciuria (HHRH)	142680
PC_1389	Defective SLC2A2 causes Fanconi-Bickel syndrome (FBS)	6514
PC_1390	Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI)	551	552	553
PC_1391	Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG)	54716
PC_1392	Defective SLC12A1 causes Bartter syndrome 1 (BS1)	6557
PC_1393	Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)	8086	2645	2646	55706	57122	55746	9972	9631	23279	23511	23165	23225	8021	129401	79023	11097	348995	10762	53371	9818	23636	79902	4927	9688	4928	9883	8480	5903	6396	81929	7175
PC_1394	Defective SLC27A4 causes ichthyosis prematurity syndrome (IPS)	10999
PC_1395	Defective SLC6A2 causes orthostatic intolerance (OI)	6530
PC_1396	Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)	213	10599
PC_1397	Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1)	6575
PC_1398	Defective SLC3A1 causes cystinuria (CSNU)	6519	11136
PC_1399	Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A)	60482
PC_1400	Anchoring of the basal body to the plasma membrane	10121	54806	10142	7840	27077	80776	26005	57545	9738	983	55755	55835	22994	9662	22995	22832	22897	55125	11190	80184	95681	9702	80254	80321	55722	79959	84131	51134	84902	79598	1069	9793	23332	11064	1453	102800317	1639	10540	11258	1778	1781	8655	85302	11116	115106	55142	79441	54930	23354	54801	55559	93323	3320	9657	347240	22919	57787	54903	54820	121441	4751	22981	4867	261734	4957	8481	5048	5108	5116	5347	10733	5518	5578	5577	8766	117177	4218	23322	132320	10806	4735	9814	8636	79600	79867	26123	51259	91147	146057	7846	7277	203068	10382	10383	7283	7531	7532
PC_1401	VxPx cargo-targeting to cilium	378	50807	1260	1262	1258	55763	55770	11336	60412	10640	54536	23265	149371	8729	5310	5311	8766	9727	117177	4218	6010
PC_1402	BBSome-mediated cargo-targeting to cilium	84100	92482	582	79738	166379	583	585	129880	55212	27241	10576	7203	10575	22948	10694	54585	2847	8195	117177	6608	6753	6950	123016
PC_1403	Intraflagellar transport	23059	79659	51626	8655	140735	83658	83657	51668	55764	9742	26160	90410	64792	11020	112752	56912	51098	55081	80173	57560	28981	8100	57576	11127	9371	3797	22920	6991	200132	255758	3842	26146	9321	79809	79989	92104	150737	57728	89891	57539	55112
PC_1404	Dectin-2 family	10462	50856	170482	338339	26253	93978	2207	2534	4067	4582	10071	56667	143662	94025	140453	283463	200958	394263	4584	4585	4586	727897	4588	4589	118430	5336	6850
PC_1405	CD209 (DC-SIGN) signaling	30835	1387	2033	2534	3265	3384	3385	3845	4067	4790	4893	5058	5062	5063	5578	5567	5568	5894	5970	5971	9252
PC_1406	Trafficking of myristoylated proteins to the cilium	403	192668	27031	6102	84747
PC_1407	ARL13B-mediated ciliary trafficking of INPP5E	200894	23203	5147
PC_1408	RHO GTPases activate PKNs	995	4628	4629	79784	4627	103910	4637	10398	5058	5170	5585	5586	29941	5500	4659	4660	94274	5879	387	388	389	2810	7529	7531	7532	7533	10971	7534
PC_1409	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	367	474382	55766	94239	3014	3015	102724334	3020	3020	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	8350	8350	8350	8350	8350	8350	8350	8350	8350	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	126961	126961	126961	121504	121504	128312	121504	23028	23081	3817	3818	10499	5585
PC_1410	RHO GTPases activate CIT	1027	11113	1742	9928	4628	4629	79784	4627	103910	4637	10398	5500	4659	4660	9055	5879	387	388	389
PC_1411	RHO GTPases activate KTN1	998	3798	3799	3831	147700	147700	89953	3895	5879	387	391
PC_1412	RHO GTPases activate IQGAPs	801	998	999	6249	1495	1499	8826	10788	128239	4221	5879
PC_1413	TNFR1-mediated ceramide production	8439	10399	6610	55512	7124	7132
PC_1414	RHO GTPases regulate CFTR trafficking	1080	57120	23433
PC_1415	RHO GTPases Activate ROCKs	1072	3984	3985	4628	4629	79784	4627	103910	4637	10398	5058	5500	4659	4660	387	388	389	6093	9475
PC_1416	RHO GTPases activate PAKs	801	998	2017	2316	3984	4628	4629	79784	4627	103910	4637	10398	4638	4771	5058	5062	5063	5500	4659	4660	5879
PC_1417	TP53 Regulates Metabolic Genes	26523	27161	192669	192670	207	208	10000	1353	84987	51241	285521	116228	1327	9377	1329	1337	1340	1345	9167	1349	1350	1351	54205	54541	2539	2744	27165	2821	2877	2936	55004	28956	8649	389541	10542	10128	64223	4343	4512	4513	4514	2475	4697	5052	7001	25824	5562	5563	5564	5565	5571	51422	53632	5728	6009	57521	10670	10325	58528	50484	6341	9997	27244	83667	143686	2810	153129	6834	51204	57103	27327	23112	57690	7157	8626	7248	7249	7295	7296	7529	7531	7532	7533	10971	7534
PC_1418	Ligand-receptor interactions	91653	50937	50846	2619	64399	3549	5727	6469
PC_1419	Hedgehog 'on' state	79577	8452	50846	22873	2121	132884	2735	2736	2737	23432	3549	83737	374654	8650	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	5727	9978	6233	7979	6469	6608	57154	64750	8405	339745	51684	7311	7314	7316	25989
PC_1420	Defective Mismatch Repair Associated With MSH3	4436	4437
PC_1421	Defective Mismatch Repair Associated With MSH2	4436	4437	2956
PC_1422	Defective Mismatch Repair Associated With MSH6	4436	2956
PC_1423	Defective Mismatch Repair Associated With PMS2	4292	5395
PC_1424	Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)	79868	199857
PC_1425	Activation of SMO	408	409	91653	50937	1452	50846	84455	2121	132884	2619	2622	156	3549	23288	11127	5727	6469	6608
PC_1426	GLI proteins bind promoters of Hh responsive genes to promote transcription	91653	2735	2736	2737	64399	5727	8643
PC_1427	Constitutive Signaling by EGFRvIII	867	11140	1950	1956	2549	2885	3265	3320	3845	4893	5290	5295	5335	6464	6654
PC_1428	Inhibition of Signaling by Overexpressed EGFR	374	685	1950	1956	255324	2069	1839	6882	7039
PC_1429	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	3980	79661	252969	4968	11284	5423	7515
PC_1430	PCNA-Dependent Long Patch Base Excision Repair	328	2237	3978	5111	5423	5424	5425	10714	57804	5426	5427	54107	56655	5981	5982	5983	5984	5985	6117	6118	6119
PC_1431	Fructose biosynthesis	231	6652
PC_1432	Lactose synthesis	2683	3906	6513
PC_1433	Phospholipase C-mediated cascade	2246	2255	8822	2247	26281	27006	8074	2248	2249	2250	2251	2253	2254	2260	9365	5335
PC_1434	Phospholipase C-mediated cascade	2246	2255	8823	8822	8817	2247	26281	27006	8074	2248	2249	2250	2251	2252	2253	2254	2263	5335
PC_1435	Phospholipase C-mediated cascade	2246	8823	8822	8817	2247	26281	8074	2249	2250	2253	2254	2261	5335
PC_1436	Phospholipase C-mediated cascade	2246	8823	8822	8817	9965	2247	26281	8074	2249	2251	2253	2254	2264	152831	5335
PC_1437	Downstream signaling of activated FGFR1	2246	2255	8822	2247	26281	27006	8074	2248	2249	2250	2251	2253	2254	2260	23769	23768	23767	9365
PC_1438	SHC-mediated cascade	2246	2255	8822	2247	26281	27006	8074	2248	2249	2250	2251	2253	2254	2260	2885	3265	9365	3845	4893	6464	6654
PC_1439	PI-3K cascade	2246	2255	8822	2247	26281	27006	8074	2248	2249	2250	2251	2253	2254	2260	10818	2549	2885	9365	5290	5295	5781
PC_1440	FRS-mediated FGFR1 signaling	2246	2255	8822	2247	26281	27006	8074	2248	2249	2250	2251	2253	2254	2260	10818	10817	2885	3265	9365	3845	4893	5781	6654
PC_1441	PI-3K cascade	2246	2255	8823	8822	8817	2247	26281	27006	8074	2248	2249	2250	2251	2252	2253	2254	2263	10818	2549	2885	5290	5295	5781
PC_1442	SHC-mediated cascade	2246	2255	8823	8822	8817	2247	26281	27006	8074	2248	2249	2250	2251	2252	2253	2254	2263	2885	3265	3845	4893	6464	6654
PC_1443	FRS-mediated FGFR2 signaling	2246	2255	8823	8822	8817	2247	26281	27006	8074	2248	2249	2250	2251	2252	2253	2254	2263	10818	10817	2885	3265	3845	4893	5781	6654
PC_1444	SHC-mediated cascade	2246	8823	8822	8817	2247	26281	8074	2249	2250	2253	2254	2261	2885	3265	3845	4893	6464	6654
PC_1445	FRS-mediated FGFR3 signaling	2246	8823	8822	8817	2247	26281	8074	2249	2250	2253	2254	2261	10818	10817	2885	3265	3845	4893	5781	6654
PC_1446	PI-3K cascade	2246	8823	8822	8817	2247	26281	8074	2249	2250	2253	2254	2261	10818	2549	2885	5290	5295	5781
PC_1447	FRS-mediated FGFR4 signaling	2246	8823	8822	8817	9965	2247	26281	8074	2249	2251	2253	2254	2264	10818	10817	2885	3265	152831	3845	4893	5781	6654
PC_1448	SHC-mediated cascade	2246	8823	8822	8817	9965	2247	26281	8074	2249	2251	2253	2254	2264	2885	3265	152831	3845	4893	6464	6654
PC_1449	PI-3K cascade	2246	8823	8822	8817	9965	2247	26281	8074	2249	2251	2253	2254	2264	10818	2549	2885	152831	5290	5295	5781
PC_1450	Negative regulation of FGFR1 signaling	3730	867	2246	2255	8822	2247	26281	27006	8074	2248	2249	2250	2251	2253	2254	2260	10818	2885	9365	5594	5595	5781	6233	7311	7314	7316
PC_1451	Negative regulation of FGFR2 signaling	867	2246	2255	8823	8822	8817	2247	26281	27006	8074	2248	2249	2250	2251	2252	2253	2254	2263	10818	2885	5594	5595	5781	6233	7311	7314	7316
PC_1452	Negative regulation of FGFR3 signaling	867	2246	8823	8822	8817	2247	26281	8074	2249	2250	2253	2254	2261	10818	2885	5594	5595	5781	6233	7311	7314	7316
PC_1453	Negative regulation of FGFR4 signaling	867	2246	8823	8822	8817	9965	2247	26281	8074	2249	2251	2253	2254	2264	10818	2885	152831	5594	5595	5781	6233	7311	7314	7316
PC_1454	Signaling by FGFR2 in disease	2246	2255	8823	8822	8817	2247	26281	27006	8074	2248	2249	2250	2251	2252	2253	2254	2263	10818	2549	2885	3265	3845	4893	5290	5295	5335	6654
PC_1455	Signaling by FGFR4 in disease	2264	10818	2549	2885	3265	3845	4893	5290	5295	5335	6654
PC_1456	Signaling by FGFR1 in disease	9530	613	11064	11052	1523	11160	2246	8822	2247	26281	8074	2249	2250	2251	2253	2254	2260	11116	26127	10818	2549	2885	3265	3845	9208	399687	4893	5290	5295	5335	6654	8805	7750
PC_1457	Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum)	9843	30061
PC_1458	Translesion synthesis by POLK	10459	5111	51426	51455	5980	5981	5982	5983	5984	5985	6117	6118	6119	6233	7311	7314	7316
PC_1459	Translesion synthesis by POLI	10459	5111	11201	51455	5980	5981	5982	5983	5984	5985	6117	6118	6119	6233	7311	7314	7316
PC_1460	Termination of translesion DNA synthesis	9636	9768	5111	5424	5425	10714	57804	5426	5427	54107	56655	10721	11201	51426	51455	5981	5982	5983	5984	5985	6117	6118	6119	6233	7706	7311	7318	7314	7316	9246	9100	124739
PC_1461	Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM)	6523
PC_1462	Hereditary fructose intolerance	229
PC_1463	Essential fructosuria	3795
PC_1464	MGMT-mediated DNA damage reversal	4255
PC_1465	HHAT G278V abrogates palmitoylation of Hh-Np	50846	55733	3549	6469
PC_1466	Defective SLC5A2 causes renal glucosuria (GLYS1)	6524
PC_1467	Regulation of RAS by GAPs	8452	153090	3265	84078	3845	4763	4893	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	5921	5922	22821	10156	8437	9462	64926	9978	6233	7979	161742	200734	399473	8831	7311	7314	7316
PC_1468	Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A)	60482
PC_1469	FGFRL1 modulation of FGFR1 signaling	2255	8822	8817	2247	27006	8074	2248	2249	2250	2253	53834	161742	200734
PC_1470	Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria	348932
PC_1471	Defective SLC6A19 causes Hartnup disorder (HND)	340024
PC_1472	Intestinal saccharidase deficiencies	3938	6476
PC_1473	RPIA deficiency	22934
PC_1474	MTF1 activates gene expression	1465	4661	6620
PC_1475	CLEC7A/inflammasome pathway	841	3553	10892	4790	29108	5970
PC_1476	Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG)	54716
PC_1477	Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)	6531
PC_1478	Defective SLC7A7 causes lysinuric protein intolerance (LPI)	6520	9056
PC_1479	Defective SLC7A9 causes cystinuria (CSNU)	6519	11136
PC_1480	Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)	10599
PC_1481	Metallothioneins bind metals	4489	4490	4493	4494	4495	4496	4495	4501	4502	4504	84560
PC_1482	Formation of xylulose-5-phosphate	10327	51084	51181	6652	9942
PC_1483	Melanin biosynthesis	1638	4948	51151	7299	7306
PC_1484	Essential pentosuria	51181
PC_1485	Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F)	10559
PC_1486	RHO GTPases Activate WASPs and WAVEs	10006	10152	25	60	71	10097	10096	10552	10095	10109	10094	10093	10092	10458	55845	695	998	23191	26999	2885	5594	5595	4690	10787	3071	51517	5747	5879	7454	8936	10163	10810	8976	7456	147179	644150
PC_1487	RHO GTPases Activate Formins	60	71	25909	9212	80776	332	699	701	9184	991	998	55143	1058	1060	1062	1063	64946	2491	64105	91687	79019	55839	79172	401541	55166	100526739	80152	79682	9793	23332	23122	6249	23002	1729	1730	81624	79980	1855	1856	1857	1778	1780	1781	51143	1783	8655	140735	54821	51466	752	114793	91010	3619	3688	23421	81930	3796	84643	11004	57082	9735	8379	4085	22919	79003	57591	10403	54820	81565	284058	10726	83540	57122	55746	23279	79023	348995	79902	4928	5048	5216	5217	5347	100527963	5501	5515	5516	5518	5519	5525	5526	5527	5528	5529	5879	5903	5905	55920	387	388	389	29984	6232	286205	6396	81929	151648	151246	220134	348235	147841	9789	54908	6714	6722	9901	57551	7514	9183	55055	11130
PC_1488	RHO GTPases Activate Rhotekin and Rhophilins	64130	387	388	389	114822	85415	54763	6242	30851
PC_1489	TNFR2 non-canonical NF-kB pathway	329	330	958	959	4049	4050	4055	9020	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	7979	7124	8792	51330	115650	7133	8600	407977	10673	8740	7186	7187
PC_1490	RHO GTPases Activate NADPH Oxidases	1535	1536	5594	5600	1432	5595	653361	4688	4689	27035	50508	10811	124056	5289	30849	5300	5578	5579	5580	5590	5879	5880	6279	6280
PC_1491	TNFs bind their physiological receptors	939	970	1896	60401	10913	128178	4049	4982	23495	8764	608	8784	7132	7133	8718	7293	8771	943	3604	8600	8741	10673	8740	9966	8995	7292	944	8744
PC_1492	RAF activation	369	673	221477	801	815	816	817	818	3265	3717	3845	8844	5604	5605	4296	4140	4893	5245	5515	5516	5518	5519	5525	5526	5527	5528	5529	5894	6714	7529
PC_1493	RAF/MAP kinase cascade	88	284	374	9048	685	801	815	816	817	818	1437	1438	1439	1739	4355	4356	1742	1950	1956	255324	2064	2065	2066	2069	2246	2255	8823	8822	8817	9965	2247	26281	27006	8074	2248	2249	2250	2251	2252	2253	2254	2260	2263	2261	2264	2322	2323	10818	10817	2534	2668	2674	2675	2676	64096	2885	2902	2904	2906	1839	3082	3265	3558	3559	3560	3561	3562	3563	3567	3568	3667	8660	3716	3717	3718	3815	4254	9365	152831	3845	27040	5594	5595	4233	4684	4747	4893	3084	9542	10718	145957	4902	5154	5155	5156	5159	8682	5623	5747	5786	55705	9693	221002	5923	5924	10125	25780	115727	5979	6464	25759	53358	6654	6708	6709	6710	6711	6712	57731	51332	7010	7039
PC_1494	MAP2K and MAPK activation	54518	369	408	409	673	10256	22866	1445	2243	2244	2266	2335	3265	54756	8826	3674	3690	3845	8844	283455	28956	8649	5604	5605	5594	5595	4140	4893	5037	5894	5906	5908	6714	7094	7414	7450	84292	7529
PC_1495	Constitutive Signaling by AKT1 E17K in Cancer	207	84335	208	10000	572	842	1026	1027	1147	1385	2308	2309	4303	2931	2932	79109	4193	64223	2475	3164	5170	55615	253260	6199	7249
PC_1496	PTEN Loss of Function in Cancer	5728
PC_1497	Negative feedback regulation of MAPK pathway	673	5604	5605	5594	5595	5894
PC_1498	Negative regulation of MAPK pathway	369	673	221477	1843	11221	80824	1844	1846	1847	1848	1849	1850	1852	3265	3845	8844	5594	5595	4140	4893	152559	5037	5515	5516	5518	5519	5525	5526	5527	5528	5529	5536	5894	6233	7311	7314	7316	7529
PC_1499	Regulation of necroptotic cell death	329	330	841	8737	8717	7186	331
PC_1500	NIK-->noncanonical NF-kB signaling	8945	1147	8454	23291	9020	4791	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	5971	6233	7979	6500	9039	7311	7314	7316	9040
PC_1501	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	329	330	958	959	4049	4050	4055	9020	8792	51330	115650	8600	407977	10673	8740	7186	7187
PC_1502	Protein repair	4482	51734	22921	253827	5110	7295
PC_1503	Defective ABCC9 causes dilated cardiomyopathy 10, familial atrial fibrillation 12 and hypertrichotic osteochondrodysplasia	10060	3767
PC_1504	Defective ABCB11 causes progressive familial intrahepatic cholestasis 2 and benign recurrent intrahepatic cholestasis 2	8647
PC_1505	Defective ABCB4 causes progressive familial intrahepatic cholestasis 3, intrahepatic cholestasis of pregnancy 3 and gallbladder disease 1	5244
PC_1506	Defective CFTR causes cystic fibrosis	1080	79139	51009	91319	27248	10613	11160	10956	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	91445	6048	6233	6400	7979	7311	7314	7316	7415
PC_1507	Defective ABCC2 causes Dubin-Johnson syndrome	1244
PC_1508	Defective ABCG8 causes gallbladder disease 4 and sitosterolemia	64240	64241
PC_1509	Defective ABCG5 causes sitosterolemia	64240	64241
PC_1510	Defective ABCA1 causes Tangier disease	19	335
PC_1511	Defective ABCA12 causes autosomal recessive congenital ichthyosis type 4B	26154
PC_1512	LGI-ADAM interactions	4185	53616	8745	10369	10368	27092	59283	1742	9211	55203	203190	163175	6804	112755
PC_1513	Defective ABCC8 can cause hypoglycemias and hyperglycemias	6833	3767
PC_1514	Defective ABCD4 causes methylmalonic aciduria and homocystinuria, cblj type (MAHCJ)	5826
PC_1515	Defective ABCB6 causes isolated colobomatous microphthalmia 7 (MCOPCB7)	10058
PC_1516	Defective ABCA3 causes pulmonary surfactant metabolism dysfunction type 3 (SMDP3)	21
PC_1517	Surfactant metabolism	21	51816	221395	135	136	150	152	29080	10970	1438	1439	1512	1755	2627	29995	9476	5029	643834	643847	5222	653509	729238	6439	6440	6441	6569	10568	7080	51201
PC_1518	Defective ABCD1 causes adrenoleukodystrophy (ALD)	215
PC_1519	MAP3K8 (TPL2)-dependent MAPK1/3 activation	8945	1147	8454	23291	3551	8517	5604	6416	1326	4790	6233	6500	79155	7311	7314	7316
PC_1520	HDR through Single Strand Annealing (SSA)	25	472	390502	84126	580	641	672	83990	1763	2067	2072	9156	3364	10524	4361	4683	5810	5884	10111	5888	5893	5883	144715	5932	5982	5983	5984	5985	83695	80010	116028	6117	6118	6119	7156	11073	7486
PC_1521	HDR through MMEJ (alt-NHEJ)	2237	3980	4361	4683	142	10038	10721	10111	5932	7515
PC_1522	HDR through Homologous Recombination (HRR)	472	580	641	672	675	83990	1763	9156	10524	4361	4683	79728	5111	5424	5425	10714	57804	5426	5427	54107	56655	10721	51426	10111	5888	10635	5890	5889	5892	5932	5981	5982	5983	5984	5985	80010	116028	6117	6118	6119	6233	7156	7311	7314	7316	7486	7516	7517
PC_1523	Regulation of TLR by endogenous ligand	338	929	948	2243	2244	2266	3146	3929	23643	6271	6279	6280	7096	7097	7099	10333
PC_1524	MAPK6/MAPK4 signaling	26523	27161	192669	192670	896	8556	8555	998	10435	10602	148170	983	3337	2118	2308	2309	3315	10642	3725	8997	5596	5597	8550	4319	4313	4343	4609	8202	5058	5062	5063	5578	5567	5568	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	5879	5896	5897	6233	7979	989	27327	23112	57690	7311	7314	7316	7514
PC_1525	Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM)	10568
PC_1526	Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF)	729238
PC_1527	Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS)	6439
PC_1528	Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)	6440
PC_1529	Defective ABCA3 causes pulmonary surfactant metabolism dysfunction 3 (SMDP3)	21
PC_1530	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	1438	1439	653509	729238	6439	6440	6441
PC_1531	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	1438	1439	653509	729238	6439	6440	6441
PC_1532	UCH proteinases	60	86	79913	93973	11047	171023	55252	8314	580	221937	3607	3054	221613	3012	8334	3013	3012	8329	85235	8329	8331	8329	8329	8329	723790	723790	317772	8338	92815	54617	83444	125476	54891	283899	221656	55777	114785	10445	4738	4798	8473	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	6233	8607	7979	123228	4092	29844	7040	7046	7048	7311	7314	7316	7345	7347	51377	9958	7528
PC_1533	Josephin domain DUBs	4287	92552	9929	126119	5071	5886	5887	6233	7311	7314	7316	7415
PC_1534	Ub-specific processing proteases	154	11047	367	408	409	6314	8312	8313	8678	329	330	8900	890	9738	991	993	1080	63967	1540	1643	23586	23770	4303	2625	9146	3091	221613	3012	8334	3013	3012	8329	85235	8329	8331	8329	8329	8329	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	723790	723790	317772	8338	8349	440689	92815	128312	3416	64135	8517	90865	2648	9817	6885	27430	4193	4194	79594	4609	4792	55611	5423	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	5728	51651	9986	55288	8737	63891	79589	81847	6233	8607	7979	6478	6502	4086	4087	4088	4089	4092	64750	8724	10254	64426	10454	93624	10474	6881	51616	7046	8658	80351	9804	9868	7157	7186	7189	8295	7311	7314	7316	7353	9100	8237	219333	8975	9097	9958	10600	401447	100287144	100287178	100287205	100287238	100287327	100287364	100287404	377630	100287441	100287478	100287513	728369	728369	728369	728369	728369	728369	645836	728369	645402	728386	392188	11274	10869	9099	10868	29761	23326	23358	29761	83844	57646	9960	84749	23032	9736	57695	7375	84132	84101	55031	84196	25862	8078	7874	9101	8239	7416	7417	7419	91833	57599
PC_1535	Ovarian tumor domain proteases	324	983	23586	2099	64135	8517	57506	10392	64127	55611	78990	23252	55593	161725	56957	5728	387	8737	8767	79589	84282	6233	7128	10318	79155	79931	7157	7187	7189	7706	7311	7314	7316	7321	7415	80124	55432	54764
PC_1536	Metalloprotease DUBs	84142	23172	29086	9577	580	672	79184	2033	221613	3012	8334	3013	3012	8329	85235	8329	8331	8329	8329	8329	723790	723790	317772	8338	92815	8850	114803	114548	10213	6233	8027	10617	57559	7311	7314	7316	51720
PC_1537	Defective ABCC6 causes pseudoxanthoma elasticum (PXE)	368
PC_1538	CD22 mediated BCR regulation	933	973	974	4067	5777
PC_1539	Sensing of DNA Double Strand Breaks	472	10524	3838	4361	4683	10111
PC_1540	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	472	580	641	672	675	83990	1763	9156	10524	4361	4683	79728	10111	5888	10635	5890	5889	5892	5932	80010	116028	51750	7156	7486	7516	7517
PC_1541	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	25	84142	322	472	29086	9577	8314	580	9031	672	79184	11200	2138	2139	2140	2070	3014	102724334	8924	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	8349	121504	121504	128312	8290	121504	10524	9682	23030	5599	9656	4361	4683	7468	51588	5536	10111	165918	9025	6233	8467	7341	7157	7158	7311	7314	7316	7329	7334	7336	51720
PC_1542	Resolution of D-loop Structures through Holliday Junction Intermediates	472	580	641	672	675	83990	1763	146956	197342	9156	348654	10524	4361	80198	4683	79728	10111	5888	10635	5890	5889	5892	5932	80010	116028	548593	548593	84464	23514	7156	7486	7516	7517
PC_1543	Nonhomologous End-Joining (NHEJ)	84142	472	29086	9577	580	672	79184	64421	3014	102724334	8924	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	8349	121504	121504	128312	8290	121504	10524	3981	9656	4361	4683	79840	7468	22976	51588	27343	27434	5591	10111	55791	165918	9025	7341	55775	51567	7158	7334	7336	51720	7518	7520	2547
PC_1544	Homologous DNA Pairing and Strand Exchange	472	580	641	672	675	83990	1763	9156	10524	4361	4683	79728	10111	5888	10635	5890	5889	5892	5932	80010	116028	7156	7486	7516	7517
PC_1545	Processing of DNA double-strand break ends	84142	472	390502	84126	29086	9577	580	641	672	79184	83990	8900	890	1017	1111	63967	1763	9156	3014	102724334	8924	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	8349	121504	121504	128312	8290	121504	3364	10524	9656	4361	4683	7468	51588	5531	151987	5810	5884	10111	5883	144715	5932	5982	5983	5984	5985	83695	80010	116028	165918	6047	9025	6117	6118	6119	6233	51548	7341	6613	8914	54962	7156	11073	7158	7311	7314	7316	7329	7334	7336	51720	7486
PC_1546	Presynaptic phase of homologous DNA pairing and strand exchange	472	390502	84126	580	641	672	675	83990	1111	1763	9156	3364	10524	4361	4683	5810	5884	10111	5888	5890	5889	5892	5883	144715	5932	5982	5983	5984	5985	83695	80010	116028	6117	6118	6119	7156	11073	7486	7516
PC_1547	Cargo concentration in the ER	374	966	10175	254263	149111	1294	1075	1522	2153	2157	2348	9570	2890	3998	79748	10960	81562	90411	4253	375056	10113	51128	9554	10484	10802	10427	9632	9871	5265	6811	7039	10972	10959
PC_1548	DNA Damage Recognition in GG-NER	60	86	79913	93973	1069	9318	8533	51138	10987	10980	50813	64708	10920	8451	8450	1642	1643	2873	54617	83444	125476	54891	283899	10445	4798	142	10038	5886	5887	9978	6233	8607	29844	7311	7314	7316	7508	7528
PC_1549	Formation of Incision Complex in GG-NER	902	1022	1069	9557	8451	8450	1642	1643	2067	2068	2071	2072	2073	2965	2966	2967	2968	404672	4331	142	10038	8554	10401	5886	5887	9978	54778	6117	6118	6119	6233	7341	6613	6612	7311	7314	7316	7329	7334	7336	85015	7507	7508
PC_1550	Gap-filling DNA repair synthesis and ligation in GG-NER	3978	3980	5111	5424	5425	10714	57804	5426	5427	54107	56655	51426	5981	5982	5983	5984	5985	6117	6118	6119	6233	7311	7314	7316	7515
PC_1551	Dual Incision in GG-NER	9557	8451	8450	1642	1643	2067	2068	2071	2072	2073	2965	2966	2967	2968	404672	142	10038	5111	5424	5425	10714	57804	5426	5427	54107	56655	51426	9978	5981	5982	5983	5984	5985	6117	6118	6119	6233	7311	7314	7316	7507
PC_1552	Deposition of new CENPA-containing nucleosomes at the centromere	1058	1060	64946	2491	64105	91687	79019	55839	79172	401541	55166	100526739	80152	79682	387103	201254	474382	55766	94239	3014	3015	102724334	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	121504	121504	128312	121504	55355	23421	57082	54069	55320	4869	11339	5928	5931	51773	8607	8467
PC_1553	Respiratory electron transport	93058	80219	1353	84987	51241	285521	116228	1327	9377	1329	1337	1340	1345	9167	1349	1350	1351	1537	54205	2108	2109	2110	10128	4512	4513	4514	4519	4535	4536	4537	4538	4540	4541	4694	4705	126328	55967	51079	4695	4696	4697	4698	4700	4701	4702	4704	4706	4707	4716	54539	4708	4709	4710	4711	4712	4713	4714	4715	4717	4718	4719	4720	4722	4724	4725	4726	374291	4728	4723	4729	4731	6341	9997	6389	6390	6391	6392	6834	51204	10131	29796	10975	7381	7384	7385	7386	7388	27089
PC_1554	Highly sodium permeable acetylcholine nicotinic receptors	1136	1137	1141	1143	1144	1145	1146
PC_1555	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	1134	1135	1136	1137	1138	8973	1139	55584	1141	1142	1143
PC_1556	Highly calcium permeable nicotinic acetylcholine receptors	1134	1135	1136	1137	1138	8973	1141	1142	1143
PC_1557	RNA Polymerase II Pre-transcription Events	27125	902	8812	904	905	79577	1022	1025	9150	9646	85403	55840	8178	6924	51224	6923	6921	2068	2071	2957	2958	2959	2960	2961	2962	2963	2965	2966	2967	2968	404672	55677	123169	4298	4300	4331	4686	22916	7469	25920	51497	7936	5828	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	23168	6749	11198	6827	6829	6830	6872	6881	6882	6883	6884	6883	138474	6873	83860	6874	6875	6877	6878	6879	54457	6880	51616	6908	6917	80349
PC_1558	Formation of TC-NER Pre-Incision Complex	9716	902	1022	9318	8533	51138	10987	10980	50813	64708	10920	8451	8450	1642	2033	2068	2071	2074	1161	2873	2965	2966	2967	2968	404672	3150	100534599	4331	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	10450	27339	9978	6233	6917	7311	7314	7316	7874	57654	56949	7507	91603
PC_1559	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	9716	902	1022	8451	8450	1642	8178	2033	2068	2071	2074	1161	2965	2966	2967	2968	404672	3150	100534599	4331	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	10450	27339	9978	6233	6917	7311	7314	7316	7874	57654	56949	91603
PC_1560	Dual incision in TC-NER	9716	902	1022	8451	8450	1642	2033	2067	2068	2071	2072	2073	2074	1161	2965	2966	2967	2968	404672	3150	100534599	4331	5111	5424	5425	10714	57804	5426	5427	54107	56655	51426	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	10450	27339	9978	5981	5982	5983	5984	5985	6117	6118	6119	6233	6917	7311	7314	7316	7874	57654	56949	7507	91603
PC_1561	Gap-filling DNA repair synthesis and ligation in TC-NER	9716	902	1022	8451	8450	1642	2033	2068	2071	2074	1161	2965	2966	2967	2968	404672	3150	100534599	3978	3980	4331	5111	5424	5425	10714	57804	5426	5427	54107	56655	51426	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	10450	27339	9978	5981	5982	5983	5984	5985	6117	6118	6119	6233	6917	7311	7314	7316	7874	57654	56949	7515	91603
PC_1562	tRNA modification in the nucleus and cytosol	23536	134637	113179	91801	54901	90353	348180	54920	2058	24140	8270	4234	54888	221078	55644	80324	83480	54517	81890	79691	63892	54974	112858	51002	1787	54802	55687	93587	60487	51504	54482	152992	51605	115708	57604	81605	10785
PC_1563	Synthesis of wybutosine at G37 of tRNA(Phe)	9836	55039	57570	55253	127253	129450
PC_1564	Fanconi Anemia Pathway	390502	84126	100526739	201254	9937	64858	146956	197342	2067	2072	80233	199990	91442	6624	2175	2187	2176	2177	2178	2188	2189	55215	55120	57697	80198	353497	6117	6118	6119	6233	548593	548593	84464	7311	7314	7316	29089	7398	57599
PC_1565	Interleukin-10 signaling	6363	6347	6364	6367	6348	414062	414062	388372	6352	1230	729230	1234	941	942	1435	1437	1440	2919	3627	2920	3576	2208	2357	3383	3586	3587	3588	3592	3593	3606	3552	3553	3554	7850	3557	3569	3716	3976	5724	5743	6774	7076	7124	7132	7133	7297
PC_1566	Glycine degradation	275	1738	2653	2731
PC_1567	tRNA processing in the nucleus	8086	79074	10614	29894	10898	1478	1653	60528	283742	55706	57122	55746	9972	9631	23279	23511	23165	23225	8021	129401	79023	11097	348995	10762	53371	9818	23636	79902	4927	9688	4928	9883	11149	10775	51367	10248	8480	5901	5903	11102	79897	54913	10556	10557	10799	51493	51637	6396	81929	7175	51095	116461	80746	79042	283989	11260	339487
PC_1568	tRNA processing in the mitochondrion	60528	3028	4508	4509	4512	4513	4514	4519	4535	4536	4537	4538	4539	4540	4541	9692	54931	51095
PC_1569	ERBB2 Regulates Cell Motility	685	1729	1950	1956	2064	2065	2066	2069	1839	51072	3084	9542	10718	145957	387
PC_1570	Interleukin-4 and Interleukin-13 signaling	207	246	240	301	10538	596	598	604	332	6356	6347	6367	595	948	1026	1052	1278	3576	2162	356	2208	2247	2335	2353	2308	2309	6624	2625	3082	3091	3162	3320	7184	3312	3383	3586	3592	3593	3596	3597	3598	3605	112744	3606	3552	3553	51561	149233	3561	3565	3566	3569	3570	3662	3684	3687	3688	3689	3716	3717	3718	3726	3911	3929	3934	3976	4128	4170	4312	4313	4314	4318	4582	4609	79923	4692	4843	4985	4988	5008	5295	5292	5443	5451	5743	58480	6095	6097	1901	6288	8651	9021	9655	6657	6772	6774	6778	7040	7076	7124	7133	7157	7291	7297	7412	7422	7431	6935
PC_1571	tRNA modification in the mitochondrion	84705	3028	25821	9692	80324	54802	54931	55006	55687
PC_1572	GDP-fucose biosynthesis	197258	8790	282969	2762	55343	7264
PC_1573	IL-6-type cytokine receptor ligand interactions	23529	1270	1271	9244	1489	3589	3590	386653	133396	3572	3716	3717	3976	3977	5008	9180	7297
PC_1574	rRNA modification in the nucleus and cytosol	9790	114049	25879	51202	54555	11056	57647	27042	27292	1736	10436	2091	51077	54433	55127	10643	56928	11103	10199	55226	79050	25926	65083	55505	8602	4839	10528	51602	22984	56902	5822	10171	6208	6187	6194	6201	6203	88745	27341	9136	4809	10607	55623	51504	115939	51118	10813	9724	84135	51096	27340	57050	84916	55813	10885	134430	23160	9277	84128
PC_1575	TALDO1 deficiency	6888
PC_1576	Major pathway of rRNA processing in the nucleolus and cytosol	9790	23246	114049	705	10438	1453	102800317	25879	9188	51202	54555	11056	57647	27042	22894	10969	10436	90459	51013	5394	23404	51010	54512	56915	118460	23016	11340	5393	2197	2091	51077	117246	26354	55127	10643	56928	81875	11103	81887	84946	10199	10200	23517	4691	51388	28987	79050	25926	79159	65083	79707	8602	10528	51602	22984	27043	23481	56902	5822	55131	10171	83732	55781	8780	6134	4736	140801	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	200916	9349	6147	6152	6154	51121	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6166	6167	6168	6169	6170	116832	6123	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	11102	79897	54913	10556	10557	10799	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6233	51065	6234	6235	6188	6189	6191	6192	140032	6193	6194	6201	6202	6203	3921	6176	88745	27341	9136	26168	4809	10607	54881	55720	7311	51118	10813	9724	84135	51096	27340	57050	84916	55813	55759	57418	10885	134430	23160	9277	84128	22803
PC_1577	RPIA deficiency	22934
PC_1578	TALDO1 deficiency	6888
PC_1579	rRNA modification in the mitochondrion	79922	29960	55178	130916	387338	51106
PC_1580	Neurexins and neuroligins	320	321	9546	57596	8573	28988	4355	4356	1742	9229	58512	22839	2035	2036	2037	23136	57669	2902	2903	2904	2905	2906	2911	2915	9456	9455	9454	8825	64130	55327	347730	26045	347731	80059	22871	57555	54413	57502	22829	9378	9379	9369	10611	50944	22941	81858	26037	6804	6812	6857	341359	91683	127833	9066	143425
PC_1581	TP53 Regulates Transcription of DNA Repair Genes	1386	472	390502	672	902	8812	904	905	51755	8621	1022	1025	1111	9150	1643	8178	6924	51224	6923	6921	2068	2071	2176	2177	55215	2353	2962	2963	2965	2966	2967	2968	404672	3725	9656	4292	4331	4436	7469	25920	51497	7936	5395	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	5892	6749	11198	6827	6829	6917	7157
PC_1582	Choline catabolism	501	635	55349	29958	1757	23446
PC_1583	Neutrophil degranulation	1	154664	30	47	55	55860	10120	10097	51816	102	101	84658	222487	175	178	10555	197	210	221	226	230	240	272	196527	290	302	26	8907	161	317	327	353	383	23526	64333	127829	25852	10092	439	411	427	83858	10533	23250	23200	10159	535	527	51382	10396	79895	566	567	2683	51411	671	25798	683	684	79169	718	719	728	387263	51719	51806	820	55832	124583	10487	823	847	10576	10694	929	57126	11314	945	948	960	961	963	1604	965	966	967	968	22918	976	978	8621	634	1084	4680	1088	80184	1675	5199	1116	1118	1143	10970	160364	170482	338339	23601	54918	1265	23412	29099	1315	23406	8904	8895	55313	1378	84766	8804	10321	83716	1460	1471	1476	5476	1508	1075	1509	1511	1512	1520	1522	2919	3577	3579	1727	1535	1536	23191	84418	28988	1650	1654	1667	1667	1669	8560	51071	8694	1729	23317	5611	80331	1774	1794	79930	29952	1827	1828	79980	1832	1778	51143	8655	6993	1915	1938	1991	22875	8288	23071	2171	23197	2204	2207	2212	2215	2219	10875	2268	388698	2352	2357	2358	2444	84443	2495	2512	2517	2519	2548	2588	25801	2665	8836	84514	2717	2720	11010	2760	9535	2799	51125	2821	53831	2896	79792	2934	2950	2990	2992	3043	23593	3074	138050	3101	3105	3106	3107	3146	3163	3240	10855	388697	3320	3326	3303	3303	3310	3312	10075	84329	3417	3482	3608	3614	3615	8826	10788	9798	3683	3684	3685	3687	3689	3728	56888	8514	3837	3848	3903	3916	3920	55004	28956	8649	3934	3958	11026	10288	102725035	79888	116844	4033	4048	4057	4069	84061	4125	4126	5594	1432	199675	25840	8972	4257	268	9761	4311	79148	4317	4318	79169	4332	158747	4353	932	9961	93100	23218	3071	23385	4718	4758	150372	23114	4790	387921	56954	4831	10577	4893	10562	4973	5004	5005	94103	126014	26578	5023	5036	11240	5049	11333	8566	5175	5211	5223	8993	5236	55276	10857	5284	5315	5317	51316	5328	5329	5337	80301	4860	5473	5478	10450	5547	10549	9588	5553	54886	5580	5645	5646	5657	5660	5663	5683	5686	5689	5695	5701	5702	5707	5717	5718	5719	10213	5708	5709	9861	5713	5724	80142	5777	5787	5788	5795	5799	5309	29108	5834	5836	25797	5768	10890	51552	22931	53917	5873	11031	326624	5864	9545	401258	53916	5869	5878	5870	7879	51209	5879	5906	5908	5912	57826	56729	387	54509	391	6036	6037	8635	6093	6282	6283	6278	6279	6280	6286	9522	6386	6402	5265	12	1992	5273	89777	6317	5269	100049587	8778	27180	140885	10326	6556	121260	11001	6515	6518	57153	353189	6590	8773	6616	9342	6709	6727	8987	6793	114790	2040	6836	258010	9145	441864	374403	10312	6947	100302736	7077	7097	64114	11322	340061	374395	55754	9725	7130	7133	54472	10043	58485	7226	81619	7276	203068	10383	81567	7305	23352	201294	8673	9218	6570	7414	7415	8876	57020	7520	2547	51646
PC_1584	Complex I biogenesis	28976	51295	4535	4536	4537	4538	4540	4541	4694	4705	126328	55967	51079	4695	4696	4698	4700	4701	4702	4704	4706	51103	91942	25915	29078	79133	137682	55471	4707	4716	54539	4708	4709	4710	4711	4712	4713	4714	4715	4717	4718	4719	4720	4722	4724	4725	4726	374291	4728	4723	4729	4731	80224	51300	55863
PC_1585	Metal sequestration by antimicrobial proteins	3934	4057	6278	338324	6279	6280
PC_1586	Signaling by moderate kinase activity BRAF mutants	54518	369	408	409	673	221477	801	815	816	817	818	10256	22866	1445	2243	2244	2266	2335	3265	8826	3674	3690	3717	3845	8844	283455	5604	5605	4296	5594	5595	4140	4893	5037	5245	5894	5906	5908	6714	7094	7414	7450	7529
PC_1587	Signaling by high-kinase activity BRAF mutants	54518	369	408	409	673	10256	22866	1445	2243	2244	2266	2335	3265	8826	3674	3690	3845	8844	283455	5604	5605	5594	5595	4140	4893	5037	5894	5906	5908	6714	7094	7414	7450	7529
PC_1588	Signaling by RAS mutants	54518	369	408	409	673	221477	801	815	816	817	818	10256	22866	1445	153090	2243	2244	2266	2335	3265	8826	3674	3690	3717	3845	8844	283455	5604	5605	4296	5594	5595	4140	4763	4893	5037	5245	5894	5906	5908	5921	5922	22821	10156	8437	9462	64926	161742	200734	399473	6714	8831	7094	7414	7450	7529
PC_1589	Signaling by BRAF and RAF fusions	55109	55750	57085	10142	8546	54518	369	408	409	10533	10018	673	801	815	816	817	818	1185	10256	22866	1445	54845	10827	9715	2243	2244	2266	2335	8087	3265	8826	3674	3690	3717	80853	57670	3845	8844	283455	4000	5604	5605	5594	5595	4140	23164	4893	9061	5037	9444	5894	5906	5908	27044	6714	11044	7094	22906	8805	7414	7450	7529	56829
PC_1590	RAS signaling downstream of NF1 loss-of-function variants	3265	3845	4763	4893
PC_1591	Paradoxical activation of RAF signaling by kinase inactive BRAF	54518	369	408	409	673	221477	801	815	816	817	818	10256	22866	1445	2243	2244	2266	2335	3265	8826	3674	3690	3717	3845	8844	283455	5604	5605	4296	5594	5595	4140	4893	5037	5245	5894	5906	5908	6714	7094	7414	7450	7529
PC_1592	Antimicrobial peptides	671	51297	140683	92747	80341	149954	128859	820	1113	1191	1511	117159	1991	100526773	10578	3346	3347	55600	116842	4057	4069	8993	114770	114771	57115	5266	5320	5645	5646	5657	5068	130120	6037	6039	84659	122665	6406
PC_1593	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	84883	472	581	27113	637	665	1387	5366	23368	27166	10650	55240	7157	63970	7159	94241	8626	7161	51499	147923
PC_1594	TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain	79370	604	332	1121	10397	64065	23368	5875	5876	7157	7159	9540	8626	7161
PC_1595	TP53 Regulates Transcription of Caspase Activators and Caspases	317	472	834	843	835	839	8738	58484	55367	7157	8626	7161
PC_1596	TP53 Regulates Transcription of Death Receptors and Ligands	355	3486	23368	124446	8797	8795	8794	8793	7157	7159	8626	7161
PC_1597	FGFR2 alternative splicing	54845	80004	2263	2962	2963	3178	3185	3187	4670	4686	22916	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	5725	23543	7072	7073
PC_1598	Ion influx/efflux at host-pathogen interface	475	538	51248	6556
PC_1599	TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	6790	581	10498	891	995	983	1874	2033	1647	5111	3276	5933	5934	2810	7027	7029	7157	25946
PC_1600	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	7832	995	55835	23019	25904	55571	4848	4849	4850	246175	29883	9337	9125	4869	5325	10769	1263	28984	85456	7157
PC_1601	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	1820	8900	890	898	9134	1017	1026	1027	1869	144455	79733	57060	7157	25946
PC_1602	Regulation of TP53 Expression	639	7157
PC_1603	Regulation of TP53 Activity through Phosphorylation	472	390502	84126	6790	9212	580	641	672	83990	8900	890	1017	1020	8851	1111	11200	1457	1459	1460	1763	8445	9156	204851	28996	3364	10524	5600	1432	8550	4193	4194	4361	4683	26155	9891	5300	1263	5562	5563	5564	5565	5571	51422	53632	5810	5884	10111	5883	144715	5932	5982	5983	5984	5985	83695	80010	116028	6117	6118	6119	6233	6749	6794	11198	6872	6881	6882	6883	6884	6883	138474	6873	83860	6874	6875	6877	6878	6879	54457	6880	51616	6908	7156	11073	7157	94241	112858	22974	7311	7314	7316	7486
PC_1604	Regulation of TP53 Degradation	207	208	10000	472	8900	890	900	983	1017	1029	11200	1616	79109	4193	4194	64223	2475	5170	51230	5515	5516	5518	5519	5527	55615	117584	253260	80196	6233	6446	7157	7311	7314	7316	9099	7874
PC_1605	Regulation of TP53 Activity through Acetylation	207	208	10000	23774	29117	7862	27154	1107	1108	2033	54815	57459	3065	3066	84289	7994	53615	64769	9219	5371	5928	5931	7157
PC_1606	Regulation of TP53 Activity through Association with Co-factors	207	208	10000	54971	51230	5457	5458	23368	10848	7157	7159	8626	7161	25946
PC_1607	Regulation of TP53 Activity through Methylation	472	11200	79813	10919	2033	133746	387893	26013	4193	4194	10419	6233	133383	56950	7157	91875	7311	7314	7316
PC_1608	Keratinization	1827	1824	1824	1828	1829	1830	147409	1832	3728	3848	3858	3859	3860	3861	3866	3868	3872	3875	3880	3849	54474	25984	192666	147183	353288	342574	162605	3850	3881	3882	3883	3884	100653049	3886	8689	8688	8687	390792	3851	125115	3852	3853	3854	286887	3855	112802	140807	319101	121391	9119	51350	374454	196374	338785	3856	144501	3887	3888	3889	3890	3891	3892	3857	81851	81850	728255	83895	386677	353333	386678	386685	386679	386682	386680	386674	386675	386681	386676	337880	353332	353323	386683	386684	140258	337959	337960	284827	254950	100505753	83902	337882	337969	337970	337971	337972	337973	337974	728299	728279	728279	730755	730755	337975	337976	337977	337978	100288323	337979	337963	643803	100131902	388818	643812	100533177	83896	83897	85293	85285	653240	85291	85290	84616	85289	81871	728224	100132386	387264	387273	440051	440021	387266	387267	439915	440023	440050	57830	3846	337966	337967	337879	728318	83899	83900	85280	100507608	100505724	83901	81870	5317	5318	11187	8502
PC_1609	Metabolism of vitamin K	29914	79001	154807
PC_1610	MET Receptor Activation	3082	3083	3249	4233	6692	10653
PC_1611	Negative regulation of MET activity	867	2060	2885	3082	9146	26018	4233	5770	5771	5795	6233	6455	6456	6457	30011	8027	10254	7311	7314	7316	9101
PC_1612	Bloch pathway	1718	1717	10682	6309
PC_1613	Kandutsch-Russell pathway	1718	1717	10682	6309
PC_1614	RNA polymerase II transcribes snRNA genes	8812	904	905	1022	1025	8178	22936	80237	2957	2958	2959	2960	2961	2962	2963	23379	79664	26173	55174	54973	57117	55726	81556	57508	65123	92105	80789	26512	25896	55656	55756	64859	79035	4686	22916	51585	51808	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	5451	5452	79871	55197	58490	23248	6617	6618	6619	6621	10302	6667	51593	29101	6827	6829	6882	6884	6877	6878	129685	6880	6908	84524	7702
PC_1615	COPI-mediated anterograde transport	55860	10121	286	287	288	372	375	377	378	381	55738	84364	26286	10282	51272	829	830	93661	832	1604	966	9382	22796	83548	25839	10466	57511	91949	84342	1314	1315	9276	11316	22820	26958	22818	51226	1639	10540	11258	51164	84516	10671	1778	1780	1781	51143	1783	8655	140735	2348	8729	2801	2804	64689	9527	9570	3630	10945	11014	11015	9476	63908	8774	4905	5861	81876	6708	6709	6710	6711	6712	57731	51332	6811	10972	10959	23423	100302736	54732	11070	8615	10652
PC_1616	Formation of the cornified envelope	823	826	23581	1041	63036	1475	1827	1824	1824	1828	1829	1830	147409	1832	2125	2260	5045	3713	3728	23254	43849	26085	43847	25818	11202	353131	353132	353133	353134	353135	353137	353139	26239	353140	353141	353142	353143	353144	84648	353145	199834	254910	448835	149018	142910	643414	340654	643418	4014	5046	64065	5266	5317	5318	11187	8502	5493	5652	126638	11005	404203	643394	6698	6699	6700	6701	6703	6704	6705	6706	6707	6768	7062	7051	9333
PC_1617	Retinoid metabolism disease events	5950
PC_1618	COPI-dependent Golgi-to-ER retrograde traffic	372	375	377	378	381	55738	84364	26286	662	1062	1314	1315	9276	11316	22820	26958	22818	51226	8729	10945	11014	11015	3832	113220	23303	56992	55614	81930	146909	124602	547	23095	10749	10112	9585	55605	23046	3835	9493	3834	26153	55083	55582	3796	84643	11004	11127	9371	3797	24137	285643	3798	3799	221458	64147	22920	3833	90990	3831	147700	147700	89953	9476	63908	8774	51594	4905	5861	81876	29127	60561	9554	53407	6836	10972	10959	23423	100302736	54732	55850	9183
PC_1619	COPI-independent Golgi-to-ER retrograde traffic	55860	10121	56894	636	23299	829	830	93661	832	1639	10540	11258	51164	84516	10671	1778	1780	1781	51143	1783	8655	140735	2589	2590	5048	5049	5050	5321	8398	22931	22930	25782	5870	51560
PC_1620	Intra-Golgi traffic	250	375	51272	9382	22796	83548	25839	10466	57511	91949	84342	1523	9267	9266	9265	27128	9950	27333	9527	9570	4121	10905	57134	4124	4122	9476	63908	8774	4905	27314	83452	9609	54734	347517	400966	57589	9342	8675	6811	10228	9321	11311	143187	10652
PC_1621	Retrograde transport at the Trans-Golgi-Network	23647	10139	400	9382	22796	83548	25839	10466	57511	91949	84342	79571	9648	2800	2803	3482	4074	122830	60560	84316	9476	63908	8774	4905	10226	339122	5870	51560	9367	51209	10244	400966	22836	57589	60592	8677	8675	10228	90196	10618	7110	9712	9341	8674	738	6293	55275	51542	143187
PC_1622	PI5P Regulates TP53 Acetylation	2033	3622	5608	5300	5305	8396	79837	90809	7157
PC_1623	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	207	374	685	930	940	941	942	1950	1956	255324	2064	2065	2066	2069	2099	2100	2246	2255	8823	8822	8817	9965	2247	26281	27006	8074	2248	2249	2250	2251	2252	2253	2254	2260	2263	2261	2264	10818	2534	2549	2885	1839	3082	29851	8870	3556	9173	90865	3630	3643	3654	51135	3667	8660	3815	4254	9365	152831	3932	5594	5595	4233	4615	3084	9542	10718	145957	5154	5155	5156	5159	118788	5290	5291	5293	5295	5296	8503	5305	8396	79837	8394	8395	23396	5515	5516	5518	5519	5525	5526	5527	5528	5529	5781	5879	5880	391	6714	6801	7039	7189	50852	7409
PC_1624	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	10576	7203	10575	22948	908	10693	10574	10694	1457	1459	1460	2770	2771	2773	2775	2779	2780	346562	2781	2782	2783	2784	59345	10681	2790	2791	55970	51764	54331	2785	2786	2787	2788	2793	2792	2793	5082	8786	9628	6000	8787	6950
PC_1625	Glycerophospholipid catabolism	133121	51573	284161	79153	81544	10908	375775
PC_1626	Assembly of the ORC complex at the origin of replication	4998	4999	23595	5000	5001	23594
PC_1627	CDC6 association with the ORC	990	1869	1870	1871	84515	4998	4999	23595	5000	5001	23594
PC_1628	CDT1 association with the CDC6	990	81620	51053	84515	4998	4999	23595	5000	5001	23594	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	6233	7979	7311	7314	7316
PC_1629	Assembly of the pre-replicative complex	990	81620	4176	4172	4173	4174	4175	4176	84515	4998	4999	23595	5000	5001	23594
PC_1630	Mitotic Prophase	891	983	4926
PC_1631	Mitotic Prometaphase	25909	9212	80776	332	699	701	9184	991	55143	1058	1060	1062	1063	64946	2491	64105	91687	79019	55839	79172	401541	55166	100526739	80152	79682	9793	23332	23122	6249	79980	1778	1780	1781	51143	1783	8655	140735	54821	3619	23421	81930	3796	84643	11004	57082	9735	8379	4085	22919	79003	10403	54820	81565	284058	10726	83540	57122	55746	23279	79023	348995	79902	4928	5048	5347	100527963	5501	5515	5516	5518	5519	5525	5526	5527	5528	5529	5903	5905	55920	6232	6396	81929	151648	151246	220134	348235	147841	9789	54908	57551	7514	9183	55055	11130
PC_1632	Mitotic Metaphase/Anaphase Transition	26271	5347
PC_1633	cell division	10112	9493	10726	5347
PC_1634	G2 Phase	8900	890	1017	1869	1871
PC_1635	Orc1 removal from chromatin	8900	890	990	1017	81620	8454	4176	4172	4173	4174	4175	4176	84515	4998	4999	23595	5000	5001	23594	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	9978	6233	7979	6500	6502	7311	7314	7316
PC_1636	DNA replication initiation	5422	23649	5426	5427	54107	56655	5557	5558
PC_1637	Activation of the pre-replicative complex	8318	990	8317	1017	81620	10926	51053	55388	4176	4172	4173	4174	4175	4176	84515	4998	4999	23595	5000	5001	23594	5422	23649	5426	5427	54107	56655	5557	5558	6117	6118	6119	29935
PC_1638	CDK-mediated phosphorylation and removal of Cdc6	64682	10393	51529	25906	119504	29882	29945	51433	51434	8900	890	898	9134	8881	8697	246184	996	990	1017	51343	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	6233	7979	7311	7314	7316	11065	7321	7324
PC_1639	Switching of origins to a post-replicative state	4176	4172	4173	4174	4175	4176
PC_1640	Polymerase switching	5111	5422	23649	5424	5425	10714	57804	5557	5558	5981	5982	5983	5984	5985
PC_1641	Removal of the Flap Intermediate	1763	2237	5111	5422	23649	5424	5425	10714	57804	5557	5558	6117	6118	6119
PC_1642	Processive synthesis on the lagging strand	3978	5111	5422	23649	5424	5425	10714	57804	5557	5558
PC_1643	Phosphorylation of proteins involved in G1/S transition by active Cyclin E	898	9134	1017	5925
PC_1644	Cyclin E associated events during G1/S transition	207	208	10000	91768	898	9134	902	993	1017	1022	1026	1027	1869	1874	1875	55957	91750	132660	286826	4149	4331	4609	5925	5928	5934	7027	7029	7465
PC_1645	G1/S-Specific Transcription	8900	898	993	8318	990	983	81620	1719	1869	1874	1875	1876	26271	3065	55957	91750	132660	286826	4998	5111	5422	5928	5933	5934	6241	7027	7029	7083	7298
PC_1646	Cyclin D associated events in G1	25	595	894	896	902	1019	1021	1022	1026	1027	1028	1029	1030	1031	1032	1163	8454	1869	1870	1871	1874	1875	3717	4067	4331	5515	5516	5518	5519	5520	28227	5753	5925	5933	5934	6233	6500	6502	6714	7027	7029	7311	7314	7316
PC_1647	Cyclin A/B1/B2 associated events during G2/M transition	8900	890	891	9133	902	993	994	995	983	1017	1022	2305	51451	4331	9088	5347	51400	5515	5516	5518	5519	5520	28227	7465	7514
PC_1648	Dimerization of procaspase-8	841	8837	8772	355	356	8737	8797	8795	8743	8717	7186
PC_1649	G2/M DNA damage checkpoint	84142	472	390502	84126	29086	9577	580	641	672	79184	83990	1111	11200	1763	9156	3014	102724334	8924	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	8349	121504	121504	128312	8290	121504	3364	10524	9656	4361	4683	7468	51588	5810	5884	10111	5883	144715	5932	5982	5983	5984	5985	83695	80010	116028	165918	9025	6117	6118	6119	7341	7156	11073	7157	7158	7334	7336	51720	7486
PC_1650	G2/M DNA replication checkpoint	891	9133	983	9088	7465
PC_1651	G2/M Checkpoints	51512	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	6233	7979	7157	7311	7314	7316
PC_1652	Stabilization of p53	472	1029	11200	4193	4194	51230	6233	7157	7311	7314	7316
PC_1653	p53-Dependent G1 DNA Damage Response	8900	890	898	9134	1017	1026	1027
PC_1654	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	993	1111	11200	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	6233	7979	7311	7314	7316
PC_1655	Cyclin A	207	208	10000	91768	8900	890	902	993	994	1017	1022	1026	1027	1869	1874	1875	51343	55957	91750	132660	286826	4149	4331	4609	5925	5928	5934	7027	7029	7465
PC_1656	Transcriptional activation of cell cycle inhibitor p21	1026	57060	7157	25946
PC_1657	Glycolysis	83440	226	229	230	669	2023	2026	2027	2597	26330	2645	10007	132789	2821	3098	3099	3101	5211	5213	5214	5223	5224	5230	5232	283209	283871	5313	5315	7167
PC_1658	Glycogen breakdown (glycogenolysis)	178	801	2548	2992	8908	55276	283209	5255	5256	5257	5260	5261	5834	5836	5837
PC_1659	Gluconeogenesis	226	229	230	2023	2026	2027	2203	8789	2538	57818	92579	2597	26330	2805	2806	2821	4190	4191	5091	5105	5106	5223	5224	5230	5232	6576	1468	8402	8604	10165	54020	219855	2542	7167
PC_1660	Pyruvate metabolism	682	1737	1738	2739	3029	3939	160287	92483	3945	3948	4199	51660	25874	5160	5161	5162	8050	6566	9123	23539	7416
PC_1661	Fructose catabolism	216	229	132158	3795	26007
PC_1662	Galactose catabolism	2582	2584	2592	55276	283209
PC_1663	Urea cycle	383	384	435	445	1373	162417	57407	5009	10166	83884
PC_1664	Proline catabolism	8659	5625	5625
PC_1665	Branched-chain amino acid catabolism	27034	36	38	4329	549	586	587	593	594	10295	1629	1738	11112	26275	3028	3712	56922	64087	152926
PC_1666	Histidine catabolism	144193	138199	57571	10841	3034	3067	3176	131669
PC_1667	Propionyl-CoA catabolism	84693	166785	4594	5095	5096
PC_1668	Lysine catabolism	51166	10157	501	1428	1738	1743	2639	123688	4967	85007	51268	89874
PC_1669	Tryptophan catabolism	51166	130013	125061	23498	3620	169355	8564	883	56267	8942	120103	6520	8140	6999
PC_1670	Carnitine synthesis	223	8424	6470	55217
PC_1671	Creatine metabolism	1152	1158	1159	1159	1160	2593	2628	6538	6539	6534	6535
PC_1672	Pentose phosphate pathway	51071	2539	5226	25796	55276	64080	6120	729020	22934	23729	6888	7086
PC_1673	Ethanol oxidation	84532	55902	124	125	126	127	128	130	131	216	219	217
PC_1674	Citric acid cycle (TCA cycle)	50	1431	1738	1743	81889	2271	3418	3419	3420	3421	4191	4200	10873	23530	4967	6389	6390	6391	6392	8803	8802	8801
PC_1675	Pyrophosphate hydrolysis	5464	27068
PC_1676	mRNA Capping	902	1022	2068	2071	2962	2963	2965	2966	2967	2968	404672	4331	4686	22916	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	8732	8731	6829
PC_1677	pre-mRNA splicing	10189	9716	10286	8896	22794	55749	10421	51362	988	10523	10614	29894	53981	51692	10898	79869	51340	1477	1478	23283	1479	56259	51503	57703	54883	10283	9416	11325	9879	1655	1665	8449	9785	1660	22826	9343	9775	1994	1993	81608	2521	6936	27238	2962	2963	10949	3178	3181	220988	3183	3184	3185	3187	3188	3190	3191	4670	10236	3192	11100	3312	100534599	57819	27258	25804	23658	11157	51690	51691	4116	55110	23517	4686	22916	11051	8106	10914	5093	5094	51585	84844	5356	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	10450	10465	51645	53938	85313	285755	23398	10084	5546	27339	9129	26121	84950	9128	55660	24148	10594	5725	22827	84991	55696	10181	9939	27316	10921	9092	2516	10291	8175	10946	23451	10992	23450	10262	83443	51639	10569	10285	23020	11017	9410	6625	6626	6627	6628	6629	6631	6632	6633	6634	6635	6636	6637	6638	4809	22938	10250	23524	51593	6426	10772	9295	6427	6428	6429	6430	6431	6432	8683	57794	25949	8189	24144	6434	10907	102724594	199746	11338	23350	65109	10713	51729	11193	55339	56949	4904
PC_1678	U12 Dependent Splicing	9416	11325	9343	2962	2963	57819	4686	22916	10081	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	24148	10594	55599	23451	10992	23450	10262	83443	51639	23020	79622	11066	9410	154007	6628	6632	6633	6634	6635	6636	6637	4809	6426	6427	6431	6432	10907	4904	85437	55954	8233
PC_1679	mRNA 3'-end processing	10189	22794	51362	26097	10614	29894	53981	51692	10898	79869	1477	1478	23283	1479	10212	7919	9785	9775	81608	84248	51213	4116	55110	4686	22916	11051	8106	10914	51585	84271	9939	10921	84324	10569	10250	6426	9295	6427	6428	6429	6430	6431	6432	8683	8189	9984	57187	84321	8563	79228	80145	102724594	199746	11338	65109	55339	9877
PC_1680	mRNA Editing	29974	339	10930	100913187	9582	27350	164668	403314
PC_1681	Processing of Capped Intron-Containing Pre-mRNA	2962	2963	10949	3178	3181	220988	3183	3184	3185	3187	3188	3190	3191	4670	10236	3192	57721	56339	4686	22916	5093	5094	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	5725	27316	9589
PC_1682	Translation initiation complex formation	1356	1964	1965	8894	1968	3692	8662	8663	8664	3646	8665	8666	8667	8668	8669	27335	51386	10480	1973	1974	1975	1977	1981	7458	2197	26986	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6233	51065	6234	6235	6188	6189	6191	6192	140032	6193	6194	6201	6202	6203	3921
PC_1683	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	1973	1974	1975	1977	1978	1981	7458
PC_1684	Formation of a pool of free 40S subunits	1964	3692	8662	8663	8664	3646	8665	8666	8667	8668	8669	27335	51386	10480	2197	6134	4736	140801	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	200916	9349	6147	6152	6154	51121	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6166	6167	6168	6169	6170	116832	6123	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6233	51065	6234	6235	6188	6189	6191	6192	140032	6193	6194	6201	6202	6203	3921	7311
PC_1685	Formation of the ternary complex, and subsequently, the 43S complex	1964	1965	8894	1968	3692	8662	8663	8664	3646	8665	8666	8667	8668	8669	27335	51386	10480	2197	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6233	51065	6234	6235	6188	6189	6191	6192	140032	6193	6194	6201	6202	6203	3921
PC_1686	Ribosomal scanning and start codon recognition	1964	1965	8894	1968	3692	8662	8663	8664	3646	8665	8666	8667	8668	8669	27335	51386	10480	1973	1974	1975	1977	1981	7458	1983	2197	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6233	51065	6234	6235	6188	6189	6191	6192	140032	6193	6194	6201	6202	6203	3921
PC_1687	GTP hydrolysis and joining of the 60S ribosomal subunit	1964	1965	8894	1968	3692	8662	8663	8664	3646	8665	8666	8667	8668	8669	27335	51386	10480	1973	1974	1975	1977	1981	7458	1983	9669	2197	6134	4736	140801	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	200916	9349	6147	6152	6154	51121	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6166	6167	6168	6169	6170	116832	6123	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6233	51065	6234	6235	6188	6189	6191	6192	140032	6193	6194	6201	6202	6203	3921	7311
PC_1688	Recycling of eIF2	1967	8892	8891	8890	8893	1965	8894	1968
PC_1689	Eukaryotic Translation Termination	327	2107	2197	2935	23708	29104	6134	4736	140801	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	200916	9349	6147	6152	6154	51121	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6166	6167	6168	6169	6170	116832	6123	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6233	51065	6234	6235	6188	6189	6191	6192	140032	6193	6194	6201	6202	6203	3921	51504	7311
PC_1690	Transport of nucleotide sugars	10559	7355	23443	347734	51000	84912	55343	23169	11046
PC_1691	Pyrimidine salvage	978	1633	8226	7083	7084	1890	83549	7371	54963	7378	151531
PC_1692	Pyrimidine catabolism	64902	1806	1807	30833	84618	51251	4907	56953	1890	51733	7378	151531
PC_1693	RNA Polymerase I Promoter Opening	474382	55766	94239	3014	3015	102724334	3020	3020	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	8350	8350	8350	8350	8350	8350	8350	8350	8350	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	126961	126961	126961	121504	121504	128312	121504	5595	8932	7343
PC_1694	RNA Polymerase I Transcription Initiation	902	10849	1022	1107	1108	10919	2068	2071	2074	54815	57459	2965	2966	2967	2968	404672	3065	3066	2648	8850	53615	4331	9112	9219	57504	25885	84172	9533	51082	9533	5434	5435	5437	5440	5441	5928	5931	54700	9015	9014	9013	79101	6908	7080	221830	7343	30834
PC_1695	RNA Polymerase I Promoter Escape	11335	902	10849	1022	2068	2071	2965	2966	2967	2968	404672	474382	55766	94239	3014	3015	102724334	3020	3020	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	8350	8350	8350	8350	8350	8350	8350	8350	8350	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	126961	126961	126961	121504	121504	128312	121504	4331	25885	84172	9533	51082	9533	5434	5435	5437	5440	5441	54700	9015	9014	9013	79101	6908	221830	7343	30834
PC_1696	RNA Polymerase II Promoter Escape	902	1022	2068	2071	2957	2958	2959	2960	2961	2962	2963	2965	2966	2967	2968	404672	4331	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	6872	6881	6882	6883	6884	6883	138474	6873	83860	6874	6875	6877	6878	6879	54457	6880	51616	6908
PC_1697	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	902	1022	2068	2071	2957	2958	2959	2960	2961	2962	2963	2965	2966	2967	2968	404672	4331	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	6872	6881	6882	6883	6884	6883	138474	6873	83860	6874	6875	6877	6878	6879	54457	6880	51616	6908
PC_1698	RNA Polymerase III Chain Elongation	27297	9533	51082	5434	5435	5437	5440	5441	11128	55703	10623	661	55718	10621	10622	84265	171568	51728
PC_1699	Purine ribonucleoside monophosphate biosynthesis	158	159	122622	471	2618	8833	3614	3615	64077	10606	5198	5471
PC_1700	PRPP biosynthesis	5631	221823	5634
PC_1701	RNA Polymerase II Transcription Termination	10189	22794	51362	26097	10614	29894	53981	51692	10898	79869	1477	1478	23283	1479	10212	7919	9785	9775	81608	84248	84967	134353	51213	4116	55110	4686	22916	11051	8106	10914	51585	84271	9939	10921	84324	7884	10569	6628	6634	6635	6636	6637	10250	6426	9295	6427	6428	6429	6430	6431	6432	8683	8189	9984	57187	84321	8563	79228	80145	102724594	199746	11338	65109	55339	9877	25888
PC_1702	RNA Polymerase I Transcription Termination	284119	902	10849	1022	2068	2071	2965	2966	2967	2968	404672	4331	25885	84172	9533	51082	9533	5434	5435	5437	5440	5441	9015	9014	9013	79101	6908	7080	221830	7343	30834
PC_1703	Abasic sugar-phosphate removal via the single-nucleotide replacement pathway	328	5423
PC_1704	Resolution of Abasic Sites (AP sites)	328
PC_1705	Reversal of alkylation damage by DNA dioxygenases	54890	79068
PC_1706	RNA Polymerase III Transcription Termination	27297	4774	4781	4782	4784	9533	51082	5434	5435	5437	5440	5441	11128	55703	10623	661	55718	10621	10622	84265	171568	51728	6741
PC_1707	Purine salvage	100	161823	132	270	271	272	353	1633	1716	2766	51292	3251	4860
PC_1708	Purine catabolism	10591	8034	2876	3704	30833	84618	100526794	22978	4907	4860	7498
PC_1709	IRS activation	2887	3630	3643	3667	8660
PC_1710	Signal attenuation	2887	2885	3630	3643	3667	8660	5594	5595	6464	6654
PC_1711	Insulin receptor signalling cascade	2887	2885	3265	3630	3643	3845	4893	6464	6654
PC_1712	Signaling by Insulin receptor	3630	3643
PC_1713	RNA Polymerase III Abortive And Retractive Initiation	55814	677	55290	27297	2971	2975	2976	9330	9329	9328	112495	4774	4781	4782	4784	9533	51082	5434	5435	5437	5440	5441	11128	55703	10623	661	55718	10621	10622	84265	171568	51728	5451	6617	6618	6619	6621	10302	6741	6908	7702
PC_1714	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B	891	995	983	1111	11200	2810	7465	7529	7531	7532	7533	10971	7534
PC_1715	Formation of the Editosome	29974	339	10930	100913187	9582	27350	164668	403314
PC_1716	C6 deamination of adenosine	103	104
PC_1717	Fatty acyl-CoA biosynthesis	31	47	84869	2194	7923	109703458	22880	55301	5538	9374	6319	79966	6576
PC_1718	Activation of BID and translocation to mitochondria	637	841	3002	4836
PC_1719	Triglyceride biosynthesis	392636	8694	84649	2710	2585	57678	150763	23175	9663	64900	116255	80168	346606
PC_1720	Apoptotic execution phase	10134	841	10059	8428
PC_1721	FasL/ CD95L signaling	843	841	8772	355	356
PC_1722	TRAIL signaling	843	841	8837	8772	8797	8795	8793	8743
PC_1723	Dissolution of Fibrin Clot	302	3273	5327	5328	5329	5340	6281	5055	5269	5271	5054	5270	5345
PC_1724	Ubiquitin-dependent degradation of Cyclin D	595	1019	2932	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	6233	7979	7311	7314	7316
PC_1725	Synthesis of very long-chain fatty acyl-CoAs	23205	81616	197322	2180	2181	2182	51703	23305	64834	54898	83401	6785	60481	79071	79993	9200	201562	51495	401494	51144	3293	11000	9524	253017
PC_1726	Platelet Adhesion to exposed collagen	2207	2534	2811	2812	2814	51206	2815	3672	8515	3673	3688	4067	7450
PC_1727	TNF signaling	6868	9530	8737	7124	7132	8717	7186
PC_1728	Plasmalogen biosynthesis	8540	25979	8443
PC_1729	RNA Polymerase II Transcription Initiation	902	1022	2068	2071	2957	2958	2959	2960	2961	2962	2963	2965	2966	2967	2968	404672	4331	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	6872	6881	6882	6883	6884	6883	138474	6873	83860	6874	6875	6877	6878	6879	54457	6880	51616	6908
PC_1730	RNA Polymerase II Transcription Elongation	27125	902	8812	904	905	79577	1022	1025	9150	9646	85403	55840	8178	6924	51224	6923	6921	2068	2071	2962	2963	2965	2966	2967	2968	404672	55677	123169	4298	4300	4331	7469	25920	51497	7936	5828	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	23168	6749	11198	6827	6829	6830	6917	80349
PC_1731	Response to elevated platelet cytosolic Ca2+	5578	5579	5582
PC_1732	Platelet Aggregation (Plug Formation)	2147	2811	2812	2814	2815	4352	7066	7450
PC_1733	RNA Polymerase II Transcription Initiation And Promoter Clearance	902	1022	2068	2071	2957	2958	2959	2960	2961	2962	2963	2965	2966	2967	2968	404672	4331	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	6872	6881	6882	6883	6884	6883	138474	6873	83860	6874	6875	6877	6878	6879	54457	6880	51616	6908
PC_1734	RNA Polymerase III Transcription Initiation From Type 1 Promoter	55814	677	27297	2971	2975	2976	9330	9329	9328	112495	9533	51082	5434	5435	5437	5440	5441	11128	55703	10623	661	55718	10621	10622	84265	171568	51728	6908
PC_1735	RNA Polymerase III Transcription Initiation From Type 2 Promoter	55814	677	27297	2975	2976	9330	9329	9328	112495	9533	51082	5434	5435	5437	5440	5441	11128	55703	10623	661	55718	10621	10622	84265	171568	51728	6908
PC_1736	RNA Polymerase III Transcription Initiation From Type 3 Promoter	55814	55290	27297	9533	51082	5434	5435	5437	5440	5441	11128	55703	10623	661	55718	10621	10622	84265	171568	51728	5451	6617	6618	6619	6621	10302	6908	7702
PC_1737	Formation of editosomes by ADAR proteins	103	104
PC_1738	RNA Pol II CTD phosphorylation and interaction with CE	902	1022	2068	2071	2962	2963	2965	2966	2967	2968	404672	4331	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	8732	8731	6829
PC_1739	Ketone body catabolism	38	622	5019	64064
PC_1740	Synthesis of Ketone Bodies	65985	38	79611	622	56898	3155	54511	3158
PC_1741	Beta oxidation of myristoyl-CoA to lauroyl-CoA	33	3030	3032
PC_1742	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	33	34	1666	1632	3030	3032
PC_1743	Mitochondrial Fatty Acid Beta-Oxidation	10449	80724	84129	84320	414149	641371	26027	134526	55856	10965	11332	23597	80221	1622	27349	4706	58488	117145	284486
PC_1744	Beta oxidation of palmitoyl-CoA to myristoyl-CoA	37	3030	3032
PC_1745	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	33	1892	3030	3030	3032
PC_1746	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	34	1892	3030	3030	3032	51102
PC_1747	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	34	1892	3030	3030	3032
PC_1748	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	35	1892	3030	3030	3032
PC_1749	Beta oxidation of butanoyl-CoA to acetyl-CoA	35	6296	142827	1892	3030
PC_1750	Insulin receptor recycling	537	535	23545	50617	533	527	9114	245972	8992	155066	523	525	526	528	245973	51382	529	90423	9296	9550	534	127124	51606	3630	3643	10312
PC_1751	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	84967	134353	4686	22916	7884	6628	6634	6635	6636	6637	25888
PC_1752	Processing of Intronless Pre-mRNAs	10614	29894	53981	51692	10898	79869	1477	1478	23283	1479	81608	4686	22916	11051	8106	10914	51585	8189	55339
PC_1753	Transport of fatty acids	347	3933	286256	389812	392399	376497	10999	28965
PC_1754	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	402	23568	291	292	293	9154	9153	64078	2030	3177	55315	222962
PC_1755	The NLRP1 inflammasome	596	598	22861
PC_1756	The NLRP3 inflammasome	351	834	3326	4210	4790	4791	114548	5027	24145	9051	29108	5970	10910	7295	10628
PC_1757	The AIM2 inflammasome	9447	834	29108
PC_1758	The IPAF inflammasome	834	58484
PC_1759	Interferon gamma signaling	567	815	816	817	818	960	4261	2209	2633	2634	51062	115361	115362	163351	388646	3105	3106	3107	3113	3115	3117	3118	3119	3120	3122	3123	3125	3126	3127	3133	3134	3135	3383	10437	3458	3459	3460	3659	3660	3661	3662	3663	3664	3665	3394	10379	3716	3717	4281	4502	4684	4938	4939	4940	8638	5371	5580	5724	5777	8651	9021	6672	6772	10107	9830	51127	23321	6737	10346	7706	7726	23650	10612	11074	53840	23087	10475	80263	80128	79097	85363	117854	55223	55128	81603	7412
PC_1760	Regulation of IFNG signaling	3458	3459	3460	3716	3717	8554	5770	5781	5771	5777	8651	9021	6772	7341
PC_1761	Advanced glycosylation endproduct receptor signaling	177	351	829	830	1650	3146	3958	5594	5595	5589	6283	6285	6288
PC_1762	Transport of organic anions	213	551	6567	6579	10599	28234	53919	6578	11309	28232	28231	353189
PC_1763	Interconversion of 2-oxoglutarate and 2-hydroxyglutarate	137872	728294	79944
PC_1764	Gastrin-CREB signalling pathway via PKC and MAPK	887	1385	2520	5594	5595	5598	6195	6196	6197
PC_1765	Synthesis of PIPs in the nucleus	5305	8396	79837	90809
PC_1766	ERBB2 Activates PTK6 Signaling	685	1950	1956	2064	2065	2066	2069	1839	3084	9542	10718	145957	5753
PC_1767	Threonine catabolism	23464	10247	10993	113675
PC_1768	PTK6 Regulates Proteins Involved in RNA Processing	10657	202559	10656	5753	6421
PC_1769	PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1	207	116985	867	420	5753	6233	7311	7314	7316
PC_1770	PTK6 Regulates Cell Cycle	595	898	1017	1019	1027	5753
PC_1771	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	2909	9564	1398	1793	9844	63916	3265	3845	4893	5753	5829	5879	5921	387
PC_1772	PTK6 Down-Regulation	5753	5770	6725
PC_1773	PTK6 Expression	2034	3091	2908	27043	5753
PC_1774	PTK6 Activates STAT3	5753	9021	55620	6774
PC_1775	Synaptic adhesion-like molecules	1739	4356	1742	10211	2319	2890	2892	2893	2902	2903	2904	2905	2906	57622	57497	79414	78999	5789	5792	5802	10313
PC_1776	Phosphate bond hydrolysis by NTPDase proteins	953	954	956	9583	957	955	57089	377841
PC_1777	Butyrophilin (BTN) family interactions	696	11120	10385	11119	11118	10384	56244	79908	153579	30835	5493	7498
PC_1778	Signaling by FGFR2 IIIa TM	2246	2247	2263	2962	2963	4686	22916	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441
PC_1779	MET activates RAS signaling	2885	3082	3265	3845	4233	200958	4893	57610	55705	6464	6654
PC_1780	MET activates PI3K/AKT signaling	2549	2885	3082	4233	5290	5295
PC_1781	The role of GTSE1 in G2/M progression after G2 checkpoint	891	9133	983	1026	63943	51512	3320	3326	22919	5347	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	6233	7979	7157	7311	7314	7316
PC_1782	Signaling by MST1	3249	4485	4486	6692	10653
PC_1783	Signaling by FGFR2 fusions	2263
PC_1784	Signaling by FGFR3 fusions in cancer	2261	10818	2549	2885	3265	3845	4893	5290	5295	6654
PC_1785	Signaling by plasma membrane FGFR1 fusions	9530	11160	2260
PC_1786	Signaling by FGFR3 point mutants in cancer	2246	8823	8822	8817	2247	26281	8074	2249	2250	2253	2254	2261	10818	2549	2885	3265	3845	4893	5290	5295	5335	6654
PC_1787	Lysosomal oligosaccharide catabolism	4125	23324	4123	4126
PC_1788	RET signaling	9048	420	9046	55715	55816	220164	10818	2549	9846	2668	2674	2675	2676	64096	2887	2885	2886	8660	5598	4902	9260	5290	5291	5293	5295	5296	8503	5335	5578	5567	5568	5578	5623	5781	5909	5979	6464	53358	6654	6714
PC_1789	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	6790	8454	23194	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	9978	6233	7979	6500	7311	7314	7316
PC_1790	TBC/RABGAPs	382	11337	11345	26088	23062	23163	81631	10133	8766	9230	9363	83452	11021	5867	5868	5869	5878	5870	51560	7879	338382	4218	51762	9135	23637	27342	84958	83874	26000	374403	54662	57533	64786	125058	79735	55357	128637	57465	4943	414060	107080638	7248	7249	8408
PC_1791	AURKA Activation by TPX2	10121	10142	7840	6790	9738	983	55755	55835	22994	9662	22995	22897	55125	11190	80184	95681	9702	80254	80321	55722	79959	84131	1069	9793	23332	11064	1453	102800317	1639	10540	11258	1778	1781	8655	11116	115106	55142	79441	54930	23354	54801	55559	93323	3161	3320	22919	54820	121441	4751	22981	4957	8481	5048	5108	5116	5347	10733	5518	5578	5577	10806	9814	8636	22974	7846	7277	203068	10382	10383	7283	7531	7532
PC_1792	Interaction between PHLDA1 and AURKA	6790	22822
PC_1793	Interleukin-20 family signaling	282618	282616	282617	163702	3588	29949	50604	53832	53833	50616	58985	116379	11009	55801	3716	3717	3718	5781	9021	6772	6773	6774	6775	6776	6777	7297
PC_1794	Cargo recognition for clathrin-mediated endocytosis	22848	154	3267	185	160	161	163	1173	1175	338	374	408	409	551	554	685	867	915	917	920	1080	1129	1211	1212	1213	8218	9318	8533	51138	10987	10980	50813	64708	10920	1601	1856	1950	1956	255324	29924	22905	2060	58513	2069	23149	115548	8322	2873	2885	156	157	1839	9146	3482	3575	6453	50618	9856	3949	26119	4036	4074	25977	55707	4738	8301	85021	9185	6233	950	84251	6455	6456	6457	30011	6572	29988	9892	8027	10254	11037	85439	6857	23208	127833	90019	143425	6869	7018	7037	7039	10618	1861	27348	7311	7314	7316	29979	29978	6844	9341	8674	6845	8673	7474
PC_1795	Clathrin-mediated endocytosis	22848	10097	10096	154	3267	185	273	160	161	163	1173	1175	338	374	382	55738	10552	10109	10094	10093	10092	408	409	551	554	274	685	867	915	917	920	1080	1129	1211	1212	1213	8218	2017	1601	9829	1759	1785	26052	1856	1950	1956	255324	29924	22905	2060	58513	2069	23149	115548	23048	54874	8322	2580	26130	2885	1839	9146	3092	9026	3312	3482	3575	6453	50618	9856	3949	26119	4036	4074	25977	55707	4952	29993	11252	29763	8301	5286	23396	5868	5869	5878	85021	9185	6233	950	84251	6455	6456	6457	30011	6572	29988	9892	112574	51429	8027	10254	11037	85439	8867	8871	6857	23208	127833	90019	143425	6869	7018	7037	7039	10618	9322	7311	7314	7316	6844	9341	8674	6845	8673	8976	7474
PC_1796	PTK6 promotes HIF1A stabilization	1956	10457	1839	3091	120892	5753
PC_1797	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models	351	10018	823	824	826	84290	10849	993	994	995	1020	8851	356	2309	2801	3725	4000	4001	5052	7001	6648	7531
PC_1798	Downregulation of ERBB2 signaling	685	11140	8065	1950	1956	2064	2065	2066	55914	2069	1839	3320	4145	3084	9542	10718	145957	5782	26469	6233	10273	7311	7314	7316
PC_1799	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	348	7913	7020
PC_1800	MET activates PTPN11	2549	2885	3082	4233	5781
PC_1801	Reelin signalling pathway	1600	2534	5649	30011	7436
PC_1802	VLDL assembly	338	341	346	4547	5034
PC_1803	VLDLR internalisation and degradation	160	161	163	1173	1175	1211	1213	29116	7376	10062	255738	7436
PC_1804	Synthesis of active ubiquitin	997	90268	6233	7317	7311	55236	7314	7316	7319	7320	11065	7321	7322	7324	10477	7326	7327	7328	3093	7332	92912	54926	27338	29089	55284	65264	7347	8078	7874	8239
PC_1805	E3 ubiquitin ligases ubiquitinate target proteins	8915	79577	9646	79139	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	3105	6596	123169	5828	5111	5192	5193	5194	5195	5828	5830	5591	56852	9781	220441	51255	56254	9810	6233	10670	23168	55829	257218	92305	7311	7314	7316	7319	7320	7321	7322	7323	7324	118424	7332	7334	7336	7415	51322	80349
PC_1806	Negative regulation of activity of TFAP2 (AP-2) family transcription factors	284252	79047	7341	7020	7021	7022	83741	339488	7329	51741
PC_1807	TFAP2 (AP-2) family regulates transcription of other transcription factors	10370	5308	7020	7022
PC_1808	Activation of the TFAP2 (AP-2) family of transcription factors	4435	10370	163732	1387	2033	7020	7021	7022	83741	339488	51741	8089
PC_1809	TFAP2 (AP-2) family regulates transcription of growth factors and their receptors	29028	1081	1082	1082	1082	1956	2064	2099	3815	7020	7021	7022	7039	7422	7528
PC_1810	TFAP2 (AP-2) family regulates transcription of cell cycle factors	1026	10765	4609	7020	7022
PC_1811	rRNA processing in the mitochondrion	60528	3028	4508	4509	4512	4513	4514	4519	4535	4536	4537	4538	4539	4540	9692	54931
PC_1812	TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation	3329	4605	4839	4869	7020
PC_1813	RAB geranylgeranylation	1121	1122	8073	10890	8766	9230	201475	5872	51552	376267	64284	22931	401409	5861	81876	55647	23011	57403	51715	53917	57111	25837	5873	5874	8934	5862	84932	27314	11031	10981	9363	83452	83871	11021	9609	326624	23682	54734	116442	5864	5865	115827	9545	142684	10966	57799	347517	115273	339122	401258	5867	53916	5868	5869	5878	5870	51560	7879	338382	4218	51762	9367	51209	5875	5876
PC_1814	MET activates PTK2 signaling	3082	3673	3675	3688	284217	3908	3909	3910	3911	3912	3915	3914	3915	3918	10319	4233	5747	6714
PC_1815	CREB3 factors activate genes	10488	90993	64764	84699	148327	153222	81501	8720	51360
PC_1816	InlB-mediated entry of Listeria monocytogenes into host cell	867	2060	2885	9146	4233	6233	6455	6456	6457	30011	8027	10254	7311	7314	7316
PC_1817	MET interacts with TNS proteins	3082	3688	4233	64759	84951
PC_1818	MET activates RAP1 and RAC1	1398	1399	85440	2549	2885	3082	4233	5879	5906	5908	2889
PC_1819	MET receptor recycling	382	1398	1399	2549	23163	2885	3082	4233	5867	53916
PC_1820	MET activates STAT3	3082	4233	6774
PC_1821	RAB GEFs exchange GTP for GDP on RABs	207	208	10000	57679	259173	84079	221960	221960	1121	1122	57706	163486	79958	27147	163259	79961	22898	10260	9909	55667	23258	160518	201627	414918	26130	2664	2665	3257	89781	8567	84315	22879	10890	201475	5872	51552	22931	5861	81876	23011	5873	5874	11031	10981	11021	23682	54734	116442	5864	22930	25782	5866	117177	5868	5869	5878	5870	51560	7879	338382	4218	51762	9367	51209	27342	400966	57589	9610	54453	79890	126432	6305	81846	6764	58485	7109	60684	51112	80006	6399	51693	27095	51399	126003	79090	122553	22878	83696	8408	7531
PC_1822	InlA-mediated entry of Listeria monocytogenes into host cells	79872	999	1499	1500	6233	6714	7311	7314	7316
PC_1823	Protein methylation	801	79823	1915	221143	399818	1938	196483	2109	254013	3312	22944	151194	79091	10196	6187	7415	79609
PC_1824	RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)	865	1378	1493	50943	3458	3558	3559	4773	861	8784
PC_1825	Vitamin E	7274
PC_1826	Transcriptional regulation by RUNX2	581	650	865	891	595	983	1019	1026	9464	10013	8493	860	6662	7291	117581
PC_1827	GABA synthesis	2571	2572
PC_1828	GABA synthesis, release, reuptake and degradation	10815	80331	2571	2572	3312	5864	22999	140679	6616	6804	6812	6857	6844
PC_1829	Reuptake of GABA	6529	6538	6539	6540
PC_1830	RUNX1 regulates estrogen receptor mediated transcription	8312	865	2099	57678	200845	861
PC_1831	Regulation of RUNX1 Expression and Activity	26523	27161	192669	192670	865	595	894	896	1021	4343	5371	5781	861	6714	27327	23112	57690
PC_1832	Receptor Mediated Mitophagy	9140	9474	1457	1459	1460	139341	84557	81631	192111	6714	8408
PC_1833	Digestion	248	2980	2981	2984	8544
PC_1834	RUNX1 regulates expression of components of tight junctions	865	7122	100506658	861	7082
PC_1835	RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function	26523	192669	192670	9070	865	84661	2033	2623	2811	474382	55766	94239	3014	3015	102724334	3020	3020	3065	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	8350	8350	8350	8350	8350	8350	8350	8350	8350	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	126961	126961	126961	121504	121504	128312	121504	3674	8850	4297	9757	58508	8085	55904	4343	10398	4778	8013	5196	5588	3276	55170	5929	861	9739	23067	25942	23309	7057	27327	23112	57690	11091	161882
PC_1836	Aryl hydrocarbon receptor signalling	196	57491	9049	405	9915	3326	10728
PC_1837	ESR-mediated signaling	2099	2100	2288	2289	3320	3326	5594	5595	5481	5536	10728
PC_1838	RUNX1 regulates transcription of genes involved in differentiation of HSCs	25	865	902	1022	2623	2624	2625	474382	55766	94239	3014	3015	102724334	3020	3020	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	8350	8350	8350	8350	8350	8350	8350	8350	8350	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	126961	126961	126961	121504	121504	128312	121504	83737	4297	8861	4004	4005	4331	4602	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	6233	861	7979	6688	6886	6938	6929	7161	7311	7314	7316	10413
PC_1839	RUNX1 regulates transcription of genes involved in differentiation of keratinocytes	865	1513	1514	1515	861	5275	9021	9306
PC_1840	RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known	86	51412	8289	57492	196528	26053	100532731	865	84733	8535	23466	57332	1457	1459	1460	2033	28996	55193	84333	1911	1912	80012	6015	6045	861	23429	22955	6595	6597	6598	6599	6601	6602	6603	6604	6605	10138
PC_1841	RUNX1 regulates transcription of genes involved in BCR signaling	640	865	1997	1998	5079	861
PC_1842	RUNX1 regulates transcription of genes involved in differentiation of myeloid cells	865	1387	1437	3958	5579	861	860
PC_1843	RUNX1 regulates transcription of genes involved in interleukin signaling	865	1997	3562	3977	861
PC_1844	RUNX1 regulates transcription of genes involved in WNT signaling	8312	865	2099	50943	84870	861
PC_1845	Regulation of RUNX2 expression and activity	650	865	8454	1749	1750	2099	2101	55294	2932	59269	4488	579	2908	10891	133522	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	9978	6233	860	7979	6500	6502	57154	6772	10273	7291	7311	7314	7316	11059
PC_1846	RUNX2 regulates osteoblast differentiation	25	367	632	865	1277	2737	8841	10013	8209	23462	23493	4094	5594	5595	5925	860	23314	121340	6714	221044	25937	10413	7525	25925
PC_1847	Invadopodia formation	8038	8751	8728	9644
PC_1848	RUNX2 regulates chondrocyte maturation	865	2736	9759	3549	860
PC_1849	RUNX2 regulates bone development	865	100526737	860	4086	4089	4091
PC_1850	RUNX2 regulates genes involved in cell migration	207	208	10000	865	3678	9358	4322	860
PC_1851	RUNX2 regulates genes involved in differentiation of myeloid cells	865	3958	861	860
PC_1852	Events associated with phagocytolytic activity of PMN cells	4025	4353
PC_1853	RUNX3 regulates CDKN1A transcription	1026	864	4088	4089	7040	7157	463
PC_1854	RUNX3 regulates NOTCH signaling	1387	2033	8209	182	2648	8850	9794	84441	55534	10046	4851	3516	864	22938
PC_1855	Regulation of RUNX3 expression and activity	865	1029	2033	4193	5682	5683	5684	5685	5686	5687	5688	5689	5699	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	9491	6233	864	7979	57154	64750	6714	7040	7311	7314	7316
PC_1856	Intestinal infectious diseases	2984	79849
PC_1857	Regulation of PTEN mRNA translation	26523	27161	192669	192670	4343	5728	27327	23112	57690	9218
PC_1858	Regulation of PTEN gene transcription	1386	1822	100532731	84733	8535	23466	57332	1107	1108	8726	1958	2146	54815	57459	3065	3066	8841	10014	51564	3725	23028	55004	28956	8649	389541	10542	84232	5594	5595	53615	2122	64223	9112	9219	57504	2475	7101	1911	1912	80012	5468	5728	5928	5931	23186	5978	6009	6015	6045	57521	10670	10325	58528	57167	22955	153129	6615	6591	23512	7157
PC_1859	Collagen chain trimerization	1300	1301	1302	1303	1305	7373	1306	1307	1308	80781	1310	1277	1278	57642	81578	169044	91522	255631	84570	136227	85301	340267	1280	1281	1282	1284	1285	1286	1287	1288	1289	1290	50509	1291	1292	1293	256076	131873	1294	1295	1296	1297	1298	1299
PC_1860	Competing endogenous RNAs (ceRNAs) regulate PTEN translation	26523	27161	192669	192670	4343	27327	23112	57690	9218
PC_1861	Regulation of PTEN localization	4734	5371	5728	6233	7311	7314	7316	7874	331
PC_1862	Regulation of PTEN stability and activity	207	208	10000	1457	1459	1460	2444	23608	4734	23252	80243	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	5728	81847	6233	7979	10273	8658	80351	5987	7311	7314	7316	8975	11060	331
PC_1863	Mitochondrial calcium ion transport	8165	3954	90550	55013	10367	221154	286097	6547	80024	91689	7416	7417	7419
PC_1864	RUNX3 Regulates Immune Response and Cell Migration	865	3676	3683	6097	864	6696
PC_1865	Cristae formation	79135	139322	498	506	509	513	514	516	517	518	521	9551	10632	515	10476	522	539	54927	84303	27109	55735	3313	10989	440574	125988	4508	4509	4580	10651	25813	8834
PC_1866	Processing of SMDT1	10939	79568	90550	55013	10367	221154	286097	55486	5245	11331	23203	9512	91689	6687	30968	10730
PC_1867	Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation	9049	302	375	552900	552900	759	829	998	1072	1265	2939	9446	3181	9987	3185	3313	3458	3586	3936	4001	268	4478	4507	5062	27250	5306	5478	5721	5898	5908	6175	5055	6627	6647	6648	6775	6888	6950
PC_1868	RUNX3 regulates WNT signaling	595	1499	51176	4609	864	6932	83439	6934
PC_1869	Neddylation	122416	51665	136371	140456	142689	79754	142686	142685	92591	127247	401036	51676	100302652	51666	140458	140459	140460	140461	140462	332	53339	90135	8945	55832	28952	83987	899	1154	150684	51397	51122	23412	54939	28991	170622	149951	54951	29099	114769	9318	8533	51138	10987	10980	50813	64708	10920	8454	8453	8452	8451	8450	8065	9820	23113	79269	80344	25879	54876	80067	26094	8816	55827	10238	50717	54165	55208	123879	23142	84259	79016	1642	1643	51514	6923	6921	2034	1161	54850	222235	144699	79176	146330	54620	84961	283807	26224	26235	26234	23194	55336	26267	80204	201456	115290	26232	23014	26263	126433	84085	79791	114907	26272	51725	150726	93611	26270	25793	26268	10517	23291	285231	26190	6468	54461	55294	26259	84261	55527	10116	56929	8139	2873	3091	64344	390594	89890	84078	84541	200845	154881	9817	55175	90293	11275	27252	9903	84861	64410	26249	10324	57542	51088	55958	4008	122769	10489	8883	4738	140825	51667	23363	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	23369	5929	5931	9978	9616	6233	7979	123228	6500	6502	8835	9021	9655	30837	80176	84727	90864	92369	56995	9039	7311	7314	7316	10537	7321	7322	7323	140739	9040	26043	7347	7428	11091	23038	26118	55884	7704
PC_1870	RUNX3 regulates YAP1-mediated transcription	1490	864	7003	8463	7005	7004	25937	10413
PC_1871	RUNX3 regulates RUNX1-mediated transcription	865	861	864
PC_1872	RUNX3 regulates p14-ARF	6046	865	595	1029	2033	9759	3845	861	864	7040
PC_1873	RUNX3 regulates BCL2L11 (BIM) transcription	10018	2309	864	4088	4089
PC_1874	Transcriptional Regulation by E2F6	317	100532731	672	11335	23468	8317	1111	1869	1876	8726	79813	10919	80314	2146	83746	4149	8972	7703	84108	1911	80012	5888	5928	5931	5932	6015	6045	6241	23429	23512	7027	7029	8409	10138
PC_1875	Carboxyterminal post-translational modifications of tubulin	123624	79841	340351	84871	60509	23287	54839	84276	91978	25941	150465	25809	254173	158135	23170	83887	26140	9654	23093	284076	79739	164395	7846	10376	84790	7278	113457	112714	81027	7280	347733	10381	10382	10383	84617	347688
PC_1876	Nucleobase catabolism	25939
PC_1877	Post-translational protein phosphorylation	102	174	197	213	258	265	401138	57719	334	335	336	116519	338	348	8542	351	9210	652	80341	718	720	813	3491	1000	1114	91851	10970	1356	1435	1471	1758	5611	10117	84141	2153	54757	56975	2200	2243	8074	2266	2335	11167	10272	2519	2621	51280	2719	3270	7184	3484	3486	3487	3488	3490	3569	3698	3827	3895	3912	3915	3915	3956	4052	4148	8720	4241	4221	56955	4240	11320	375056	10232	54587	147111	4924	5034	255738	10130	5179	57104	5589	5624	11098	5768	5954	4221	29106	6383	5265	51156	462	3053	51246	8404	6696	6694	8614	7018	10618	7076	54972	3371	1462	7425	64856	7466
PC_1878	Intestinal lipid absorption	29881
PC_1879	Tyrosine catabolism	2184	2954	3081	3242	6898
PC_1880	Aspartate and asparagine metabolism	440	443	374569	2346	219595	339896	2805	2806	10003	339983	8604	10165
PC_1881	Chylomicron assembly	335	336	337	338	344	345	348	4547	5034	51128
PC_1882	Assembly of active LPL and LIPC lipase complexes	27329	51129	55908	337	116519	344	63924	84699	26291	5045	338328	3990	64788	91289	4023	8720	51360	5125	5046
PC_1883	HDL assembly	2	19	335	649	5578	5567	5568	29801
PC_1884	Chylomicron remodeling	335	336	337	116519	338	344	345	348	338328	4023
PC_1885	HDL clearance	81693	335	8029	3069	949
PC_1886	Chylomicron clearance	338	348	3949	26119	3990
PC_1887	LDL clearance	160	161	163	1173	1175	338	23491	1211	1213	3949	26119	3988	51599	57552	4864	10577	255738	6646	8435
PC_1888	LDL remodeling	338	319	1071	4018
PC_1889	VLDL clearance	338	55911	341	346	51599	7436
PC_1890	HDL remodeling	9619	213	335	344	345	348	1071	3931	9388	5360
PC_1891	Phenylalanine metabolism	80150	259307	883	5053	5092	5860
PC_1892	G beta	695	2782	2783	2784	59345	10681	2790	2791	55970	51764	54331	2785	2786	2787	2788	2793	2792	2793
PC_1893	Glutamate and glutamine metabolism	5832	2744	27165	2746	2747	2752	2806	883	4942	5831	29920	65263	284716	57494
PC_1894	Alanine metabolism	2875	84706
PC_1895	Lipid particle organization	1149	63924	161247	128486	29923	345275
PC_1896	G beta	9459	998	2782	2783	2784	59345	10681	2790	2791	55970	51764	54331	2785	2786	2787	2788	2793	2792	2793	5058
PC_1897	Intestinal hexose absorption	6248	6514	6518	6523
PC_1898	Intracellular oxygen transport	114757	4151	58157
PC_1899	Interleukin-15 signaling	9846	2885	3600	3601	3560	3561	3716	3718	6464	6654	6655	6774	6776	6777
PC_1900	OAS antiviral response	6059	23586	2316	4938	4939	4940	8638	201626	6041
PC_1901	Interleukin-35 Signalling	821	10148	3592	3595	9466	3572	3716	3717	6772	6774	6775	7297
PC_1902	SLIT2	4650	387	6091	9353
PC_1903	Regulation of cortical dendrite branching	8440	6091	6092	6585
PC_1904	Interleukin-9 signaling	3561	3578	3581	3716	3718	6772	6774	6776	6777
PC_1905	Transcriptional Regulation by MECP2	26523	27161	192669	192670	54487	2593	3654	4204	4336	4343	5728	5816	6446	6657	27327	23112	57690
PC_1906	Signaling by Erythropoietin	2056	2057	8660	3717	4067
PC_1907	Interleukin-38 signaling	84639	11141	8808	5599
PC_1908	Interleukin-37 signaling	834	10068	8809	27178	5781	5782	5783	5784	26469	5771	26095	25930	5775	84867	5777	5778	5780	59307	4088	6774	29110
PC_1909	Extra-nuclear estrogen signaling	207	374	685	801	857	858	1950	1956	255324	2069	2099	2100	2770	2771	2773	346562	2782	2783	2784	59345	10681	2790	2791	55970	51764	54331	2785	2786	2787	2788	2793	2792	2793	1839	3320	3480	4313	4314	4316	4318	4846	5290	5295	5296	8503	3276	5747	1903	6464	8877	6714	6801	7039	340481	55625
PC_1910	ER Quality Control Compartment (ERQC)	267	51009	9695	55741	80267	11253	10299	10956	7844	11236	91445	6048	6233	6400	84447	10206	7311	7314	7316	56886	55757
PC_1911	Calnexin/calreticulin cycle	811	821	23193	2923	5589
PC_1912	Regulation of expression of SLITs and ROBOs	22794	1287	8453	1605	9775	1981	6923	6921	2107	2197	2935	23708	3199	3670	8861	9355	8022	89884	56956	4116	55110	4440	4686	22916	26986	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	9939	9978	10921	6091	6092	64221	6134	4736	140801	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	200916	9349	6147	6152	6154	51121	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6166	6167	6168	6169	6170	116832	6123	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6233	51065	6234	6235	6188	6189	6191	6192	140032	6193	6194	6201	6202	6203	3921	7979	6585	9353	7311	7314	7316	26019	65110	65109	23032	23053
PC_1913	ROBO receptors bind AKAP5	9495	5532	5578	5567	5568	5576	5578	6092	64221
PC_1914	Interleukin-18 signaling	240	3596	3606	10068	8809	8807	27178	3565
PC_1915	NOTCH3 Activation and Transmission of Signal to the Nucleus	102	51107	83464	28514	54567	1950	1956	182	3714	57534	142678	23385	9148	54492	4854	5663	5664	55851	6233	10460	7311	7314	7316	11060
PC_1916	NOTCH3 Intracellular Domain Regulates Transcription	1387	9787	2033	2173	8209	388585	23462	23493	26508	10320	2648	8850	9794	84441	55534	10046	4851	4854	5087	23129	171558	3516	22938	6772	23286
PC_1917	NOTCH4 Intracellular Domain Regulates Transcription	59	1387	2033	2324	8209	388585	23462	23493	2648	8850	9794	84441	55534	10046	4851	4853	4855	3516	4088	22938
PC_1918	NOTCH4 Activation and Transmission of Signal to the Nucleus	102	51107	83464	54567	182	23385	4855	5663	5664	55851	7534
PC_1919	TLR3-mediated TICAM1-dependent programmed cell death	841	8772	8737	11035	148022	7098
PC_1920	TICAM1-dependent activation of IRF3/IRF7	9641	3661	3665	6233	10010	29110	148022	7098	7187	7311	7314	7316
PC_1921	TICAM1,TRAF6-dependent induction of TAK1 complex	6885	6233	10454	23118	257397	148022	7098	7189	7311	7314	7316
PC_1922	Interleukin-36 pathway	84639	3556	8808	27179	27177	56300	26525
PC_1923	Interleukin-33 signaling	3556	9173	90865
PC_1924	Noncanonical activation of NOTCH3	51107	83464	23385	4854	5663	5664	55851	4904
PC_1925	Estrogen-dependent gene expression	26523	27161	192669	192670	1386	8312	596	10498	865	595	904	1025	1105	4435	1387	1509	6387	51523	1655	9166	2033	2066	2099	2288	2353	2354	3169	2625	57678	9687	2957	2958	2962	2963	474382	55766	94239	3014	3015	102724334	3020	3020	3065	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	8350	8350	8350	8350	8350	8350	8350	8350	8350	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	126961	126961	126961	121504	121504	128312	121504	3320	3326	3725	3727	23189	8850	10524	200845	23028	23030	3838	8930	4343	4602	4609	8648	10499	8202	2494	8204	5241	5430	5431	5432	5433	5434	5435	5436	5437	5438	5439	5440	5441	5451	3276	10728	5885	861	8243	9126	6667	10274	10735	6908	7031	7033	7039	7090	27327	23112	57690	7391	7392	7528	7764
PC_1926	Biosynthesis of D-series resolvins	240	2879	3248	4048
PC_1927	Biosynthesis of DHA-derived SPMs	239	246	5743
PC_1928	Biosynthesis of EPA-derived SPMs	5743
PC_1929	Biosynthesis of protectins	246	1543	1544	4048
PC_1930	Biosynthesis of maresins	240	2053
PC_1931	Biosynthesis of E-series 18(S)-resolvins	246	240	2879	3248	4048
PC_1932	Biosynthesis of aspirin-triggered D-series resolvins	240	2879	4048
PC_1933	Interleukin-2 signaling	3558	3559	3560	3561	3716	3718	3932	2185	6464	6776	6777	6850
PC_1934	Interleukin-12 signaling	3592	3593	3594	3595	3716	3717	5034	6775	7297	6845
PC_1935	Interleukin-1 signaling	8945	1147	8454	3551	8517	3552	3553	3554	7850	3556	3557	3654	3656	11213	51135	5608	4215	6885	4615	4790	4792	10392	64127	57162	57161	246330	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	9978	5970	8767	6233	7979	6500	8878	10454	23118	257397	54472	7189	7311	7314	7316	7334	387522
PC_1936	Interleukin-23 signaling	3593	3594	51561	149233	3717	5034	6774	6775	7297
PC_1937	Interleukin-27 signaling	821	9244	10148	246778	9466	3572	3716	3717	6772	6774	7297
PC_1938	Interleukin-21 signaling	59067	50615	3561	3716	3718	6772	6774	6775	6776	6777
PC_1939	Loss of MECP2 binding ability to 5hmC-DNA	4204
PC_1940	Loss of phosphorylation of MECP2 at T308	801	814	4204	5578
PC_1941	Loss of MECP2 binding ability to the NCoR/SMRT complex	2874	8841	4204	9611	9612	6907	79718
PC_1942	Loss of MECP2 binding ability to 5mC-DNA	627	3065	4204	25942
PC_1943	Regulation of MECP2 expression and activity	26523	27161	192669	192670	9212	801	815	816	817	818	814	1385	2290	2874	3065	3066	8841	28996	6532	3930	4204	4343	9611	9612	5578	25942	6907	79718	27327	23112	57690
PC_1944	MECP2 regulates neuronal receptors and channels	1385	2289	114787	2891	2903	2904	3065	3066	4204	4233	4851	4986	4988	5770	5775	25942	6515	7222
PC_1945	MECP2 regulates transcription of neuronal ligands	627	1385	1392	28514	3065	4204	25942	6750
PC_1946	MECP2 regulates transcription factors	1385	4204	4208	5468	54715
PC_1947	MECP2 regulates transcription of genes involved in GABA signaling	2571	2572	4204
PC_1948	Biosynthesis of E-series 18(R)-resolvins	246	240	2879	4048
PC_1949	BDNF activates NTRK2 (TRKB) signaling	627	4915
PC_1950	NTF3 activates NTRK2 (TRKB) signaling	4908	4915
PC_1951	Biosynthesis of DPAn-3 SPMs	5743
PC_1952	Biosynthesis of DPAn-6 SPMs	239	246
PC_1953	Biosynthesis of DPAn-3-derived protectins and resolvins	246	240
PC_1954	Biosynthesis of DPAn-3-derived maresins	239	240
PC_1955	NTF4 activates NTRK2 (TRKB) signaling	4909	4915
PC_1956	Biosynthesis of DPAn-3-derived 13-series resolvins	240
PC_1957	Activated NTRK2 signals through RAS	627	2885	3265	3845	4893	4909	4915	6464	6654
PC_1958	Activated NTRK2 signals through PLCG1	627	4909	4915	5335
PC_1959	Biosynthesis of maresin conjugates in tissue regeneration (MCTR)	2948	4056
PC_1960	Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR)	4056
PC_1961	Erythropoietin activates Phosphoinositide-3-kinase (PI3K)	2056	2057	2549	8660	3717	4067	5290	5291	5293	5294	5295	23533
PC_1962	Erythropoietin activates Phospholipase C gamma (PLCG)	2056	2057	8660	3717	4067	5335	5336
PC_1963	Erythropoietin activates STAT5	2056	2057	8660	3717	4067	6776	6777
PC_1964	Erythropoietin activates RAS	1399	2056	2057	2885	3265	8660	3717	3845	4067	4893	2889	6464	6654	7409
PC_1965	Biosynthesis of maresin-like SPMs	1544	1558	1559	1565	1571	1576
PC_1966	Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives	240	5743
PC_1967	Activated NTRK2 signals through PI3K	627	2549	2885	4909	4915	5290	5295
PC_1968	Activated NTRK2 signals through FRS2 and FRS3	627	10818	10817	2885	3265	3845	4893	4909	4915	5781	6654
PC_1969	Activated NTRK2 signals through FYN	627	2534	2904	4915	6714
PC_1970	NTRK2 activates RAC1	627	1795	2534	4915	5879
PC_1971	Activated NTRK2 signals through CDK5	627	1020	8851	4915	5879	7074
PC_1972	Peroxisomal protein import	30	10965	122970	10005	51	8309	8310	8540	189	23600	570	847	1384	54677	1610	8528	26063	10901	1891	10455	1962	2053	8443	373156	26061	54363	51179	3155	3295	3416	3417	83752	23417	4358	4843	390916	283927	196743	55825	5189	5192	5193	5194	5195	5828	55670	5830	5190	5191	5264	51268	6233	10106	11001	219743	7311	7314	7316	7321	7322	7323	8239	54469
PC_1973	TYSND1 cleaves peroxisomal proteins	30	51	8540	3295	5264	10106	219743
PC_1974	ABO blood group biosynthesis	28	2523	2524
PC_1975	NTF3 activates NTRK3 signaling	4908	4916
PC_1976	Signaling by NTRK3 (TRKC)	4908	4916	5800	5802
PC_1977	Activated NTRK3 signals through PLCG1	4908	4916	5335
PC_1978	Activated NTRK3 signals through RAS	2885	3265	3845	4893	4908	4916	6464	6654
PC_1979	Defective GGT1 causes Glutathionuria (GLUTH)	2678
PC_1980	Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI)	551	554
PC_1981	Rhesus blood group biosynthesis	6006	6007
PC_1982	Lewis blood group biosynthesis	8708	8707	8705	10317	124872	84750	170384	2524	2525	2526	2527	2528	2529	10690	6487	6484	10402	30815
PC_1983	Interferon alpha/beta signaling	6059	103	684	1958	2634	3105	3106	3107	3133	3134	3135	3429	3430	2537	3434	3433	3437	8519	10581	10410	3439	3446	3439	3448	3449	3451	3440	3452	3441	3442	3443	3444	3445	3454	3455	3456	51447	3659	3660	3661	3662	3663	3664	3665	3394	10379	9636	3669	3716	4599	4600	4938	4939	4940	8638	5696	5781	5777	6041	91543	25939	8651	9021	6772	6773	7297	54739
PC_1984	Meiotic recombination	472	641	672	675	1017	1019	11144	474382	55766	94239	3014	3015	102724334	3020	3020	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	8350	8350	8350	8350	8350	8350	8350	8350	8350	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	126961	126961	126961	121504	121504	128312	8290	121504	4292	27030	84057	4361	4438	4439	4683	56979	29893	10111	5888	5889	5932	6117	6118	6119	23626	7156
PC_1985	Interleukin receptor SHC signaling	1437	1438	1439	9846	2885	3558	3559	3560	3561	3562	3563	3567	3568	3635	3636	3716	3717	3718	5290	5291	5293	5295	5296	8503	5777	6464	6654
PC_1986	Regulation of signaling by CBL	29760	867	1398	1399	2534	2885	3055	4067	5290	5291	5293	5295	5296	8503	2889	6850	7409	7525
PC_1987	Regulation of IFNA signaling	3439	3446	3439	3448	3449	3451	3440	3452	3441	3442	3443	3444	3445	3454	3455	3456	3716	5770	5781	5777	8651	9021	6772	6773	7297	11274
PC_1988	O-linked glycosylation of mucins	51146	10678	10331	79369	84002	11041	93010	146712	84752	146712	9334	9331	56913	29071	10164	2589	55568	63917	79695	114805	79623	168391	57452	442117	374378	2590	2591	100528030	11227	11226	51809	26290	50614	168391	442117	2650	9245	140687	4582	10071	56667	143662	94025	140453	283463	200958	394263	4584	4585	4586	727897	4588	4589	118430
PC_1989	Degradation of GABA	18	7915
PC_1990	Endosomal Sorting Complex Required For Transport (ESCRT)	27243	25978	100526767	29082	128866	92421	51510	79643	91782	9146	93343	89853	6233	11267	8027	10254	7251	7311	51271	7314	7316	84313	51160	51028	137492	79720	55048	155382	27183	9525	51534
PC_1991	Iron uptake and transport	9429	48	210	55832	1356	8454	79901	26234	28982	2495	2512	94033	10539	9843	3162	3163	3658	3934	4738	6233	6500	4891	51310	30061	113235	7018	7037	7311	7314	7316
PC_1992	Transferrin endocytosis and recycling	537	535	23545	50617	533	527	9114	245972	8992	155066	523	525	526	528	245973	51382	529	90423	9296	9550	534	127124	51606	3077	57192	261729	55240	10312	7018	7036	7037
PC_1993	TRAF3-dependent IRF activation pathway	1387	23586	2033	64135	3456	9641	3661	3665	57506	84282	80143	29110	7187	7706
PC_1994	TRAF6 mediated IRF7 activation	1387	23586	2033	64135	3439	3446	3439	3448	3449	3451	3440	3452	3441	3442	3443	3444	3445	3456	9641	3661	3665	57506	84282	80143	10010	29110	7186	7189	7706
PC_1995	TRAF6 mediated NF-kB activation	177	351	1147	23586	3146	64135	3551	8517	4214	57506	4790	4791	4792	4793	28512	28511	5970	84282	6283	6285	6288	7186	7189	7706
PC_1996	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	843	841	1147	23586	8772	64135	3551	8517	57506	8737	84282	7706
PC_1997	Negative regulators of RIG-I/MDA5 signaling	9140	9474	1540	23586	51191	64135	9641	3661	9636	83737	57506	84166	79671	55593	5094	5300	54941	84282	54476	6233	8887	29110	7128	7187	7706	7311	7318	7314	7316	7321	7322	7323	3093	9246
PC_1998	Ion transport by P-type ATPases	57194	23120	57205	23250	23200	286410	479	57130	23400	84239	344905	476	477	478	480	481	482	483	487	488	489	490	493	492	493	27032	9914	495	496	538	540	10396	51761	5205	57198	148229	79895	10079	374868	801	815	816	817	818	51076	5348	486	5349	53828	53826	53822	51248	5350	6588	6717
PC_1999	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	929	9641	3661	3665	23643	5781	6233	23098	10010	29110	148022	100302736	7099	7187	7311	7314	7316
PC_2000	IRAK1 recruits IKK complex	1147	3551	8517	3654	57162	57161	246330	7189	7334	387522
PC_2001	IKK complex recruitment mediated by RIP1	329	330	929	1147	3551	8517	23643	8737	11035	6233	23098	148022	100302736	7099	7189	7311	7314	7316	7321	7322	7323	7334	387522
PC_2002	IRAK2 mediated activation of TAK1 complex	3656	6885	6233	10454	23118	257397	7189	7311	7314	7316
PC_2003	TRAF6-mediated induction of TAK1 complex within TLR4 complex	929	3656	23643	6885	6233	23098	10454	23118	257397	148022	100302736	7099	7189	7311	7314	7316
PC_2004	Molybdenum cofactor biosynthesis	10243	55034	4337	4338	27304	9054
PC_2005	Transport to the Golgi and subsequent modification	3998	90411
PC_2006	Activated NTRK3 signals through PI3K	3667	4908	4916	5290	5295	6714
PC_2007	NTRK3 as a dependence receptor	581	25920	4916
PC_2008	Class I peroxisomal membrane protein import	215	225	5825	91452	224	84896	51024	54332	8799	5193	5194	5195	9409	5824	5828	55670	8504	5827	11264	10478
PC_2009	Negative regulation of NOTCH4 signaling	207	8454	55294	4855	5682	5683	5684	5685	5686	5687	5688	5689	5699	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	9491	9978	6233	7979	6500	10460	7311	7314	7316	7534
PC_2010	FLT3 Signaling	2322	2323	2534	9846	2885	3055	3265	3845	4893	5295	5781	6654
PC_2011	Defective MUTYH substrate binding	4595
PC_2012	Defective MUTYH substrate processing	4595
PC_2013	Insertion of tail-anchored proteins into the endoplasmic reticulum membrane	224	351	439	7917	819	1528	2010	51608	3162	9381	5621	10952	23480	27230	6449	6804	6811	118424	8266	6844	9218	7485
PC_2014	Assembly and cell surface presentation of NMDA receptors	88	320	815	816	817	818	8573	1739	4355	4356	1742	2902	2903	2904	2905	2906	116443	116444	57576	8825	64130	55327	4747
PC_2015	Lipophagy	3312	123	10226	5563	5564	5565	5571	51422	53632
PC_2016	Chaperone Mediated Autophagy	1915	2670	3043	3320	3326	3312	3920	123	10226	6035
PC_2017	Regulation of localization of FOXO transcription factors	207	208	10000	2308	2309	4303	2810	7529	7532	10971	7534
PC_2018	FOXO-mediated transcription of cell death genes	27113	10018	604	10370	1387	2033	356	2308	2309	4303	4800	4801	4802	65018	6794
PC_2019	FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes	23460	181	4287	847	114907	2308	2309	4303	2538	2645	3065	3066	3484	3630	4852	2908	5105	91584	5443	10891	56729	25942	23410	4087	4088	4089	6648	6720	84676
PC_2020	Microautophagy	27243	25978	100526767	29082	128866	92421	79643	91782	3043	3312	93343	89853	123	10226	6035	7251	51271	51160	137492	79720	55048	155382
PC_2021	Transcriptional regulation of granulopoiesis	865	1017	1019	1026	1050	1051	1053	1385	1441	7913	1869	2033	2313	2624	2672	474382	55766	94239	3014	3015	102724334	3020	3020	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	8350	8350	8350	8350	8350	8350	8350	8350	8350	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	126961	126961	126961	121504	121504	128312	121504	3570	688	4297	51176	4602	4609	5371	5914	861	6256	6688	6774	6886	7027	7029
PC_2022	Defective Base Excision Repair Associated with NEIL1	79661
PC_2023	Negative regulation of NMDA receptor-mediated neuronal transmission	88	801	8536	815	816	817	818	814	1739	4355	4356	1742	2902	2903	2904	2905	2906	4747	22843	9647
PC_2024	Regulation of FOXO transcriptional activity by acetylation	1387	2033	2308	2309	4303	8850	23411	23410	7295	10628
PC_2025	FOXO-mediated transcription of cell cycle genes	694	857	901	1026	1027	2290	2308	2309	4303	1647	9314	2660	57060	5934	4087	4088	4089
PC_2026	Activation of RAC1 downstream of NMDARs	8874	801	8536	84254	10645	28964	5879
PC_2027	Activation of AMPK downstream of NMDARs	801	10645	4137	5562	5563	5564	5565	5571	51422	53632
PC_2028	Long-term potentiation	88	801	815	816	817	818	1739	4355	4356	1742	2066	2890	2891	2902	2903	2904	2905	2906	4747	3084	4900	6714
PC_2029	Regulation of the apoptosome activity	317	51074	57099	22900	842	54205	56616	5594	5595	55075	331
PC_2030	Defective Base Excision Repair Associated with NEIL3	55247
PC_2031	Defective NTHL1 substrate processing	4913
PC_2032	Defective NTHL1 substrate binding	4913
PC_2033	Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4	1019	1029
PC_2034	Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6	1019	1021	1029
PC_2035	Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4	1019	1029
PC_2036	Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6	1019	1021	1029
PC_2037	Regulation of glycolysis by fructose 2,6-bisphosphate metabolism	5207	5208	5209	5210	5515	5516	5518	5519	5528	5578	5567	5568
PC_2038	Estrogen-stimulated signaling through PRKCZ	3265	3845	5594	4893	5170	5590
PC_2039	Estrogen-dependent nuclear events downstream of ESR-membrane signaling	207	208	10000	374	596	685	595	1027	1385	1950	1956	2002	255324	2069	2353	2309	1839	5594	5595	5747	6722	7039	127933	7514
PC_2040	NEIL3-mediated resolution of ICLs	55247
PC_2041	Wax biosynthesis	158833	158835	84188	55711
PC_2042	STAT5 Activation	2322	2323	9846	2885	5781	6776	6777
PC_2043	N-glycan trimming and elongation in the cis-Golgi	79694	4245
PC_2044	Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2	4121	10905	57134
PC_2045	Vitamins B6 activation to pyridoxal phosphate	316	8566	55163
PC_2046	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	3654	51135	3665	4615	51284	51311	54106	7189	7334	387522
PC_2047	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	51295	3654	3656	51135	4214	4615	51284	51311	54106	7189
PC_2048	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	1147	3551	8517	3654	57162	57161	246330	7189	7334	387522
PC_2049	MyD88 dependent cascade initiated on endosome	3654	3656	51135	4615	51284	51311	54106	7189
PC_2050	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	929	3656	23643	6885	6233	10454	23118	257397	148022	100302736	7099	7189	7311	7314	7316
PC_2051	Reactions specific to the hybrid N-glycan synthesis pathway	4248
PC_2052	N-Glycan antennae elongation	2683	8704	8703	8702	9334	9331	11320	11282	25834	4249	6484	6480	8128	51046	338596
PC_2053	Reactions specific to the complex N-glycan synthesis pathway	1081	9486	64377	2517	2525	2530	3972	4124	4122	4247
PC_2054	Retinoid metabolism and transport	375790	57016	1645	8644	1109	335	336	337	338	344	345	348	55937	53630	83875	1208	2817	221914	2719	2239	2262	10082	338328	3339	3949	4023	9227	4035	4038	29967	4036	7804	151056	5406	9256	23504	5950	51109	54884	6382	6383	9672	6385	7276
PC_2055	MyD88 cascade initiated on plasma membrane	51295	3654	3656	51135	4214	4615	81793	7100	7189
PC_2056	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	1981	2107	2197	2935	23708	4686	22916	26986	6134	4736	140801	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	200916	9349	6147	6152	6154	51121	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6166	6167	6168	6169	6170	116832	6123	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6233	51065	6234	6235	6188	6189	6191	6192	140032	6193	6194	6201	6202	6203	3921	7311	5976
PC_2057	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	22794	55802	9775	1981	2107	2197	2935	23708	4116	55110	4686	22916	26986	55629	5515	5518	5520	9939	10921	6134	4736	140801	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	200916	9349	6147	6152	6154	51121	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6166	6167	6168	6169	6170	116832	6123	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6233	51065	6234	6235	6188	6189	6191	6192	140032	6193	6194	6201	6202	6203	3921	23049	23381	23293	9887	55181	56006	7311	5976	26019	65110	65109
PC_2058	Termination of O-glycan biosynthesis	4582	10071	56667	143662	94025	140453	283463	200958	394263	4584	4585	4586	727897	4588	4589	118430	6482	6483	6487	6484	6480	10610	256435	27090
PC_2059	Amyloid fiber formation	102	325	51107	83464	335	337	351	567	23621	793	796	1471	2243	5045	26088	23062	23163	2934	474382	3014	3015	102724334	3020	3020	3012	8334	3013	3012	8331	255626	3018	3017	3017	3017	3017	3017	8345	3017	8970	85236	8340	8342	8341	8348	8350	8350	8350	8350	8350	8350	8350	8350	8350	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	723790	723790	8338	8349	126961	126961	126961	121504	121504	128312	121504	3339	3375	3630	9445	4057	4069	4240	9027	51471	23385	4878	54959	5071	5617	55851	6233	6288	6406	6477	6478	6622	9627	6653	7045	81619	23555	340348	10098	7276	7311	7314	7316	9246	8239
PC_2060	Serine biosynthesis	26227	29968	5723	57515	347735	10955	619189	256987	63826
PC_2061	GABA receptor activation	23229	2554	2555	2556	2557	2558	2559	2560	2561	2562	2566	2567	55879	2569	2570	200959	27020
PC_2062	GABA B receptor activation	2550	9568
PC_2063	Regulation of Complement cascade	712	713	714	715	716	717	718	719	720	100293534	722	725	100293534	727	728	27202	729	730	731	732	733	735	930	4179	1604	966	975	629	3075	3078	3080	10878	10877	81494	3426	1191	1361	1369	1370	1378	1380	1991	2147	5627	710	7448
PC_2064	Growth hormone receptor signaling	6868	1154	1442	2688	2689	2690	3667	8660	3717	4067	5594	5595	5617	5618	5770	5777	25970	8651	8835	9021	6772	6774	6776	6777
PC_2065	Antigen processing	64682	10393	51529	25847	29882	29945	51433	51434	9870	10425	51665	136371	140456	142689	79754	142686	142685	92591	127247	401036	51676	100302652	51666	140458	140459	140460	140461	140462	10533	642	53339	90135	8945	868	158506	899	8881	991	8697	246184	996	997	8454	8453	8452	8065	9820	9730	55070	151636	9666	6923	6921	54850	222235	144699	79176	146330	54620	84961	283807	26224	26235	26234	23194	55336	26267	80204	201456	115290	26232	23014	26263	126433	84085	79791	114907	26272	51725	150726	93611	26270	25793	26268	10517	23291	285231	26190	6468	54461	55294	26259	84261	51343	8139	11146	57531	25831	143279	79654	57520	8925	8924	8916	26091	51191	55008	10075	83737	390594	89890	84078	84541	200845	154881	9817	55175	90293	11275	27252	9903	84861	64410	26249	10324	57542	51088	55958	4008	4012	84708	91694	122769	10489	90678	26046	51320	23295	142678	23608	29116	4734	23327	9520	64219	9867	5071	5682	5683	5684	5685	5686	5687	5688	143471	5689	5699	122706	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5706	5707	5716	5717	5718	5719	10213	5708	5709	5710	5711	9861	5713	5714	5715	5720	5721	10197	23198	9491	5930	10616	9978	25898	51132	54778	55905	27246	63891	55658	55819	51444	9604	255488	221687	25897	127544	57674	154214	55182	64320	80196	6047	10193	6049	9616	6233	7979	57630	6477	6478	6500	6502	57154	64750	8651	9021	80176	84727	92369	10273	7064	7174	84231	10293	81559	6737	22954	55521	4591	56658	89122	90933	135892	84676	140691	114088	9320	7317	9039	79876	7311	55236	7318	10422	7314	7316	7319	7320	11065	7321	7322	7323	51619	7324	7325	10477	140739	7326	7327	7328	51465	118424	3093	7332	9246	9040	7334	63893	55585	92912	54926	27338	148581	387522	7336	55284	65264	7337	89910	9690	90025	9354	22888	197131	23304	23352	23376	64718	7428	26118	11059	7704	84937	223082
PC_2066	Antigen Presentation	567	811	821	51752	64167	3105	3106	3107	3133	3134	3135	3309	2923	51128	6396	10484	10802	10427	9632	9871	22872	6890	6891	6892
PC_2067	Kinesins	1062	3832	113220	23303	56992	55614	81930	146909	124602	547	23095	10749	10112	9585	55605	23046	3835	9493	3834	26153	55083	55582	3796	84643	11004	11127	9371	3797	24137	285643	3798	3799	221458	64147	22920	3833	90990	3831	147700	147700	89953	29127
PC_2068	Factors involved in megakaryocyte development and platelet production	25	205	8165	11216	91768	81928	829	830	832	55604	23468	998	1017	1020	1793	55619	139818	1794	1795	9732	80005	57572	85440	81704	23348	10938	30845	30845	2623	2624	2625	2626	140628	2627	3020	3020	3043	3045	3046	3047	3048	3065	3066	8350	8350	8350	8350	8350	8350	8350	8350	8350	126961	126961	126961	10362	3439	3446	3439	3448	3449	3451	3440	3452	3441	3442	3443	3444	3445	3456	3659	3660	3705	3717	221037	23028	23764	4097	7975	55669	9927	64780	4602	4778	51317	5578	5567	5568	5573	5575	5576	5577	5868	5879	5890	5889	64145	23186	25970	10603	10019	25942	7157	11311	7465	161882	23414
PC_2069	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	10768	640	29760	695	801	930	933	973	974	27071	2534	2885	3708	3709	3710	4067	4690	84876	80228	118788	5293	5295	5336	5777	30011	6654	6786	6850	7220	7409
PC_2070	Ion channel transport	537	535	23545	50617	533	527	9114	245972	8992	155066	523	525	526	528	245973	51382	529	90423	9296	9550	534	127124	51606	10312
PC_2071	Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits	2550	9568	2782	2783	2784	2790	55970	54331	2785	2786	2787	2788	2793	2792	2793	3766	3768	3772	3773	3759	3760	3761	3762	3763	3765
PC_2072	Citrullinemia Type I	383	435	445	1373	27165	2746	2806	2875	5009	6509	6510	8604	10166
PC_2073	Carbamoyl Phosphate Synthetase Deficiency	383	435	445	1373	27165	2746	2806	2875	5009	6509	6510	8604	10166
PC_2074	Argininosuccinic Aciduria	383	435	445	1373	27165	2746	2806	2875	5009	6509	6510	8604	10166
PC_2075	Glycine and Serine Metabolism	189	211	217	275	1491	1738	29958	2593	2617	2628	23464	2731	132158	27232	4128	26227	29968	5723	1757	6301	10993	6470	6472	63826
PC_2076	Pterine Biosynthesis	231	873	1719	2643	2644	5805	5860	6697
PC_2077	Tyrosine Metabolism	124	218	26	1312	1621	1638	1644	2184	2805	2954	23498	3081	4128	268	5409	7299
PC_2078	beta-Alanine Metabolism	18	217	4329	8639	84735	1806	1807	2571	51733
PC_2079	Phenylalanine and Tyrosine Metabolism	2184	2193	10056	2805	2954	3081	3242	259307	5053	6898	8565
PC_2080	Ammonia Recycling	275	343	440	80150	1373	1738	2731	27165	2746	3034	10993
PC_2081	Nucleotide Sugars Metabolism	2582	2584	2592	2645	5236	7358	7360	80146
PC_2082	Inositol Metabolism	55626	8678	9896	3612	3628	3631	27124	253430	64768	51477	3705	3706	9562	55586	5297	5289	5290	30849	200576	113026	114971	55697
PC_2083	Catecholamine Biosynthesis	1644	5409	7054
PC_2084	Cysteine Metabolism	833	1036	1491	1497	2729	2730	2805	3939	4357
PC_2085	Glutathione Metabolism	290	840	2729	2730	79017	124975	2876	2936	2937	119391	26873
PC_2086	Propanoate Metabolism	18	31	34	38	84532	79611	4329	593	594	1629	1738	1892	26275	92483	84693	23417	5095	5096
PC_2087	Vitamin B6 Metabolism	249	316	8566	57026	55163
PC_2088	Alpha Linolenic Acid and Linoleic Acid Metabolism	6785	60481	3992	9415	100137049
PC_2089	Arginine and Proline Metabolism	8659	383	435	445	1152	1373	1610	2058	2593	2628	2746	2805	4842	4942	5009	283208	5625	29920	57038	10166
PC_2090	Taurine and Hypotaurine Metabolism	84890	1036	51380	2571	124975
PC_2091	Steroid Biosynthesis	8435	1595	1718	10682	2222	2224	9453	3156	51478	3422	3988	4047	6307	4597	4598	50814	10654	6309	6646	6713	7108
PC_2092	Porphyrin Metabolism	210	211	644	1352	1355	1371	2235	55640	94033	2990	3145	3162	3060	10720	7389	7390
PC_2093	Phospholipid Biosynthesis	10554	10423	11200	1103	1119	54675	1606	51573	57678	2819	2820	10434	5130	10400	9489	162466	23761	23659	26279	100137049	5338	8611	9791	81490	114971
PC_2094	Pantothenate and CoA Biosynthesis	80347	5167	53354	60490	79717	8876
PC_2095	Caffeine Metabolism	1544	1548	1558	1559	1571	1576	10	7498
PC_2096	Selenoamino Acid Metabolism	191	102724560	1491	2678	4141	4144	27430	131965	9061	51540	22928	64116
PC_2097	Oxidation of Branched-Chain Fatty Acids	215	225	2180	217	1376	1384	26061	5194	5195	5264	788
PC_2098	Pentose Phosphate Pathway	226	51071	2203	2539	2821	5211	5226	25796	5236	221823	64080	6120	22934	6888	7086
PC_2099	Valine, Leucine, and Isoleucine Degradation	18	10449	27034	34	35	36	38	217	4329	316	549	586	593	594	1629	1738	1892	11112	26275	3155	3158	3028	3712	56922	64087	5019	5095	5096
PC_2100	Methionine Metabolism	262	635	102724560	55349	1491	1786	259307	4141	4144	27430	22921	253827	4507	4524	6470	6723
PC_2101	Sphingolipid Metabolism	125981	55331	439	9331	64781	123099	339221	9514	2581	2629	2717	2720	2531	10825	8611	259230	8879	130367	56848	10558	9517	7357	7368
PC_2102	Bile Acid Biosynthesis	8309	1109	6718	23600	570	9023	1593	51302	10858	1581	9420	1582	3295	80270	3988	10106	10998
PC_2103	D-Arginine and D-Ornithine Metabolism	1610
PC_2104	Lysine Degradation	51166	10157	38	501	55526	1738	1743	1892	2639	3030	51268	83884	6542
PC_2105	Glycerolipid Metabolism	10554	231	218	132158	57678	2819	2820	3990	4023	8611	8612
PC_2106	Glycolysis	226	669	2023	2538	130589	2597	2821	3099	5213	5223	5224	5230	5313	6514
PC_2107	Sulfate/Sulfite Metabolism	10380	50515	9060	6817	6820	6821
PC_2108	Galactose Metabolism	231	2683	2538	2548	2582	2592	2717	2720	3098	3938	5236	7360
PC_2109	Histidine Metabolism	217	218	144193	26	138199	57571	84735	55748	10841	3034	3035	23438	3067	3176	4128	10196	131669
PC_2110	Amino Sugar Metabolism	51005	1118	55907	2673	10020	10007	64841	3073	3098	55577	140838	54187	80896	5238	5973	26503	6675
PC_2111	Pyrimidine Metabolism	205	1677	124583	978	129607	1503	1635	1723	1806	1807	1854	8034	3704	10201	22978	6241	50484	7083	1890	7298	54963	51733	151531
PC_2112	Nicotinate and Nicotinamide Metabolism	316	683	5167	65220	55191	10135	23057	54981	4837	23530	22978	83594	4860	23475
PC_2113	Purine Metabolism	100	108	158	159	203	270	353	84896	471	1716	957	377841	2618	8034	2766	8833	2977	2983	2987	3251	3614	3704	10201	22978	318	11164	10606	10846	5144	5198	4860	5471	221823	6240	6241	7295	7498
PC_2114	Fatty Acid Metabolism	10449	33	34	35	36	37	38	2180	1374	1376	1892	2639	3030	3032
PC_2115	Beta Oxidation of Very Long Chain Fatty Acids	215	225	2180	1376	1384	54677	92960	5194	5195	788
PC_2116	Folate Metabolism	10840	1719	2356	10841	8836	123263	4522	25902	10797	4524	10588	113235
PC_2117	Fatty Acid Elongation in Mitochondria	10449	1892	3030	3032	3028	51102	5538
PC_2118	Alanine Metabolism	57505	189	2875	51660	5091
PC_2119	Citric Acid Cycle	50	1431	55526	1737	1738	1743	2271	3419	3420	3421	4190	51660	5091	5160	5162	6389	6390	6391	6392	8802	8801
PC_2120	Starch and Sucrose Metabolism	178	276	276	276	2632	2645	2821	2990	2998	3099	8972	5236	283209	5836	6476	7358	7360	10720
PC_2121	Urea Cycle	383	435	445	1373	27165	2746	2806	2875	5009	6509	6510	8604	10166
PC_2122	Pyruvate Metabolism	31	38	134526	55902	97	231	217	1737	1738	2739	9380	3029	3939	197257	4190	4199	5091	5105	5160	5162	5313
PC_2123	Tryptophan Metabolism	51166	15	130013	125061	217	438	847	1543	1644	23498	3620	11185	8564	8942	6999	7166	7453	10352
PC_2124	Fructose and Mannose Degradation	231	226	229	2203	197258	8790	2762	29925	3098	3795	4351	5207	5211	29085	5372	6652	7167	7264
PC_2125	Ubiquinone Biosynthesis	27235	51805	84274	51004	10229
PC_2126	Biotin Metabolism	32	686	3141	28972
PC_2127	Aspartate Metabolism	18	158	122622	435	440	443	80150	445	1677	1615	8528	2571	259307	4677
PC_2128	Androgen and Estrogen Metabolism	6718	1586	1588	3292	3293	3283	6715	412	6783	6820	10720	7367
PC_2129	Riboflavin Metabolism	52	5167	80308	55312	7299
PC_2130	Ketone Body Metabolism	38	622	3155	5019
PC_2131	Glutamate Metabolism	18	8659	7915	1677	1373	124454	2571	2729	2730	2673	27165	2746	8833	64841	2806	2875	2936	2937	55577	5471	2058
PC_2132	Butyrate Metabolism	35	38	116285	1892	3030	3155	5019
PC_2133	Retinol Metabolism	124	216	8854	158833	53630	1592	1553	1548	1549	1555	1576	64816	1577	100861540	8694	9249	10901	10170	51726	10961	3309	9227	64714	9601	10130	8228	5479	51109	145226	8608	50700	54884	6121	23753	54658
PC_2134	Arachidonic Acid Metabolism	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2135	Thiamine Metabolism	84284	10560	79178	27010
PC_2136	Piroxicam Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2137	Chlorothiazide Action Pathway	476	477	478	480	481	482	483	1187	486	6337	6338	6339	6340	6557	6559	9990	8170	6505	6582	9356	55089	6519	6520	54716	8140	9057	9056	23428	11136
PC_2138	Ibandronate Action Pathway	8435	1595	1718	10682	2222	2224	9453	3156	51478	3422	3988	4047	6307	4597	4598	50814	10654	6309	6646	6713	7108
PC_2139	Polythiazide Action Pathway	476	477	478	480	481	482	483	1187	486	6337	6338	6339	6340	6557	6559	9990	8170	6505	6582	9356	55089	6519	6520	54716	8140	9057	9056	23428	11136
PC_2140	Methyclothiazide Action Pathway	476	477	478	480	481	482	483	1187	486	6337	6338	6339	6340	6557	6559	9990	8170	6505	6582	9356	55089	6519	6520	54716	8140	9057	9056	23428	11136
PC_2141	Simvastatin Action Pathway	8435	1595	1718	10682	2222	2224	9453	3156	51478	3422	3988	4047	6307	4597	4598	50814	10654	6309	6646	6713	7108
PC_2142	Acetylsalicylic Acid Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2143	Etodolac Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2144	Ketoprofen Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2145	Ibuprofen Action Pathway	8644	239	242	246	247	240	873	1555	1557	1558	1559	1571	1573	113612	1576	1579	8529	4051	11283	51726	2053	10961	2678	2876	3309	4048	4056	64714	9601	10130	100137049	5479	127281	5730	9536	5740	5742	5743	23753	9356	9376	6916	54658	54575	54659	54600	7363	7364
PC_2146	Rofecoxib Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2147	Bumetanide Action Pathway	476	477	478	480	481	482	483	1187	486	6337	6338	6339	6340	6557	6559	9990	8170	6505	6582	9356	55089	6519	6520	54716	8140	9057	9056	23428	11136
PC_2148	Pravastatin Action Pathway	8435	1595	1718	10682	2222	2224	9453	3156	51478	3422	3988	4047	6307	4597	4598	50814	10654	6309	6646	6713	7108
PC_2149	Bendroflumethiazide Action Pathway	476	477	478	480	481	482	483	1187	486	6337	6338	6339	6340	6557	6559	9990	8170	6505	6582	9356	55089	6519	6520	54716	8140	9057	9056	23428	11136
PC_2150	Quinethazone Action Pathway	476	477	478	480	481	482	483	1187	486	6337	6338	6339	6340	6557	6559	9990	8170	6505	6582	9356	55089	6519	6520	54716	8140	9057	9056	23428	11136
PC_2151	Rosuvastatin Action Pathway	8435	1595	1718	10682	2222	2224	9453	3156	51478	3422	3988	4047	6307	4597	4598	50814	10654	6309	6646	6713	7108
PC_2152	Diclofenac Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2153	Sulindac Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2154	Alendronate Action Pathway	8435	1595	1718	10682	2222	2224	9453	3156	51478	3422	3988	4047	6307	4597	4598	50814	10654	6309	6646	6713	7108
PC_2155	Celecoxib Action Pathway	124	125	8644	239	242	246	247	240	873	1555	1558	1559	1565	1571	1573	113612	1576	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916	54575
PC_2156	Ethacrynic Acid Action Pathway	476	477	478	480	481	482	483	1187	486	6337	6338	6339	6340	6557	6559	9990	8170	6505	6582	9356	55089	6519	6520	54716	8140	9057	9056	23428	11136
PC_2157	Ketorolac Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2158	Lovastatin Action Pathway	8435	1595	1718	10682	2222	2224	9453	3156	51478	3422	3988	4047	6307	4597	4598	50814	10654	6309	6646	6713	7108
PC_2159	Hydrochlorothiazide Action Pathway	476	477	478	480	481	482	483	1187	486	6337	6338	6339	6340	6557	6559	9990	8170	6505	6582	9356	55089	6519	6520	54716	8140	9057	9056	23428	11136
PC_2160	Suprofen Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2161	Bromfenac Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2162	Cyclothiazide Action Pathway	476	477	478	480	481	482	483	1187	486	6337	6338	6339	6340	6557	6559	9990	8170	6505	6582	9356	55089	6519	6520	54716	8140	9057	9056	23428	11136
PC_2163	Indomethacin Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2164	Metolazone Action Pathway	476	477	478	480	481	482	483	1187	486	6337	6338	6339	6340	6557	6559	9990	8170	6505	6582	9356	55089	6519	6520	54716	8140	9057	9056	23428	11136
PC_2165	Meloxicam Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2166	Zoledronate Action Pathway	8435	1595	1718	10682	2222	2224	9453	3156	51478	3422	3988	4047	6307	4597	4598	50814	10654	6309	6646	6713	7108
PC_2167	Hydroflumethiazide Action Pathway	476	477	478	480	481	482	483	1187	486	6337	6338	6339	6340	6557	6559	9990	8170	6505	6582	9356	55089	6519	6520	54716	8140	9057	9056	23428	11136
PC_2168	Mefenamic Acid Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2169	Indapamide Action Pathway	476	477	478	480	481	482	483	1187	486	6337	6338	6339	6340	6557	6559	9990	8170	6505	6582	9356	55089	6519	6520	54716	8140	9057	9056	23428	11136
PC_2170	Cerivastatin Action Pathway	8435	1595	1718	10682	2222	2224	9453	3156	51478	3422	3988	4047	6307	4597	4598	50814	10654	6309	6646	6713	7108
PC_2171	Risedronate Action Pathway	8435	1595	1718	10682	2222	2224	9453	3156	51478	3422	3988	4047	6307	4597	4598	50814	10654	6309	6646	6713	7108
PC_2172	Oxaprozin Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2173	Nabumetone Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2174	Furosemide Action Pathway	476	477	478	480	481	482	483	1187	486	6337	6338	6339	6340	6557	6559	9990	8170	6505	6582	9356	55089	6519	6520	54716	8140	9057	9056	23428	11136
PC_2175	Valdecoxib Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2176	Pamidronate Action Pathway	8435	1595	1718	10682	2222	2224	9453	3156	51478	3422	3988	4047	6307	4597	4598	50814	10654	6309	6646	6713	7108
PC_2177	Torsemide Action Pathway	476	477	478	480	481	482	483	1187	486	6337	6338	6339	6340	6557	6559	9990	8170	6505	6582	9356	55089	6519	6520	54716	8140	9057	9056	23428	11136
PC_2178	Fluvastatin Action Pathway	8435	1595	1718	10682	2222	2224	9453	3156	51478	3422	3988	4047	6307	4597	4598	50814	10654	6309	6646	6713	7108
PC_2179	Naproxen Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2180	Trichlormethiazide Action Pathway	476	477	478	480	481	482	483	1187	486	6337	6338	6339	6340	6557	6559	9990	8170	6505	6582	9356	55089	6519	6520	54716	8140	9057	9056	23428	11136
PC_2181	Chlorthalidone Action Pathway	476	477	478	480	481	482	483	1187	486	6337	6338	6339	6340	6557	6559	9990	8170	6505	6582	9356	55089	6519	6520	54716	8140	9057	9056	23428	11136
PC_2182	Betaine Metabolism	191	501	635	55349	4144	27430	4548	10400
PC_2183	Glycerol Phosphate Shuttle	2597	2819	2820
PC_2184	Phenylacetate Metabolism	116285	348158	10249
PC_2185	Glucose-Alanine Cycle	2746	2875	84706	6509	79751	6514	6517	55089
PC_2186	Gluconeogenesis	226	669	2023	2203	2538	130589	2597	2821	3099	3939	4191	51660	53354	5091	5105	5223	5224	5236	8402	6514	2542	7167
PC_2187	Malate-Aspartate Shuttle	2806	4191	8402	8604
PC_2188	Steroidogenesis	1109	6718	1583	1584	1585	1586	1589	3290	3291	3283	3284
PC_2189	Atorvastatin Action Pathway	8435	1595	1718	10682	2222	2224	9453	3156	51478	3422	3988	4047	6307	4597	4598	50814	10654	6309	6646	6713	7108
PC_2190	Triamterene Action Pathway	476	477	478	480	481	482	483	1187	486	6337	6338	6339	6340	6557	6559	9990	8170	6505	6582	9356	55089	6519	6520	54716	8140	9057	9056	23428	11136
PC_2191	Amiloride Action Pathway	476	477	478	480	481	482	483	1187	486	6337	6338	6339	6340	6557	6559	9990	8170	6505	6582	9356	55089	6519	6520	54716	8140	9057	9056	23428	11136
PC_2192	Spironolactone Action Pathway	476	477	478	480	481	482	483	1187	486	6337	6338	6339	6340	6557	6559	9990	8170	6505	6582	9356	55089	6519	6520	54716	8140	9057	9056	23428	11136
PC_2193	Eplerenone Action Pathway	476	477	478	480	481	482	483	1187	486	6337	6338	6339	6340	6557	6559	9990	8170	6505	6582	9356	55089	6519	6520	54716	8140	9057	9056	23428	11136
PC_2194	2-Hydroxyglutric Aciduria (D and L Form)	18	8659	7915	1677	1373	124454	2571	2729	2730	2673	27165	2746	8833	64841	2806	2875	2936	2937	55577	5471	2058
PC_2195	2-Methyl-3-hydroxybutyryl-CoA Dehydrogenase Deficiency	18	10449	27034	34	35	36	38	217	4329	316	549	586	593	594	1629	1738	1892	11112	26275	3155	3158	3028	3712	56922	64087	5019	5095	5096
PC_2196	3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency	18	10449	27034	34	35	36	38	217	4329	316	549	586	593	594	1629	1738	1892	11112	26275	3155	3158	3028	3712	56922	64087	5019	5095	5096
PC_2197	3-Methylglutaconic Aciduria Type I	18	10449	27034	34	35	36	38	217	4329	316	549	586	593	594	1629	1738	1892	11112	26275	3155	3158	3028	3712	56922	64087	5019	5095	5096
PC_2198	3-Methylglutaconic Aciduria Type III	18	10449	27034	34	35	36	38	217	4329	316	549	586	593	594	1629	1738	1892	11112	26275	3155	3158	3028	3712	56922	64087	5019	5095	5096
PC_2199	3-Methylglutaconic Aciduria Type IV	18	10449	27034	34	35	36	38	217	4329	316	549	586	593	594	1629	1738	1892	11112	26275	3155	3158	3028	3712	56922	64087	5019	5095	5096
PC_2200	5-Oxoprolinuria	290	840	2729	2730	79017	124975	2876	2936	2937	119391	26873
PC_2201	Adenosine Deaminase Deficiency	100	108	158	159	203	270	353	84896	471	1716	957	377841	2618	8034	2766	8833	2977	2983	2987	3251	3614	3704	10201	22978	318	11164	10606	10846	5144	5198	4860	5471	221823	6240	6241	7295	7498
PC_2202	Benazepril Action Pathway	1636	183	5972
PC_2203	Captopril Action Pathway	1636	183	5972
PC_2204	Cilazapril Action Pathway	1636	183	5972
PC_2205	Enalapril Action Pathway	1636	183	5972
PC_2206	Fosinopril Action Pathway	1636	183	5972
PC_2207	Lisinopril Action Pathway	1636	183	5972
PC_2208	Moexipril Action Pathway	1636	183	5972
PC_2209	Perindopril Action Pathway	1636	183	5972
PC_2210	Quinapril Action Pathway	1636	183	5972
PC_2211	Ramipril Action Pathway	1636	183	5972
PC_2212	Rescinnamine Action Pathway	1636	183	5972
PC_2213	Spirapril Action Pathway	1636	183	5972
PC_2214	Trandolapril Action Pathway	1636	183	5972
PC_2215	Candesartan Action Pathway	1636	183	185	2776	2782	54331	5972
PC_2216	Eprosartan Action Pathway	1636	183	185	2776	2782	54331	5972
PC_2217	Forasartan Action Pathway	1636	183	5972
PC_2218	Irbesartan Action Pathway	1636	183	185	2776	2782	54331	5972
PC_2219	Losartan Action Pathway	1636	183	185	2776	2782	54331	5972
PC_2220	Olmesartan Action Pathway	1636	183	185	2776	2782	54331	5972
PC_2221	Telmisartan Action Pathway	1636	183	185	2776	2782	54331	5972
PC_2222	Valsartan Action Pathway	1636	183	185	2776	2782	54331	5972
PC_2223	Adenylosuccinate Lyase Deficiency	100	108	158	159	203	270	353	84896	471	1716	957	377841	2618	8034	2766	8833	2977	2983	2987	3251	3614	3704	10201	22978	318	11164	10606	10846	5144	5198	4860	5471	221823	6240	6241	7295	7498
PC_2224	AICA-Ribosiduria	100	108	158	159	203	270	353	84896	471	1716	957	377841	2618	8034	2766	8833	2977	2983	2987	3251	3614	3704	10201	22978	318	11164	10606	10846	5144	5198	4860	5471	221823	6240	6241	7295	7498
PC_2225	Alkaptonuria	124	218	26	1312	1621	1638	1644	2184	2805	2954	23498	3081	4128	268	5409	7299
PC_2226	Aromatic L-Aminoacid Decarboxylase Deficiency	1644	5409	7054
PC_2227	beta-Ureidopropionase Deficiency	205	1677	124583	978	129607	1503	1635	1723	1806	1807	1854	8034	3704	10201	22978	6241	50484	7083	1890	7298	54963	51733	151531
PC_2228	beta-Ketothiolase Deficiency	18	10449	27034	34	35	36	38	217	4329	316	549	586	593	594	1629	1738	1892	11112	26275	3155	3158	3028	3712	56922	64087	5019	5095	5096
PC_2229	Biotinidase Deficiency	32	686	3141	28972
PC_2230	Canavan Disease	18	158	122622	435	440	443	80150	445	1677	1615	8528	2571	259307	4677
PC_2231	Cystathionine beta-Synthase Deficiency	262	635	102724560	55349	1491	1786	259307	4141	4144	27430	22921	253827	4507	4524	6470	6723
PC_2232	Dihydropyrimidinase Deficiency	205	1677	124583	978	129607	1503	1635	1723	1806	1807	1854	8034	3704	10201	22978	6241	50484	7083	1890	7298	54963	51733	151531
PC_2233	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	189	211	217	275	1491	1738	29958	2593	2617	2628	23464	2731	132158	27232	4128	26227	29968	5723	1757	6301	10993	6470	6472	63826
PC_2234	Ethylmalonic Encephalopathy	10449	33	34	35	36	37	38	2180	1374	1376	1892	2639	3030	3032
PC_2235	Galactosemia	231	2683	2538	2548	2582	2592	2717	2720	3098	3938	5236	7360
PC_2236	gamma-Glutamyltransferase Deficiency	290	840	2729	2730	79017	124975	2876	2936	2937	119391	26873
PC_2237	Glucose Transporter Defect (SGLT2)	476	477	478	480	481	482	483	1187	486	6337	6338	6339	6340	6557	6559	9990	8170	6505	6582	9356	55089	6519	6520	54716	8140	9057	9056	23428	11136
PC_2238	Glutaric Aciduria Type I	10449	33	34	35	36	37	38	2180	1374	1376	1892	2639	3030	3032
PC_2239	Glutaric Aciduria Type I	51166	10157	38	501	55526	1738	1743	1892	2639	3030	51268	83884	6542
PC_2240	Glycerol Kinase Deficiency	10554	231	218	132158	57678	2819	2820	3990	4023	8611	8612
PC_2241	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	8659	383	435	445	1152	1373	1610	2058	2593	2628	2746	2805	4842	4942	5009	283208	5625	29920	57038	10166
PC_2242	Hartnup Disorder	476	477	478	480	481	482	483	1187	486	6337	6338	6339	6340	6557	6559	9990	8170	6505	6582	9356	55089	6519	6520	54716	8140	9057	9056	23428	11136
PC_2243	Hawkinsinuria	124	218	26	1312	1621	1638	1644	2184	2805	2954	23498	3081	4128	268	5409	7299
PC_2244	Histidinemia	217	218	144193	26	138199	57571	84735	55748	10841	3034	3035	23438	3067	3176	4128	10196	131669
PC_2245	Hypoacetylaspartia	18	158	122622	435	440	443	80150	445	1677	1615	8528	2571	259307	4677
PC_2246	Iminoglycinuria	476	477	478	480	481	482	483	1187	486	6337	6338	6339	6340	6557	6559	9990	8170	6505	6582	9356	55089	6519	6520	54716	8140	9057	9056	23428	11136
PC_2247	Leigh Syndrome	31	38	134526	55902	97	231	217	1737	1738	2739	9380	3029	3939	197257	4190	4199	5091	5105	5160	5162	5313
PC_2248	Lysinuric Protein Intolerance	476	477	478	480	481	482	483	1187	486	6337	6338	6339	6340	6557	6559	9990	8170	6505	6582	9356	55089	6519	6520	54716	8140	9057	9056	23428	11136
PC_2249	Malonic Aciduria	18	31	34	38	84532	79611	4329	593	594	1629	1738	1892	26275	92483	84693	23417	5095	5096
PC_2250	Maple Syrup Urine Disease	18	10449	27034	34	35	36	38	217	4329	316	549	586	593	594	1629	1738	1892	11112	26275	3155	3158	3028	3712	56922	64087	5019	5095	5096
PC_2251	Methylmalonic Aciduria	18	10449	27034	34	35	36	38	217	4329	316	549	586	593	594	1629	1738	1892	11112	26275	3155	3158	3028	3712	56922	64087	5019	5095	5096
PC_2252	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	18	31	34	38	84532	79611	4329	593	594	1629	1738	1892	26275	92483	84693	23417	5095	5096
PC_2253	MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy)	205	1677	124583	978	129607	1503	1635	1723	1806	1807	1854	8034	3704	10201	22978	6241	50484	7083	1890	7298	54963	51733	151531
PC_2254	Molybdenum Cofactor Deficiency	100	108	158	159	203	270	353	84896	471	1716	957	377841	2618	8034	2766	8833	2977	2983	2987	3251	3614	3704	10201	22978	318	11164	10606	10846	5144	5198	4860	5471	221823	6240	6241	7295	7498
PC_2255	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	383	435	445	1373	27165	2746	2806	2875	5009	6509	6510	8604	10166
PC_2256	Phenylketonuria	2184	2193	10056	2805	2954	3081	3242	259307	5053	6898	8565
PC_2257	Prolidase Deficiency (PD)	8659	383	435	445	1152	1373	1610	2058	2593	2628	2746	2805	4842	4942	5009	283208	5625	29920	57038	10166
PC_2258	Prolinemia Type II	8659	383	435	445	1152	1373	1610	2058	2593	2628	2746	2805	4842	4942	5009	283208	5625	29920	57038	10166
PC_2259	Hypercholesterolemia	8435	1595	1718	10682	2222	2224	9453	3156	51478	3422	3988	4047	6307	4597	4598	50814	10654	6309	6646	6713	7108
PC_2260	Purine Nucleoside Phosphorylase Deficiency	100	108	158	159	203	270	353	84896	471	1716	957	377841	2618	8034	2766	8833	2977	2983	2987	3251	3614	3704	10201	22978	318	11164	10606	10846	5144	5198	4860	5471	221823	6240	6241	7295	7498
PC_2261	Pyruvate Dehydrogenase Complex Deficiency	31	38	134526	55902	97	231	217	1737	1738	2739	9380	3029	3939	197257	4190	4199	5091	5105	5160	5162	5313
PC_2262	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	262	635	102724560	55349	1491	1786	259307	4141	4144	27430	22921	253827	4507	4524	6470	6723
PC_2263	Sialuria or French Type Sialuria	51005	1118	55907	2673	10020	10007	64841	3073	3098	55577	140838	54187	80896	5238	5973	26503	6675
PC_2264	Tyrosinemia Type I	124	218	26	1312	1621	1638	1644	2184	2805	2954	23498	3081	4128	268	5409	7299
PC_2265	UMP Synthase Deficiency (Orotic Aciduria)	205	1677	124583	978	129607	1503	1635	1723	1806	1807	1854	8034	3704	10201	22978	6241	50484	7083	1890	7298	54963	51733	151531
PC_2266	Xanthine Dehydrogenase Deficiency (Xanthinuria)	100	108	158	159	203	270	353	84896	471	1716	957	377841	2618	8034	2766	8833	2977	2983	2987	3251	3614	3704	10201	22978	318	11164	10606	10846	5144	5198	4860	5471	221823	6240	6241	7295	7498
PC_2267	Methionine Adenosyltransferase Deficiency	262	635	102724560	55349	1491	1786	259307	4141	4144	27430	22921	253827	4507	4524	6470	6723
PC_2268	Glycine N-Methyltransferase Deficiency	262	635	102724560	55349	1491	1786	259307	4141	4144	27430	22921	253827	4507	4524	6470	6723
PC_2269	Non-Ketotic Hyperglycinemia	189	211	217	275	1491	1738	29958	2593	2617	2628	23464	2731	132158	27232	4128	26227	29968	5723	1757	6301	10993	6470	6472	63826
PC_2270	Neuron Function	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2271	Esomeprazole Action Pathway	495	496	759	1193
PC_2272	Omeprazole Action Pathway	495	496	759	1193
PC_2273	Lansoprazole Action Pathway	495	496	759	1193
PC_2274	Pantoprazole Action Pathway	495	496	759	1193
PC_2275	Rabeprazole Action Pathway	495	496	759	1193
PC_2276	Ranitidine Action Pathway	495	496	759	1193
PC_2277	Famotidine Action Pathway	495	496	759	1193
PC_2278	Cimetidine Action Pathway	495	496	759	1193	3274
PC_2279	Nizatidine Action Pathway	495	496	759	1193
PC_2280	Short-Chain Acyl-CoA Dehydrogenase Deficiency (SCAD Deficiency)	10449	33	34	35	36	37	38	2180	1374	1376	1892	2639	3030	3032
PC_2281	Propionic Acidemia	18	10449	27034	34	35	36	38	217	4329	316	549	586	593	594	1629	1738	1892	11112	26275	3155	3158	3028	3712	56922	64087	5019	5095	5096
PC_2282	3-Methylcrotonyl-CoA Carboxylase Deficiency Type I	18	10449	27034	34	35	36	38	217	4329	316	549	586	593	594	1629	1738	1892	11112	26275	3155	3158	3028	3712	56922	64087	5019	5095	5096
PC_2283	Isovaleric Aciduria	18	10449	27034	34	35	36	38	217	4329	316	549	586	593	594	1629	1738	1892	11112	26275	3155	3158	3028	3712	56922	64087	5019	5095	5096
PC_2284	Saccharopinuria/Hyperlysinemia II	51166	10157	38	501	55526	1738	1743	1892	2639	3030	51268	83884	6542
PC_2285	Salla Disease/Infantile Sialic Acid Storage Disease	51005	1118	55907	2673	10020	10007	64841	3073	3098	55577	140838	54187	80896	5238	5973	26503	6675
PC_2286	Dimethylglycine Dehydrogenase Deficiency	189	211	217	275	1491	1738	29958	2593	2617	2628	23464	2731	132158	27232	4128	26227	29968	5723	1757	6301	10993	6470	6472	63826
PC_2287	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	18	8659	7915	1677	1373	124454	2571	2729	2730	2673	27165	2746	8833	64841	2806	2875	2936	2937	55577	5471	2058
PC_2288	Sarcosinemia	189	211	217	275	1491	1738	29958	2593	2617	2628	23464	2731	132158	27232	4128	26227	29968	5723	1757	6301	10993	6470	6472	63826
PC_2289	Pirenzepine Action Pathway	495	496	759	1193
PC_2290	Clopidogrel Action Pathway	5243	1544	1555	1557	1559	1576	1577	5444
PC_2291	Ticlopidine Action Pathway	64805
PC_2292	Cilostazol Action Pathway	1557	1576	1577	5144
PC_2293	Warfarin Action Pathway	2159	2160	2161	2162	2165	2147	2152	2153	2155	2157	2158	2243	2244	2266	2677	5327	5340	79001
PC_2294	Acenocoumarol Action Pathway	2159	2160	2161	2162	2165	2147	2152	2153	2155	2157	2158	2243	2244	2266	2677	5327	5340	79001
PC_2295	Dicumarol Action Pathway	2159	2160	2161	2162	2165	2147	2152	2153	2155	2157	2158	2243	2244	2266	2677	5327	5340	79001
PC_2296	Phenprocoumon Action Pathway	2159	2160	2161	2162	2165	2147	2152	2153	2155	2157	2158	2243	2244	2266	2677	5327	5340	79001
PC_2297	Enoxaparin Action Pathway	2159	2160	2161	2162	2165	2147	2152	2153	2155	2157	2158	2243	2244	2266	2677	5327	5340	79001
PC_2298	Fondaparinux Action Pathway	2159	2160	2161	2162	2165	2147	2152	2153	2155	2157	2158	2243	2244	2266	2677	5327	5340	79001
PC_2299	Heparin Action Pathway	2159	2160	2161	2162	2165	2147	2152	2153	2155	2157	2158	2243	2244	2266	2677	5327	5340	79001
PC_2300	Ardeparin Action Pathway	2159	2160	2161	2162	2165	2147	2152	2153	2155	2157	2158	2243	2244	2266	2677	5327	5340	79001
PC_2301	Argatroban Action Pathway	2159	2160	2161	2162	2165	2147	2152	2153	2155	2157	2158	2243	2244	2266	2677	5327	5340	79001
PC_2302	Bivalirudin Action Pathway	2159	2160	2161	2162	2165	2147	2152	2153	2155	2157	2158	2243	2244	2266	2677	5327	5340	79001
PC_2303	Lepirudin Action Pathway	2159	2160	2161	2162	2165	2147	2152	2153	2155	2157	2158	2243	2244	2266	2677	5327	5340	79001
PC_2304	Ximelagatran Action Pathway	2159	2160	2161	2162	2165	2147	2152	2153	2155	2157	2158	2243	2244	2266	2677	5327	5340	79001
PC_2305	Alteplase Action Pathway	2159	2160	2161	2162	2165	2147	2152	2153	2155	2157	2158	2243	2244	2266	2677	5327	5340	79001
PC_2306	Anistreplase Action Pathway	2159	2160	2161	2162	2165	2147	2152	2153	2155	2157	2158	2243	2244	2266	2677	5327	5340	79001
PC_2307	Streptokinase Action Pathway	2159	2160	2161	2162	2165	2147	2152	2153	2155	2157	2158	2243	2244	2266	2677	5327	5340	79001
PC_2308	Tenecteplase Action Pathway	2159	2160	2161	2162	2165	2147	2152	2153	2155	2157	2158	2243	2244	2266	2677	5327	5340	79001
PC_2309	Urokinase Action Pathway	2159	2160	2161	2162	2165	2147	2152	2153	2155	2157	2158	2243	2244	2266	2677	5327	5340	79001
PC_2310	Reteplase Action Pathway	2159	2160	2161	2162	2165	2147	2152	2153	2155	2157	2158	2243	2244	2266	2677	5327	5340	79001
PC_2311	Aminocaproic Acid Action Pathway	2159	2160	2161	2162	2165	2147	2152	2153	2155	2157	2158	2243	2244	2266	2677	5327	5340	79001
PC_2312	Tranexamic Acid Action Pathway	2159	2160	2161	2162	2165	2147	2152	2153	2155	2157	2158	2243	2244	2266	2677	5327	5340	79001
PC_2313	Aprotinin Action Pathway	2159	2160	2161	2162	2165	2147	2152	2153	2155	2157	2158	2243	2244	2266	2677	5327	5340	79001
PC_2314	Diflunisal Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2315	Acebutolol Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2316	Alprenolol Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2317	Atenolol Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2318	Betaxolol Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2319	Bisoprolol Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2320	Esmolol Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2321	Metoprolol Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2322	Nadolol Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2323	Oxprenolol Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2324	Penbutolol Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2325	Pindolol Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2326	Propranolol Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2327	Dopamine Activation of Neurological Reward System	108	1812	2778	5567
PC_2328	Excitatory Neural Signalling Through 5-HTR 4 and Serotonin	1385	2778	2782	2792	3360	5499	5567
PC_2329	Corticotropin Activation of Cortisol Production	2778	2782	2792	4158	5443	5567
PC_2330	Excitatory Neural Signalling Through 5-HTR 7 and Serotonin	1385	2778	2782	2792	3363	5499	5567
PC_2331	Excitatory Neural Signalling Through 5-HTR 6 and Serotonin	1385	2778	2782	2792	3362	5499	5567
PC_2332	Lactic Acidemia	57505	189	2875	51660	5091
PC_2333	Congenital Bile Acid Synthesis Defect Type II	8309	1109	6718	23600	570	9023	1593	51302	10858	1581	9420	1582	3295	80270	3988	10106	10998
PC_2334	Cerebrotendinous Xanthomatosis (CTX)	8309	1109	6718	23600	570	9023	1593	51302	10858	1581	9420	1582	3295	80270	3988	10106	10998
PC_2335	Zellweger Syndrome	8309	1109	6718	23600	570	9023	1593	51302	10858	1581	9420	1582	3295	80270	3988	10106	10998
PC_2336	Familial Hypercholanemia (FHCA)	8309	1109	6718	23600	570	9023	1593	51302	10858	1581	9420	1582	3295	80270	3988	10106	10998
PC_2337	Congenital Bile Acid Synthesis Defect Type III	8309	1109	6718	23600	570	9023	1593	51302	10858	1581	9420	1582	3295	80270	3988	10106	10998
PC_2338	Lysosomal Acid Lipase Deficiency (Wolman Disease)	8435	1595	1718	10682	2222	2224	9453	3156	51478	3422	3988	4047	6307	4597	4598	50814	10654	6309	6646	6713	7108
PC_2339	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	135	207	8874	1386	572	673	998	1147	1385	2002	2778	2782	2792	3265	3551	3725	5605	5608	5609	4214	4216	5594	5600	5599	4790	4791	4792	5058	50855	5170	5290	5567	5590	5906	9693	10411	6195
PC_2340	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	108	136	207	8874	1386	572	673	998	1147	1385	2002	2778	2782	2792	3265	3551	3725	5605	5608	5609	4214	4216	5594	5600	5599	4790	4791	4792	5058	50855	5170	5290	5567	5590	5906	9693	10411	6195
PC_2341	Vasopressin Regulation of Water Homeostasis	108	554	2492	2778	2782	55970	2792	5567
PC_2342	Quinidine Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2343	Procainamide (Antiarrhythmic) Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2344	Disopyramide Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2345	Fosphenytoin (Antiarrhythmic) Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2346	Phenytoin (Antiarrhythmic) Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1312	1544	1557	1559	1571	1576	1739	51726	2052	10961	486	10021	3309	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	1728	64714	9601	10130	5479	6262	6331	23753	6546	6640	6641	6645	7168	7169	54658	54657	54578	54600
PC_2347	Lidocaine (Antiarrhythmic) Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1544	1576	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2348	Mexiletine Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2349	Tocainide Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2350	Flecainide Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2351	Ibutilide Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2352	Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone	108	1385	2492	2778	2782	55970	2792	5499	5567
PC_2353	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	31	38	134526	55902	97	231	217	1737	1738	2739	9380	3029	3939	197257	4190	4199	5091	5105	5160	5162	5313
PC_2354	Intracellular Signalling Through Histamine H2 Receptor and Histamine	108	1385	2778	2782	2792	3274	5499	5567
PC_2355	Vitamin A Deficiency	124	216	8854	158833	53630	1592	1553	1548	1549	1555	1576	64816	1577	100861540	8694	9249	10901	10170	51726	10961	3309	9227	64714	9601	10130	8228	5479	51109	145226	8608	50700	54884	6121	23753	54658
PC_2356	Glutathione Synthetase Deficiency	290	840	2729	2730	79017	124975	2876	2936	2937	119391	26873
PC_2357	Intracellular Signalling Through LHCGR Receptor and Luteinizing Hormone/Choriogonadotropin	108	1081	1385	2778	2782	2792	3972	3973	5499	5567
PC_2358	Hyperinsulinism-Hyperammonemia Syndrome	18	8659	7915	1677	1373	124454	2571	2729	2730	2673	27165	2746	8833	64841	2806	2875	2936	2937	55577	5471	2058
PC_2359	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	262	635	102724560	55349	1491	1786	259307	4141	4144	27430	22921	253827	4507	4524	6470	6723
PC_2360	Hypermethioninemia	262	635	102724560	55349	1491	1786	259307	4141	4144	27430	22921	253827	4507	4524	6470	6723
PC_2361	Hereditary Coproporphyria (HCP)	210	211	644	1352	1355	1371	2235	55640	94033	2990	3145	3162	3060	10720	7389	7390
PC_2362	Intracellular Signalling Through PGD2 receptor and Prostaglandin D2	108	2778	2782	2792	5567	5729
PC_2363	Acute Intermittent Porphyria	210	211	644	1352	1355	1371	2235	55640	94033	2990	3145	3162	3060	10720	7389	7390
PC_2364	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	210	211	644	1352	1355	1371	2235	55640	94033	2990	3145	3162	3060	10720	7389	7390
PC_2365	Porphyria Variegata (PV)	210	211	644	1352	1355	1371	2235	55640	94033	2990	3145	3162	3060	10720	7389	7390
PC_2366	Metachromatic Leukodystrophy (MLD)	125981	55331	439	9331	64781	123099	339221	9514	2581	2629	2717	2720	2531	10825	8611	259230	8879	130367	56848	10558	9517	7357	7368
PC_2367	Globoid Cell Leukodystrophy	125981	55331	439	9331	64781	123099	339221	9514	2581	2629	2717	2720	2531	10825	8611	259230	8879	130367	56848	10558	9517	7357	7368
PC_2368	Gaucher Disease	125981	55331	439	9331	64781	123099	339221	9514	2581	2629	2717	2720	2531	10825	8611	259230	8879	130367	56848	10558	9517	7357	7368
PC_2369	Pyruvate Carboxylase Deficiency	57505	189	2875	51660	5091
PC_2370	GABA-Transaminase Deficiency	18	217	4329	8639	84735	1806	1807	2571	51733
PC_2371	Primary Hyperoxaluria Type I	57505	189	2875	51660	5091
PC_2372	Leukotriene C4 Synthesis Deficiency	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2373	Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin	108	2778	2782	2792	4634	4638	5567	5739
PC_2374	Mitochondrial Electron Transport Chain	498	506	509	513	514	517	515	54205	2597	2820	4508	4512	4694	6389	6390	6391	6392	291	2542	7384
PC_2375	17-beta Hydroxysteroid Dehydrogenase III Deficiency	6718	1586	1588	3292	3293	3283	6715	412	6783	6820	10720	7367
PC_2376	Argininemia	383	435	445	1373	27165	2746	2806	2875	5009	6509	6510	8604	10166
PC_2377	Fc Epsilon Receptor I Signaling in Mast Cells	207	695	2205	2207	2534	9846	2885	3265	3845	27040	3937	4067	5604	5605	5606	6416	5608	5609	5594	1432	5599	2206	4893	5170	5290	5295	5321	5335	5578	5879	5894	6654	6850	10451
PC_2378	Diltiazem Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2379	Hyperprolinemia Type II	8659	383	435	445	1152	1373	1610	2058	2593	2628	2746	2805	4842	4942	5009	283208	5625	29920	57038	10166
PC_2380	Hyperprolinemia Type I	8659	383	435	445	1152	1373	1610	2058	2593	2628	2746	2805	4842	4942	5009	283208	5625	29920	57038	10166
PC_2381	Arginine	8659	383	435	445	1152	1373	1610	2058	2593	2628	2746	2805	4842	4942	5009	283208	5625	29920	57038	10166
PC_2382	Ornithine Aminotransferase Deficiency (OAT Deficiency)	8659	383	435	445	1152	1373	1610	2058	2593	2628	2746	2805	4842	4942	5009	283208	5625	29920	57038	10166
PC_2383	Lesch-Nyhan Syndrome (LNS)	100	108	158	159	203	270	353	84896	471	1716	957	377841	2618	8034	2766	8833	2977	2983	2987	3251	3614	3704	10201	22978	318	11164	10606	10846	5144	5198	4860	5471	221823	6240	6241	7295	7498
PC_2384	Gout or Kelley-Seegmiller Syndrome	100	108	158	159	203	270	353	84896	471	1716	957	377841	2618	8034	2766	8833	2977	2983	2987	3251	3614	3704	10201	22978	318	11164	10606	10846	5144	5198	4860	5471	221823	6240	6241	7295	7498
PC_2385	Nebivolol Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2386	Carvedilol Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2387	Labetalol Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2388	Tyrosinemia Type 2 (or Richner-Hanhart Syndrome)	2184	2193	10056	2805	2954	3081	3242	259307	5053	6898	8565
PC_2389	Tyrosinemia Type 3 (TYRO3)	2184	2193	10056	2805	2954	3081	3242	259307	5053	6898	8565
PC_2390	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	1109	6718	1583	1584	1585	1586	1589	3290	3291	3283	3284
PC_2391	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency	1109	6718	1583	1584	1585	1586	1589	3290	3291	3283	3284
PC_2392	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency	1109	6718	1583	1584	1585	1586	1589	3290	3291	3283	3284
PC_2393	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	226	669	2023	2203	2538	130589	2597	2821	3099	3939	4191	51660	53354	5091	5105	5223	5224	5236	8402	6514	2542	7167
PC_2394	Verapamil Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2395	Amlodipine Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2396	Felodipine Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2397	Isradipine Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2398	Nifedipine Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2399	Nimodipine Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2400	Nisoldipine Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2401	Nitrendipine Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2402	Methylmalonate Semialdehyde Dehydrogenase Deficiency	18	10449	27034	34	35	36	38	217	4329	316	549	586	593	594	1629	1738	1892	11112	26275	3155	3158	3028	3712	56922	64087	5019	5095	5096
PC_2403	Homocarnosinosis	18	8659	7915	1677	1373	124454	2571	2729	2730	2673	27165	2746	8833	64841	2806	2875	2936	2937	55577	5471	2058
PC_2404	Desmosterolosis	8435	1595	1718	10682	2222	2224	9453	3156	51478	3422	3988	4047	6307	4597	4598	50814	10654	6309	6646	6713	7108
PC_2405	CHILD Syndrome	8435	1595	1718	10682	2222	2224	9453	3156	51478	3422	3988	4047	6307	4597	4598	50814	10654	6309	6646	6713	7108
PC_2406	Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2)	8435	1595	1718	10682	2222	2224	9453	3156	51478	3422	3988	4047	6307	4597	4598	50814	10654	6309	6646	6713	7108
PC_2407	Smith-Lemli-Opitz Syndrome (SLOS)	8435	1595	1718	10682	2222	2224	9453	3156	51478	3422	3988	4047	6307	4597	4598	50814	10654	6309	6646	6713	7108
PC_2408	Tay-Sachs Disease	51005	1118	55907	2673	10020	10007	64841	3073	3098	55577	140838	54187	80896	5238	5973	26503	6675
PC_2409	Insulin Signalling	207	2308	2885	3265	3643	3667	8660	5604	5605	5594	5599	5170	5294	146850	5894	6464	6517	6654
PC_2410	Benzocaine Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2411	Bupivacaine Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2412	Chloroprocaine Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2413	Cocaine Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2414	Dibucaine Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2415	Levobupivacaine Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2416	Lidocaine (Local Anaesthetic) Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	1544	1576	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2417	Mepivacaine Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2418	Oxybuprocaine Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2419	Prilocaine Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2420	Procaine Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2421	Proparacaine Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2422	Ropivacaine Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2423	Codeine Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	1565	1576	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532	7364
PC_2424	Morphine Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	51726	10961	486	2902	2903	116443	3309	3751	30819	5126	64714	9601	10130	5443	5479	6336	6324	23753	6530	6531	6532	54658	54659	54576	7366	7363	7364
PC_2425	Methadone Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	1555	1557	1558	1565	1576	100861540	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2426	Oxycodone Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2427	Hydromorphone Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2428	Hydrocodone Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2429	Oxymorphone Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2430	Alfentanil Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2431	Carfentanil Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2432	Fentanyl Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2433	Remifentanil Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2434	Sufentanil Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2435	Imipramine Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	1544	1557	1565	1576	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2436	Desipramine Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	1565	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2437	Citalopram Action Pathway	316	476	477	478	480	481	482	483	773	9254	782	1137	1141	1557	1565	100861540	486	2902	2903	116443	3751	30819	4128	4129	5126	5443	6336	6324	6530	6531	6532
PC_2438	Escitalopram Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2439	Fluoxetine Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	1557	1559	1565	1576	1577	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2440	Azathioprine Action Pathway	10257	10057	100	108	132	158	159	203	270	316	353	84896	471	1716	957	377841	2618	8034	2766	8833	2977	2983	2987	3251	3614	3704	10201	22978	318	11164	10606	10846	5144	5198	4860	5471	221823	6240	6241	9153	64078	2030	3177	7172	7295	7498
PC_2441	Mercaptopurine Action Pathway	10257	10057	100	108	132	158	159	203	270	316	353	84896	471	1716	957	377841	2618	8034	2766	8833	2977	2983	2987	3251	3614	3704	10201	22978	318	11164	10606	10846	5144	5198	4860	5471	221823	6240	6241	9153	64078	2030	3177	7172	7295	7498
PC_2442	Disulfiram Action Pathway	84532	55902	124	125	219	217	218	26	847	1312	1571	1621	1638	1644	2184	2805	2954	23498	3081	4128	268	5409	7299
PC_2443	Thioguanine Action Pathway	10257	10057	100	108	132	158	159	203	270	316	353	84896	471	1716	957	377841	2618	8034	2766	8833	2977	2983	2987	3251	3614	3704	10201	22978	318	11164	10606	10846	5144	5198	4860	5471	221823	6240	6241	9153	64078	2030	3177	7172	7295	7498
PC_2444	Nicotine Action Pathway	316	476	477	478	480	481	482	483	773	9254	782	1137	1141	1548	1555	2328	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532	54657	54600
PC_2445	Methotrexate Action Pathway	10840	1719	2356	10841	8836	123263	4522	25902	10797	4524	10588	113235
PC_2446	Irinotecan Action Pathway	5243	4363	1244	9429	590	4502	8824	1576	1577	51726	10961	3309	64714	9601	10130	5479	23753	10599	54658	54575	54600
PC_2447	Paclitaxel Action Pathway	5243	4363	1244	9429	28234
PC_2448	Docetaxel Action Pathway	5243	4363	1244	9429	28234
PC_2449	Vinblastine Action Pathway	5243	4363	89845	1244	8714	1576	10928
PC_2450	Vincristine Action Pathway	5243	4363	89845	1244	8714	10928
PC_2451	Vindesine Action Pathway	5243	4363	89845	1244	8714	10928
PC_2452	Vinorelbine Action Pathway	5243	4363	89845	1244	8714	1576	10928
PC_2453	Prednisone Action Pathway	1576
PC_2454	Prednisolone Action Pathway	2908
PC_2455	Etoposide Action Pathway	5243	8714	1576	1577	51726	10961	3309	4353	64714	9601	10130	5479	5742	5743	23753	54658
PC_2456	Teniposide Action Pathway	1576	1577	4353
PC_2457	Lactose Synthesis	2683	124583	51727	2538	2592	3906	4831	6513	7355	7360
PC_2458	Spermidine and Spermine Biosynthesis	262	4144	27430	4953	6611	6723
PC_2459	Gemcitabine Action Pathway	51727	1633	1635	4830	30833	9154	64078	2030
PC_2460	Cyclophosphamide Action Pathway	216	218	1548	1555	1557	1558	1559	1576	2944
PC_2461	Ifosfamide Action Pathway	216	218	1548	1555	1558	1559	1576	1577
PC_2462	Ethanol Degradation	84532	55902	125	219	217	847	1571
PC_2463	Phytanic Acid Peroxisomal Oxidation	215	225	224	26061	5264	11001
PC_2464	Refsum Disease	215	225	224	26061	5264	11001
PC_2465	Threonine and 2-Oxobutanoate Degradation	593	594	1629	1738	4594	5095	5096	10993
PC_2466	Nateglinide Action Pathway	6833	773	9254	782	3630	6514
PC_2467	Repaglinide Action Pathway	6833	773	9254	782	3630	6514
PC_2468	Homocysteine Degradation	102724560	1491
PC_2469	Fatty Acid Biosynthesis	31	2194
PC_2470	Lactose Degradation	476	477	478	480	481	482	483	486	3938	6514	6523
PC_2471	Lactose Intolerance	476	477	478	480	481	482	483	486	3938	6514	6523
PC_2472	Pyruvaldehyde Degradation	2739	3029	197257
PC_2473	Glibenclamide Action Pathway	6833	773	9254	782	3630	6514
PC_2474	Gliclazide Action Pathway	6833	773	9254	782	3630	6514
PC_2475	Inositol Phosphate Metabolism	3612	3628	3631	8821	27124	9807	253430	64768	51477	3705	3706	9562	11165	9677
PC_2476	Phosphatidylinositol Phosphate Metabolism	55626	8678	10423	2064	9896	8821	3635	23203	5297	5286	5289	5293	5295	30849	200576	5305	8394	23236	5728	8867	55697
PC_2477	Vitamin K Metabolism	2677	1728	79001
PC_2478	Carnitine Synthesis	223	8424	80854	6470	55217
PC_2479	Transfer of Acetyl Groups into Mitochondria	47	4190	4199	51660	5091	5160	5162	8402
PC_2480	Trehalose Degradation	476	477	478	480	481	482	483	486	2645	6514	6523	11181
PC_2481	Degradation of Superoxides	847	6647	6648	6649	7306
PC_2482	Capecitabine Action Pathway	978	4502	9154	1890
PC_2483	Fluorouracil Action Pathway	7298
PC_2484	Tamoxifen Action Pathway	1555	1565	1576	1577	2099	2326	2328	6817	54575	54657
PC_2485	Erlotinib Action Pathway	5243	9429
PC_2486	Plasmalogen Synthesis	10554	8540	10390	8443	8611
PC_2487	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	10449	33	35	38	79611	1892	3030	3028
PC_2488	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	10449	34	116285	1892	3030	3030	3032	788
PC_2489	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	10449	33	2180	1374	1376	1892	3030	3030	3032	788
PC_2490	Dimethylglycine Dehydrogenase Deficiency	189	211	217	275	1491	1738	29958	2593	2617	2628	23464	2731	132158	27232	4128	26227	29968	5723	1757	6301	10993	6470	6472	63826
PC_2491	Hyperglycinemia, Non-Ketotic	189	211	217	275	1491	1738	29958	2593	2617	2628	23464	2731	132158	27232	4128	26227	29968	5723	1757	6301	10993	6470	6472	63826
PC_2492	DOPA-Responsive Dystonia	231	873	1719	2643	2644	5805	5860	6697
PC_2493	Hyperphenylalaninemia Due to Guanosine Triphosphate Cyclohydrolase Deficiency	231	873	1719	2643	2644	5805	5860	6697
PC_2494	Hyperphenylalaninemia Due to 6-Pyruvoyltetrahydropterin Synthase Deficiency (ptps)	231	873	1719	2643	2644	5805	5860	6697
PC_2495	Hyperphenylalaninemia Due to DHPR-Deficiency	231	873	1719	2643	2644	5805	5860	6697
PC_2496	Segawa Syndrome	231	873	1719	2643	2644	5805	5860	6697
PC_2497	Sepiapterin Reductase Deficiency	231	873	1719	2643	2644	5805	5860	6697
PC_2498	Carnosinuria, Carnosinemia	18	217	4329	8639	84735	1806	1807	2571	51733
PC_2499	Tyrosinemia, Transient, of the Newborn	124	218	26	1312	1621	1638	1644	2184	2805	2954	23498	3081	4128	268	5409	7299
PC_2500	Galactosemia II (GALK)	2582	2584	2592	2645	5236	7358	7360	80146
PC_2501	Galactosemia III	2582	2584	2592	2645	5236	7358	7360	80146
PC_2502	Tyrosine Hydroxylase Deficiency	1644	5409	7054
PC_2503	Dopamine beta-Hydroxylase Deficiency	124	218	26	1312	1621	1638	1644	2184	2805	2954	23498	3081	4128	268	5409	7299
PC_2504	beta-Mercaptolactate-Cysteine Disulfiduria	833	1036	1491	1497	2729	2730	2805	3939	4357
PC_2505	5-Oxoprolinase Deficiency	290	840	2729	2730	79017	124975	2876	2936	2937	119391	26873
PC_2506	gamma-Glutamyltranspeptidase Deficiency	290	840	2729	2730	79017	124975	2876	2936	2937	119391	26873
PC_2507	Malonyl-CoA Decarboxylase Deficiency	18	31	34	38	84532	79611	4329	593	594	1629	1738	1892	26275	92483	84693	23417	5095	5096
PC_2508	Hypophosphatasia	249	316	8566	57026	55163
PC_2509	Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency	8659	383	435	445	1152	1373	1610	2058	2593	2628	2746	2805	4842	4942	5009	283208	5625	29920	57038	10166
PC_2510	Hyperornithinemia with Gyrate Atrophy (HOGA)	8659	383	435	445	1152	1373	1610	2058	2593	2628	2746	2805	4842	4942	5009	283208	5625	29920	57038	10166
PC_2511	Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome]	8659	383	435	445	1152	1373	1610	2058	2593	2628	2746	2805	4842	4942	5009	283208	5625	29920	57038	10166
PC_2512	L-Arginine	8659	383	435	445	1152	1373	1610	2058	2593	2628	2746	2805	4842	4942	5009	283208	5625	29920	57038	10166
PC_2513	Cholesteryl Ester Storage Disease	8435	1595	1718	10682	2222	2224	9453	3156	51478	3422	3988	4047	6307	4597	4598	50814	10654	6309	6646	6713	7108
PC_2514	Hyper-IgD Syndrome	8435	1595	1718	10682	2222	2224	9453	3156	51478	3422	3988	4047	6307	4597	4598	50814	10654	6309	6646	6713	7108
PC_2515	Mevalonic Aciduria	8435	1595	1718	10682	2222	2224	9453	3156	51478	3422	3988	4047	6307	4597	4598	50814	10654	6309	6646	6713	7108
PC_2516	Wolman Disease	8435	1595	1718	10682	2222	2224	9453	3156	51478	3422	3988	4047	6307	4597	4598	50814	10654	6309	6646	6713	7108
PC_2517	Xanthinuria Type I	100	108	158	159	203	270	353	84896	471	1716	957	377841	2618	8034	2766	8833	2977	2983	2987	3251	3614	3704	10201	22978	318	11164	10606	10846	5144	5198	4860	5471	221823	6240	6241	7295	7498
PC_2518	Xanthinuria Type II	100	108	158	159	203	270	353	84896	471	1716	957	377841	2618	8034	2766	8833	2977	2983	2987	3251	3614	3704	10201	22978	318	11164	10606	10846	5144	5198	4860	5471	221823	6240	6241	7295	7498
PC_2519	gamma-Cystathionase Deficiency (CTH)	102724560	1491
PC_2520	Homocystinuria, Cystathionine beta-Synthase Deficiency	102724560	1491
PC_2521	Adrenoleukodystrophy, X-Linked	215	225	2180	1376	1384	54677	92960	5194	5195	788
PC_2522	Carnitine-Acylcarnitine Translocase Deficiency	215	225	2180	1376	1384	54677	92960	5194	5195	788
PC_2523	Glucose-6-phosphate Dehydrogenase Deficiency	226	51071	2203	2539	2821	5211	5226	25796	5236	221823	64080	6120	22934	6888	7086
PC_2524	Ribose-5-phosphate Isomerase Deficiency	226	51071	2203	2539	2821	5211	5226	25796	5236	221823	64080	6120	22934	6888	7086
PC_2525	Transaldolase Deficiency	226	51071	2203	2539	2821	5211	5226	25796	5236	221823	64080	6120	22934	6888	7086
PC_2526	3-Hydroxyisobutyric Acid Dehydrogenase Deficiency	18	10449	27034	34	35	36	38	217	4329	316	549	586	593	594	1629	1738	1892	11112	26275	3155	3158	3028	3712	56922	64087	5019	5095	5096
PC_2527	3-Hydroxyisobutyric Aciduria	18	10449	27034	34	35	36	38	217	4329	316	549	586	593	594	1629	1738	1892	11112	26275	3155	3158	3028	3712	56922	64087	5019	5095	5096
PC_2528	Isobutyryl-CoA Dehydrogenase Deficiency	18	10449	27034	34	35	36	38	217	4329	316	549	586	593	594	1629	1738	1892	11112	26275	3155	3158	3028	3712	56922	64087	5019	5095	5096
PC_2529	Isovaleric Acidemia	18	10449	27034	34	35	36	38	217	4329	316	549	586	593	594	1629	1738	1892	11112	26275	3155	3158	3028	3712	56922	64087	5019	5095	5096
PC_2530	Fabry Disease	125981	55331	439	9331	64781	123099	339221	9514	2581	2629	2717	2720	2531	10825	8611	259230	8879	130367	56848	10558	9517	7357	7368
PC_2531	Krabbe Disease	125981	55331	439	9331	64781	123099	339221	9514	2581	2629	2717	2720	2531	10825	8611	259230	8879	130367	56848	10558	9517	7357	7368
PC_2532	Hyperlysinemia I, Familial	51166	10157	38	501	55526	1738	1743	1892	2639	3030	51268	83884	6542
PC_2533	Hyperlysinemia II or Saccharopinuria	51166	10157	38	501	55526	1738	1743	1892	2639	3030	51268	83884	6542
PC_2534	D-Glyceric Acidura	10554	231	218	132158	57678	2819	2820	3990	4023	8611	8612
PC_2535	Familial Lipoprotein Lipase Deficiency	10554	231	218	132158	57678	2819	2820	3990	4023	8611	8612
PC_2536	Glycogenosis, Type VII. Tarui Disease	226	669	2023	2538	130589	2597	2821	3099	5213	5223	5224	5230	5313	6514
PC_2537	Sulfite Oxidase Deficiency	10380	50515	9060	6817	6820	6821
PC_2538	Monoamine Oxidase-A Deficiency (MAO-A)	124	218	26	1312	1621	1638	1644	2184	2805	2954	23498	3081	4128	268	5409	7299
PC_2539	G(M2)-Gangliosidosis	51005	1118	55907	2673	10020	10007	64841	3073	3098	55577	140838	54187	80896	5238	5973	26503	6675
PC_2540	Adenine Phosphoribosyltransferase Deficiency (APRT)	100	108	158	159	203	270	353	84896	471	1716	957	377841	2618	8034	2766	8833	2977	2983	2987	3251	3614	3704	10201	22978	318	11164	10606	10846	5144	5198	4860	5471	221823	6240	6241	7295	7498
PC_2541	Mitochondrial DNA Depletion Syndrome-3	100	108	158	159	203	270	353	84896	471	1716	957	377841	2618	8034	2766	8833	2977	2983	2987	3251	3614	3704	10201	22978	318	11164	10606	10846	5144	5198	4860	5471	221823	6240	6241	7295	7498
PC_2542	Myoadenylate Deaminase Deficiency	100	108	158	159	203	270	353	84896	471	1716	957	377841	2618	8034	2766	8833	2977	2983	2987	3251	3614	3704	10201	22978	318	11164	10606	10846	5144	5198	4860	5471	221823	6240	6241	7295	7498
PC_2543	Carnitine Palmitoyl Transferase Deficiency I	10449	33	34	35	36	37	38	2180	1374	1376	1892	2639	3030	3032
PC_2544	Long Chain Acyl-CoA Dehydrogenase Deficiency (LCAD)	10449	33	34	35	36	37	38	2180	1374	1376	1892	2639	3030	3032
PC_2545	Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency (VLCAD)	10449	33	34	35	36	37	38	2180	1374	1376	1892	2639	3030	3032
PC_2546	Carnitine Palmitoyl Transferase Deficiency II	10449	33	34	35	36	37	38	2180	1374	1376	1892	2639	3030	3032
PC_2547	Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCAD)	10449	33	34	35	36	37	38	2180	1374	1376	1892	2639	3030	3032
PC_2548	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	10840	1719	2356	10841	8836	123263	4522	25902	10797	4524	10588	113235
PC_2549	Long-Chain-3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD)	10449	1892	3030	3032	3028	51102	5538
PC_2550	Trifunctional Protein Deficiency	10449	33	34	35	36	37	38	2180	1374	1376	1892	2639	3030	3032
PC_2551	Congenital Lactic Acidosis	50	1431	55526	1737	1738	1743	2271	3419	3420	3421	4190	51660	5091	5160	5162	6389	6390	6391	6392	8802	8801
PC_2552	Fumarase Deficiency	50	1431	55526	1737	1738	1743	2271	3419	3420	3421	4190	51660	5091	5160	5162	6389	6390	6391	6392	8802	8801
PC_2553	Mitochondrial Complex II Deficiency	50	1431	55526	1737	1738	1743	2271	3419	3420	3421	4190	51660	5091	5160	5162	6389	6390	6391	6392	8802	8801
PC_2554	2-Ketoglutarate Dehydrogenase Complex Deficiency	50	1431	55526	1737	1738	1743	2271	3419	3420	3421	4190	51660	5091	5160	5162	6389	6390	6391	6392	8802	8801
PC_2555	Pyruvate Dehydrogenase Deficiency (E3)	50	1431	55526	1737	1738	1743	2271	3419	3420	3421	4190	51660	5091	5160	5162	6389	6390	6391	6392	8802	8801
PC_2556	Pyruvate Dehydrogenase Deficiency (E2)	50	1431	55526	1737	1738	1743	2271	3419	3420	3421	4190	51660	5091	5160	5162	6389	6390	6391	6392	8802	8801
PC_2557	Glycogen Synthetase Deficiency	178	276	276	276	2632	2645	2821	2990	2998	3099	8972	5236	283209	5836	6476	7358	7360	10720
PC_2558	Glycogenosis, Type III. Cori Disease, Debrancher Glycogenosis	178	276	276	276	2632	2645	2821	2990	2998	3099	8972	5236	283209	5836	6476	7358	7360	10720
PC_2559	Glycogenosis, Type IV. Amylopectinosis, Anderson Disease	178	276	276	276	2632	2645	2821	2990	2998	3099	8972	5236	283209	5836	6476	7358	7360	10720
PC_2560	Glycogenosis, Type VI. Hers Disease	178	276	276	276	2632	2645	2821	2990	2998	3099	8972	5236	283209	5836	6476	7358	7360	10720
PC_2561	Mucopolysaccharidosis VII. Sly Syndrome	178	276	276	276	2632	2645	2821	2990	2998	3099	8972	5236	283209	5836	6476	7358	7360	10720
PC_2562	Sucrase-Isomaltase Deficiency	178	276	276	276	2632	2645	2821	2990	2998	3099	8972	5236	283209	5836	6476	7358	7360	10720
PC_2563	Primary Hyperoxaluria II, PH2	31	38	134526	55902	97	231	217	1737	1738	2739	9380	3029	3939	197257	4190	4199	5091	5105	5160	5162	5313
PC_2564	Pyruvate Kinase Deficiency	31	38	134526	55902	97	231	217	1737	1738	2739	9380	3029	3939	197257	4190	4199	5091	5105	5160	5162	5313
PC_2565	Phosphoenolpyruvate Carboxykinase Deficiency 1 (PEPCK1)	226	669	2023	2203	2538	130589	2597	2821	3099	3939	4191	51660	53354	5091	5105	5223	5224	5236	8402	6514	2542	7167
PC_2566	Fructosuria	231	226	229	2203	197258	8790	2762	29925	3098	3795	4351	5207	5211	29085	5372	6652	7167	7264
PC_2567	Fructose-1,6-diphosphatase Deficiency	226	669	2023	2203	2538	130589	2597	2821	3099	3939	4191	51660	53354	5091	5105	5223	5224	5236	8402	6514	2542	7167
PC_2568	Triosephosphate Isomerase Deficiency	226	669	2023	2203	2538	130589	2597	2821	3099	3939	4191	51660	53354	5091	5105	5223	5224	5236	8402	6514	2542	7167
PC_2569	Multiple Carboxylase Deficiency, Neonatal or Early Onset Form	32	686	3141	28972
PC_2570	Aromatase Deficiency	6718	1586	1588	3292	3293	3283	6715	412	6783	6820	10720	7367
PC_2571	17-alpha-Hydroxylase Deficiency (CYP17)	1109	6718	1583	1584	1585	1586	1589	3290	3291	3283	3284
PC_2572	Succinic Semialdehyde Dehydrogenase Deficiency	18	8659	7915	1677	1373	124454	2571	2729	2730	2673	27165	2746	8833	64841	2806	2875	2936	2937	55577	5471	2058
PC_2573	Short-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency (SCHAD)	10449	33	35	38	79611	1892	3030	3028
PC_2574	Succinyl CoA	38	622	3155	5019
PC_2575	Homocystinuria-Megaloblastic Anemia Due to Defect in Cobalamin Metabolism, cblG Complementation Type	262	635	102724560	55349	1491	1786	259307	4141	4144	27430	22921	253827	4507	4524	6470	6723
PC_2576	Pyridoxine Dependency with Seizures	51166	10157	38	501	55526	1738	1743	1892	2639	3030	51268	83884	6542
PC_2577	Fanconi-Bickel Syndrome	226	669	2023	2538	130589	2597	2821	3099	5213	5223	5224	5230	5313	6514
PC_2578	Glycogenosis, Type IB	226	669	2023	2203	2538	130589	2597	2821	3099	3939	4191	51660	53354	5091	5105	5223	5224	5236	8402	6514	2542	7167
PC_2579	Glycogenosis, Type IC	226	669	2023	2203	2538	130589	2597	2821	3099	3939	4191	51660	53354	5091	5105	5223	5224	5236	8402	6514	2542	7167
PC_2580	11-beta-Hydroxylase Deficiency (CYP11B1)	1109	6718	1583	1584	1585	1586	1589	3290	3291	3283	3284
PC_2581	21-Hydroxylase Deficiency (CYP21)	1109	6718	1583	1584	1585	1586	1589	3290	3291	3283	3284
PC_2582	Corticosterone Methyl Oxidase I Deficiency (CMO I)	1109	6718	1583	1584	1585	1586	1589	3290	3291	3283	3284
PC_2583	Corticosterone Methyl Oxidase II Deficiency (CMO II)	1109	6718	1583	1584	1585	1586	1589	3290	3291	3283	3284
PC_2584	Congenital Disorder of Glycosylation CDG-IId	2683	124583	51727	2538	2592	3906	4831	6513	7355	7360
PC_2585	GLUT-1 Deficiency Syndrome	2683	124583	51727	2538	2592	3906	4831	6513	7355	7360
PC_2586	Glycogenosis, Type IA. Von Gierke Disease	226	669	2023	2203	2538	130589	2597	2821	3099	3939	4191	51660	53354	5091	5105	5223	5224	5236	8402	6514	2542	7167
PC_2587	Joubert Syndrome	55626	8678	10423	2064	9896	8821	3635	23203	5297	5286	5289	5293	5295	30849	200576	5305	8394	23236	5728	8867	55697
PC_2588	Blue Diaper Syndrome	476	477	478	480	481	482	483	1187	486	6337	6338	6339	6340	6557	6559	9990	8170	6505	6582	9356	55089	6519	6520	54716	8140	9057	9056	23428	11136
PC_2589	Lysinuric Protein Intolerance (LPI)	476	477	478	480	481	482	483	1187	486	6337	6338	6339	6340	6557	6559	9990	8170	6505	6582	9356	55089	6519	6520	54716	8140	9057	9056	23428	11136
PC_2590	Coagulation	2159	2160	2161	2162	2165	2147	2152	2153	2155	2157	2158	2243	2244	2266	2677	5327	5340	79001
PC_2591	Angiotensin Metabolism	1636	183	5972
PC_2592	Striated Muscle Contraction	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2593	Gastric Acid Production	495	496	759	1193
PC_2594	Ibuprofen Metabolism Pathway	1557	1558	1559	1576	51726	10961	3309	64714	9601	10130	5479	23753	9356	9376	54658	54575	54659	54600	7363	7364
PC_2595	Irinotecan Metabolism Pathway	5243	4363	1244	9429	590	4502	8824	1576	1577	51726	10961	3309	64714	9601	10130	5479	23753	10599	54658	54575	54600
PC_2596	Etoposide Metabolism Pathway	5243	8714	1576	1577	51726	10961	3309	4353	64714	9601	10130	5479	5742	5743	23753	54658
PC_2597	Teniposide Metabolism Pathway	1576	1577	4353
PC_2598	Gemcitabine Metabolism Pathway	51727	1633	1635	4830	30833	9154	64078	2030
PC_2599	Cyclophosphamide Metabolism Pathway	216	218	1548	1555	1557	1558	1559	1576	2944
PC_2600	Ifosfamide Metabolism Pathway	216	218	1548	1555	1558	1559	1576	1577
PC_2601	Tamoxifen Metabolism Pathway	1555	1565	1576	1577	2099	2326	2328	6817	54575	54657
PC_2602	Capecitabine Metabolism Pathway	978	4502	9154	1890
PC_2603	Fluorouracil Metabolism Pathway	7298
PC_2604	Mercaptopurine Metabolism Pathway	10257	10057	132	316	8833	3251	3614	9153	64078	2030	3177	7172	7498
PC_2605	Clopidogrel Metabolism Pathway	5243	1544	1555	1557	1559	1576	1577	5444
PC_2606	Ticlopidine Metabolism Pathway	64805
PC_2607	Cimetidine Metabolism Pathway	3274
PC_2608	Felodipine Metabolism Pathway	775	9254	782
PC_2609	Lidocaine (Local Anaesthetic) Metabolism Pathway	1544	1576
PC_2610	Codeine Metabolism Pathway	1565	1576	7364
PC_2611	Morphine Metabolism Pathway	51726	10961	3309	64714	9601	10130	5479	23753	54658	54659	54576	7366	7363	7364
PC_2612	Heroin Metabolism Pathway	590	4502	8824
PC_2613	Methadone Metabolism Pathway	1555	1557	1558	1565	1576	100861540
PC_2614	Imipramine Metabolism Pathway	1544	1557	1565	1576
PC_2615	Desipramine Metabolism Pathway	1565
PC_2616	Citalopram Metabolism Pathway	316	1557	1565	100861540	4128	4129
PC_2617	Nicotine Metabolism Pathway	316	1548	1555	2328	54657	54600
PC_2618	Adefovir Dipivoxil Metabolism Pathway	203	204	4830	4831
PC_2619	Tenofovir Metabolism Pathway	203	204	4830	4831
PC_2620	Prednisone Metabolism Pathway	1576
PC_2621	Prednisolone Metabolism Pathway	2908
PC_2622	Felbamate Metabolism Pathway	124	218	1571	1576
PC_2623	Carbamazepine Metabolism Pathway	1555	1557	1558	1576	1577	100861540	2052
PC_2624	Valproic Acid Metabolism Pathway	36	116285	1548	1555	1559	1962	3030	3032	3028	3712	54659
PC_2625	Venlafaxine Metabolism Pathway	5243	1557	1565	1576
PC_2626	Tramadol Metabolism Pathway	1244	1555	1565	1576	6580	54576	7364
PC_2627	Levomethadyl Acetate Metabolism Pathway	100861540
PC_2628	Clomipramine Metabolism Pathway	1544	1557	1565	1576
PC_2629	Acetaminophen Metabolism Pathway	5243	4363	10257	10057	9429	1544	1548	1565	1571	1576	51726	10961	2950	2952	3309	64714	9601	10130	5479	23753	6817	445329	445329	6783	6822	54658	54578	54600	7366
PC_2630	Doxepin Metabolism Pathway	1544	1557	1559	1565	1576
PC_2631	Nevirapine Metabolism Pathway	89845	216	1555	1559	1565	1576	1577	54575
PC_2632	Celecoxib Metabolism Pathway	124	125	1559	1565	1576	5742	5743	54575
PC_2633	Fluoxetine Metabolism Pathway	1557	1559	1565	1576	1577
PC_2634	Thioguanine Metabolism Pathway	3251
PC_2635	Sorafenib Metabolism Pathway	1576	54600
PC_2636	Lamivudine Metabolism Pathway	5243	4363	1244	8714	10257	9429	56994	51727	1633	4830	30833	5130	5833	5230	6580	6582	6581	6817
PC_2637	Doxorubicin Metabolism Pathway	5243	4363	1244	9429	10327	8644	873	874	4720	4722	374291	4846	1728	5447	10928	85413	7498
PC_2638	Artemether Metabolism Pathway	1576	1577	54600	7364
PC_2639	Mycophenolic Acid Metabolism Pathway	5243	1244	9429	4502	8824	1558	1576	1577	10599	28234	54577	54576	54600	7364
PC_2640	Rosiglitazone Metabolism Pathway	1558	1559	10599
PC_2641	Warburg Effect	48	50	229	1431	55526	1737	1738	1743	2023	2271	2539	2597	27165	2746	2821	3099	3417	3419	3420	3421	3939	4190	51660	5091	5160	5162	5211	5224	5226	5230	25796	5313	22934	6389	6390	6391	6392	6566	6510	6514	8802	8801	6888	7086
PC_2642	Phenindione Action Pathway	2159	2160	2161	2162	2165	2147	2152	2153	2155	2157	2158	2243	2244	2266	2677	5327	5340	79001
PC_2643	Dicoumarol Action Pathway	2159	2160	2161	2162	2165	2147	2152	2153	2155	2157	2158	2243	2244	2266	2677	5327	5340	79001
PC_2644	Bopindolol Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2645	Carteolol Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2646	Timolol Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2647	Sotalol Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2648	Epinephrine Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2649	Dobutamine Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2650	Isoprenaline Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2651	Arbutamine Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2652	Amiodarone Action Pathway	6833	10060	153	144245	476	477	478	480	481	482	483	23439	488	775	8913	8912	9254	782	1739	486	2778	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	90550	5578	5567	5568	5573	5575	5576	5577	6262	6331	6546	6548	6640	6641	6645	7168	7169	10975
PC_2653	Levobunolol Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2654	Metipranolol Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2655	Bevantolol Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2656	Practolol Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2657	Bupranolol Action Pathway	6833	10060	144245	476	477	478	480	481	482	483	488	775	8913	8912	9254	782	1739	486	10021	3741	3752	3753	9992	3757	30819	3767	3759	3760	3761	3762	3764	3775	3784	6262	6331	6546	6640	6641	6645	7168	7169
PC_2658	Tramadol Action Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2659	Propoxyphene Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2660	Levorphanol Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2661	Anileridine Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2662	Diphenoxylate Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2663	Dezocine Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2664	Levomethadyl Acetate Action Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2665	Methadyl Acetate Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2666	3-Methylthiofentanyl Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2667	Dimethylthiambutene Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2668	Ethylmorphine Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2669	Leucine Stimulation on Insulin Signaling	1978	3643	3667	8660	2475	5294	146850	8140
PC_2670	Levallorphan Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2671	Buprenorphine Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2672	Alvimopan Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2673	Pentazocine Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2674	Naltrexone Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2675	Naloxone Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2676	Dihydromorphine Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2677	Ketobemidone Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2678	Nalbuphine Action Pathway	476	477	478	480	481	482	483	773	9254	782	1137	1141	486	2902	2903	116443	3751	30819	5126	5443	6336	6324	6530	6531	6532
PC_2679	Antipyrine Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2680	Antrafenine Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2681	Carprofen Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2682	Etoricoxib Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2683	Fenoprofen Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2684	Flurbiprofen Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2685	Magnesium Salicylate Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2686	Lumiracoxib Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2687	Lornoxicam Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2688	Phenylbutazone Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2689	Nepafenac Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2690	Trisalicylate-Choline Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2691	Tolmetin Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2692	Tiaprofenic Acid Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2693	Tenoxicam Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2694	Salsalate Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2695	Salicylate-Sodium Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2696	Salicylic Acid Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2697	Acetaminophen Action Pathway	8644	239	242	246	247	240	873	1555	1558	1571	1573	113612	1579	8529	4051	11283	2053	2678	2876	4048	4056	100137049	127281	5730	9536	5740	5742	5743	6916
PC_2698	Thyroid Hormone Synthesis	1535	1536	53905	50506	50508	50507	6528	7038	7173
PC_2699	Apparent Mineralocorticoid Excess Syndrome	1109	6718	1583	1584	1585	1586	1589	3290	3291	3283	3284
PC_2700	3-beta-Hydroxysteroid Dehydrogenase Deficiency	1109	6718	1583	1584	1585	1586	1589	3290	3291	3283	3284
PC_2701	2-Aminoadipic 2-Oxoadipic Aciduria	51166	10157	38	501	55526	1738	1743	1892	2639	3030	51268	83884	6542
PC_2702	27-Hydroxylase Deficiency	8309	1109	6718	23600	570	9023	1593	51302	10858	1581	9420	1582	3295	80270	3988	10106	10998
PC_2703	3-Phosphoglycerate Dehydrogenase Deficiency	189	211	217	275	1491	1738	29958	2593	2617	2628	23464	2731	132158	27232	4128	26227	29968	5723	1757	6301	10993	6470	6472	63826
PC_2704	Cystinosis, Ocular Nonnephropathic	833	1036	1491	1497	2729	2730	2805	3939	4357
PC_2705	Cystinuria	476	477	478	480	481	482	483	1187	486	6337	6338	6339	6340	6557	6559	9990	8170	6505	6582	9356	55089	6519	6520	54716	8140	9057	9056	23428	11136
PC_2706	Folate Malabsorption, Hereditary	10840	1719	2356	10841	8836	123263	4522	25902	10797	4524	10588	113235
PC_2707	Fructose Intolerance, Hereditary	231	226	229	2203	197258	8790	2762	29925	3098	3795	4351	5207	5211	29085	5372	6652	7167	7264
PC_2708	Temocapril Action Pathway	1636	183	5972
PC_2709	Roxatidine Acetate Action Pathway	495	496	759	1193	3274
PC_2710	Metiamide Action Pathway	495	496	759	1193	3274
PC_2711	Betazole Action Pathway	495	496	759	1193	3274
PC_2712	Activation of PKC Through G Protein-Coupled Receptor	2776	3708	23236	5578
PC_2713	The Oncogenic Action of 2-Hydroxyglutarate	48	50	1431	55526	1737	1738	1743	2271	27165	3417	3418	3419	3420	3421	51660	5091	5160	5162	6389	6390	6391	6392	8802	8801
PC_2714	The Oncogenic Action of Succinate	48	50	1431	55526	1737	1738	1743	54583	112398	112399	2271	3417	3418	3419	3420	3421	51660	5091	5160	5162	6389	6390	6391	6392	1468	8802	8801
PC_2715	The Oncogenic Action of Fumarate	48	50	1431	55526	1737	1738	1743	54583	112398	112399	2271	3417	3418	3419	3420	3421	51660	5091	5160	5162	6389	6390	6391	6392	1468	8802	8801
PC_2716	Glutaminolysis and Cancer	47	50	1431	55526	1737	1738	1743	2271	27165	2746	2806	3418	3419	3420	3421	3939	4199	51660	26292	5091	5160	5162	6389	6390	6391	6392	6566	6509	6510	92745	9056	8802	8801
PC_2717	Sarcosine Oncometabolite Pathway	501	635	55349	29958	27232	4144	27430	4548	1757	6470	6472	23446	57153
PC_2718	The Oncogenic Action of L-2-Hydroxyglutarate in Hydroxyglutaric aciduria	48	50	1431	55526	1737	1738	1743	2271	27165	2746	3417	3418	3419	3420	3421	79944	51660	5091	5160	5162	6389	6390	6391	6392	8802	8801
PC_2719	The Oncogenic Action of D-2-Hydroxyglutarate in Hydroxyglutaric aciduria	48	50	1431	728294	55526	1737	1738	1743	2271	27165	2746	3417	3418	3419	3420	3421	79944	51660	5091	5160	5162	6389	6390	6391	6392	8802	8801
PC_2720	Phosphatidylcholine Biosynthesis	10390	1119	5130	5833	10400	23761
PC_2721	De Novo Triacylglycerol Biosynthesis	10554	8694	57678	2819	23175
PC_2722	Cardiolipin Biosynthesis	55326	54675	57678	2819	9489	114971
PC_2723	Phosphatidylethanolamine Biosynthesis	10390	1119	5833	23761	9791
PC_2724	Androstenedione Metabolism	1109	6718	1584	1588	51726	10961	3290	3293	3309	64714	9601	10130	5479	23753	6715	54658
PC_2725	Estrone Metabolism	1312	1543	1577	51726	10961	3292	3309	64714	9601	10130	5479	23753	6783	54658
PC_2726	BCR-ABL Action in CML Pathogenesis	572	598	867	1027	1398	1399	9846	2885	3717	4193	2475	4609	5295	6198	6502	6654	6776	7157
PC_2727	Imatinib Inhibition of BCR-ABL	5243	572	598	867	1027	1398	1399	9846	2885	3717	4193	2475	4609	5295	6198	6502	6580	6654	6776	7157
PC_2728	Dasatinib Inhibition of BCR-ABL	572	598	867	1027	1398	1399	9846	2885	3717	4193	2475	4609	5295	6198	6502	6654	6776	7157
PC_2729	Nilotinib Inhibition of BCR-ABL	572	598	867	1027	1398	1399	9846	2885	3717	4193	2475	4609	5295	6198	6502	6654	6776	7157
PC_2730	Bosutinib Inhibition of BCR-ABL	572	598	867	1027	1398	1399	9846	2885	3717	4193	2475	4609	5295	6198	6502	6654	6776	7157
PC_2731	Bafetinib Inhibition of BCR-ABL	572	598	867	1027	1398	1399	9846	2885	3717	4193	2475	4609	5295	6198	6502	6654	6776	7157
PC_2732	Ponatinib Inhibition of BCR-ABL	572	598	867	1027	1398	1399	9846	2885	3717	4193	2475	4609	5295	6198	6502	6654	6776	7157
PC_2733	Lafutidine H2-Antihistamine Action	495	496	759	1193	3274
PC_2734	Chlorphenamine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2735	Pheniramine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2736	Dexchlorpheniramine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2737	Brompheniramine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2738	Dexbrompheniramine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2739	Triprolidine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2740	Dimetindene H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2741	Mepyramine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2742	Antazoline H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2743	Chloropyramine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2744	Talastine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2745	Tripelennamine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2746	Histapyrrodine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2747	Methapyrilene H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2748	Thonzylamine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2749	Diphenhydramine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2750	Carbinoxamine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2751	Doxylamine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2752	Orphenadrine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2753	Bromodiphenhydramine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2754	Clemastine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2755	Chlorphenoxamine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2756	Diphenylpyraline H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2757	Phenyltoloxamine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2758	Cyclizine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2759	Chlorcyclizine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2760	Hydroxyzine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2761	Meclizine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2762	Buclizine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2763	Oxatomide H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2764	Cetirizine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2765	Cinnarizine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2766	Levocetirizine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2767	Promethazine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2768	Alimemazine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2769	Cyproheptadine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2770	Phenbenzamine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2771	Fenethazine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2772	Hydroxyethylpromethazine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2773	Isothipendyl H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2774	Mequitazine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2775	Methdilazine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2776	Oxomemazine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2777	Azatadine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2778	Ketotifen H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2779	Doxepin H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2780	Acrivastine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2781	Astemizole H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2782	Bepotastine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2783	Bilastine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2784	Loratadine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2785	Desloratadine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2786	Ebastine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2787	Terfenadine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2788	Fexofenadine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2789	Levocabastine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2790	Mizolastine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2791	Rupatadine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2792	Olopatadine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2793	Azelastine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2794	Thiazinamium H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2795	Quifenadine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2796	Betahistine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2797	Emedastine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2798	Flunarizine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2799	Mebhydrolin H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2800	Phenindamine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2801	Epinastine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2802	Tolpropamine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2803	Embramine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2804	Latrepirdine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2805	Thenyldiamine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2806	Propiomazine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2807	Clocinizine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2808	Homochlorcyclizine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2809	Temelastine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2810	Alcaftadine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2811	Bamipine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2812	Deptropine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2813	Quetiapine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2814	Mirtazapine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2815	Pimethixene H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2816	Pyrrobutamine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2817	Thenalidine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2818	Tritoqualine H1-Antihistamine Action	2776	2782	54331	3269	3708	4790	23236	5579
PC_2819	Histamine H1 Receptor Activation	2776	2782	54331	3269	3708	4790	23236	5579
PC_2820	Lysophosphatidic Acid LPA1 Signalling	107	207	2782	54331	3708	1902	23236	6093	6722
PC_2821	Lysophosphatidic Acid LPA2 Signalling	107	207	2782	54331	3708	9170	23236	6093	6722
PC_2822	Lysophosphatidic Acid LPA3 Signalling	107	207	2778	2782	54331	3708	23566	23236
PC_2823	Lysophosphatidic Acid LPA4 Signalling	107	207	2778	2782	54331	3708	2846	23236	6093	6722
PC_2824	Lysophosphatidic Acid LPA5 Signalling	107	207	2778	2782	54331	3708	57121	23236	6093	6722
PC_2825	Lysophosphatidic Acid LPA6 Signalling	107	207	2778	2782	54331	10161	6093	6722
PC_2826	Activation of cAMP-dependent protein kinase, PKA	55811	2778	2782	2792	5578	5567	5568	5573	5575	5576	5577
PC_2827	Ahr Signal Transduction Pathway	196	405	3320
PC_2828	Apoptotic DNA Fragmentation and Tissue Homeostasis	1677	836	840	1676	2021	3002	3146	3148	7153
PC_2829	BTG Family Proteins and Cell Cycle Regulation	694	7832	595	10036	2246	3219	4803	3276	5925	7157
PC_2830	Nitric Oxide Signaling Pathway	217	801	1742	2902	2903	116443	3708	4842	5530	5567	5578	7498
PC_2831	Ion Channels and Their Functional Role in Vascular Endothelium	55811	2982	2977	2983	3785	3786	9132	56479	4846	5592	5593	7222	7223	7226	59341
PC_2832	P53 Signaling Pathway	317	581	596	891	595	898	983	1017	1019	1026	1869	4616	5111	5925
PC_2833	Phospholipase C Signaling Pathway	207	5294	146850	23236	5335	5578	7409
PC_2834	Ras Signaling Pathway	207	317	572	598	842	998	1147	54205	2002	4303	3265	5604	5595	5290	5337	5879	5894	5898	10928	5900	387	4088	4089	10451
PC_2835	TNF/Stress Related Signaling	466	835	1147	8738	3551	8517	3725	5606	6416	5608	5609	4214	5871	1432	5599	4790	4792	8737	10010	7124	8717	7186
PC_2836	Rac 1 Cell Motility Signaling Pathway	60	23647	10487	595	896	1020	1026	1072	3984	4214	4633	4638	5058	5111	5156	5337	4660	5879	10928	6198	10451	8936
PC_2837	Cadmium Induces DNA Synthesis and Proliferation in Macrophages	775	776	778	779	3265	3708	5604	5594	5595	4790	4792	23236	5578	5579	5894	5970
PC_2838	Growth Hormone Signaling Pathway	2688	2690	2885	3265	3630	3643	3667	3717	5604	5594	5595	5335	5578	5777	5894	6195	6464	6517	8651	6654	6776	6777
PC_2839	EGF Signalling Pathway	1457	1950	1956	2002	2353	2885	3265	3716	3725	5604	6416	4214	5595	5599	5335	5578	5579	5894	5921	6464	6654	6722	6772	6773	6774	6778
PC_2840	GnRH Signaling Pathway	81	107	468	775	776	778	779	9254	782	163688	815	998	1081	1956	1958	2002	2488	2767	2778	2796	2798	2885	1839	3265	3708	3725	3972	5604	5606	5609	4214	10746	5594	1432	5599	4323	4313	100137049	23236	5337	5578	5578	5579	5894	6654	6714
PC_2841	NF-kB Signaling Pathway	84254	10645	1147	8772	3551	8517	3552	3554	3654	4214	9020	6885	4615	8202	4790	4792	5970	8737	10454	7099	7124	7132	7133	8717	7189	7316
PC_2842	Complement Pathway	712	713	714	715	716	717	718	720	100293534	100293534	727	729	730	731	735	629	1675	5648	10747	4153	710
PC_2843	Alternative Complement Pathway	718	727	729	730	731	735	629	1675	5199
PC_2844	Ubiquitin–Proteasome Pathway	5682	5683	5684	5685	5686	5687	5688	5689	5690	5691	5692	5693	5694	5695	5700	5701	5702	5704	5705	5706	5719	5710	10273	7317	7314	7316	10537	7324
PC_2845	Lectin-Induced Complement Pathway	717	718	720	100293534	100293534	727	729	730	731	735	5648	10747	4153
PC_2846	Toll-Like Receptor Pathway 1	929	1147	51295	5610	2002	2353	3551	8517	3654	3725	23643	5606	6416	5608	4214	6885	1432	5599	4615	4790	4792	5465	5970	10454	23118	114609	7097	7098	7099	51284	54106	54472	7189
PC_2847	Classical Complement Pathway	712	713	714	715	716	717	718	720	100293534	100293534	727	729	730	731	735
PC_2848	CXCR4 Signaling Pathway	9564	1398	6387	7852	2770	2776	2782	2792	3265	5604	5594	5595	4790	4792	5288	5335	5747	2185	5829	5894
PC_2849	D4-GDI Signaling Pathway	317	9743	394	397	834	843	836	841	842	54205	3002	3725	142	5551
PC_2850	T Cell Receptor Signaling Pathway	801	801	801	919	915	916	917	2002	2353	2534	2885	3265	3725	27040	3932	5604	6416	4214	5595	5599	4772	4773	4775	4776	4790	4792	5290	5294	5295	5335	5530	5532	5533	5578	5579	5778	5879	5894	10125	5970	6464	6654	7316	7409	7535
PC_2851	Stat3 Signaling Pathway	3716	5594	2475	6774	7297
PC_2852	Toll-Like Receptor Pathway 2	929	1147	51295	3551	8517	3654	23643	6416	4214	6885	1432	5599	4615	4790	4792	5970	10454	23118	257397	114609	7096	7097	7098	7099	7100	10333	51284	51311	54106	54472	7189
PC_2853	EPO Signaling Pathway	2002	2056	2057	2353	2885	3265	3717	3725	5604	5595	5599	5335	5777	5894	6464	6654	6776
PC_2854	FAS signaling pathway ( CD95 )	397	843	836	839	840	841	8837	1616	1676	1677	8772	11124	355	356	3725	4000	4001	84823	6416	4214	6885	5599	5058	5062	142	5591	5783	5925	8767	6709
PC_2855	BCR Signaling Pathway	29760	695	801	801	801	973	974	2002	2353	2885	3265	3725	4067	5604	4214	5595	5599	4772	4773	4775	4776	84876	5335	5530	5532	5533	5578	5579	5879	5894	6464	6654	6850	7409
PC_2856	Cardiolipin Biosynthesis (Barth Syndrome)	55326	54675	57678	2819	9489	114971
PC_2857	Succinate Signalling	3091	3553	114548	283208	23410	7099
PC_2858	NAD+ Signalling Pathway (Cancer)	84883	952	65220	10135	64802	23057	349565	1728	23411	7157
PC_2859	NAD+ Signalling and Aging	9575	65220	10135	64802	23057	349565	4881	1728	10891	6095	23411
PC_2860	Succinate Signalling During Inflammation	1147	1385	3551	8517	5594	5600	5595	4790	4846	23236	5578	5742	56670
PC_2861	Bile Acid Direct Signalling Pathway (1)	10257	151306	9971	6555	6579
PC_2862	Bile Acid Indirect Signalling Pathway	9965	2260	2263	2261	2264	152831	9971	6555
PC_2863	Bile Acid Direct Signalling Pathway (2)	2740	151306	6555
PC_2864	CD40L Signalling Pathway	958	959	1147	1843	8518	3551	8517	4214	1432	4790	4792	7128	7187	7189
PC_2865	G-Protein Signaling Through Tubby Proteins	1128	2776	2782	2792	3358	23236	7275
PC_2866	g-Secretase Mediated ErbB4 Signalling Pathway	6868	2065	2066	9542	5578	5663
PC_2867	Ion Channel and Phorbal Esters Signaling Pathway	5029	5335	5578	5579	2185
PC_2868	Circadian Rhythms	9575	1407	102800317	4881	5187
PC_2869	Hop Pathway in Cardiac Development	2626	84525	1482	6722
PC_2870	LPS and Citrate Signaling and Inflammation	31	47	929	1147	1431	3551	8517	23643	4190	4199	4615	4790	4792	5970	6389	6390	6391	6392	6576	114609	7099	7189
PC_2871	Protein Synthesis	16	2197	10399	6134	4736	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	9349	6147	6152	6154	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6167	6168	6169	6170	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6234	6235	6188	6189	6191	6193	6194	6201	6202	6203	3921	7311
PC_2872	Protein Synthesis	2197	10399	5917	6134	4736	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	9349	6147	6152	6154	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6167	6168	6169	6170	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6234	6235	6188	6189	6191	6193	6194	6201	6202	6203	3921	7311
PC_2873	Protein Synthesis	2197	4677	10399	6134	4736	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	9349	6147	6152	6154	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6167	6168	6169	6170	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6234	6235	6188	6189	6191	6193	6194	6201	6202	6203	3921	7311
PC_2874	Protein Synthesis	1615	2197	10399	6134	4736	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	9349	6147	6152	6154	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6167	6168	6169	6170	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6234	6235	6188	6189	6191	6193	6194	6201	6202	6203	3921	7311
PC_2875	Protein Synthesis	833	2197	10399	6134	4736	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	9349	6147	6152	6154	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6167	6168	6169	6170	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6234	6235	6188	6189	6191	6193	6194	6201	6202	6203	3921	7311
PC_2876	Protein Synthesis	2197	2058	10399	6134	4736	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	9349	6147	6152	6154	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6167	6168	6169	6170	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6234	6235	6188	6189	6191	6193	6194	6201	6202	6203	3921	7311
PC_2877	Protein Synthesis	2058	2197	10399	6134	4736	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	9349	6147	6152	6154	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6167	6168	6169	6170	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6234	6235	6188	6189	6191	6193	6194	6201	6202	6203	3921	7311
PC_2878	Protein Synthesis	2197	2617	10399	6134	4736	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	9349	6147	6152	6154	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6167	6168	6169	6170	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6234	6235	6188	6189	6191	6193	6194	6201	6202	6203	3921	7311
PC_2879	Protein Synthesis	2197	3035	10399	6134	4736	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	9349	6147	6152	6154	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6167	6168	6169	6170	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6234	6235	6188	6189	6191	6193	6194	6201	6202	6203	3921	7311
PC_2880	Protein Synthesis	2197	3376	10399	6134	4736	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	9349	6147	6152	6154	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6167	6168	6169	6170	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6234	6235	6188	6189	6191	6193	6194	6201	6202	6203	3921	7311
PC_2881	Protein Synthesis	2197	51520	10399	6134	4736	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	9349	6147	6152	6154	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6167	6168	6169	6170	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6234	6235	6188	6189	6191	6193	6194	6201	6202	6203	3921	7311
PC_2882	Protein Synthesis	2197	3735	10399	6134	4736	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	9349	6147	6152	6154	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6167	6168	6169	6170	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6234	6235	6188	6189	6191	6193	6194	6201	6202	6203	3921	7311
PC_2883	Protein Synthesis	2197	4141	10399	6134	4736	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	9349	6147	6152	6154	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6167	6168	6169	6170	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6234	6235	6188	6189	6191	6193	6194	6201	6202	6203	3921	7311
PC_2884	Protein Synthesis	2193	10056	2197	10399	6134	4736	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	9349	6147	6152	6154	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6167	6168	6169	6170	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6234	6235	6188	6189	6191	6193	6194	6201	6202	6203	3921	7311
PC_2885	Protein Synthesis	2058	2197	10399	6134	4736	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	9349	6147	6152	6154	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6167	6168	6169	6170	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6234	6235	6188	6189	6191	6193	6194	6201	6202	6203	3921	7311
PC_2886	Protein Synthesis	2197	10399	6134	4736	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	9349	6147	6152	6154	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6167	6168	6169	6170	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6234	6235	6188	6189	6191	6193	6194	6201	6202	6203	3921	6301	7311
PC_2887	Protein Synthesis	2197	10399	6134	4736	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	9349	6147	6152	6154	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6167	6168	6169	6170	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6234	6235	6188	6189	6191	6193	6194	6201	6202	6203	3921	6897	7311
PC_2888	Protein Synthesis	2197	10399	6134	4736	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	9349	6147	6152	6154	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6167	6168	6169	6170	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6234	6235	6188	6189	6191	6193	6194	6201	6202	6203	3921	7311	7453
PC_2889	Protein Synthesis	2197	10399	6134	4736	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	9349	6147	6152	6154	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6167	6168	6169	6170	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6234	6235	6188	6189	6191	6193	6194	6201	6202	6203	3921	7311	8565
PC_2890	Protein Synthesis	2197	10399	6134	4736	6135	6136	6137	23521	9045	6138	6139	6141	6142	6143	6144	6146	9349	6147	6152	6154	6155	6157	6158	6159	6122	6156	6160	6161	6164	11224	6165	25873	6173	6167	6168	6169	6170	6124	6171	6125	6128	6129	6130	6132	6133	6133	6133	6133	6175	6176	6181	6204	6205	6206	6207	6208	6209	6210	6217	6218	6222	6223	6187	6224	6227	6228	6229	6230	6231	6232	6234	6235	6188	6189	6191	6193	6194	6201	6202	6203	3921	7311	7407
PC_2891	Kidney Function- Proximal Convoluted Tubule	358	759	6505	6582	9356	55089	6519	6520	8671	54716	8140	9057	9056	23428	11136	6548
PC_2892	Kidney Function - Descending Limb of the Loop of Henle	358
PC_2893	Kidney Function - Ascending Limb of The Loop of Henle	476	477	478	480	481	482	483	1187	486	5972	6557	9990
PC_2894	Kidney Function - Collecting Duct	359	360	476	477	478	480	481	482	483	525	759	486	5972	6337	6338	6339	6340	8170	6521
PC_2895	Kidney Function - Distal Convoluted Tubule	359	360	476	477	478	480	481	482	483	495	496	1187	486	5972	6559	6546	56302
PC_2896	Pancreas Function - Beta Cell	6833	55811	773	9254	782	84254	1131	2740	2776	2782	54331	3710	23236	5578	5864	11069	9699	6514	6844
PC_2897	Pancreas Function - Alpha Cell	6833	773	9254	782	2641	6331	6514	6640	6641	6645
PC_2898	Mevalonate Pathway	38	2222	2224	3156	3157	3422	4047	4597	4598	10654	6713
PC_2899	Bloch Pathway (Cholesterol Biosynthesis)	1595	1718	1717	10682	51478	3930	6307	50814	6309
PC_2900	Kandutsch-Russell Pathway (Cholesterol Biosynthesis)	1595	1718	1717	10682	51478	3930	6307	50814	6309
PC_2901	Arsenate Detoxification	364	364	57412	9446	4860	6513	6517
PC_2902	Eumelanin Biosynthesis	1638	7299
PC_2903	Aldosterone from Steroidogenesis	185	1583	1585	1589	2776	2782	54331	3283
PC_2904	Pancreas Function - Delta Cell	6833	773	9254	782	6514	6750
PC_2905	2-Amino-3-Carboxymuconate Semialdehyde Degradation	130013	64577	55526	1738	1743
PC_2906	Arginine and Proline metabolism ( Arginine and Proline metabolism )	216	219	217	224	8659	501	223	262	26	314	8639	383	384	445	2058	2593	4128	4129	4842	4843	4846	4953	5009	5033	8974	5917	6303	6611	6723
PC_2907	Reelin signaling pathway	207	9181	867	1020	8851	1399	1600	2534	2903	2904	2932	3675	3688	7804	4043	4131	5609	4296	5599	4137	8440	5048	5290	5295	5906	2889	5649	7436
PC_2908	Wnt secretory pathway (Canonical) ( Canonical Wnt signaling pathway Diagram )	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484
PC_2909	TGF-beta_super_family_signaling_pathway(canonical) ( TGF-beta_super_family_signaling_pathway(canonical) )	90	91	92	93	94	269	27302	9210	650	651	652	653	654	655	656	657	658	659	1387	2033	2662	10220	2658	9573	8200	392255	151449	2661	3623	3624	3625	3626	83729	9794	84441	55534	2660	4838	4086	4087	4088	4089	4090	4093	6597	7040	7042	7043	7046	7048	7490
PC_2910	ERK cascade ( CD4 T cell receptor signaling )	369	673	5604	5605	5594	5595	5894
PC_2911	Drosophila Notch signaling pathway ( Notch signaling pathway Diagram )	1387	2033	5663	5664
PC_2912	Ras signaling in the CD4+ TCR pathway	673	2002	2353	3265	3845	5604	1326	5594	5595	4893	5578	5579	5778	5894
PC_2913	Signaling events mediated by PTP1B	25	207	9564	640	823	857	1000	1398	1435	1436	1445	1447	420	1950	1956	2212	2241	2268	2534	2885	3055	3630	3643	3667	3674	3690	3717	27040	3932	3952	54741	4067	50507	5155	5159	5290	5295	5617	5618	5770	387	6464	9021	10253	6714	6774	6776	6777	55503	7295	7297	4904	7525
PC_2914	cysteine biosynthesis/homocysteine degradation	102724560	1491
PC_2915	Gene expression of IL2 by AP-1 ( CD4 T cell receptor signaling )	2353	2354	8061	2355	3725
PC_2916	IKK-NF-kappaB cascade ( CD4 T cell receptor signaling )	1147	3551	8517	4790	4792	4793	4794	5970
PC_2917	NADH + (S)-1-Pyrroline-5-carboxylic acid = NAD+ + L-Proline ( Arginine and Proline metabolism )	5831	65263
PC_2918	D-Ribose 5-phosphate = D-Ribulose 5-phosphate ( Pentose phosphate cycle )	22934
PC_2919	ketogenesis	30	38	622	3032	3155	3158
PC_2920	acyl carrier protein metabolism	60496
PC_2921	ID	467	1017	2002	2004	2005	2114	2274	8209	3397	3398	3399	3400	3428	5604	5605	5594	5595	4617	4618	4654	4656	116448	10215	5076	5079	7849	5710	5894	5925	5933	5934	4088	64750	6720	6938	6929	6925	6934
PC_2922	DNA-PK pathway in nonhomologous end joining	200558	54840	64421	1791	3981	79840	11284	27343	27434	5591	7518	7520	2547
PC_2923	NAD+ + (S)-Lactic acid = NADH + Pyruvic acid ( Pyruvate metabolism )	3939	92483	3945	3948
PC_2924	Beta catenin degradation signaling (Canonical) ( Canonical Wnt signaling pathway Diagram )	324	8312	8313	8945	1499	8454	2932	6500
PC_2925	Toll-like receptor signaling pathway (through ECSIT, MEKK1, MKKs, JNK cascade) ( Toll-like receptor signaling pathway (through ECSIT, MEKK1, MKKs, JNK cascade) )	929	51295	3552	3553	3554	3556	3654	51135	3929	23643	4214	4615	7099	54472	7189
PC_2926	G alpha s GDP-GTP exchange signaling ( GPCR signaling (G alpha q) )	134	135	136	185	186	3577	3579	1812	1813	1814	1815	1816	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	2776	2784	10681	2793	2911	2912	2913	2914	2915	2916	2917	2918	6608
PC_2927	JNK cascade ( PDGF signaling pathway )	3725	6416	4214	5599
PC_2928	purine ribonucleosides degradation to ribose-1-phosphate	100	113179	4860
PC_2929	4-hydroxyproline degradation I	8659
PC_2930	Cytosolic calcium ion concentration elevation (through IP3 receptor) ( VEGF signaling pathway )	3708	3710
PC_2931	2-Oxo-glutaric acid + L-erythro-4-Hydroxy-glutamic acid = L-Glutamic acid + D-4-Hydroxy-2-oxo-glutaric acid ( Arginine and Proline metabolism )	2805	2806
PC_2932	catecholamine biosynthesis	1621	1644	5409
PC_2933	Validated nuclear estrogen receptor alpha network	21	8125	162	322	522	8313	672	718	57658	595	3732	1051	1147	80781	1509	10521	79039	1826	9166	2033	2099	2100	9687	3065	9759	3298	3725	3823	84458	8543	8930	4350	9112	4609	8648	10499	8202	135112	9611	9612	4731	4738	190	8431	8204	5111	64714	5241	11331	5457	5458	63977	5617	6294	6418	9814	4089	6647	58506	6776	7031	286827	9039	9040	7494
PC_2934	Alpha4 beta1 integrin signaling events	10006	10863	382	9564	929	975	998	1398	1793	2335	28964	93185	3676	3688	58494	120425	4192	4620	5578	5567	5573	5575	5747	2185	5786	5829	5879	6696	6714	7057	7058	7094	7412	7534
PC_2935	Signaling events mediated by TCPTP	390502	1387	1435	1436	1950	1956	1965	5610	2549	2885	3082	3630	3643	3672	3688	3716	3718	3791	3838	3837	3998	4233	5155	5159	8554	5290	5291	5295	5770	5771	5867	6464	6654	6714	6772	6774	6776	6777	6778	7422
PC_2936	FOXA1 transcription factor network	162	338	367	522	672	725	595	1027	1051	80781	1387	1562	1826	2033	2099	2353	3169	3170	3171	2641	3630	3725	3818	8202	4731	4774	4781	4782	4824	7026	8204	23761	5451	63977	7356	5265	653509	729238	6441	6469	6647	6667	7031	7448	7494
PC_2937	Deoxy-uridine + Orthophosphate = 2-Deoxy-D-ribose 1-phosphate + Uracil ( Pyrimidine Nucleotides and Nucleosides metabolism )	1890
PC_2938	N-cadherin signaling events	8312	801	801	801	818	998	1000	1268	1495	1499	1500	2017	747	221955	1639	2241	2260	2596	2697	2891	2934	3728	3799	4041	5599	22919	4633	5290	5295	23396	5335	5770	5781	5879	387	6093
PC_2939	arginine biosynthesis IV	435	445	2746	2747	4942	5009
PC_2940	Notch secretory pathway (Drosophila) ( Notch signaling pathway Diagram )	5045
PC_2941	EGFR-dependent Endothelin signaling events	1906	1909	1950	1956	2885	3265	2475	6464	6654
PC_2942	glycogen degradation II	178	5236	55276	5239	5834	5836	5837
PC_2943	Negative regulation of (G alpha i GDP-GTP exchange signaling) ( GPCR signaling (G alpha i) )	2770	2771	5996	6001	8786	6002	6003	10636	6004	26575	64407	10287	5997	8601	5998	5999	8490	9628	6000	85397	8787
PC_2944	ATP + IDP = ADP + ITP ( Purine nucleotides and Nucleosides metabolism )	4830	4831	4832	4833	8382	10201	29922
PC_2945	ATP + UDP = ADP + UTP ( Pyrimidine Nucleotides and Nucleosides metabolism )	4830	4831	4832	4833	8382	10201	29922
PC_2946	formaldehyde oxidation II (glutathione-dependent)	128	2098
PC_2947	dermatan sulfate degradation (metazoa)	3073	3373	3425	6677
PC_2948	ethanol degradation II	84532	55902	79611	125	217	224
PC_2949	EGFR1	10006	25	27	52	59	60	87	81	10097	10096	6868	8754	84632	10768	79026	207	213	226	23294	84168	301	302	307	160	163	1175	334	351	26060	334	369	116985	378	9743	2909	143872	394	50649	7984	8874	50807	55616	466	476	509	6311	558	572	10458	55971	9564	8412	596	673	91894	10241	800	801	801	801	815	57513	842	857	858	284119	8436	867	868	23624	54862	152137	966	998	999	1000	1001	983	1017	1020	1018	55573	634	1050	1051	1072	1211	1213	1308	1385	51232	1398	1399	1445	1476	1487	8727	1500	2017	1540	375791	1601	27071	131566	1654	1656	4356	1759	1793	9732	420	9046	1829	1832	1843	8655	1859	9149	8444	8798	1915	1917	1948	1950	1956	1978	1981	1999	2002	2005	63916	2023	2029	2041	1969	2043	2047	2048	2049	2050	29924	22905	55040	83481	2060	58513	2059	2064	2065	55914	54206	23344	2317	10211	2319	2353	2308	4303	2444	10818	10817	2534	2549	9846	64762	28964	9815	2697	9052	2887	2888	2885	2886	156	2931	2932	2934	8520	3065	9146	3092	28996	10114	8290	3178	9987	10236	3265	3308	3336	6532	10075	54756	3636	3643	8826	8660	83737	3675	3688	3691	142683	50618	3716	3717	3725	3727	3728	10657	56243	55243	3815	8462	3845	3872	3875	3852	3853	3855	3856	8844	9741	3932	3939	3949	8994	4026	51599	4067	154043	5604	5605	5606	5607	5609	4214	9020	10746	4215	4216	11184	11183	5594	1432	5595	5598	5599	5601	153562	4168	4233	50488	23164	9019	4513	9219	2475	9961	4609	4627	103910	4646	4690	8440	8202	51079	5818	4734	4739	4790	4846	51633	5058	56288	10015	5159	9124	8572	5170	51248	5037	5216	5223	90102	23239	29085	10401	5287	5290	5291	5293	5294	5295	5296	8503	5306	5315	5586	5318	11187	8502	51196	5335	5336	5337	5338	5339	54477	22874	84069	5359	4659	26472	5523	5562	5563	5573	5578	5579	5580	5582	5584	5590	5587	5613	8899	5728	5747	2185	5753	5770	5781	5782	26469	25930	84867	5777	5786	5791	5792	5796	5801	754	5829	5834	5868	5879	29127	5894	5898	5899	10928	5900	5906	5921	5931	10616	5935	5970	85021	9185	8625	6004	387	253260	9610	8737	6156	6175	6204	6187	51065	6195	6196	6197	9252	6198	6281	6282	57402	10067	6382	9672	6385	6386	6317	6421	25970	9047	10044	6451	6456	6457	30011	6461	6464	6477	6478	140885	10723	293	54407	6528	84189	4087	4088	55234	6622	6633	257364	27131	8651	9021	6654	6655	6667	23111	10252	10253	10251	81848	6714	6717	8027	10254	10617	6772	6773	6774	6776	6777	10963	6794	6810	6812	8407	10342	7037	7050	9414	7086	7094	10318	10188	7145	23371	64759	84951	54472	10043	10040	146691	7157	23650	7205	7297	84959	7314	57478	9712	7408	7409	7410	10451	7414	7431	8976	23558	65125	7529	7534	25921	9765	8882
PC_2950	BCR signaling pathway	207	8915	597	604	613	29760	695	801	801	801	818	84433	930	933	971	973	974	1147	1445	1457	27071	420	2002	2113	2213	2353	2885	3265	25998	3551	8517	3635	3725	4067	10892	5604	4214	6885	11184	5594	1432	5595	5599	4772	4790	4792	4793	55824	5170	5290	5295	5336	5452	5530	5532	5533	112476	5728	5777	5788	5879	5894	5921	5970	9467	6464	6654	6850	7189	7410
PC_2951	CD28 signaling ( CD4 T cell receptor signaling )	207	208	10000	940	941	942	2534	3932	5170	5290	5291	5293	5295	5296
PC_2952	5-Formimino-tetrahydro-folic acid = 5,10-Methenyl-tetrahydro-folic acid + NH3 ( Folate metabolism )	10841
PC_2953	L-Arginine + Glycine = L-Ornithine + Guanidino-acetic acid ( Glycine and Serine metabolism )	2628
PC_2954	L-glutamine biosynthesis II (tRNA-dependent)	5188	55278
PC_2955	pentose phosphate pathway (non-oxidative branch)	6120	22934	6888	7086	8277	84076
PC_2956	Signaling events mediated by HDAC Class II	57763	604	54880	815	814	2099	2623	2624	2782	54331	156	83933	79885	8841	9759	10014	10013	51564	9734	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	8338	8349	126961	126961	126961	121504	121504	121504	3320	4208	9612	2908	9972	23225	8021	23636	5901	5903	5905	8625	6722	7341	10376	7280	7329	7514	7529	7531
PC_2957	PKA activation signaling ( GPCR signaling (G alpha s, PKA and ERK) )	107	55811	108	109	196883	111	112	113	114	115	2778	5578	5567	5568	5573	5575	5576	5577
PC_2958	Negative regulation of (Phosphorylation of cytokine receptor) in JAK STAT pathway ( JAK-STAT pathway and regulation pathway Diagram )	1271	1438	1439	1441	3577	3579	2057	2690	3454	3455	3459	3460	3587	3588	3594	3595	3597	3598	3601	23765	8809	3554	7850	3556	3559	3560	3561	3563	3566	3568	3570	3572	3575	3581	54741	3977	4352	9180	5618	5777
PC_2959	Angiopoietin receptor Tie2-mediated signaling	185	207	284	285	51378	660	1026	1398	9046	1997	1998	2002	2113	2147	2242	2247	2335	2308	2534	2888	2885	2886	3678	3688	5594	1432	5595	5599	4313	4690	4790	4846	5058	5290	5295	5338	5340	5747	5781	5829	5879	5921	5970	6198	6464	6776	6777	7010	7124	79155
PC_2960	5'-Phospho-ribosyl-4-(N-succino-carboxamide)-5-amino-imidazole = 5'-Phospho-ribosyl-4-carboxamido-5-amino-imidazole + Fumaric acid ( Purine nucleotides and Nucleosides metabolism )	158
PC_2961	Caspase9 activation signaling ( TNFR1 signaling pathway )	317	842	54205
PC_2962	EPO signaling pathway(JAK2 STAT1 STAT3 STAT5) ( EPO signaling pathway(JAK2 STAT1 STAT3 STAT5) )	2056	2057	3717	5290	5291	5293	5295	5296	6772	6774	6776	6777
PC_2963	ERK cascade ( EGF signaling pathway Diagram )	2002	5604	5605	5594	5595	5894
PC_2964	phosphatidylethanolamine biosynthesis III	81490
PC_2965	Negative regulation of (nuclear import of R-smad	5594	5602	5600	6300	5603	1432	5595	5598	5599	5601	4086
PC_2966	IL8- and CXCR1-mediated signaling events	207	408	409	867	3576	3577	1759	2268	9630	2769	2771	2782	54331	156	3055	4067	92170	5170	5294	146850	23236	5330	5331	5337	5578	5579	5581	5582	5868
PC_2967	AKT(PKB) activation signaling ( Insulin receptor signaling (Mammal) )	207	208	10000	79109	64223	2475	5170	5290	5291	5293	253260	7248	7249
PC_2968	serotonin and melatonin biosynthesis	15	438	1644	7166	121278
PC_2969	D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis	253430	3705
PC_2970	Citric acid = cis-Aconitic acid + H2O ( Citrate cycle )	48	50
PC_2971	Signaling without Wnt (Drosophila) ( Drosophila Wingless/Wnt signaling pathway Diagram )	7088	7089	7090	7091
PC_2972	T cell receptor signaling pathway ( CD4 T cell receptor signaling )	919	915	916	917	920	2885	3113	3115	3117	3118	3119	3120	3122	3123	3125	3126	27040	3932	4790	5335	5336	5588	5879	5880	5881	5970	7409	7535
PC_2973	Citrate cycle ( Citrate cycle )	1431
PC_2974	3-Hydroxy-propanoyl-CoA = Propenoyl-CoA + H2O ( Propanoate metabolism )	1892	1962	3030
PC_2975	myo-inositol biosynthesis	3612	3613	54928	51477
PC_2976	2-Oxo-glutaric acid + L-O-Phospho-serine = L-Glutamic acid + 3-Phospho-hydroxy-pyruvic acid ( Glycine and Serine metabolism )	29968
PC_2977	S-adenosyl-L-methionine biosynthesis	4143	4144	27430
PC_2978	Canonical Wnt signaling pathway ( Mammalian Wnt signaling pathway Diagram )	375790	25776	960	1499	56998	22943	27123	27122	27121	2487	2817	2239	3339	83999	79412	51176	4041	4040	6885	51701	6382	6383	9672	6385	2810	6423	6424	6932	83439	6934	11197	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484	7529	7531	7532	7533	10971	7534
PC_2979	trehalose degradation II (trehalase)	130589	2645	80201	11181
PC_2980	Signaling events mediated by the Hedgehog family	207	409	91653	50937	50846	84976	2619	2736	2737	156	55733	64399	3549	4036	4043	5290	5295	5727	8643	5744	6469	6608	6491	7042
PC_2981	HGF signaling pathway ( HGF signaling pathway )	1398	1399	1793	2549	2885	3082	3265	3845	4233	4893	5290	5291	5293	5295	5335	5336	5781	5879	5880	5881	5894	5906	5908	2889	6464	25759	53358	6654	6655	6714
PC_2982	Regulation of nuclear SMAD2/3 signaling	207	367	1386	467	865	1017	1019	1026	1030	1051	4435	1278	1385	1387	1487	55802	1745	1874	1875	2033	2099	2353	2290	8928	2308	2309	4303	2625	145258	3065	3066	3172	3312	3456	3586	3567	3665	3693	3725	2648	8850	3915	4149	51586	4208	4609	4654	8648	10499	9611	1482	2908	10401	51588	5928	5931	5933	861	860	864	10284	8819	5054	25942	23309	6497	6498	4087	4088	4089	4092	79753	6667	6670	6929	7027	7030	7050	60436	7421	7709
PC_2983	Beta catenin degradation signaling (Canonical) ( Xenopus axis formation Wnt signaling pathway Diagram )	324	8312	8313	8945	1499	8454	2932	6500
PC_2984	Aurora A signaling	84962	207	8874	6790	54998	9212	332	672	994	1058	9793	64506	9787	51343	1647	28964	2932	3836	3837	4193	81565	4792	4946	5058	5528	5578	5901	5921	6867	10460	23424	7157	22974
PC_2985	Nectin adhesion pathway	4301	998	999	9076	1398	1495	1499	50848	9855	8826	3685	3690	5818	5819	25945	5155	5159	5290	5295	23396	5747	5797	5817	5879	5906	5908	2889	6714	7094	7410
PC_2986	pyrimidine ribonucleotides de novo biosynthesis	1677	124583	51727	129607	1503	56474	4830	4831	4832	4833	8382	10201	29922	7372
PC_2987	thiamin salvage III	27010
PC_2988	Heterotrimeric GTP-binding protein coupled receptor signaling pathway (through G alpha i, adenylate cyclase and cAMP) ( GPCR signaling (G alpha i) )	134	135	136	183	185	186	374	551	627	27302	9210	650	651	652	653	654	655	656	685	796	797	885	959	941	942	1081	1392	1437	1440	3576	3577	3579	1622	50846	28514	10683	54567	1812	1813	1814	1815	1816	1906	1907	1908	1950	2056	2069	356	2246	2255	2256	2258	2259	8823	8822	8817	9965	2247	26281	26291	27006	8074	2248	2249	2250	2251	2252	2253	2254	2488	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	51083	2520	2641	2662	10220	2658	9573	8200	392255	151449	2661	2668	2688	2691	2695	2770	2771	2784	10681	2793	2796	2911	2912	2913	2914	2915	2916	2917	2918	2922	1839	3082	3439	3446	3439	3448	3449	3451	3440	3452	3441	3442	3443	3444	3445	3456	3458	3467	3479	3481	3549	3586	3589	3592	3593	3596	3600	3603	3605	3606	3552	3553	3562	3565	3567	3569	3574	3578	3623	3624	3625	3626	83729	3630	182	3714	4254	3827	3952	3972	3976	4049	100507027	2660	4693	4803	4838	4878	4852	3084	9542	10718	145957	4908	4909	5020	5154	5155	5443	5539	5617	51052	5697	6343	6469	6608	6750	6863	6866	7039	7040	7042	7043	7066	7124	8743	7200	7252	200081	7422	7423	7424	2277	7432	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484
PC_2989	NAD+ + Isocitric acid = NADH + 2-Oxo-glutaric acid + CO2 ( Citrate cycle )	3419	3420	3421
PC_2990	flavin biosynthesis IV (mammalian)	80308	55312
PC_2991	glycolysis I	226	229	669	2023	2026	2027	2203	8789	2597	26330	2821	5211	5213	5214	5223	5224	5230	5232	5313	5315	7167	1462
PC_2992	ERK cascade ( Insulin receptor signaling (Mammal) )	369	673	2002	5604	5605	5594	5595	5894
PC_2993	Folate metabolism ( Folate metabolism )	10840	275	471	1719	2356	2618	2643	4522	25902	4524	10588	4548	5805	5860	6697	7298
PC_2994	Raf activation signaling (through Grb2 and Sos) ( CD4 T cell receptor signaling (ERK cascade) )	369	673	2885	3265	3845	4893	5894	6654	6655
PC_2995	D-Glucose 1-phosphate = D-Glucose 6-phosphate ( Glycolysis and Gluconeogenesis )	5236
PC_2996	Choloyl-CoA + Taurine = CoA + Taurocholic acid ( Methionine and Cysteine metabolism )	570
PC_2997	TGF-beta receptor signaling	409	8312	25805	815	857	1490	1499	1601	168002	1616	83658	1965	2280	2885	83737	6885	23327	100506658	50855	5170	5371	5499	23645	5515	5516	5520	54778	6198	6464	4087	4088	4089	4092	57154	64750	6654	6711	11171	10454	23118	7021	7040	7043	7046	7048	7049	9392	11059	331	10413	7531	9765	9372
PC_2998	Butanoate metabolism ( Butanoate metabolism )	65985	116285	3157	3158
PC_2999	IL1-mediated signaling events	834	1147	23085	3551	8517	3552	3553	3554	7850	3556	3557	3654	11213	51135	3725	5608	4215	6885	5599	4615	4790	5290	5295	5584	5590	5970	8878	10454	23118	100302736	54472	7189	7334	387522
PC_3000	JNK cascade ( IL-1 signaling pathway (through JNK cascade) )	3725	5604	5605	5606	6416	5607	5608	5609	6885	5602	5600	6300	5603	1432	5599	5601
PC_3001	uracil degradation II (reductive)	1400	1806	1807	1808	1809	10570	56896	51733
PC_3002	Posttranslational regulation of adherens junction stability and dissassembly	25	102	382	627	91768	836	79872	998	999	1000	1387	1495	1499	1500	1785	1832	1950	1956	2241	2534	2668	2674	2768	10672	9146	3265	3480	3481	8826	3728	4225	4233	4314	4316	4830	4915	10204	5770	5777	5868	7879	5879	5979	54453	6091	6585	6642	6714	7074	10009
PC_3003	histamine biosynthesis	3067
PC_3004	2 Acetyl-CoA = CoA + Acetoacetyl-CoA ( Pyruvate metabolism )	38	8435
PC_3005	C. elegans Notch signaling pathway ( Notch signaling pathway Diagram )	1387	2033	4851	4853	4854	4855	5663	5664
PC_3006	spermine and spermidine degradation I	8639	196743	6303	112483	54498
PC_3007	threonine degradation II	23464
PC_3008	(S)-3-Hydroxy-3-methyl-glutaryl-CoA = Acetyl-CoA + Acetoacetic acid ( Butanoate metabolism )	3155
PC_3009	phosphatidylethanolamine biosynthesis II	10390	1120	55500	55224	5833	85465
PC_3010	2 Acetyl-CoA = CoA + Acetoacetyl-CoA ( Butanoate metabolism )	38	8435
PC_3011	ATP + Pyruvic acid + CO2 + H2O = ADP + Oxaloacetic acid + Orthophosphate ( Alanine,Aspartic acid and Asparagine metabolism )	5091
PC_3012	NAD+ + 4-Trimethyl-ammonio-butanal + H2O = NADH + 4-Trimethyl-ammonio-butanoic acid ( Lysine degradation )	216	8854	219	217	224	501	223
PC_3013	E-cadherin signaling in keratinocytes	84962	207	208	846	999	1495	1499	1500	1956	342184	2534	3728	5290	5295	8394	5335	5879	387	6714	7408	7791
PC_3014	2-Oxo-glutaric acid + 4-Amino-butanoic acid = L-Glutamic acid + Succinate semialdehyde ( Glutamic acid and Glutamine metabolism )	18
PC_3015	ERK cascade ( FGF signaling pathway )	369	673	2002	2004	2005	2078	2113	2114	2119	2120	2313	5604	5605	5594	5595	5894	6688
PC_3016	galactose degradation I (Leloir pathway)	2582	2584	130589	2592
PC_3017	ERK cascade ( NGF signaling pathway )	369	673	2002	5604	5605	5594	5595	5894
PC_3018	Ci/Gli processing signaling ( Hedgehog signaling pathway )	8945	1026	1027	1028	1029	1030	1031	1032	8454	2735	2736	2737	2932	5578	5567	5568	6500
PC_3019	guanosine nucleotides degradation III	8034	22978	4860	7498
PC_3020	Validated transcriptional targets of AP1 family members Fra1 and Fra2	468	632	6347	890	595	1029	1278	3576	1634	9988	2033	8061	2355	2697	3162	3569	3691	3713	3725	3726	3727	3909	3976	4256	4312	4313	4318	4772	4773	4775	4846	5328	5329	6667	7056	55787	7392
PC_3021	Regulation of CDC42 activity	324	392	79658	55114	396	115557	9459	8874	23229	8412	998	23268	55619	139818	57572	23348	9855	2245	28964	6453	50618	4168	23263	25791	4830	5335	29127	10928	221178	7410	10451
PC_3022	Gene expression of MuRF1 by FOXO ( Insulin receptor signaling (Mammal) )	2308	2309	4303
PC_3023	PDGFR-alpha signaling pathway	857	859	1398	1399	1457	2002	2353	2885	3685	3716	3725	5156	5290	5295	5335	112476	2889	6461	6464	6654	6722
PC_3024	NAD+ + (S)-Malic acid = NADH + Pyruvic acid + CO2 ( Glycolysis and Gluconeogenesis )	4200
PC_3025	2 Acetyl-CoA = CoA + Acetoacetyl-CoA ( Tryptophan degradation )	38	8435
PC_3026	ATP + CMP = ADP + CDP ( Pyrimidine Nucleotides and Nucleosides metabolism )	51727
PC_3027	Negative regulation of heterotrimeric GPCR signaling pathway (through G alpha s) ( GPCR signaling (cholera toxin) )	107	55811	108	109	196883	111	112	113	114	115	2770	2771
PC_3028	arginine degradation VI (arginase 2 pathway)	383	384	4942	5831	29920	65263
PC_3029	glutamine degradation I	440	2744	27165
PC_3030	(S)-3-Hydroxy-2-methyl-butanoyl-CoA = 2-Methylbut-2-enoyl-CoA + H2O ( Valine,Leucine and Isoleucine degradation )	1892	1962	3030
PC_3031	Glutamic acid and Glutamine metabolism ( Glutamic acid and Glutamine metabolism )	1677	1373	2058	2571	2572	2729	2730	2936	2937	2058
PC_3032	N-acetylglucosamine degradation II	51005	10007	132789	55577
PC_3033	Toll-like receptor signaling pathway (through LPS, TLR4, MyD88, IRAK, TAK1 and IKK-NF-kappaB cascade)(Canonical) ( Toll-like receptor signaling pathway (trough NF-kappaB) )	929	51295	3552	3553	3554	3556	3654	51135	3929	23643	6885	4615	10454	23118	7099	54472	7189	7334	387522
PC_3034	p75(NTR)-mediated signaling	2532	6868	207	317	51107	83464	351	396	572	10018	627	55859	27018	329	330	836	839	842	1147	54205	56616	1869	11319	5045	79158	3551	8517	3654	84894	4099	9500	28986	5602	5599	5601	4314	4316	92170	4615	23385	4692	4782	4803	4804	56160	4908	4909	4914	4974	5290	5295	5340	11108	5567	5584	5590	5663	55851	5879	387	388	389	8767	57142	65078	6464	6610	6272	8878	7157	7189	331	7531	10782
PC_3035	Signaling mediated by p38-alpha and p38-beta	466	1386	22926	1051	1385	1977	1978	2005	2099	2664	26959	3315	3725	3880	3856	5600	1432	9261	7867	8550	4205	4208	4286	8569	4843	5321	10891	5743	5868	8986	9252	6548	7157	7391
PC_3036	noradrenaline and adrenaline degradation	125	127	130	217	224	1312	220074	4128	4129	5409
PC_3037	ERK cascade ( HGF signaling pathway )	2002	5604	5605	5594	5595	5894
PC_3038	1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)	253430	64768	3705
PC_3039	Tryptophan degradation ( Tryptophan degradation )	15	130013	125061	216	8854	219	217	224	501	223	26	314	8639	316	438	847	1588	1543	1544	1545	1553	1548	1549	1555	1562	1557	1558	1559	1565	1571	1572	1573	1576	64816	1577	100861540	1580	57834	66002	11283	1644	1892	1962	2639	23498	3030	3620	11185	8564	8942	4128	4129	4193	4799	64320	6999	7166	7337	7453	10352
PC_3040	(S)-Malic acid = Fumaric acid + H2O ( Arginine and Proline metabolism )	2271
PC_3041	NAD+ + (S)-3-Hydroxy-butanoyl-CoA = NADH + Acetoacetyl-CoA ( Tryptophan degradation )	1962	3030	3030	3028
PC_3042	IKK-NF-kappaB cascade ( CD4 T cell receptor signaling (NF-kB cascade) )	1147	3551	8517	4790	4792	4793	4794	5970
PC_3043	2-Oxo-glutaric acid + L-Cysteic acid = L-Glutamic acid + 3-Sulfo-pyruvic acid ( Methionine and Cysteine metabolism )	2805	2806
PC_3044	Stabilization and accumulation of cytoplasmic beta-catenin (Canonical) ( C. elegans endoderm induction Wnt signaling pathway Diagram )	324	8312	8313	102800317	1499	1855	1856	1857	10023	23401	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	2932	4041	4040
PC_3045	tyrosine biosynthesis IV	5053
PC_3046	Lissencephaly gene (LIS1) in neuronal migration and development	25	801	801	801	998	1020	8851	8941	6249	1457	1600	1641	1778	6993	8826	11104	7804	4043	4131	81565	10726	5048	5049	5050	7941	5528	5879	5649	387	7436	7531
PC_3047	Vitamin B6 metabolism ( Vitamin B6 metabolism )	316	8566	55163	29968
PC_3048	Arf6 trafficking events	9744	154	185	382	8853	554	274	999	1213	1363	1495	1499	1500	1785	55763	55770	11336	60412	10640	54536	23265	149371	3630	3672	8515	22801	3673	3675	3676	3678	3655	3679	8516	3680	3685	3688	3831	23162	4830	23396	5337	5338	5898	10066	6517	9043	7253	9341
PC_3049	purine nucleotides degradation II (aerobic)	100	113179	8034	3614	3615	84618	22978	51251	115024	4907	4860	7498
PC_3050	Regulation of cytoplasmic and nuclear SMAD2/3 signaling	801	801	801	58190	10106	10217	3838	3837	4214	5594	5595	9972	8021	51588	5494	4087	4088	4089	9392	7329
PC_3051	heme biosynthesis II	210	211	212	1371	2235	3145	3060	7389	7390
PC_3052	ATP + dADP = ADP + dATP ( Purine nucleotides and Nucleosides metabolism )	4830	4831	4832	4833	8382	10201	29922
PC_3053	Cytosolic calcium ion concentration elevation (through IP3 receptor) ( GPCR signaling (G alpha q) )	3708	3710
PC_3054	Drosophila Toll-like receptor signaling ( Drosophila Toll-like receptor signaling )	90	91	92	93	94	102	6868	207	208	10000	238	269	51107	83464	369	649	657	658	659	673	695	815	816	817	818	834	843	23581	835	836	837	838	839	840	841	842	902	8317	983	1017	1018	1019	1020	1021	1022	1024	1025	1147	84735	1445	1452	1453	102800317	53944	1455	1456	1956	9700	2147	2260	2263	2261	2264	2321	2324	5045	2534	2674	156	157	2868	2869	2870	131890	2931	2932	3002	3480	3551	9641	8517	3643	3654	3656	51135	3702	3716	3717	3718	3791	3815	3818	3932	4058	5604	5605	5606	6416	5607	5608	5609	4214	4294	4296	7786	9175	9020	10746	84451	4215	4217	6885	1326	4293	5871	8491	5594	5602	5600	6300	5603	1432	5595	5598	5599	5601	9261	7867	8550	4233	8569	4331	4342	2475	23385	4804	51701	4914	5058	5062	10298	106821730	106821730	5156	5159	5170	5347	1263	5562	5563	5564	5565	5578	5567	5568	5571	51422	53632	5573	5575	5576	5577	5578	5579	5580	5581	5582	5584	5588	5590	5592	5593	5663	5664	55851	5682	5683	5684	5685	5686	5687	5688	5689	5699	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5707	5716	5717	5718	5719	5708	5709	5710	5711	9861	5713	5714	5715	5747	2185	5894	9028	54933	8737	8767	11035	6195	6196	6197	27330	6198	6199	6259	6714	6850	7006	7046	7048	7092	7093	7297	7465	7535
PC_3055	Stabilization and accumulation of cytoplasmic beta-catenin (Mammal) ( Mammalian Wnt signaling pathway Diagram )	324	8312	8313	102800317	1499	1855	1856	1857	10023	23401	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	2932	4041	4040
PC_3056	FGF signaling pathway (D. melanogaster tracheal cells) ( FGF signaling pathway )	2810	7529	7531	7532	7533	10971	7534
PC_3057	IL12-mediated signaling events	1386	567	6348	388372	1234	919	915	916	917	920	925	926	8320	356	2353	4616	10912	3001	3002	3105	3122	3123	3142	3458	3592	3593	3594	3595	3606	8809	8807	3553	3554	3558	3559	3560	3561	3565	3717	3932	5606	5608	1432	2475	4790	4791	4843	7879	5970	5971	8767	8651	56848	6772	6774	6775	6776	6778	30009	7297
PC_3058	stearate biosynthesis I (animals)	641371	10965	122970	11332	23205	81616	2180	2181	2182	51703	64834	79071	11001
PC_3059	ATP + dCMP = ADP + dCDP ( Pyrimidine Nucleotides and Nucleosides metabolism )	51727
PC_3060	UTP + N-Acetyl-D-glucosamine 1-phosphate = Pyrophosphate + UDP-N-acetyl-D-glucosamine ( Aminosugars metabolism )	6675
PC_3061	L-Alanine + 2-Oxo-glutaric acid = Pyruvic acid + L-Glutamic acid ( Alanine,Aspartic acid and Asparagine metabolism )	2875	84706
PC_3062	IL3	207	466	1386	572	581	596	598	10018	867	1154	1385	1398	1399	1439	1759	420	9046	2207	2242	2308	2309	2534	2549	9846	2623	2624	2885	2931	2932	3055	3265	3315	3562	3563	3635	3716	3717	30818	3932	4067	5604	5594	1432	5595	5599	4790	5058	5293	5295	5296	29990	5515	5530	5578	5578	5579	5747	5781	5777	5788	5829	10399	5894	2889	5914	5925	6256	6464	6513	8835	9021	6654	6714	6774	6776	6777	6850	7006	7297	7409	7414	7529	10971	7534
PC_3063	4-hydroxybenzoate biosynthesis	6898
PC_3064	Mammalian Wnt signaling pathway ( Mammalian Wnt signaling pathway Diagram )	375790	25776	960	1499	56998	22943	27123	27122	27121	2487	2817	2239	3339	83999	79412	51176	4041	4040	6885	51701	6382	6383	9672	6385	6423	6424	6932	83439	6934	11197	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484
PC_3065	IFN-gamma pathway	207	801	801	801	815	816	817	818	834	867	1051	1387	1399	1612	2033	3458	3459	3553	3659	10379	3716	3717	5604	4214	4296	5594	5595	2475	8554	51588	5290	5295	5580	80142	5781	5771	5906	5908	2889	4092	8651	6772	6774
PC_3066	AMP + Pyrophosphate = Adenine + D-5-Phospho-ribosyl 1-diphosphate ( Purine nucleotides and Nucleosides metabolism )	3251
PC_3067	Toll-like receptor signaling pathway (through ECSIT, MEKK1, MKKs, p38 cascade) ( Toll-like receptor signaling pathway (through ECSIT, MEKK1, MKKs, p38 cascade) )	929	51295	3654	51135	3929	23643	4214	6885	4615	10454	23118	7099	54472	7189
PC_3068	Adenylate cyclase activation signaling ( GPCR signaling (G alpha i) )	107	55811	108	109	196883	111	112	113	114	115	2778
PC_3069	NAD biosynthesis III	10135	64802	23057	349565
PC_3070	cholesterol biosynthesis II (via 24,25-dihydrolanosterol)	1595	1718	1717	10682	2222	51478	3930	4047	6307	50814	6309	6713	7108
PC_3071	proline biosynthesis I	5832	5831	29920	65263
PC_3072	glutamate degradation X	2746	2747
PC_3073	superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism	3612	3613	54928	3628	3632	3633	3635	22876	27124	51763	3636	253430	3706	3707	80271	9562	4952	5728	8867	8871
PC_3074	Negative regulation of (Binding of GPCR ligand and GPCR) ( GPCR signaling (pertussis toxin) )	2770	2771
PC_3075	2-Oxo-glutaric acid + L-Cysteine = L-Glutamic acid + 3-Mercapto-pyruvic acid ( Methionine and Cysteine metabolism )	2805	2806
PC_3076	adenosine nucleotides degradation II	100	113179	84618	22978	51251	4907	4860	7498
PC_3077	CD40/CD40L signaling	207	598	329	330	722	868	958	959	83953	3565	3718	3725	6416	4214	9020	5602	5600	1432	5599	5601	4609	4790	4792	5290	5291	5294	5295	146850	5970	6776	51567	7128	7185	7186	7187	7189
PC_3078	tetrahydrobiopterin biosynthesis II	2643	5805	6697
PC_3079	dermatan sulfate biosynthesis (late stages)	113189	51363	29940	10090
PC_3080	NAD+ + L-Glutamic acid + H2O = NADH + 2-Oxo-glutaric acid + NH3 ( Arginine and Proline metabolism )	2746	2747
PC_3081	Notch degradation signaling ( Notch signaling pathway Diagram )	55294	4851	4853	4854	4855
PC_3082	ERK cascade ( FGF signaling pathway )	369	673	2002	5604	5605	5594	5595	5894
PC_3083	Fc-epsilon receptor I signaling in mast cells	207	695	867	868	1147	420	1843	2205	2207	2213	2241	2353	2534	9846	2571	2885	3059	3265	3551	8517	3635	3702	3725	10219	27040	7462	3937	4067	5604	5605	6416	5609	4214	5594	5595	5599	2206	4773	4790	5062	5290	5295	5319	5321	5335	5338	8611	5579	112476	5747	5781	5783	5829	5894	5921	5970	1901	6464	6654	8877	6850	7409	7456
PC_3084	Rapoport-Luebering glycolytic shunt	669	9562	5223	5224
PC_3085	Nicotinate and Nicotinamide metabolism ( Nicotinate and Nicotinamide metabolism )	683	952	5167	5168	5169	8776	8898	9107	65220	55191	4837	30833	100526794	22978	51251	4907	56953	23475
PC_3086	Secretory pathway of Hh ( Hedgehog signaling pathway )	50846	55733	3549	6469
PC_3087	Signaling events mediated by VEGFR1 and VEGFR2	8165	207	375	673	801	801	801	10645	857	867	998	1003	1495	1499	1605	1785	23291	2242	2321	2534	2549	2887	2885	9146	3320	3326	8826	3685	3690	3791	5604	5605	5606	5608	5594	5600	1432	5595	9261	26509	4690	8440	4734	4846	5062	5170	5290	5295	5335	5578	5578	5579	5580	5747	2185	5781	5771	5777	5795	5829	5894	387	6093	9047	6461	6714	7414	7422	7448
PC_3088	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	3632	3633	3635	27124	51763	3636	253430	64768	3705	3706	3707	80271	4952	8867	8871
PC_3089	Activation of Smo ( Hedgehog signaling pathway )	409	156	11127	6608
PC_3090	3-Methyl-butanoyl-CoA + Acceptor = 3-Methylbut-2-enoyl-CoA + Reduced acceptor ( Valine,Leucine and Isoleucine degradation )	84129	34
PC_3091	Deoxy-inosine + Orthophosphate = 2-Deoxy-D-ribose 1-phosphate + Hypoxanthine ( Purine nucleotides and Nucleosides metabolism )	1890
PC_3092	GMP + Pyrophosphate = Guanine + D-5-Phospho-ribosyl 1-diphosphate ( Purine nucleotides and Nucleosides metabolism )	353
PC_3093	zymosterol biosynthesis	1595	51478	3930	6307	50814	7108
PC_3094	5-Formimino-tetrahydro-folic acid + L-Glutamic acid = L-Tetrahydro-folic acid + N-Formimino-L-glutamic acid ( Histidine degradation )	10841
PC_3095	Signaling with Wnt (Canonical) ( Mammalian Wnt signaling pathway Diagram )	607	1387	1499	2033	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	51176	4041	4040	26108	90780	4089	6597	6932	83439	6934	7088	7089	7090	7091	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484
PC_3096	putrescine biosynthesis III	113451	4953
PC_3097	Adenylo-succinic acid = AMP + Fumaric acid ( Purine nucleotides and Nucleosides metabolism )	158
PC_3098	Arf6 signaling events	9744	23527	11033	154	185	116984	382	408	409	9266	9265	1942	1950	1956	1969	26269	28964	2767	9630	2769	2776	51454	3082	26034	9922	3674	3690	23303	3973	4233	4690	5662	5829	6714	7253	9098
PC_3099	Dimethylallyl diphosphate = Isopentenyl diphosphate ( Steroids metabolism )	3422	91734
PC_3100	AndrogenReceptor	196	207	26060	367	405	1386	573	672	1620	811	834	836	840	841	857	595	896	898	902	993	994	11140	983	984	1020	1022	1025	1050	1329	1385	1387	1499	1613	1616	1629	1644	1655	64800	1956	2033	2068	2071	2099	2119	2274	2288	2316	3169	2308	2597	2932	2934	2962	2963	2965	2966	2967	2968	3065	51564	10114	3320	7184	3303	3303	3308	3309	3312	3315	3572	3725	8850	10524	11143	23028	55818	23081	10542	9404	4110	4193	4331	8648	10499	8202	8031	23054	9611	9612	51497	4841	8431	7181	7182	2908	8204	64324	7468	5036	106821730	11315	142	23598	27043	8554	9063	10401	51588	5295	5296	5325	10957	5451	5499	94274	5052	3276	3275	29893	5728	5747	5829	5881	10399	23132	5901	55705	5925	57786	25898	9604	6047	6049	861	860	29843	2516	25942	23411	291	4088	6599	6605	6047	6667	25803	6714	6736	6774	10273	6840	6925	7041	7050	166	7110	7150	55128	7329	7337	8409	7432	7520	2547	57178	83637
PC_3101	oxidized GTP and dGTP detoxification	4521
PC_3102	Caspase3 activation signaling ( TNFR1 signaling pathway )	836	841
PC_3103	Aurora C signaling	9212	6795	3020	3020	3619
PC_3104	glutamate degradation III (via 4-aminobutyrate)	18	7915	2571	2572
PC_3105	Signaling with Wnt (Drosophila) ( Drosophila Wingless/Wnt signaling pathway Diagram )	7088	7089	7090	7091
PC_3106	ERK cascade ( GPCR signaling (G alpha s, PKA and ERK) )	673	5604	5605	5594	5595
PC_3107	UTP + AMP = UDP + ADP ( Pyrimidine Nucleotides and Nucleosides metabolism )	205
PC_3108	Notch degradation signaling (C. elegans) ( Notch signaling pathway Diagram )	4851	4853	4854	4855
PC_3109	coenzyme A biosynthesis	80347	60490	79717
PC_3110	salvage pathways of pyrimidine ribonucleotides	57379	978	4830	4831	4832	4833	8382	10201	29922	83549	7371	54963	7378	151531	139596
PC_3111	ATP + D-Ribose 5-phosphate = AMP + D-5-Phospho-ribosyl 1-diphosphate ( Purine nucleotides and Nucleosides metabolism )	221823	5634
PC_3112	eumelanin biosynthesis	1638	7220	7299	7306
PC_3113	Caspase3 activation signaling ( Fas signaling pathway )	836	842
PC_3114	L-cysteine degradation III	4357
PC_3115	ERK cascade ( Integrin signaling pathway )	5604	5605	5594	5595	5894
PC_3116	ALK1 pathway	90	94	2280
PC_3117	superpathway of inositol phosphate compounds	10423	9896	3632	3633	3635	27124	51763	3636	9807	51447	117283	253430	64768	3705	3706	3707	80271	9562	64419	8897	4952	55361	55300	5297	5298	5286	5287	5288	5289	5290	5291	5293	5294	5295	5296	8503	30849	23533	146850	200576	5305	8396	79837	90809	55529	8394	8395	23396	138429	23236	5330	5331	5332	5333	113026	84812	51196	5335	5336	23007	9651	89869	9677	23262	5728	22908	8867	8871
PC_3118	Negative feedback regulation of FGF8 signaling by Sprouty1 (Xenopus) ( FGF signaling pathway )	6654	6655	10252
PC_3119	thiosulfate disproportionation III (rhodanese)	7263
PC_3120	D-Sedoheptulose 7-phosphate + D-Glyceraldehyde 3-phosphate = D-Erythrose 4-phosphate + D-Fructose 6-phosphate ( Pentose phosphate cycle )	6888
PC_3121	Signaling without Hh ( Hedgehog signaling pathway )	2735	2736	2737	5727	6608	51684
PC_3122	p38 cascade ( IL-1 signaling pathway (through p38 cascade) )	1386	5608	6885	5602	5600	6300	5603	1432	5599	5601
PC_3123	JNK cascade ( IL-1 signaling pathway (through JNK cascade) )	3725	5608	6885	5602	5600	6300	5603	1432	5599	5601
PC_3124	Gene expression of smad7 by R-smad	4086	4087	4088	4089	4090	4092	4093
PC_3125	Ephrin B reverse signaling	640	1759	1947	1948	2047	2048	2050	2268	2534	3055	3674	3690	3932	4067	6416	6885	5599	8440	5290	5295	5783	5879	5998	6714	7074	7525
PC_3126	CoA + GTP + Succinic acid = Succinyl-CoA + GDP + Orthophosphate ( Citrate cycle )	8802	8801
PC_3127	Signaling without Wnt (Canonical) ( Canonical Wnt signaling pathway Diagram )	51176	6932	83439	6934	7088	7089	7090	7091
PC_3128	Insulin-mediated glucose transport	207	208	434	801	801	801	2932	2997	3630	3643	4012	5501	5506	5584	5590	23433	2810	6517	6810	252983	9882	9322	6844	10652	7529	7531	7532	7533	10971	7534
PC_3129	IMP + Pyrophosphate = Hypoxanthine + D-5-Phospho-ribosyl 1-diphosphate ( Purine nucleotides and Nucleosides metabolism )	3251
PC_3130	colanic acid building blocks biosynthesis	2582	2584	2592	2762	29926	29925	2821	4351	5372	5373	7264	7358	7360
PC_3131	Notch-mediated HES/HEY network	367	405	429	632	817	920	1027	1387	1487	1869	2033	2548	2623	2626	2627	2690	3065	8209	55502	23462	23493	3091	3717	23028	3791	9794	84441	4602	4654	8648	9611	9612	50674	4851	142	256297	5730	5925	5932	3516	1827	860	23013	6774	6929	7088	7291	7528
PC_3132	N-Acetyl-D-glucosamine 1-phosphate = N-Acetyl-D-glucosamine 6-phosphate ( Aminosugars metabolism )	5238
PC_3133	NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde	55191	64802	23057	349565	23475
PC_3134	EphrinB-EPHB pathway	1947	1948	2047	2048	2049	2050
PC_3135	Regulation of retinoblastoma protein	26574	25	1386	11016	632	6046	8535	890	595	894	896	898	1017	1019	1021	1026	1027	1029	1050	1051	1052	1158	1387	1437	1487	1786	1869	1870	1871	1874	1997	2033	145258	3065	8841	3398	3725	5600	1432	5601	4193	4208	4233	4286	4632	4654	5077	5468	5515	28227	5894	5925	5928	23504	860	6441	23411	6502	6597	6598	6688	6839	6872	6908	7027	7042	7343
PC_3136	Negative regulation of heterotrimeric GPCR signaling pathway (through G alpha q and PLC beta) ( GPCR signaling (G alpha q) )	2776	5996	6001	8786	6002	6003	10636	6004	26575	64407	10287	5997	8601	5998	5999	8490	9628	6000	85397	8787
PC_3137	CXCR3-mediated signaling events	207	408	6356	3627	6373	10563	4283	2833	1759	2770	2771	2773	2775	2781	2782	54331	3265	3845	5604	5605	5606	5608	5594	5600	1432	5595	79109	64223	2475	4893	5170	5196	5290	5291	5295	5894	253260	6714
PC_3138	Noncanonical Wnt signaling pathway	409	815	998	55636	1452	115908	23002	1855	1856	1857	2316	2535	7855	8323	8324	6885	5602	5599	5601	4773	51701	5468	5590	5879	387	6093	4920	9869	10454	23118	89780	7474	7525
PC_3139	Gene expression of SOCS by STAT dimer ( JAK-STAT pathway and regulation pathway Diagram )	8651	8835	9021	9306	9655	30837	30837	6772	6773	6774	6775	6776	6777	6778
PC_3140	Coregulation of Androgen receptor activity	207	26060	367	672	10498	841	595	896	984	1021	1029	146225	58190	10106	1499	2274	2288	2934	3092	3178	23028	55818	23081	3817	3818	26524	4117	8930	10499	8031	23054	4824	8204	5036	23598	5074	27043	8554	10401	51588	5052	5591	2185	55705	6197	6047	6722	6840	6925	7041	7050	7110	7113	9039	7329	7337	10451	7520	2547	57178	24149
PC_3141	Glycine and Serine metabolism ( Glycine and Serine metabolism )	57016	211	212	26	314	8639	635	102724560	1491	1610	29958	2593	2617	2731	27232	51144	4128	4129	50814	10400	51268	23761	5723	22949	6301	10993	6897
PC_3142	CMP-N-acetylneuraminate biosynthesis I (eukaryotes)	55907	10020	140838	54187
PC_3143	regulation of target gene expression by AP-1 ( IL-1 signaling pathway (through p38 cascade) )	1386
PC_3144	IL2 signaling events mediated by PI3K	207	596	598	801	801	801	1869	3692	2309	9846	2885	3320	3558	3559	3560	3561	3716	3718	3932	2475	4602	4609	4773	4790	5290	5295	5590	5781	5879	5970	6194	6198	259230	6464	6609	6654	7015	7357
PC_3145	Presenilin action in Notch and Wnt signaling	102	324	51107	83464	8312	8945	595	1387	1452	1457	1487	1499	22943	27123	28514	1840	1855	23291	2353	10023	8321	2932	3065	6927	3725	79412	4040	6885	5594	5595	4609	23385	4734	85407	51701	4851	5467	5528	5663	55851	3516	10454	7088	166	11197	7471
PC_3146	Cytokine receptor degradation signaling ( JAK-STAT pathway and regulation pathway Diagram )	1271	1438	1439	1441	3577	3579	2057	2690	3454	3455	3459	3460	3587	3588	3594	3595	3597	3598	3601	23765	8809	3554	7850	3556	3559	3560	3561	3563	3566	3568	3570	3572	3575	3581	54741	3977	4352	9180	5618	9021
PC_3147	Signaling events regulated by Ret tyrosine kinase	9564	1385	1398	420	55715	55816	220164	10818	2549	2668	2674	2887	2885	2886	3265	3667	8660	3725	5594	5595	5599	4690	9260	5290	5295	5578	5578	5747	5781	5829	5879	5906	5921	5979	387	6464	6654	6714
PC_3148	IL27-mediated signaling events	10148	2625	3458	3592	3593	3594	3595	3605	3606	3553	3558	246778	9466	3569	3572	3716	3717	6772	6773	6774	6775	6776	30009	7040	7124	7297
PC_3149	Validated nuclear estrogen receptor beta network	718	79039	2100	8648	10499	8202	4738	190	8431	6597	6598	6605	9039	9040	7561
PC_3150	TWEAK	207	208	572	329	841	9332	1147	1499	8772	2932	3065	3551	6885	5594	1432	5595	5599	5601	4790	4791	4792	4793	142	5879	5970	5971	8737	7124	51330	8718	407977	7185	7186	7187	7188
PC_3151	2-Oxo-glutaric acid + beta-Alanine = L-Glutamic acid + Malonate semialdehyde ( Alanine,Aspartic acid and Asparagine metabolism )	18
PC_3152	p38 MAPK signaling pathway	472	801	801	801	816	83605	1647	4616	10912	5606	5608	4214	4294	4215	4216	4217	9064	6885	5600	1432	5879	10454	23118	57551	9344	51347	7186	7189	7295
PC_3153	Canonical Notch signaling pathway ( Notch signaling pathway Diagram )	102	6868	1387	28514	10683	54567	2033	182	3714	9794	84441	55534	4851	4853	4854	4855	5663	5664	3516
PC_3154	5,6-Dihydro-uracil + H2O = Ureido-propanoic acid ( Pyrimidine Nucleotides and Nucleosides metabolism )	1807
PC_3155	Citric acid = Isocitric acid ( Citrate cycle )	48	50
PC_3156	Validated transcriptional targets of deltaNp63 isoforms	100	11047	472	558	624	675	9133	1029	1052	1289	1749	1750	2194	55294	2355	2877	2932	26959	3070	8209	3486	3552	83737	3675	3861	3852	4193	4361	4851	3084	64065	5452	5525	23682	10399	6236	861	23541	2810	252983	6862	83439	7153	8626	7421	11059	10413
PC_3157	molybdenum cofactor biosynthesis	10243	4338	27304	9054
PC_3158	ERK cascade ( FGF signaling pathway )	369	673	2002	2004	2005	2078	2113	2114	2119	2120	2313	5604	5605	5594	5595	5894	6688
PC_3159	G alpha s GDP-GTP exchange signaling ( GPCR Dopamine D1like receptor signaling pathway )	1812	1816	2778	2784	10681	2793
PC_3160	Heterotrimeric GPCR signaling pathway (through_G alpha s_ACs_PKA_BRaf_and_ERKcascade)(canonical) ( GPCR signaling (G alpha s, PKA and ERK) )	134	135	136	183	185	186	374	551	627	27302	9210	650	651	652	653	654	655	656	685	796	797	885	959	941	942	1081	1392	1437	1440	3576	3577	3579	1622	50846	28514	10683	54567	1812	1813	1814	1815	1816	1906	1907	1908	1950	2056	2069	356	2246	2255	2256	2258	2259	8823	8822	8817	9965	2247	26281	26291	27006	8074	2248	2249	2250	2251	2252	2253	2254	2488	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	51083	2520	2641	2662	10220	2658	9573	8200	392255	151449	2661	2668	2688	2691	2695	2778	2784	10681	2793	2796	2911	2912	2913	2914	2915	2916	2917	2918	2922	1839	3082	3439	3446	3439	3448	3449	3451	3440	3452	3441	3442	3443	3444	3445	3456	3458	3467	3479	3481	3549	3586	3589	3592	3593	3596	3600	3603	3605	3606	3552	3553	3562	3565	3567	3569	3574	3578	3623	3624	3625	3626	83729	3630	182	3714	4254	3827	3952	3972	3976	4049	100507027	2660	4693	4803	4838	4878	4852	3084	9542	10718	145957	4908	4909	5020	5154	5155	5443	5539	5617	51052	5697	6343	6469	6608	6750	6863	6866	7039	7040	7042	7043	7066	7124	8743	7200	7252	200081	7422	7423	7424	2277	7432	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484
PC_3161	GTP + Oxaloacetic acid = GDP + Phosphoenol-pyruvic acid + CO2 ( Citrate cycle )	5105	5106
PC_3162	Porphyrin_metabolism ( Porphyrin metabolism )	210	1371	2235	3145	3060	7389	7390
PC_3163	4-aminobutyrate degradation I	18	7915
PC_3164	L-Alanine + 2-Oxo-glutaric acid = Pyruvic acid + L-Glutamic acid ( Glutamic acid and Glutamine metabolism )	2875	84706
PC_3165	Validated targets of C-MYC transcriptional repression	223	596	672	6352	595	1026	1027	1030	1050	1052	8837	1191	1278	1385	7812	22943	1788	1791	2033	2064	2309	2495	1647	2672	2966	3065	8841	3158	3398	3394	3655	3688	3691	3956	4149	10608	4609	10397	57447	4800	4801	4802	5159	5786	5933	6278	6422	81855	6556	4087	4088	4089	6667	6688	6908	9414	23671	84233	7249	7474	7709	677
PC_3166	Hypoxic and oxygen homeostasis regulation of HIF-1-alpha	405	1029	10987	8453	54583	112398	112399	6923	6921	3091	55662	64344	3320	8260	10956	10399	9978	7157	7428
PC_3167	Purine nucleotides and Nucleosides metabolism ( Purine nucleotides and Nucleosides metabolism )	100	107	55811	108	109	196883	111	112	113	114	115	132	159	122622	55821	270	271	272	471	124583	953	954	956	9583	957	955	2618	8034	2766	51292	8833	2982	2977	2983	2984	3000	2986	3614	3615	3704	4881	4882	30833	100526794	22978	51251	4907	56953	318	11164	53343	10606	9061	9060	10846	5136	5153	5137	5138	5139	5140	5141	5142	5143	5144	8654	5145	5158	5146	5147	5148	5149	5150	27115	5151	8622	5152	5198	5313	5315	5471	6240	6241	7498
PC_3168	Ephrin A reverse signaling	1946	2044	2534
PC_3169	S1P5 pathway	2768	2770	2771	2773	2775	2781	387	53637
PC_3170	B-Raf activation signaling ( GPCR signaling (G alpha s, Epac and ERK) )	673	5906	5908
PC_3171	BMP signaling in Drosophila (dorsolateral) ( BMP signaling in Drosophila )	1387	2033	9794	84441	55534	6597	7490
PC_3172	Negative feedback regulation pathway of TGF beta superfamily signaling by (binding of smad6/7 and TGF beta receptor I) ( TGF-beta_super_family_signaling_pathway(canonical) )	90	91	94	657	658	4091	4092	7046
PC_3173	Rap1 activation signaling (through cAMP, PKA, Cbl and C3G) ( GPCR signaling (G alpha s, PKA and ERK) )	867	868	23624	1399	5578	5567	5568	5906	5908	2889	6714
PC_3174	Integrin family cell surface interactions	3672	8515	22801	3673	3674	3675	3676	3678	3655	3679	8516	3680	3681	3682	3683	3684	3685	3687	3688	3689	3690	3691	3693	3694	3695	3696
PC_3175	ERK cascade ( Insulin receptor signaling )	369	673	2002	5604	5605	5594	5595	5894
PC_3176	EPHA2 forward signaling	52	2909	9564	867	1942	1969	2885	3636	5058	5290	5295	5747	5879	387	6464	6714	7074	7410	10451
PC_3177	Xenopus axis formation Wnt signaling pathway ( Xenopus axis formation Wnt signaling pathway Diagram )	22943	27123	27122	27121	83999	79412	4041	4040	11197	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484
PC_3178	Negative feedback regulation of FGF8 signaling by Mkp3 (Xenopus) ( FGF signaling pathway )	1848	5594	5595
PC_3179	Signaling events mediated by HDAC Class I	8945	1107	1108	1387	2033	2287	2623	2624	54815	57459	3065	83933	79885	3066	8841	9759	10014	10013	51564	55869	9734	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	8338	8349	126961	126961	126961	121504	121504	121504	8850	4149	8932	53615	125997	9219	4084	9611	9612	4790	4792	7181	9972	23225	8021	23636	5468	5578	10419	5901	5903	5905	5928	5931	5970	10284	8819	25942	23309	23411	22933	23410	23409	23408	51548	51547	4092	23381	57154	6774	7341	7024	7124	7132	7329	79084	7514	7528	161882
PC_3180	Inactivation of Ptc by Hh ( Hedgehog signaling pathway )	50846	3549	5727	8643	6469
PC_3181	IL9	207	2885	3561	3578	3581	3667	8660	3716	3718	10524	5604	5605	5594	5595	5295	5781	6464	6772	6774	6776	6777	6778	7297	7415
PC_3182	Xanthosine + Orthophosphate = Xanthine + D-Ribose 1-phosphate ( Purine nucleotides and Nucleosides metabolism )	4860
PC_3183	JNK cascade ( TNFR1 signaling pathway )	3725	6416	5609	4217	5602	5599	5601
PC_3184	folate polyglutamylation	2356	4522	25902	6470	6472
PC_3185	NAD salvage pathway III	64802	23057	349565	54981	27231
PC_3186	oleate biosynthesis II (animals)	641371	10965	122970	3992	9415	283985	6319	79966
PC_3187	glutathione biosynthesis	2729	2730	2937
PC_3188	CD4 T cell receptor signaling (through Vav, Rac and JNK cascade ( CD4 T cell receptor signaling (JNK cascade) )	919	915	916	917	920	3113	3115	3117	3118	3119	3120	3122	3123	3125	3126	27040	3932	5335	5336	5588	5879	5880	5881	7409	7535
PC_3189	Alpha6Beta4Integrin	25	207	367	572	836	977	1179	9635	1308	1832	667	1956	1977	1978	3692	2048	2064	55914	2353	2534	2549	2885	3667	8660	3655	3691	3725	284217	3908	3909	3911	3912	3915	3914	3915	3918	5594	1432	5595	4233	4486	2475	91807	9423	5058	5290	5291	5293	5294	5295	5296	8503	5339	5578	5580	5747	5781	5879	387	3921	6242	2810	6464	4087	4088	6714	7161	7431	7525	7529	7531	7533	10971	7534
PC_3190	IL2	207	1386	572	596	867	898	1017	1154	1385	1398	1399	8662	1977	1978	2002	2113	2114	2309	2534	9846	2885	3320	3600	3558	3559	3560	3561	3667	8660	9445	3716	3717	3718	3725	3932	4067	5604	5605	5594	1432	5595	5599	8569	2475	4790	9111	2908	5290	5291	5293	5294	5295	5296	8503	23236	5590	2185	5781	5777	5894	5970	6194	6198	6446	6461	6464	8651	9021	6654	8027	10254	6772	6774	6775	6776	6777	6850	7015	7409	7429	4904
PC_3191	tryptophan degradation III (eukaryotic)	30	38	8435	130013	125061	2639	23498	3032	8564	8942	6999
PC_3192	pentose phosphate pathway (oxidative branch)	2539	9563	5226	25796
PC_3193	fatty acid beta-oxidation I	30	10449	23205	81616	2180	2181	2182	51703	23305	1892	1632	10455	1962	3030	3030	3032	3028	11001
PC_3194	Integrins in angiogenesis	25960	207	27329	9564	841	867	1027	1301	1302	1277	1278	1280	1281	1282	1284	1285	1286	1287	1288	1289	1290	1291	1292	1293	256076	131873	1294	1435	1436	10085	50848	2247	2335	3320	3479	3480	3611	3667	3685	3690	3791	5594	5595	4240	5297	5298	5286	5290	5295	5747	2185	5781	5829	5879	387	6093	6198	6382	6696	6714	7048	7094	10451	7414	7422	7448
PC_3195	Wnt	207	324	50649	408	409	8312	8313	607	8945	595	999	1000	1021	55636	1139	1452	1453	102800317	1487	1488	1499	23002	1601	85458	22943	1855	1856	1857	10023	23401	2487	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	2646	2719	2931	2932	3611	3725	3728	9365	83999	51176	4035	4041	4040	6416	4214	4216	6885	5594	5595	5599	2011	23184	4773	51701	5076	55361	5300	8395	5468	5499	84152	5515	5578	5578	5579	5580	5581	5582	5588	5879	5894	387	4919	4920	6199	284654	340419	84870	6259	9869	6422	6423	6424	9368	4086	6656	6714	6929	6925	6934	11197	7471	7481	7472	7473	89780	54361	7474	81029	7475	7476	7477	7483	7484	7525	7529
PC_3196	NAD+ + 3-Methoxy-4-hydroxy-phenyl-glycolaldehyde + H2O = NADH + 3-Methoxy-4-hydroxy-mandelic acid ( Tyrosine metabolism )	220	218	221
PC_3197	Raf activation signaling (through Grb2 and Sos) ( JAK-STAT pathway and regulation pathway Diagram )	369	673	2885	3265	3845	4893	5894	6654	6655
PC_3198	IFN alpha signaling pathway((JAK1 TYK2 STAT1 STAT2) ( IFN alpha signaling(JAK1 TYK2 STAT1 STAT2 STAT3) )	3439	3446	3439	3448	3449	3451	3440	3452	3441	3442	3443	3444	3445	3454	3455	10379	3716	6772	6773	7297
PC_3199	FSH	25	207	208	26060	407	408	409	1081	1385	1956	1978	2308	2309	2488	2492	2534	2697	156	2868	2870	8290	3315	5604	5605	5594	1432	5595	4193	2475	5333	5563	5578	5573	5801	5894	5914	5970	6194	6197	6446	6714	7052	7249	10971
PC_3200	sulfite oxidation IV	6821
PC_3201	NAD+ + (S)-3-Hydroxy-butanoyl-CoA = NADH + Acetoacetyl-CoA ( Butanoate metabolism )	1962	3030	3030	3028
PC_3202	Signaling events mediated by PRL	183	22809	9564	890	898	1017	1026	1958	3672	3688	5594	5595	7803	8073	11156	5875	5876	5879	387	389	6093	6714	10376
PC_3203	NAD+ + (S)-3-Hydroxy-2-methyl-butanoyl-CoA = NADH + 2-Methyl-3-acetoacetyl-CoA ( Valine,Leucine and Isoleucine degradation )	1962	3030	3030	3028
PC_3204	histamine degradation	26	314	3176
PC_3205	arginine degradation I (arginase pathway)	8659	383	384	4942
PC_3206	IL-5 signaling pathway(JAK1 JAK2 STAT1 STAT5) ( IL-5 signaling(JAK1 JAK2 STAT1 STAT5) )	1439	3567	3568	3716	3717	6464	25759	53358	6772	6776	6777
PC_3207	urate biosynthesis/inosine 5'-phosphate degradation	3614	3615	22978	115024	4907	4860	7498
PC_3208	Gene expression of SOCS1 by STAT dimer ( JAK-STAT pathway and regulation pathway Diagram )	8651	6772	6773	6774	6775	6776	6777	6778
PC_3209	Gene expression of MAFbx by FOXO ( Insulin receptor signaling (Mammal) )	2308	2309	4303
PC_3210	D-Glucose 1-phosphate = D-Glucose 6-phosphate ( Galactose metabolism )	5236
PC_3211	NAD+ + Succinate semialdehyde + H2O = NADH + Succinic acid ( Glutamic acid and Glutamine metabolism )	7915
PC_3212	PLC beta signaling ( GPCR GroupI metabotropic glutamate receptor signaling pathway )	2776	23236	5330	5331	5332
PC_3213	G alpha i GDP-GTP exchange signaling ( GPCR signaling (G alpha i) )	134	135	136	185	186	3577	3579	1812	1813	1814	1815	1816	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	2770	2771	2784	10681	2793	2911	2912	2913	2914	2915	2916	2917	2918	6608
PC_3214	diphthamide biosynthesis	51611
PC_3215	L-Glutamine + H2O = L-Glutamic acid + NH3 ( Glutamic acid and Glutamine metabolism )	2744	27165
PC_3216	Regulation of p38-alpha and p38-beta	640	83605	998	1843	11221	80824	1850	2268	2534	3055	3932	4067	5606	6416	5608	7786	4215	5600	1432	5058	5062	5063	5592	5879	5898	5899	8737	6714	10454	7189	7525
PC_3217	D-myo-inositol-5-phosphate metabolism	64419	8897	5305	79837	90809	55529	23236	5330	5331	5332	5333	113026	84812	51196	5335	5336	23007	9651	89869
PC_3218	citrulline degradation	5009
PC_3219	TRAIL signaling pathway	843	841	8837	1147	58512	8772	3551	8517	6416	4214	5594	5595	5599	5290	5291	5295	8737	6609	8797	8795	8794	8793	8743	8717	7186
PC_3220	Phospholipase C gamma signaling ( CD4 T cell receptor signaling (JNK cascade) )	3702	3708	3710	5335	5336
PC_3221	IL12 signaling mediated by STAT4	919	940	915	916	917	920	941	942	1387	2119	2353	3122	3123	3458	3596	3606	8809	8807	3558	3559	3659	3725	5599	5601	4773	9063	5551	6774	6775	30009	7040
PC_3222	Signaling without Wnt (Canonical) ( Xenopus axis formation Wnt signaling pathway Diagram )	51176	6932	83439	6934	7088	7089	7090	7091
PC_3223	Stabilization and expansion of the E-cadherin adherens junction	10006	87	4301	360	362	382	57662	999	1495	1499	1500	26999	1729	1942	1950	1956	55740	1969	55763	11336	60412	28964	3082	3479	3480	3801	51474	4026	4233	4248	4633	4646	4690	10787	5819	23396	144100	387	6093	6810	7408	7414	7791
PC_3224	Aminosugars metabolism ( Aminosugars metabolism )	55907	2645	10020	64841	3098	3099	3101	55577	54187
PC_3225	Pyrimidine Nucleotides and Nucleosides metabolism ( Pyrimidine Nucleotides and Nucleosides metabolism )	57379	1677	124583	978	1503	56474	1633	1635	1854	953	956	9583	957	955	3704	30833	100526794	22978	51251	4907	56953	6240	6241	7083	7084	7298	83549	7371	7372	51733
PC_3226	ErbB1 downstream signaling	10006	10097	10096	207	378	10095	10109	10094	10093	10092	466	1386	572	10458	598	673	55845	801	801	801	824	998	1124	1385	26999	81624	1843	1848	1950	1956	1958	2002	2059	2151	2353	2549	2885	3265	8826	3725	3845	8844	5604	5605	6416	5607	4214	10746	5594	5595	5598	5599	5601	79109	4208	64223	2475	29895	10787	4893	5170	5037	5290	5291	5295	5337	5338	5515	5518	5520	5536	5578	5580	5590	5868	5879	5894	5898	5900	253260	9610	6194	6197	8986	9252	2810	9047	6548	4086	6654	6714	6722	6772	6774	9712	7410	10163	8976	7529	7531	7532	7533	10971	7534	55552
PC_3227	NAD+ + L-Saccharopine + H2O = NADH + L-2-Amino-adipate 6-semialdehyde + L-Glutamic acid ( Lysine degradation )	10157
PC_3228	Nongenotropic Androgen signaling	207	367	998	1385	2353	2770	2771	2773	2775	2781	2782	54331	2796	3265	5604	5605	5594	5595	27043	5290	5295	23236	5330	5331	5335	5336	5747	5879	5894	6462	6714
PC_3229	ATP + D-Ribose 5-phosphate = AMP + D-5-Phospho-ribosyl 1-diphosphate ( Pentose phosphate cycle )	221823	5634
PC_3230	Syndecan-1-mediated signaling events	682	8573	6352	1301	1302	1277	1278	1280	1281	1282	1284	1285	1286	1287	1288	1289	1290	1291	1292	1293	256076	131873	1294	9965	8074	2263	2261	2264	3082	10855	3911	5594	5595	4233	4312	4316	4318	5479	5578	6382	6386	7040
PC_3231	5,10-Methenyl-tetrahydro-folic acid + H2O = 10-Formyl-tetrahydro-folic acid ( Folate metabolism )	4522	25902	10797
PC_3232	Beta5 beta6 beta7 and beta8 integrin cell surface interactions	3491	10085	2200	2335	3676	3685	3693	3694	3695	3696	8174	5328	5329	6382	7046	7412	7448
PC_3233	Integrin signaling pathway ( Integrin signaling pathway )	176	60	375790	9459	63827	9564	633	673	857	960	998	1300	1301	1302	1303	1306	1307	80781	1310	1277	1278	1280	1281	1282	1284	1285	1286	1287	1288	1289	1290	1291	1292	1294	1295	1296	1297	1298	1299	1398	1634	1793	55619	1794	1795	9732	80005	57572	85440	81704	23348	2006	2335	2534	2817	2239	2885	3265	3339	3672	8515	22801	3673	3674	3675	3676	3678	3655	3679	8516	3680	3681	3682	3683	3684	3685	3687	3688	3689	3690	3691	3693	3694	3695	3696	11081	3845	3914	3918	3932	4060	5602	5599	5601	4168	1463	4893	5747	5829	5879	5894	5906	5908	2889	387	6382	6383	9672	6385	6464	25759	53358	9126	6654	6655	6714	7094	83660	3371	7148	7409	1462	7414
PC_3234	NAD+ + (R)-Lactic acid = NADH + Pyruvic acid ( Pyruvate metabolism )	197257
PC_3235	Hh signaling pathway ( Hedgehog signaling pathway )	91653	50937	50846	3549	6469
PC_3236	IL6-mediated signaling events	1	2	207	598	1051	1052	1401	2266	2353	2308	2549	9846	2885	3055	7184	3569	3570	3572	3659	3716	3717	3725	3726	3929	8543	6416	5608	5600	1432	4170	4286	4609	8554	10401	5290	5295	5580	5781	5791	5879	9021	6654	6772	6774	7076	8600	7297	7409
PC_3237	Heterotrimeric GPCR signaling pathway (through G alpha i and pertussis toxin) ( GPCR signaling (pertussis toxin) )	134	135	136	183	185	186	374	551	627	27302	9210	650	651	652	653	654	655	656	685	796	797	885	959	941	942	1081	1392	1437	1440	3576	3577	3579	1622	50846	28514	10683	54567	1812	1813	1814	1815	1816	1906	1907	1908	1950	2056	2069	356	2246	2255	2256	2258	2259	8823	8822	8817	9965	2247	26281	26291	27006	8074	2248	2249	2250	2251	2252	2253	2254	2488	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	51083	2520	2641	2662	10220	2658	9573	8200	392255	151449	2661	2668	2688	2691	2695	2770	2771	2784	10681	2793	2796	2911	2912	2913	2914	2915	2916	2917	2918	2922	1839	3082	3439	3446	3439	3448	3449	3451	3440	3452	3441	3442	3443	3444	3445	3456	3458	3467	3479	3481	3549	3586	3589	3592	3593	3596	3600	3603	3605	3606	3552	3553	3562	3565	3567	3569	3574	3578	3623	3624	3625	3626	83729	3630	182	3714	4254	3827	3952	3972	3976	4049	100507027	2660	4693	4803	4838	4878	4852	3084	9542	10718	145957	4908	4909	5020	5154	5155	5443	5539	5617	51052	5697	6343	6469	6608	6750	6863	6866	7039	7040	7042	7043	7066	7124	8743	7200	7252	200081	7422	7423	7424	2277	7432	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484
PC_3238	trans, trans-farnesyl diphosphate biosynthesis	2224	9453	3422	91734
PC_3239	TSLP	207	64109	1978	3575	3716	3717	5594	1432	5595	5599	5601	4790	4791	4792	5970	5971	6194	6772	6774	6775	6776	6777	6778	85480
PC_3240	2 Acetyl-CoA = CoA + Acetoacetyl-CoA ( Citrate cycle )	38	8435
PC_3241	Osteopontin-mediated events	58	9564	960	998	1147	2353	2934	3611	3685	3690	3725	4214	9020	5594	5595	5599	4313	4318	4790	4792	5290	5295	8394	5328	2185	5879	5970	387	9475	6696	6850	10451
PC_3242	TSH	207	84335	301	328	375	1386	476	682	811	821	896	898	1017	1019	1027	1081	1385	1390	1508	1978	2767	2768	10672	2770	2771	2773	2775	2776	2778	3150	3151	3265	3309	3312	3480	3551	8660	3716	3717	30818	3952	5604	5606	5608	5594	1432	5595	2475	4792	4793	5144	5170	5290	5295	5296	84152	5578	5578	5590	5747	5894	5900	5909	5925	5970	387	6194	6195	6464	6566	6513	8651	9021	6714	6772	6774	7038	7252	7253	7408
PC_3243	Gene expression of SOCS3 by STAT dimer ( JAK-STAT pathway and regulation pathway Diagram )	9021	6772	6773	6774	6775	6776	6777	6778
PC_3244	Plexin-D1 Signaling	382	9922	3672	8515	22801	3673	3675	3676	3678	3655	3679	8516	3680	3685	3688	8829	8395	23129	8153	6237	10512	9723	64218	7422
PC_3245	p73 transcription factor network	25	100	64782	174	578	581	27113	10018	274	675	699	9184	835	890	891	898	9134	983	1017	1021	1026	1111	9635	196513	9191	2033	355	2194	200933	2319	2309	2623	9518	23151	3029	23493	3297	3556	3566	83737	3714	3716	10524	5600	1432	4193	4609	4720	23327	27065	4914	8682	5204	5300	5347	1263	8611	5371	5567	10399	5888	5925	25898	5970	54894	6273	5265	5054	2810	23411	6667	63970	9540	8626	7161	7846	10277	7490	51741	10413
PC_3246	S1P1 pathway	4363	2770	2771	2773	2775	2781	3791	5594	5595	5155	5159	5330	5335	112476	5743	5879	387	1901	8877	7422
PC_3247	Succinic acid + Ubiquinone = Fumaric acid + Ubiquinol ( Arginine and Proline metabolism )	6389	6390
PC_3248	Negative regulation of (Phosphorylation of JAK) in JAK STAT pathway ( JAK-STAT pathway and regulation pathway Diagram )	3716	3717	3718	5777	7297
PC_3249	methylglyoxal degradation I	2739	3029	197257
PC_3250	Role of Calcineurin-dependent NFAT signaling in lymphocytes	9495	572	581	596	598	23523	801	801	801	814	836	11261	1387	1452	1457	2033	2280	23770	2932	3838	3837	4214	1326	1432	5595	5599	5601	4209	4772	4773	4775	3164	8021	5292	5578	5578	5579	5580	5581	5582	5588	5590	5901	1827	10231	2810	7514	7529	7531	7532	7533	10971	7534
PC_3251	Caspase3 activation signaling ( TNFR1 signaling pathway )	836	842
PC_3252	Caspase Cascade in Apoptosis	58	207	317	351	397	581	596	598	637	330	843	835	836	839	840	841	842	1073	8738	54205	1676	1677	56616	8772	355	356	2620	2934	3002	3875	3984	4000	4001	84823	8567	4214	4926	142	55367	5551	5747	8737	6304	9748	6709	6720	7020	7124	8797	8795	7132	8743	7150	8717	7186	7431	331
PC_3253	methylthiopropionate biosynthesis	55256
PC_3254	Syndecan-2-mediated signaling events	581	8573	836	858	1437	3576	2035	2048	7430	9965	8074	2263	2261	2264	2335	3265	3673	3688	3827	284217	3909	5594	5595	5599	4313	4763	5578	5580	112476	10399	5921	387	6383	6386	6714	7040	23495	51399
PC_3255	L-Arginino-succinic acid = L-Arginine + Fumaric acid ( Alanine,Aspartic acid and Asparagine metabolism )	435
PC_3256	Deoxy-guanosine + Orthophosphate = 2-Deoxy-D-ribose 1-phosphate + Guanine ( Purine nucleotides and Nucleosides metabolism )	1890
PC_3257	Thymidine + Orthophosphate = 2-Deoxy-D-ribose 1-phosphate + Thymine ( Pyrimidine Nucleotides and Nucleosides metabolism )	1890
PC_3258	NAD+ + 2-Propyn-1-al + H2O = NADH + Propiolic acid ( Propanoate metabolism )	216	8854	219	217	224	501	223
PC_3259	2-Oxo-glutaric acid + 4-Amino-butanoic acid = L-Glutamic acid + Succinate semialdehyde ( Arginine and Proline metabolism )	18
PC_3260	Glucocorticoid receptor regulatory network	174	207	581	632	1020	8851	1026	1081	1385	1387	1437	1447	3576	1958	2033	2212	2266	2288	2289	2353	2625	2932	3065	3066	3320	3383	3458	3596	3558	3565	3567	3569	3659	3725	51111	3861	3872	3852	5594	5602	5600	1432	5595	5599	5601	4193	4312	8648	10499	4772	4773	4790	9970	2908	3164	5087	5106	5443	5449	5451	5536	5578	5567	5568	5617	5970	6401	2810	6446	6597	6599	6601	6602	6688	6772	6776	6777	6613	6898	6908	30009	7157	7251	7433	7533
PC_3261	4-hydroxy-2-nonenal detoxification	2938	2940	2941	221357	2950
PC_3262	Rapid glucocorticoid signaling	1392	2774	2778	2782	54331	5600	1432	5599	5601	92170
PC_3263	Notch	102	6868	207	51107	83464	351	429	2647	4856	9541	1272	8454	28514	10683	54567	1840	2033	55294	2273	5045	2932	3065	3066	8209	388585	55502	23493	83737	182	3714	3717	8850	3932	51176	3955	4100	9794	84441	55534	5594	5595	4208	4242	9611	9612	23385	4790	4851	4853	4854	4855	8650	9253	5295	5296	23509	5663	5664	55851	3516	9978	5970	6015	8819	25942	6500	6502	4086	4088	22938	23013	6714	6774	6929	55759	7528
PC_3264	Succinyl-CoA + Acetoacetic acid = Succinic acid + Acetoacetyl-CoA ( Butanoate metabolism )	5019
PC_3265	Visual signal transduction	407	1261	54714	2780	2784	10681	2793	6011	131890	118142757	2979	9626	3000	2986	9227	101060233	5146	5149	145226	5959	8787	388531	6121	25769
PC_3266	Notch secretory pathway (C. elegans) ( Notch signaling pathway Diagram )	5045	4851	4853	4854	4855
PC_3267	pyrimidine ribonucleotides interconversion	124583	51727	129607	1503	56474	4830	4831	4832	4833	8382	10201	29922
PC_3268	Stabilization and accumulation of cytoplasmic beta-catenin (Xenopus) ( Xenopus axis formation Wnt signaling pathway Diagram )	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	4041	4040
PC_3269	citrulline-nitric oxide cycle	435	445	4842	4843	4846
PC_3270	D-glucuronate degradation I	51084	51181
PC_3271	phenylethylamine degradation I	217	224	314	8639
PC_3272	N-acetylglucosamine degradation I	51005	10007	132789
PC_3273	aspartate biosynthesis	2805	137362	2806
PC_3274	acyl-CoA hydrolysis	11332	10005	23597
PC_3275	PLC gamma signaling ( PDGF signaling pathway )	5156	5335
PC_3276	KitReceptor	25	10097	207	1386	572	695	867	868	1017	1213	1398	1399	1439	420	9046	79930	1978	2002	2033	2057	7430	2241	2242	2268	2309	2533	2534	10146	9846	10750	2887	2885	2886	2931	2932	2997	3055	3265	3575	3635	3717	3718	3725	3815	4254	27040	4067	4085	5604	5605	5594	6300	1432	5595	5599	4145	4286	8777	4478	2475	4773	5058	5290	5295	5296	5335	5336	5578	5579	5781	5777	10076	7879	5894	5921	5962	5970	6194	6195	6198	10603	10019	30011	6464	8935	8651	9306	9655	30837	6654	161742	200734	6714	26228	6772	6774	6776	6777	7006	8797	7409	7454	7456	7525
PC_3277	ERK cascade ( Integrin signaling pathway )	673	5604	5605	5594	5595
PC_3278	ERK cascade ( JAK-STAT pathway and regulation pathway Diagram )	369	673	5604	5605	5594	5595	5894
PC_3279	ATR signaling pathway	390502	84126	675	8945	890	993	995	990	1017	22897	1111	63967	2177	23291	3364	4176	4176	4193	4683	5347	5515	5518	5521	5810	5884	5888	5883	5982	5983	5984	5985	6117	6118	50485	8914	54962	11073	7529	7534
PC_3280	Gene expression of Sprouty1 ( FGF signaling pathway )	10252
PC_3281	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	55256	51074	58478	84245
PC_3282	Negative feedback regulation of FGF8 signaling by Mkp3 (Mouse) ( FGF signaling pathway )	5594	5595
PC_3283	a4b7 Integrin signaling	3676	3688	3695	8174	5747	5829	387	7412
PC_3284	Signaling with high concentrations of Hh ( Hedgehog signaling pathway )	1387	2033
PC_3285	L-cysteine degradation I	1036	2805
PC_3286	ATP + dUMP = ADP + dUDP ( Pyrimidine Nucleotides and Nucleosides metabolism )	1841
PC_3287	Fanconi anemia pathway	472	390502	84126	8553	641	672	675	83990	8945	100526739	1111	80233	91442	6624	2175	2187	2176	2177	2178	2188	2189	55215	55120	57697	23291	3014	8209	3364	4361	4683	79728	5810	5884	10111	5883	5982	5983	5984	5985	80010	6117	6118	7156	11073	29089	7398	57599	7517
PC_3288	ErbB2/ErbB3 signaling events	207	572	998	1134	1145	85440	2064	2065	2353	2885	3265	3717	3725	3845	5604	5605	5594	5602	5595	5599	5601	2475	4771	4776	4893	3084	9542	5290	5291	5295	5532	5578	5781	5879	5894	10193	6464	6654	6714	6774	9101
PC_3289	2-Methyl-butanoyl-CoA + Acceptor = 2-Methylbut-2-enoyl-CoA + Reduced acceptor ( Valine,Leucine and Isoleucine degradation )	84129	34
PC_3290	tyrosine degradation I	2184	2954	3081	3242	6898
PC_3291	2-Oxo acid + L-Ornithine = L-Amino acid + L-Glutamate 5-semialdehyde ( Arginine and Proline metabolism )	4942
PC_3292	C-MYB transcription factor network	100	136	290	490	596	330	759	839	8535	8900	891	595	947	920	1021	1026	1027	1029	1050	1051	1052	1211	1278	1314	1387	1436	1991	2033	2113	2114	2623	2625	2944	3015	8209	28996	3265	3309	3312	8826	3815	4254	3845	3950	51176	4069	8379	4094	6885	4144	4173	4353	4602	4609	4618	4654	9611	51701	4893	5079	10401	5292	5481	5530	5657	171558	5743	5897	25942	6497	6510	5250	6595	27044	6667	6688	10454	23118	22797	10043	10155	7329	7471	8089	463	161882
PC_3293	Signaling by Aurora kinases	6790	9212	6795
PC_3294	5,6-Dihydro-thymine + H2O = 3-Ureido-2-methyl-propanoic acid ( Pyrimidine Nucleotides and Nucleosides metabolism )	1807
PC_3295	Negative regulation of (G alpha GDP-GTP exchange signaling) ( GPCR signaling (G alpha s, PKA and ERK) )	2778	5996	6001	8786	6002	6003	10636	6004	26575	64407	10287	5997	8601	5998	5999	8490	9628	6000	85397	8787
PC_3296	proline biosynthesis II (from arginine)	4942	5009	5831	29920	65263
PC_3297	D-Glucose 6-phosphate = D-Fructose 6-phosphate ( Pentose phosphate cycle )	2821
PC_3298	Effects of Botulinum toxin	1134	25782	22999	6616	6804	6812	6857	10497	6844
PC_3299	Inactivation of Ptc by Hh ( Hedgehog signaling pathway )	50846	3549	5727	6469
PC_3300	androgen biosynthesis	8644	1586	3293	3283	3284	6715	6716
PC_3301	Class IB PI3K non-lipid kinase events	5604	5594	5140	5294	146850
PC_3302	lanosterol biosynthesis	4047
PC_3303	5-Formimino-tetrahydro-folic acid + L-Glutamic acid = L-Tetrahydro-folic acid + N-Formimino-L-glutamic acid ( Folate metabolism )	10841
PC_3304	FGF signaling pathway	207	632	815	867	999	1000	1500	2017	1848	2246	9965	8074	2260	2263	2261	2264	2353	10818	2549	2885	3002	3082	54756	3725	9365	152831	5594	1432	5595	4233	4318	4684	10298	5170	5290	5295	5328	5329	5335	5663	2185	5781	6195	860	6383	6385	6464	6654	6696	10253	6714	54434	6772	6774	6777
PC_3305	IKK activation signaling (through PKC beta and CARMA1	8915	84433	3551	8517	10892	6885	5579	7189	7334	387522
PC_3306	Beta catenin degradation signaling (Canonical) ( Drosophila Wingless/Wnt signaling pathway Diagram )	324	8312	8313	8945	1499	8454	2932	6500
PC_3307	Syndecan-3-mediated signaling events	181	51107	83464	8573	2017	3576	1956	9965	8074	2263	2261	2264	2534	4160	1463	23385	5443	112476	5663	55851	5764	9672	6714
PC_3308	Proteoglycan syndecan-mediated signaling events	6382	6383	9672	6385
PC_3309	Gene expression of smad7 by R-smad	4086	4087	4088	4089	4090	4092	4093
PC_3310	Wnt secretory pathway (Canonical) ( C. elegans endoderm induction Wnt signaling pathway Diagram )	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484
PC_3311	lysine degradation II	10157	501	51097
PC_3312	5'-Phospho-ribosyl-5-amino-imidazole-4-carboxylic acid = 5'-Phospho-ribosyl-5-amino-imidazole + CO2 ( Purine nucleotides and Nucleosides metabolism )	10606
PC_3313	ERK cascade ( GPCR signaling (G alpha q) )	369	673	5604	5605	5594	5595	5894
PC_3314	NAD+ + (S)-Malic acid = NADH + Pyruvic acid + CO2 ( Pyruvate metabolism )	4199	10873
PC_3315	NAD+ + 3,4-Dihydroxy-phenyl-acetaldehyde + H2O = NADH + 3,4-Dihydroxy-phenyl-acetic acid ( Tyrosine metabolism )	220	218	221
PC_3316	tetrapyrrole biosynthesis II	210	211	212	3145	7390
PC_3317	Phenylalanine degradation ( Phenylalanine degradation )	26	314	8639	1644	4128	4129
PC_3318	VEGF and VEGFR signaling network	2321	2324	3791	8829	8828	5228	7422	7423	7424	2277
PC_3319	IL5	207	240	1386	581	695	867	1399	1439	1499	1785	2002	2309	2885	2931	2932	3055	3059	3265	3560	3567	3568	3716	3717	3725	4067	5605	5594	1432	5595	4790	4792	5294	5295	5296	5321	5579	5580	2185	5781	5777	10399	5894	2889	6195	6386	10603	6464	25759	8651	6654	6659	6772	6774	6776	6777	6850	9094	7409	7534
PC_3320	Canonical NF-kappaB pathway	472	8915	329	8945	1147	1540	23085	3551	8517	10892	4215	4790	4792	64127	5578	5901	5970	8767	7124	7128	7132	7189	7323	7514
PC_3321	urea cycle	383	384	435	445	1373	5009
PC_3322	alanine biosynthesis III	9054
PC_3323	2-Oxo-glutaric acid + beta-Alanine = L-Glutamic acid + Malonate semialdehyde ( Pyrimidine Nucleotides and Nucleosides metabolism )	18
PC_3324	Glypican 2 network	221914	4192
PC_3325	TGF beta receptor I degradation signaling ( TGF-beta_super_family_signaling_pathway(canonical) )	90	91	94	657	658	5682	5683	5684	5685	5686	5687	5688	5689	5699	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5707	5716	5717	5718	5719	5708	5709	5710	5711	9861	5713	5714	5715	4092	64750	7046
PC_3326	Nicotinamide D-ribonucleotide + Pyrophosphate = Nicotinamide + D-5-Phospho-ribosyl 1-diphosphate ( Nicotinate and Nicotinamide metabolism )	10135
PC_3327	oxidative ethanol degradation III	84532	55902	79611	217	224	1571
PC_3328	(R)-Methyl-malonyl-CoA = Succinyl-CoA ( Propanoate metabolism )	4594
PC_3329	superpathway of cholesterol biosynthesis	30	38	8435	1595	1718	1717	10682	2222	2224	9453	3032	3156	3157	3158	51478	3422	91734	3930	4047	6307	4597	4598	50814	10654	6309	6713	7108
PC_3330	PDGF receptor signaling network	5154	5155	56034	80310	5156	5159
PC_3331	phosphatidylglycerol biosynthesis II (non-plastidic)	51099	10554	10555	56894	56895	55326	11200	57678	150763	84803	137964	2820	253558	10162	254531	154141	129642	79143	9489
PC_3332	Beta catenin degradation signaling (Canonical) ( C. elegans endoderm induction Wnt signaling pathway Diagram )	324	8312	8313	8945	1499	8454	2932	6500
PC_3333	PLK1 signaling events	6790	79866	8945	699	701	891	8555	991	994	995	983	1062	79682	63967	1894	54821	26271	23291	51343	2801	64689	3619	10112	3796	55857	9587	10403	22981	10726	4957	5058	5347	5500	4659	5515	5518	9055	5786	5861	387	9475	151648	147841	10735	7178	22974	7283	7465
PC_3334	leukotriene biosynthesis	240	1800	64174	4048	4056
PC_3335	Acetyl-CoA + Dihydro-lipoamide = CoA + 6-S-Acetyl-dihydro-lipoamide ( Pyruvate metabolism )	1737	8050
PC_3336	AKT(PKB)-Bad signaling ( Insulin receptor signaling )	207	208	10000	572	2810	7529	7531	7532	7533	10971	7534
PC_3337	NADP+ + Cholesterol = NADPH + 7-Dehydro-cholesterol ( Steroids metabolism )	1717
PC_3338	salvage pathways of pyrimidine deoxyribonucleotides	57379	978	7083	7084	1890
PC_3339	5'-Orotidylic acid + Pyrophosphate = Orotic acid + D-5-Phospho-ribosyl 1-diphosphate ( Pentose phosphate cycle )	7372
PC_3340	Deoxy-adenosine + Orthophosphate = 2-Deoxy-D-ribose 1-phosphate + Adenine ( Purine nucleotides and Nucleosides metabolism )	1890
PC_3341	2-Oxo-glutaric acid + L-Cysteine = L-Glutamic acid + 3-Mercapto-pyruvic acid ( Glycine and Serine metabolism )	2805	2806
PC_3342	TCR	10006	25	84320	47	52	58	55860	100	8754	191	207	311	302	2909	397	9181	9459	8874	1386	476	478	8915	622	90427	51759	23523	801	801	801	84433	57513	867	868	10694	914	919	940	23607	915	916	917	920	921	924	941	3732	8832	942	925	998	983	1051	57530	1147	1154	1213	1385	1387	1398	1399	1493	1499	23191	28988	1654	54555	1671	1606	1729	1739	3337	1785	1794	420	9046	1808	1840	1845	1859	9149	1958	10480	9844	55140	55740	2026	2042	2058	55914	51466	115352	2241	2317	2353	2533	2534	2539	9846	2665	9815	9950	10750	9402	2885	2932	51564	9146	3189	9454	3326	29851	23308	3551	3635	83737	3702	3708	50618	3718	3725	10657	55243	27040	54900	3932	3937	3939	3945	54923	4012	9404	4063	4067	10892	5604	5605	4214	9020	1326	11184	5594	5600	1432	5595	5598	5599	5601	9019	55167	54893	4582	4690	4691	4739	150372	4772	4773	4790	4792	4793	3164	4969	55824	5058	56288	5175	5223	5236	653583	5297	118788	5287	5295	5296	5315	8502	5335	5336	5532	5580	5588	5587	25865	8899	9051	5747	2185	5781	5782	26191	5774	5777	5786	5788	5794	754	5829	27291	5894	5901	5906	2889	5921	10125	10235	5966	5970	8767	9252	6198	6386	10019	9047	10044	6452	6461	6464	54716	8631	8935	6503	84174	114836	6625	6654	6655	6714	10254	6772	6775	6776	6777	27347	6789	6850	7006	7037	7189	50852	7706	7251	7846	7277	203068	7294	7296	84959	9094	7408	7409	7410	10451	7454	10163	9948	7456	10971	7534	7535	23390	342908
PC_3343	S1P2 pathway	1003	2002	2353	2767	2768	10672	9630	2769	2770	2771	2773	2775	2776	2781	3667	3725	5594	1432	5595	5599	5058	5290	5295	5879	387	9294
PC_3344	Raf activation signaling (through RasGRP) ( CD4 T cell receptor signaling (ERK cascade) )	369	673	3265	3845	4893	5588	5894	10125
PC_3345	asparagine biosynthesis I	440
PC_3346	regulation of target gene expression by NF-kB ( IL-1 signaling pathway (through NF-kappaB) )	3725	4790	5970
PC_3347	AP-1 transcription factor network	58	183	1386	467	573	10018	865	6347	3491	595	983	1027	1029	1278	10987	1385	23373	1437	1499	3576	1758	9988	1843	1906	1958	1997	2033	2099	2113	2167	2353	2354	8061	2355	2624	2697	3091	3105	3458	3586	3558	3565	3567	3569	3725	3726	3727	4094	4097	4312	4318	4502	4602	4609	4772	4773	4775	4878	2908	4922	5179	5328	5728	149603	6667	6934	7040	7054	7076	7157	7205
PC_3348	JNK cascade ( Toll-like receptor signaling pathway (through JNK cascade) )	3725	5608	6885	5602	5599	5601
PC_3349	NAD+ + 5,10-Methylene-tetrahydro-folic acid = NADH + 5,10-Methenyl-tetrahydro-folic acid ( Folate metabolism )	10797
PC_3350	Negative regulation of (G alpha i GDP-GTP exchange signaling) ( GPCR signaling (pertussis toxin) )	2770	2771	5996	6001	8786	6002	6003	10636	6004	26575	64407	10287	5997	8601	5998	5999	8490	9628	6000	85397	8787
PC_3351	Adenylate cyclase activation signaling ( GPCR signaling (pertussis toxin) )	107	55811	108	109	196883	111	112	113	114	115	2778
PC_3352	D-Mannose 6-phosphate = D-Fructose 6-phosphate ( Fructose and Mannose metabolism )	4351
PC_3353	Class I PI3K signaling events	11033	207	64411	375	381	382	640	29760	695	9267	9266	9265	27071	2268	2309	2534	3055	3265	3320	3635	3636	3702	3845	27040	3932	4067	4893	5170	5290	5291	5294	5295	146850	5335	5336	59338	59339	5728	5879	5906	387	6446	6714	6850	7525	7535
PC_3354	cholesterol biosynthesis III (via desmosterol)	1595	1718	1717	10682	2222	51478	3930	4047	6307	50814	6309	6713	7108
PC_3355	L-Glutamine + D-Fructose 6-phosphate = L-Glutamic acid + D-Glucosamine 6-phosphate ( Aminosugars metabolism )	2673	9945
PC_3356	fatty acid alpha-oxidation III	224	79152	26061
PC_3357	Prolactin	116986	207	673	8945	819	867	595	916	55835	1154	1387	1509	1785	1956	1978	2002	2033	2064	2066	2099	23291	2316	2353	2309	2534	9846	2885	2932	6596	3151	3476	3667	8660	3688	3716	3717	3725	10657	4067	5604	5605	5594	1432	5595	5596	5598	5599	5601	2475	4602	4609	4690	4752	4790	4792	4793	5058	10401	5290	5291	5294	5295	5296	5328	5478	5479	5515	5579	5580	5617	5618	5747	5770	5781	5777	5829	5894	5925	5970	6194	6196	5054	25970	6464	140885	6558	8651	8835	9021	30837	6654	6714	6772	6774	6776	6777	7006	7068	7297	7409	7410	7532	7534	7535
PC_3358	2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA	130013
PC_3359	IL-12 signaling pathway(JAK2 TYK2 STAT4) ( IL-12 signaling(JAK2 TYK2 STAT4) )	3592	3593	3594	3595	3717	6775	7297
PC_3360	ERK cascade ( PDGF signaling pathway )	2002	5604	5605	5594	5595	5894
PC_3361	Glycolysis and Gluconeogenesis ( Glycolysis and Gluconeogenesis )	2203	8789	2538	2645	3098	3099	3101	5211	5213	5214	5313	5315
PC_3362	Signaling with Wnt (Canonical) ( C. elegans endoderm induction Wnt signaling pathway Diagram )	607	1387	1499	2033	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	51176	4041	4040	26108	90780	4089	6597	6932	83439	6934	7088	7089	7090	7091	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484
PC_3363	S1P4 pathway	998	2768	10672	2770	2771	2773	2775	2781	5594	5595	5335	387	8698	53637
PC_3364	phenylalanine degradation I (aerobic)	5053	5092	84105	5860
PC_3365	2-Oxo-glutaric acid + L-Phenylalanine = L-Glutamic acid + Phenyl-pyruvic acid ( Phenylalanine degradation )	6898
PC_3366	Signaling events mediated by focal adhesion kinase	58	87	88	89	81	23092	2909	9826	64283	8874	50807	9564	660	673	824	595	1398	1793	9844	2113	2534	9815	2885	2886	3678	3685	3688	3693	3725	11279	3932	5604	6416	5594	5599	23162	5601	4638	4690	8440	5058	5290	5295	5335	5747	11099	5829	5879	5894	5906	5908	2889	5921	387	9475	6237	6455	6654	6714	7094	7414	8976	7525
PC_3367	AKT(PKB) activation signaling ( Insulin receptor signaling )	207	208	10000	5170	5290	5291	5293
PC_3368	Calcium signaling in the CD4+ TCR pathway	9495	55509	23523	801	801	801	959	11261	1390	1437	356	2280	2353	8061	3458	3558	3559	3562	3565	3725	3726	4772	4773	4775	5451	5578	5743	1827	10231
PC_3369	glutamate biosynthesis II	2746	2747
PC_3370	IFN gamma signaling pathway(JAK1 JAK2 STAT1) ( IFN gamma signaling(JAK1 JAK2 STAT1) )	3458	3459	3460	3716	3717	6772
PC_3371	ATP + Pyruvic acid + CO2 + H2O = ADP + Oxaloacetic acid + Orthophosphate ( Glycolysis and Gluconeogenesis )	5091
PC_3372	AlphaE beta7 integrin cell surface interactions	999	3682	3695
PC_3373	Gene expression of smad6/7 by R-smad	4086	4087	4088	4089	4090	4091	4092	4093
PC_3374	Galactose metabolism ( Galactose metabolism )	2683	8704	2584	2585	2720	3906
PC_3375	EphrinA-EPHA pathway	1946	1969	2042	2043	2044	285220	2045	2046
PC_3376	FOXA2 and FOXA3 transcription factor networks	6833	34	37	174	207	211	213	229	335	622	1050	1051	1052	1374	1375	126129	1385	8788	2147	3169	3170	3171	2294	2538	2645	3030	3157	6927	3172	3484	3630	3767	4023	4763	7080	2908	5105	8050	5313	6514	6667	6898	7037	7276	7351
PC_3377	ERK cascade ( PDGF signaling pathway )	2002	2005	5604	5605	5594	5595	5894
PC_3378	B cell receptor signaling pathway ( B cell receptor signaling )	29760	930	973	974	27071	2534	2885	3932	5290	5291	5293	5295	5296	5336	5579	6714	6850	7409
PC_3379	ATP + L-Glutamic acid + NH3 = ADP + L-Glutamine + Orthophosphate ( Arginine and Proline metabolism )	2752
PC_3380	CD28 signaling ( CD4 T cell receptor signaling (NF-kB cascade) )	207	208	10000	940	941	942	2534	3932	5170	5290	5291	5293	5295	5296
PC_3381	NADP+ + GDP-L-fucose = NADPH + GDP-4-dehydro-6-deoxy-D-mannose ( Fructose and Mannose metabolism )	7264
PC_3382	IFN alpha signaling pathway(JAK1 TYK2 STAT1 STAT3) ( IFN alpha signaling(JAK1 TYK2 STAT1 STAT2 STAT3) )	3439	3446	3439	3448	3449	3451	3440	3452	3441	3442	3443	3444	3445	3454	3455	3716	6772	6774	7297
PC_3383	TGF_beta_Receptor	94	207	64682	10393	29882	29945	51433	51434	163	367	409	1386	467	8312	8313	9564	672	8945	815	816	817	818	857	9133	595	898	960	8881	8697	993	996	983	1017	1019	1021	1026	1147	4435	10987	1387	1398	1455	10664	1495	1496	1499	8454	1601	1616	55802	1655	1855	1780	83658	83657	1874	1875	163126	8668	1978	2022	2033	55914	2099	2113	2130	2280	2339	2353	2354	2290	8928	2308	2309	4303	51343	10755	2885	2932	3065	9146	3172	3205	3312	3551	3622	26145	83737	3688	3690	3725	3726	3727	8850	7071	3837	51176	5604	5605	5606	5608	6885	11184	5594	1432	5595	5599	51586	4205	4208	2475	4609	8648	23327	4790	4792	4800	4801	4802	4830	9972	8021	116448	56288	50855	5170	5170	8554	9063	5290	5295	5296	64219	5371	5494	5501	23645	5515	5518	5520	5575	5576	5747	5829	5894	5925	5933	5934	9978	387	54778	6093	9252	6198	861	860	864	154075	6383	6464	102724428	6497	6498	6500	4087	4088	4089	4091	4092	57154	64750	79753	22938	6642	6643	8723	58533	6654	6662	6667	6678	6711	6714	57559	6794	114790	11171	7341	10454	6925	7027	7029	7040	7042	7043	7046	7048	7049	7050	7157	7161	7189	10131	51592	7321	7322	7323	7329	51377	7421	23339	11059	25937	7514	64328	10413	6935	9839	9765	9372
PC_3384	Gene expression of Mkp3 ( FGF signaling pathway )	1848
PC_3385	dolichol and dolichyl phosphate biosynthesis	79947	22845	79644
PC_3386	phosphatidylcholine biosynthesis I	10390	1119	1120	56994	5130	9468
PC_3387	regulation of target gene expression by AP-1 ( Toll-like receptor signaling pathway (through ECSIT, MEKK1, MKKs, JNK cascade) )	3725
PC_3388	GDP-L-fucose biosynthesis I (from GDP-D-mannose)	2762	7264
PC_3389	D-Fructose 1-phosphate = Dihydroxy-acetone phosphate + D-Glyceraldehyde ( Fructose and Mannose metabolism )	226	229	230
PC_3390	IKK activation signaling (through PKC theta and CARMA1	8915	84433	3551	8517	10892	6885	5588	7189	7334	387522
PC_3391	Degradation of beta catenin	324	8312	8313	8945	1452	1453	102800317	1499	8454	1855	1856	1857	7855	2931	2932	4040	6500	89780
PC_3392	D-Glycerate 2-phosphate = Phosphoenol-pyruvic acid + H2O ( Glycolysis and Gluconeogenesis )	2023	2026	2027
PC_3393	dolichyl-diphosphooligosaccharide biosynthesis	56052	79868	10195	29880	29929	79053	1798	8813	54344
PC_3394	mTOR signaling pathway	207	84335	9776	664	673	8945	898	1017	6249	54205	54541	64798	1938	29904	1973	1975	1977	1978	23291	3265	3551	3667	3845	5604	5605	5594	5595	79109	64223	2475	4893	27250	5170	5337	5338	5371	84271	10891	5578	55615	5894	9821	6009	253260	6195	6198	57521	10670	10325	64121	58528	54700	2810	6446	6720	7248	7249	8408	9706	7529	7531	7532	7533	10971	7534	7528
PC_3395	chondroitin sulfate degradation (metazoa)	411	2588	3073	3373	23553	6677
PC_3396	Wnt secretory pathway (Mammal) ( Mammalian Wnt signaling pathway Diagram )	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484
PC_3397	Signaling without Wnt (Canonical) ( Mammalian Wnt signaling pathway Diagram )	51176	6932	83439	6934	7088	7089	7090	7091
PC_3398	ATP + GDP = ADP + GTP ( Folate metabolism )	4830	4831	4832	4833	8382	10201	29922
PC_3399	FGF8 signaling pathway(Xenopus) ( FGF signaling pathway )	369	673	2002	2004	2005	2078	2113	2114	2119	2120	2313	3265	3845	4893	5894	6654	6655	6688
PC_3400	L-Arginine + Glycine = L-Ornithine + Guanidino-acetic acid ( Arginine and Proline metabolism )	2628
PC_3401	tetrahydrobiopterin biosynthesis I	2643	5805	6697
PC_3402	cholesterol biosynthesis I	1595	1718	1717	10682	2222	51478	3930	4047	6307	50814	6309	6713	7108
PC_3403	Integrin-linked kinase signaling	87	207	9459	8874	6790	595	11140	998	9793	1385	1499	1729	63916	9815	2932	3320	3611	80895	8826	3725	51176	3987	55679	10398	8440	142	55742	29780	64098	4659	94274	26472	81706	5829	5879	391	253260	8607	10856	6615	10460	7145	7514	6935	7791
PC_3404	5'-Phospho-ribosyl-4-carboxamido-5-amino-imidazole + Pyrophosphate = 5-Amino-4-imidazole-carboxyamide + D-5-Phospho-ribosyl 1-diphosphate ( Purine nucleotides and Nucleosides metabolism )	353
PC_3405	purine nucleotides de novo biosynthesis II	158	159	122622	471	2618	8833	3614	3615	10606	5198	5471
PC_3406	adenine and adenosine salvage VI	132
PC_3407	Thromboxane A2 receptor signaling	207	9138	407	409	640	1759	1950	1956	2268	2534	2767	2768	10672	9630	2769	2771	2776	2782	10681	54331	156	157	3055	3383	3932	4067	5600	1432	4846	5294	146850	5330	5578	5578	5579	5580	5581	5582	5588	5590	5592	5729	5739	8766	5879	387	6093	6401	9368	6714	6850	6915	7052	7412	7525
PC_3408	glutamate degradation II	2805	137362	2806
PC_3409	Direct p53 effectors	174	84883	317	324	1820	467	578	581	27113	596	597	598	79370	599	604	624	637	665	7832	10498	834	843	839	857	891	900	8812	3732	1026	10153	80781	114769	1387	1434	1509	6376	1643	54541	1655	54487	22943	29102	1843	1847	1869	1870	1871	1907	1956	2033	1969	355	2232	3169	1647	9518	2876	3066	3082	3090	3303	3303	6532	3486	3663	133746	3725	2648	3976	9448	4170	4193	4233	4292	4313	4436	10397	4800	4801	4802	58484	57060	5111	64065	55367	1263	5366	5371	5395	5457	5458	333926	23368	639	5564	3276	5728	29108	5925	25898	28984	255488	51065	50484	6273	55800	5268	5054	27244	2810	4068	6597	6591	6667	6696	55240	93624	6880	6890	7027	7039	57103	8797	8795	8794	8793	7157	7159	9540	94241	8626	7161	51499	8295	7249	7306	1462	7421	25946
PC_3410	ATP + Creatine = ADP + N-Phospho-creatine ( Arginine and Proline metabolism )	1152	1158	1159	1159	1160
PC_3411	Signaling with Wnt (Xenopus) ( Xenopus axis formation Wnt signaling pathway Diagram )	1387	2033	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	51176	4041	4040	4089	6932	83439	6934
PC_3412	NAD+ + 3-Methoxy-4-hydroxy-phenyl-acetaldehyde + H2O = NADH + Homovanillic acid ( Tyrosine metabolism )	220	218	221
PC_3413	L-dopa degradation	1312
PC_3414	Alpha-synuclein signaling	572	640	823	1457	2268	2280	2534	2869	3055	3308	5653	3932	4067	4129	11315	5330	5337	5338	5528	5580	5071	112476	2185	6531	6622	9627	6714	10273	6850	7054	1861	7332	7345	7525
PC_3415	Hedgehog signaling events mediated by Gli proteins	207	409	8945	1387	1452	1453	102800317	53944	1455	1456	23291	3170	2735	2736	2737	2770	2771	2773	2775	2781	2782	54331	2932	3065	3066	26160	8100	11127	4254	3958	5604	9788	8554	5578	5580	5727	51715	5928	5931	10284	8819	6469	25942	23309	6608	8405	27148	51684	7514
PC_3416	creatine-phosphate biosynthesis	1152	1158	1159	1159	1160
PC_3417	IL1	176	207	1386	1147	420	51295	9451	1965	8518	54461	2932	3316	3551	8517	3552	3553	3554	7850	3556	3557	3654	3656	11213	51135	3667	3725	5604	5605	5606	6416	5608	5609	9020	10746	4215	6885	5594	1432	5595	5599	5601	4615	4790	4792	4793	57162	57161	5295	5296	5321	5335	5537	5590	5781	5925	5966	5970	6285	140885	6647	8878	6774	10454	23118	257397	54472	7189	7334	387522
PC_3418	JNK cascade ( PDGF signaling pathway )	3725	6416	4214	5599
PC_3419	NADH + L-1-Pyrroline-3-hydroxy-5-carboxylic acid = NAD+ + trans-4-Hydroxy-L-proline ( Arginine and Proline metabolism )	5831	65263
PC_3420	UTP + D-Glucose 1-phosphate = Pyrophosphate + UDP-D-glucose ( Galactose metabolism )	7360
PC_3421	uridine-5'-phosphate biosynthesis	1677	7372
PC_3422	FOXM1 transcription factor network	9212	332	675	890	891	9133	595	898	994	983	1017	1019	1029	1058	1059	1063	11200	1163	1387	2033	2099	2119	2353	2305	2619	2931	255626	3303	3303	3910	5604	4313	4609	4751	4775	3175	5347	5925	6502	6667	7039	7515
PC_3423	PKA activation signaling ( GPCR Dopamine D1like receptor signaling pathway )	111	2778	5578	5567	5568	5573	5575	5576	5577
PC_3424	Alternative NF-kappaB pathway	8945	1147	9020	4790	4791	5971
PC_3425	inosine-5'-phosphate biosynthesis II	158	471	10606
PC_3426	RANKL	25	207	208	1386	529	572	823	867	868	1051	1147	1385	1540	1956	1978	2119	2204	2214	2215	2274	4303	2534	9846	3320	3309	3312	3551	8517	3716	3725	4067	5604	5608	5609	6885	1326	5594	1432	5595	5599	5601	4286	2475	4772	4790	4791	4792	126014	5295	5296	29992	5335	5336	5562	5563	10213	5747	5777	5966	5970	5971	6198	6199	861	10326	6597	6688	8878	6714	6772	6850	10454	23118	8792	4982	8600	7185	7186	7187	7188	7189	54209	7305	10451
PC_3427	D-Glycerate 2-phosphate = Phosphoenol-pyruvic acid + H2O ( Citrate cycle )	2023	2026	2027
PC_3428	Insulin Pathway	207	208	857	867	1398	420	1978	55763	55770	11336	60412	10640	54536	23265	149371	2151	2309	2887	2888	2885	3265	3635	3630	3643	3667	4690	8440	50855	5170	5290	5295	5584	5590	5770	5781	5786	2889	5921	23433	6198	6337	6446	10603	6464	10580	6654	9322
PC_3429	superoxide radicals degradation	847	6647	6648	6649	7306
PC_3430	T cell receptor signaling (PLC gamma, PKC, Ras and ERK cascade) ( CD4 T cell receptor signaling (ERK cascade) )	919	915	916	917	920	2885	3113	3115	3117	3118	3119	3120	3122	3123	3125	3126	27040	3932	5335	5336	7409	7535
PC_3431	AKT(PKB)-Bad signaling ( EPO signaling pathway(JAK2 STAT1 STAT3 STAT5) )	90	91	92	93	94	207	208	10000	238	269	369	572	657	658	659	673	695	815	816	817	818	902	8317	983	1017	1018	1019	1020	1021	1022	1024	1025	1147	1445	1452	1453	102800317	53944	1455	1456	1956	2260	2263	2261	2264	2321	2324	2534	2674	156	157	2868	2869	2870	131890	2931	2932	3480	3551	9641	8517	3643	3654	3656	51135	3702	3716	3717	3718	3791	3815	3932	4058	5604	5605	5606	6416	5607	5608	5609	4214	4294	4296	7786	9175	9020	10746	84451	4215	4217	6885	1326	4293	5871	8491	5594	5602	5600	6300	5603	1432	5595	5598	5599	5601	9261	7867	8550	4233	8569	4331	4342	2475	4804	51701	4914	5058	5062	10298	106821730	106821730	5156	5159	5170	5347	1263	5562	5563	5564	5565	5578	5567	5568	5571	51422	53632	5573	5575	5576	5577	5578	5579	5580	5581	5582	5584	5588	5590	5592	5593	5747	2185	5894	8737	8767	11035	6195	6196	6197	27330	6198	6199	6259	6714	6850	7006	7046	7048	7297	7465	10971	7535
PC_3432	Wnt secretory pathway (Canonical) ( Xenopus axis formation Wnt signaling pathway Diagram )	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484
PC_3433	IL2 signaling events mediated by STAT5	596	598	890	894	896	1021	1997	356	50943	9846	2885	3558	3559	3560	3561	3565	3716	3718	3932	4049	4609	5290	5295	5551	5781	6464	6654	6667	6776	6777
PC_3434	mitochondrial L-carnitine shuttle pathway	1374	126129	1376
PC_3435	thyroid hormone biosynthesis	1509	7173
PC_3436	IL-6 signaling pathway(JAK1 JAK2 STAT3) ( IL-6 signaling(JAK1 JAK2 STAT3) )	3569	3570	3572	3716	3717	6774
PC_3437	ATP + GMP = ADP + GDP ( Purine nucleotides and Nucleosides metabolism )	2987
PC_3438	Leptin	31	32	207	466	1386	572	960	1020	1073	1147	1154	1385	1401	1457	1956	1977	1978	2002	2033	2064	2099	2308	2534	2596	2776	2885	2931	2932	3315	3316	3480	3551	8517	3667	8660	8471	3693	3716	3717	3718	10657	3932	3952	54741	3984	5604	5605	5606	5608	5594	1432	5595	5599	9261	4137	4323	2475	8648	4790	4792	4846	5139	2923	5295	5296	5335	5336	5562	5563	5564	5565	5580	5581	5590	5728	5747	5781	5894	5966	5970	6194	6195	6196	6198	860	25970	6464	6517	8835	9021	30837	6667	6670	6714	6772	6774	6776	6777
PC_3439	(S)-3-Hydroxy-butanoyl-CoA = Crotonoyl-CoA + H2O ( Lysine degradation )	1892	1962	3030
PC_3440	IL4	207	1386	572	598	695	867	958	1050	1051	1147	1387	7852	9046	2002	2033	2113	2242	2534	9846	2885	157	126961	126961	126961	8290	3551	3596	3597	3561	3565	3566	3635	3667	8660	3716	3717	3718	3932	5594	5600	1432	5595	5599	8202	4790	4792	5290	5293	5295	5296	5335	5336	5580	5590	5747	5781	5777	5921	5970	6198	6464	27044	8651	9021	9655	6654	6688	8027	6772	6774	6776	6777	6778	6850	7297
PC_3441	D-Mannose 1-phosphate = D-Mannose 6-phosphate ( Fructose and Mannose metabolism )	55276	5372	5373
PC_3442	L-2-Amino-adipic acid + 2-Oxo-glutaric acid = 2-Oxo-adipic acid + L-Glutamic acid ( Lysine degradation )	51166
PC_3443	p38 signaling mediated by MAPKAP kinases	994	1385	2115	3315	4046	5600	1432	9261	7867	5894	2810	6722	6929	7054	7249	7529	7531	7532	7533	10971	7534
PC_3444	Secretory pathway of Hh ( Hedgehog signaling pathway )	50846	55733	3549	6469
PC_3445	Endothelins	107	108	109	196883	111	112	113	114	115	207	9564	998	1278	1281	1398	10800	57105	1906	1907	1908	1909	1910	2353	2767	2768	9630	2769	2770	2771	2773	2774	2775	2776	2778	2781	3265	3717	3725	5604	5605	5594	1432	5595	5599	4312	5321	23236	5330	5331	5578	5579	5580	5581	5582	5588	2185	5879	5894	387	6548	6550	6714	7225
PC_3446	IKK activation signaling (through PKC theta and CARMA1	8915	84433	3551	8517	10892	6885	5588	7189	7334	387522
PC_3447	adenine and adenosine salvage I	353
PC_3448	PDGF signaling pathway ( PDGF signaling pathway )	2885	3265	3845	4214	4893	5154	5155	5156	5159	5894	6464	25759	53358	6654	6655
PC_3449	glycerol degradation I	2710	2585	256356
PC_3450	ErbB4 signaling events	6868	685	863	1742	2064	2066	2069	2534	2885	2904	1839	83737	3717	26018	5594	5595	4193	9611	4734	3084	9542	10718	145957	5290	5291	5295	5617	5618	6464	6776	6777	23118	51741	11059	10413
PC_3451	D-mannose degradation	4351
PC_3452	D-myo-inositol (1,4,5)-trisphosphate degradation	3612	3613	54928	3628	3632	3633	22876	27124	51763	3636	4952	8867	8871
PC_3453	regulation of target gene expression by AP-1 ( Toll-like receptor signaling pathway (p38 cascade) )	1386
PC_3454	ALK1 signaling events	90	92	93	94	409	659	857	1460	2022	2280	2658	3397	3624	5594	5595	5499	4086	4089	4090	4092	4093	7040	7043	7046	7048	3196
PC_3455	Caspase8 activation signaling ( Fas signaling pathway )	841	8772
PC_3456	IFN alpha signaling pathway(JAK1 TYK2 STAT3) ( IFN alpha signaling(JAK1 TYK2 STAT1 STAT2 STAT3) )	3439	3446	3439	3448	3449	3451	3440	3452	3441	3442	3443	3444	3445	3454	3455	3716	6774	7297
PC_3457	acetyl-CoA biosynthesis III (from citrate)	47
PC_3458	all-trans-decaprenyl diphosphate biosynthesis	23590	57107
PC_3459	IKK-NFkB cascade ( TNFR1 signaling pathway )	1147	3551	8517	4790	4792	4793	4794	5970	8737	8767	11035
PC_3460	Signaling events mediated by HDAC Class III	84532	55902	581	1026	1387	2033	2274	2308	2309	4303	3020	3020	9759	3008	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	121504	3206	8850	4209	4654	10891	23411	22933	23410	51547	7157	10376	7280	2547
PC_3461	Adenosine + Orthophosphate = Adenine + D-Ribose 1-phosphate ( Purine nucleotides and Nucleosides metabolism )	4860
PC_3462	Beta catenin degradation signaling (Xenopus) ( Xenopus axis formation Wnt signaling pathway Diagram )	8945	8454	6500
PC_3463	NAD+ + Dihydro-lipoamide = NADH + Lipoamide ( Citrate cycle )	1738
PC_3464	ERK cascade ( IGF1 signaling pathway )	369	673	2002	5604	5605	5594	5595	5894
PC_3465	Mammalian Hh signaling pathway ( Hedgehog signaling pathway )	91653	50937	50846	64399	3549	6469
PC_3466	Pentose phosphate cycle ( Pentose phosphate cycle )	2203	8789	2539	9563	5211	5213	5214	5226	25796	64080
PC_3467	Nicotinate D-ribonucleoside + Orthophosphate = Nicotinic acid + D-Ribose 1-phosphate ( Nicotinate and Nicotinamide metabolism )	4860
PC_3468	glutathione redox reactions I	2876	2877	2878	2879	2880	257202	2882	493869	2936
PC_3469	cardiolipin biosynthesis II	54675	9489
PC_3470	a6b1 and a6b4 Integrin signaling	207	836	840	928	999	1308	1950	1956	2064	2065	2885	3265	3552	3655	3688	3691	284217	3908	3909	3910	3911	3912	3915	3914	3915	3918	4233	4485	4486	5290	5295	5376	5578	5879	6198	6256	6257	6258	2810	6464	7529	7531	7532	7533	10971	7534
PC_3471	Fructose and Mannose metabolism ( Fructose and Mannose metabolism )	197258	2645	2762	29926	29925	3098	3099	3101	3795	5207	5208	5209	5210
PC_3472	NAD+ + Acetaldehyde + H2O = NADH + Acetic acid ( Pyruvate metabolism )	216	8854	219	217	224	501	223
PC_3473	2-oxoglutarate + [dihydrolipoyllysine-residue succinyltransferase] lipoyllysine = [dihydrolipoyllysine-residue succinyltransferase] S-succinyldihydrolipoyllysine + CO2 ( Citrate cycle )	4967
PC_3474	Arf6 downstream pathway	375	382	8997	5594	5595	4830	8394	5329	5337	5338	8766	9727	5879	387	7074
PC_3475	EGF signaling pathway ( EGF signaling pathway Diagram )	1950	1956	2885	3265	3845	4214	4893	5894	6464	25759	53358	6654	6655
PC_3476	(R)-S-Lactoyl-glutathione = Glutathione + Methyl-glyoxal ( Pyruvate metabolism )	2739
PC_3477	TGF beta receptor complex degradation signaling ( TGF-beta_super_family_signaling_pathway(canonical) )	90	91	92	93	94	269	657	658	659	5682	5683	5684	5685	5686	5687	5688	5689	5699	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5707	5716	5717	5718	5719	5708	5709	5710	5711	9861	5713	5714	5715	4092	57154	7046	7048
PC_3478	ATP + CoA + Citric acid = ADP + Acetyl-CoA + Oxaloacetic acid + Orthophosphate ( Lysine degradation )	47
PC_3479	ATP + AMP = 2 ADP ( Purine nucleotides and Nucleosides metabolism )	203	204	205	26289
PC_3480	tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate	2618	4522	10797	441024
PC_3481	IFN alpha signaling pathway(JAK1 TYK2 STAT1) ( IFN alpha signaling(JAK1 TYK2 STAT1 STAT2 STAT3) )	3439	3446	3439	3448	3449	3451	3440	3452	3441	3442	3443	3444	3445	3454	3455	3716	6772	7297
PC_3482	Glypican pathway	2817	221914	2719
PC_3483	JNK signaling in the CD4+ TCR pathway	1398	1399	28988	9402	3725	27040	3937	6416	4214	6885	1326	11184	5599	5579
PC_3484	Succinyl-CoA + Acetoacetic acid = Succinic acid + Acetoacetyl-CoA ( Valine,Leucine and Isoleucine degradation )	5019
PC_3485	Regulation of Telomerase	25	65057	207	472	641	595	1027	64858	1736	1869	1950	1956	2099	2353	3065	3066	3183	3320	3364	3455	3458	3558	3659	3725	5594	5595	4149	4361	2475	4084	4609	4683	4691	4790	7026	10038	80119	54984	25913	5578	10728	5810	10111	5883	5928	5931	6198	10284	8819	25942	23309	4088	23381	23293	6667	6670	7013	7014	54386	7015	7040	26277	8658	7337	7486	7490	7520	2547	7531	57169
PC_3486	G alpha s GDP-GTP exchange signaling ( GPCR signaling (G alpha s, PKA and ERK) )	134	135	136	185	186	3577	3579	1812	1813	1814	1815	1816	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	2778	2784	10681	2793	2911	2912	2913	2914	2915	2916	2917	2918	6608
PC_3487	2-Methyl-butanoyl-CoA + Acceptor = 2-Methylbut-2-enoyl-CoA + Reduced acceptor ( Valine,Leucine and Isoleucine degradation )	35
PC_3488	Alanine,Aspartic acid and Asparagine metabolism ( Alanine,Aspartic acid and Asparagine metabolism )	16	159	122622	440	443	445	1677	1615	8528	2571	2572	4677
PC_3489	amb2 Integrin signaling	177	338	1490	3055	3146	3383	3569	3684	3689	58494	83700	4018	4035	4313	4318	4485	4486	4620	4790	5327	5328	5329	5340	5906	5908	387	6093	6403	6404	7070	7094	7124
PC_3490	Signaling mediated by p38-gamma and p38-delta	595	29904	5606	5608	51776	6300	5603	4137	5585	6640	3925
PC_3491	fatty acid activation	23205	81616	2180	2181	2182	51703	23305	11001
PC_3492	Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)	207	84335	208	324	382	50649	572	9564	867	998	999	1398	1399	1495	1499	64798	1958	1977	1978	2060	2113	2151	2549	9846	2885	3082	9146	3265	3635	3636	3725	3837	5604	5605	6416	4214	5594	5595	5599	4233	64223	2475	200958	4690	8440	8650	5058	5062	10298	50855	5170	5290	5295	5335	5584	5590	5747	5770	5781	5771	5795	5829	5868	5879	5894	57610	55705	5906	5908	2889	387	54453	57521	6456	30011	6464	6615	6654	6714	8976
PC_3493	Notch signaling pathway	102	8038	51107	83464	8945	867	595	1026	1272	27255	1487	8454	8788	28514	10683	54567	92737	1759	1840	2023	2033	2060	55294	5045	2625	3065	3565	83737	182	3714	23028	84708	9794	84441	2011	4237	8076	57534	4609	26292	9611	9612	23385	9148	4851	4853	4854	4855	8650	55851	171558	8766	5932	3516	6500	6502	23013	7528
PC_3494	(S)-3-Hydroxy-3-methyl-glutaryl-CoA = Acetyl-CoA + Acetoacetic acid ( Pyruvate metabolism )	3155
PC_3495	Methionine and Cysteine metabolism ( Methionine and Cysteine metabolism )	191	10768	23382	635	833	102724560	1036	51380	1491	2571	2572	4141	4143	4144	4357	4548
PC_3496	IMP + H2O = 5'-Phospho-ribosyl-4-carboxamido-5-formamido-imidazole ( Purine nucleotides and Nucleosides metabolism )	471
PC_3497	histidine degradation III	144193	10841	3034	4522	10797	441024	131669
PC_3498	JAK degradation signaling ( JAK-STAT pathway and regulation pathway Diagram )	3716	3717	3718	8651	7297
PC_3499	Atypical NF-kappaB pathway	409	602	8945	3551	3932	1432	4790	4792	5290	5295	5966	5970	6714	6850
PC_3500	Thrombin/protease-activated receptor (PAR) pathway	2147
PC_3501	Drosophila Wingless/Wnt signaling pathway ( Drosophila Wingless/Wnt signaling pathway Diagram )	375790	960	2817	2239	3339	6382	6383	9672	6385
PC_3502	Adenylate cyclase inactivation signaling ( GPCR signaling (pertussis toxin) )	107	55811	108	109	196883	111	112	113	114	115	2770	2771
PC_3503	ketolysis	30	38	622	56898	3032	5019
PC_3504	2 Acetyl-CoA = CoA + Acetoacetyl-CoA ( Lysine degradation )	38	8435
PC_3505	glycine biosynthesis III	189	64902
PC_3506	Gene expression of c-FLIP ( TNFR1 signaling pathway )	8837	4790	5970
PC_3507	AKT(PKB)-mTOR signaling ( Insulin receptor signaling (Mammal) )	207	208	10000	1973	1974	1977	1978	1981	8672	2475	5728	6009	6194	6198	7249
PC_3508	UDP-N-acetyl-D-glucosamine biosynthesis II	2673	9945	64841	5238	6675
PC_3509	sphingosine and sphingosine-1-phosphate metabolism	125981	340485	427	56624	22949	81537	130367	8877	56848
PC_3510	HIF-2-alpha transcription factor network	9429	135	328	405	8553	10370	1387	1942	54583	112398	112399	3646	2002	6923	6921	2033	2034	2056	2113	2321	2395	55662	3791	4323	5230	5460	5054	23411	4891	6513	6667	7291	7422	7428
PC_3511	Raf activation signaling (through Grb2 and Sos) ( CD4 T cell receptor signaling )	369	673	2885	3265	3845	4893	5894	6654	6655
PC_3512	NAD+ + 4-Trimethyl-ammonio-butanal + H2O = NADH + 4-Trimethyl-ammonio-butanoic acid ( Lysine degradation )	223
PC_3513	NAD+ + D-Glycerate 3-phosphate = NADH + 3-Phospho-hydroxy-pyruvic acid ( Glycine and Serine metabolism )	26227
PC_3514	Adenylo-succinic acid = AMP + Fumaric acid ( Alanine,Aspartic acid and Asparagine metabolism )	158
PC_3515	mevalonate pathway I	30	38	8435	3032	3156	3157	3158	3422	91734	4597	4598	10654
PC_3516	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	3632	3633	3635	27124	51763	3636	253430	3706	3707	80271	9562	4952	5728	8867	8871
PC_3517	JAK-STAT pathway and regulation pathway ( JAK-STAT pathway and regulation pathway Diagram )	959	1271	1437	1438	1439	1440	1441	3576	3577	3579	2056	2057	356	2690	2885	3439	3446	3439	3448	3449	3451	3440	3452	3441	3442	3443	3444	3445	3454	3455	3456	3458	3459	3460	3467	3586	3587	3588	3589	3592	3593	3594	3595	3596	3597	3598	3600	3601	3603	3605	23765	3606	8809	3552	3553	3554	7850	3556	3559	3560	3561	3562	3563	3565	3566	3567	3568	3569	3570	3572	3574	3575	3578	3581	3716	3717	3718	4254	54741	3976	3977	4049	4352	9180	5618	6772	6773	6774	6775	6776	6777	6778	7066	7124	8743	200081	7297
PC_3518	NAD+ + (R)-3-Hydroxy-butanoic acid = NADH + Acetoacetic acid ( Butanoate metabolism )	622
PC_3519	PLC gamma signaling ( PDGF signaling pathway )	5159	5335
PC_3520	Rap1 activation signaling (through cAMP and Epac) ( GPCR signaling (G alpha s, Epac and ERK) )	5906	5908	10411	11069
PC_3521	p38 cascade ( IL-1 signaling pathway (through p38 cascade) )	1386	5604	5605	5606	6416	5607	5608	5609	6885	5602	5600	6300	5603	1432	5599	5601
PC_3522	IL-3 signaling pathway(JAK1 JAK2 STAT5) ( IL-3 signaling(JAK1 JAK2 STAT5) )	1439	3562	3563	3716	3717	6776	6777
PC_3523	JNK cascade ( Toll-like receptor signaling pathway (through ECSIT, MEKK1, MKKs, JNK cascade) )	3725	5604	5605	5606	6416	5607	5608	5609	4214	5602	5599	5601
PC_3524	Signaling with Wnt (Canonical) ( Drosophila Wingless/Wnt signaling pathway Diagram )	607	1387	1499	2033	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	51176	4041	4040	26108	90780	4089	6597	6932	83439	6934	7088	7089	7090	7091	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484
PC_3525	2-Oxo-glutaric acid + L-Cysteine-sulfinic acid = L-Glutamic acid + 3-Sulfinyl-pyruvic acid ( Methionine and Cysteine metabolism )	2805	2806
PC_3526	JNK cascade ( EGF signaling pathway Diagram )	3725	6416	4214	5599
PC_3527	Signaling without Wnt (Canonical) ( Drosophila Wingless/Wnt signaling pathway Diagram )	51176	6932	83439	6934	7088	7089	7090	7091
PC_3528	TNFR1 signaling pathway ( TNFR1 signaling pathway )	581	637	841	8837	54205	8772	83737	4217	8737	8767	11035	7124	7132	8717	7186
PC_3529	IL6	207	367	572	660	695	867	958	1020	1025	1051	1387	1616	1965	1977	1978	2033	2064	2065	2242	2268	2353	2308	2309	4303	2534	2549	9846	2885	2932	3055	3065	6927	3178	3265	3320	3315	3569	3570	3572	3635	3636	3716	3717	3725	4067	5604	5605	6416	5608	4216	6885	5594	1432	5595	5599	4137	8648	4790	4792	51701	10401	5295	5296	5335	5580	5747	2185	5781	5829	5879	5925	6196	6198	6446	6464	140885	9021	6654	6772	6774	6776	6777	7006	7297	7409
PC_3530	choline biosynthesis III	10390	56994	5130	9468	5337	5338	23646	122618	201164
PC_3531	tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde	125061	23498	8564	8942	6999
PC_3532	methylglyoxal degradation VI	197257
PC_3533	Plasma membrane estrogen receptor signaling	207	9564	2099	2100	2767	10672	9630	2769	2770	2771	2773	2774	2775	2776	2778	2781	2782	54331	2885	1839	3265	3479	3480	3845	5600	4313	4318	4478	4846	4893	27043	5290	5295	23236	5330	5331	387	9475	6464	6654	6714	6801
PC_3534	BMP2 signaling pathway(through TAK1) ( BMP2 signaling(through TAK1) )	650	657	658	659	6885	4091	10454	331
PC_3535	ATP + Pyruvic acid + CO2 + H2O = ADP + Oxaloacetic acid + Orthophosphate ( Citrate cycle )	5091
PC_3536	Calcineurin-regulated NFAT-dependent transcription in lymphocytes	55509	801	801	801	836	868	959	1019	1390	1437	1493	3576	1606	1869	1958	1959	1960	1961	356	2353	8061	50943	2625	51062	3458	10320	3558	3559	3562	3565	3567	3662	83737	3725	3726	4094	4772	4773	4775	5451	5468	5588	5743	5770	5796	79589	6520	30009	7124
PC_3537	ATF-2 transcription factor network	43	383	1386	467	596	598	672	865	890	595	1019	255631	1385	1466	8452	3576	1843	11221	1847	1850	2033	2099	2353	1647	9555	3048	8209	8739	3458	51561	3569	3630	122953	3725	3726	3727	10524	5594	5600	1432	5595	5599	5601	4313	4763	4843	5156	5328	5451	10891	5578	5925	10856	6401	5268	9021	7042	7054
PC_3538	LIF signaling pathway ( LIF signaling(JAK1 JAK2 STAT3) )	1387	2033	3572	3716	3717	3976	3977	4086	4089	6774
PC_3539	2-Methyl-propanoyl-CoA + Acceptor = 2-Methylprop-2-enoyl-CoA + Reduced acceptor ( Valine,Leucine and Isoleucine degradation )	84129	34
PC_3540	Steroids metabolism ( Steroids metabolism )	2224	9453	3156	4597	4598	10654	6309	6646	8435	6713
PC_3541	Trk receptor signaling mediated by PI3K and PLC-gamma	116986	207	572	815	814	595	1385	1958	2036	2309	2549	2885	2932	3265	3845	4803	4893	4914	5170	5290	5295	5335	5580	2810	6464	6654	6714	6776	7222	7442	7529	7531	7532	7533	10971	7534
PC_3542	Signaling with Hh ( Hedgehog signaling pathway )	2735	2736	2737
PC_3543	Raf activation signaling (through RasGRP) ( CD4 T cell receptor signaling )	369	673	3265	3845	4893	5894	10125
PC_3544	(S)-Malic acid = Fumaric acid + H2O ( Citrate cycle )	2271
PC_3545	ATP + dGMP = ADP + dGDP ( Purine nucleotides and Nucleosides metabolism )	2987
PC_3546	S-methyl-5'-thioadenosine degradation II	4507
PC_3547	EPHB forward signaling	998	1398	1759	1946	1947	1948	1949	2047	2048	2049	2050	2885	2886	3265	6453	8997	3845	5604	9448	5594	5595	4690	4893	5058	5290	5295	5747	5829	5879	5906	5908	5921	6093	6237	6456	6464	6714	8867	7018	8976
PC_3548	aspartate degradation II	2805	137362	2806	4190	4191
PC_3549	Valine,Leucine and Isoleucine degradation ( Valine,Leucine and Isoleucine degradation )	30	10449	216	8854	219	217	224	501	223	3032	11112	3157	3158	3712	56922	64087
PC_3550	ALK2 signaling events	90	268	269	655	659	2280	4086	4089	4090	4093	3196
PC_3551	JNK cascade ( CD4 T cell receptor signaling (JNK cascade) )	2353	2354	8061	2355	3725	5604	5605	5594	5602	5595	5599	5601
PC_3552	Guanosine + Orthophosphate = Guanine + D-Ribose 1-phosphate ( Purine nucleotides and Nucleosides metabolism )	4860
PC_3553	IKK-NF-kappaB cascade ( B cell receptor signaling )	1147	3551	8517	4790	4792	4793	4794	5970
PC_3554	Tyrosine metabolism ( Tyrosine metabolism )	26	314	8639	1312	1621	1644	2184	2954	3081	3242	4128	4129	5409	7054	7299
PC_3555	glutathione-mediated detoxification I	290	8836	2678	124975	2686	2938	2939	2940	2941	221357	373156	2944	2946	2947	2948	2949	119391	2950	2952	2953	653689	2954	4257	4258	4259
PC_3556	thymine degradation	1400	1806	1807	1808	1809	10570	56896	51733
PC_3557	Internalization of ErbB1	273	8874	867	868	998	100526767	1759	1950	1956	29924	2060	2885	9146	3265	6453	3845	26018	4893	5290	5291	5295	5747	5868	5894	6456	30011	6464	6654	10253	6714	10617	8867	7251	7321	7322	7323	9101	57732
PC_3558	IL-2 signaling pathway(JAK1 JAK3 STAT5) ( IL-2 signaling(JAK1 JAK3 STAT5) )	3559	3560	3561	3716	3718	6776	6777
PC_3559	N6-Acetyl-L-lysine + 2-Oxo-glutaric acid = 6-Acetamido-2-oxo-hexanoic acid + L-Glutamic acid ( Lysine degradation )	51166
PC_3560	ATP + D-Glycerate 3-phosphate = ADP + 1,3-Bisphospho-D-glyceric acid ( Glycolysis and Gluconeogenesis )	5230	5232
PC_3561	Sphingosine 1-phosphate (S1P) pathway	4363	2767	2768	10672	9630	2769	2770	2771	2773	2775	2776	2781	1901	9294	1903	8698	53637	8879	81537	8877	56848
PC_3562	2 Farnesyl diphosphate + NADPH => NADP+ + Squalene + 2 Pyrophosphate ( Steroids metabolism )	2222
PC_3563	D-Mannose 6-phosphate = D-Fructose 6-phosphate ( Aminosugars metabolism )	4351
PC_3564	NAD+ + 3-Mercapto-lactic acid = NADH + 3-Mercapto-pyruvic acid ( Methionine and Cysteine metabolism )	3939	92483	3945	3948
PC_3565	Alpha9 beta1 integrin signaling events	8038	8751	2515	101	9564	1437	1438	2162	2335	3680	3688	3772	4843	196743	5829	5879	6303	6696	6714	7052	3371	7412	7422	7424	2277
PC_3566	Cytosolic calcium ion concentration elevation (through IP3 receptor) ( GPCR GroupI metabotropic glutamate receptor signaling pathway )	3708	3710
PC_3567	IL3-mediated signaling events	598	1051	1154	10256	1439	9846	2885	3065	3397	3562	3563	3635	3717	5008	5290	5295	5292	5578	5567	5568	5781	6464	6726	6776	6777	7532	7534
PC_3568	Signaling with Hh ( Hedgehog signaling pathway )	2736
PC_3569	ATP + CoA + Citric acid = ADP + Acetyl-CoA + Oxaloacetic acid + Orthophosphate ( Citrate cycle )	47
PC_3570	Arf1 pathway	10097	10096	160	1173	375	55738	10565	23647	79658	50807	920	1211	1212	1314	9267	9266	2069	8729	23163	28964	9570	10945	10914	8394	5338	5879	8615	10652
PC_3571	selenocysteine biosynthesis II (archaea and eukaryotes)	118672	6301	54938	22929	22928	51091
PC_3572	Canonical Wnt signaling pathway ( C. elegans endoderm induction Wnt signaling pathway Diagram )	375790	25776	960	1499	56998	22943	27123	27122	27121	2487	2817	2239	3339	83999	79412	51176	4041	4040	6885	51701	6382	6383	9672	6385	2810	6423	6424	6932	83439	6934	11197	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484	7529	7531	7532	7533	10971	7534
PC_3573	ERK cascade ( VEGF signaling pathway )	2002	5604	5605	5594	5595	5894
PC_3574	N-Ribosyl-nicotinamide + Orthophosphate = Nicotinamide + D-Ribose 1-phosphate ( Nicotinate and Nicotinamide metabolism )	4860
PC_3575	xanthine and xanthosine salvage	4860
PC_3576	D-Fructose 1,6-bisphosphate = Dihydroxy-acetone phosphate + D-Glyceraldehyde 3-phosphate ( Fructose and Mannose metabolism )	226	229	230
PC_3577	gamma-glutamyl cycle	290	55748	54878	2729	2730	79017	2678	124975	2686	2937	26873
PC_3578	Trk receptor signaling mediated by the MAPK pathway	673	1020	8851	1385	1958	30844	2002	2353	3265	3845	5604	5606	5607	5608	10746	5594	1432	5595	5598	9261	4208	4893	4908	5580	5894	5906	5908	6016	6014	6195	9252	23623	6722	7442
PC_3579	(S)-3-Hydroxy-2-methyl-propanoyl-CoA = 2-Methylprop-2-enoyl-CoA + H2O ( Valine,Leucine and Isoleucine degradation )	1892	1962	3030
PC_3580	EPHA forward signaling	22899	640	867	1020	1398	1399	1942	1943	1944	1946	2041	1969	2042	2043	2044	285220	2045	2046	2268	2534	3055	3932	4067	25791	5294	146850	5335	387	6093	6714	7410	10451	7525
PC_3581	S1P3 pathway	207	10000	7852	2321	2767	2768	10672	9630	2769	2770	2771	2773	2775	2776	2781	3717	5594	5595	5155	5159	5879	387	1903	6714	7422
PC_3582	2-Oxo-glutaric acid + L-Tyrosine = L-Glutamic acid + 4-Hydroxy-phenyl-pyruvic acid ( Tyrosine metabolism )	6898
PC_3583	NADP+ + D-Glucose = NADPH + D-Glucono-1,5-lactone ( Pentose phosphate cycle )	9563
PC_3584	Acetyl-CoA + Glycine = CoA + L-2-Amino-3-oxo-butanoic acid ( Glycine and Serine metabolism )	23464
PC_3585	Lysine degradation ( Lysine degradation )	10157	8424	2639	6470	6472	55217
PC_3586	IL8- and CXCR2-mediated signaling events	207	408	409	867	3576	3579	1759	1794	9844	2268	9630	2769	2771	2782	54331	3055	4067	92170	5170	5294	146850	23236	5330	5331	5338	5515	5518	5578	5579	5582	8766	5868	7879	5880	7408
PC_3587	IL-1_signaling(through_JNK_cascade)(canonical) ( IL-1 signaling pathway (through JNK cascade) )	3552	3553	3554	3556	3654	51135	6885	4615	10454	23118	54472	7189	7334	387522
PC_3588	AKT(PKB) activation signaling ( IGF1 signaling pathway )	207	208	10000	5170	5290	5291	5293
PC_3589	2-Oxo-glutaric acid + L-Valine = L-Glutamic acid + 3-Methyl-2-oxo-butanoic acid ( Valine,Leucine and Isoleucine degradation )	586	587
PC_3590	5'-Orotidylic acid + Pyrophosphate = Orotic acid + D-5-Phospho-ribosyl 1-diphosphate ( Pyrimidine Nucleotides and Nucleosides metabolism )	7372
PC_3591	Calcineurin activation signaling ( CD4 T cell receptor signaling (JNK cascade) )	5530	5532	5533	5534
PC_3592	glycerol-3-phosphate shuttle	2819	2820
PC_3593	D-Fructose 1,6-bisphosphate = Dihydroxy-acetone phosphate + D-Glyceraldehyde 3-phosphate ( Glycolysis and Gluconeogenesis )	226	229	230
PC_3594	NAD+ + (S)-Malic acid = NADH + Pyruvic acid + CO2 ( Pyruvate metabolism )	4200
PC_3595	Regulation of RAC1 activity	10006	29	392	55114	9743	64333	396	9181	115557	9459	8874	613	1123	1124	1671	1793	1794	57572	9844	2059	8997	4168	25791	57580	80243	5879	29127	10928	5910	5923	5924	6654	221178	7074	26230	7204	7409	7410	10451
PC_3596	FGF signaling pathway ( FGF signaling pathway )	369	673	2246	2255	2256	2258	2259	8823	8822	8817	9965	2247	26281	26291	27006	8074	2248	2249	2250	2251	2252	2253	2254	2260	2263	2261	2264	10818	10817	2549	2885	3265	3845	4893	5290	5291	5293	5295	5335	5336	5580	5894	6654	6655
PC_3597	BARD1 signaling events	472	390502	571	580	672	898	1017	1477	2130	2175	2176	2177	2178	2188	2189	55120	4361	4683	5111	5591	10111	5888	5932	11073	7157	7323	7332	7520	2547
PC_3598	Validated targets of C-MYC transcriptional activation	86	581	586	332	100532731	1677	891	894	993	83879	1019	1387	8886	1736	1871	1965	1973	1977	1981	2023	2033	8061	2597	57678	3159	3320	3308	3329	10075	3398	3658	2648	10524	3811	3939	389421	4149	4318	9112	92140	4609	80177	4683	4691	91942	4830	4831	4869	4953	11235	23089	5213	5292	5366	661	10935	5757	1104	84864	6135	8607	10856	5274	6470	6513	4088	4089	6615	8464	9913	6881	6883	6875	6880	7015	7037	7083	7157	8295	7343
PC_3599	Regulation of nuclear beta catenin signaling and target gene transcription	113	324	367	8313	607	8945	8913	814	25776	3491	595	894	999	1029	1044	1046	57680	1487	1499	56998	8454	3576	22943	27121	1857	2033	2249	26959	3065	3066	3398	10642	3619	3725	80333	9314	3848	51176	29969	9968	4286	4313	4318	4513	4609	4617	4656	10499	4762	5308	10856	57167	2810	6500	6597	6591	389058	6907	79718	6862	6925	6932	83439	6934	7015	7088	7089	7091	166	23043	8295	1462	7514	7529	7531	7532	7533	10971	7534	170261
PC_3600	FoxO family signaling	207	10018	604	847	891	1017	1027	1147	1387	1452	1453	102800317	53944	1455	1456	1499	2033	356	114907	2308	2309	4303	2538	1647	3551	8850	5602	5599	5601	4485	5347	5898	5899	5901	5934	2810	6446	23411	6502	6648	7874	7514	7529	7531	7532	7533	10971	7534	7763
PC_3601	VEGFR1 specific signals	207	801	801	801	857	867	23607	2321	3091	3320	5594	5595	4690	4846	8829	8828	5170	5228	5290	5295	5335	5578	5578	5579	5781	5921	25759	7422	7423
PC_3602	L-cysteine degradation II	1491
PC_3603	glutamate removal from folates	8836
PC_3604	Canonical Wnt signaling pathway ( Drosophila Wingless/Wnt signaling pathway Diagram )	375790	25776	960	1499	56998	22943	27123	27122	27121	2487	2817	2239	3339	83999	79412	51176	4041	4040	6885	51701	6382	6383	9672	6385	2810	6423	6424	6932	83439	6934	11197	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484	7529	7531	7532	7533	10971	7534
PC_3605	JNK cascade ( Toll-like receptor signaling pathway (through JNK cascade) )	3725	5604	5605	5606	6416	5607	5608	5609	6885	5602	5599	5601
PC_3606	IL5-mediated signaling events	1154	1439	2885	3567	3568	3717	4067	5290	5295	5292	5781	6386	6776	6777
PC_3607	Endogenous TLR signaling	633	929	1147	3146	3329	3551	8517	3654	3656	51135	23643	4615	387	6279	6280	6288	6289	653509	148022	114609	7096	7097	7098	7099	10333	1462
PC_3608	BMP signaling pathway ( BMP signaling in Drosophila )	27302	9210	650	651	652	653	654	655	656	657	658	659	1387	2033	2662	10220	2658	9573	8200	392255	151449	2661	9794	84441	55534	2660	4086	4087	4088	4089	4090	4093	6597	7490
PC_3609	IL-23 signaling pathway(JAK2 TYK2 STAT3 STAT4) ( IL-23 signaling(JAK2 TYK2 STAT3 STAT4) )	3593	3594	3717	6774	6775	7297
PC_3610	IGF1 pathway	207	572	9564	1398	1399	2887	2885	3265	3479	3480	3667	8660	8440	5170	5290	5295	5580	5590	5587	5747	5770	5781	5829	10399	5894	6198	6464	6654	7531	7534
PC_3611	RhoA signaling pathway	58	1386	3491	998	1027	1072	11113	1729	2119	7430	2151	2353	3688	3725	3984	3985	5606	6416	5608	6300	5599	57591	4478	4633	50855	8394	8395	23396	5585	5586	5337	5338	4659	5590	5728	5962	387	6093	9475	286205	6456	6548	6550	6722	7094	7414
PC_3612	TGF beta signaling pathway(through TAK1) ( TGF-beta signaling(through TAK1) )	6885	10454	7040	7042	7043	7046	7048	331
PC_3613	glucose and glucose-1-phosphate degradation	2645	80201	5236	55276	5239
PC_3614	AKT(PKB)-GSK3beta signaling ( Insulin receptor signaling (Mammal) )	207	208	10000	2932	2997	2998
PC_3615	EGF signaling pathway (D. melanogaster) ( EGF signaling pathway Diagram )	2810	7529	7531	7532	7533	10971	7534
PC_3616	Beta3 integrin cell surface interactions	3491	961	1277	1278	1282	1284	1285	1286	1287	1288	10085	50848	2200	2243	2244	2266	2335	3146	3381	3674	3685	3690	3791	3897	3910	3912	3915	5155	5159	5175	5328	5329	5817	6382	6385	8877	6696	7045	7048	7057	7070	3371	7422	7448
PC_3617	TNFalpha	86	10270	207	208	249	317	9138	9181	9530	581	598	602	605	637	329	330	1620	8945	843	835	836	840	841	842	857	904	997	11140	1020	1025	1072	8837	1147	150684	9276	8533	10987	8738	1385	1387	1410	1457	8454	1535	10238	1654	56616	420	5977	8726	1956	8518	2033	2064	2065	8772	11124	2177	2091	23291	55294	2289	2316	2308	9908	2549	2720	2734	2752	2885	2969	3065	3066	10013	8290	3146	3320	3326	3303	3303	3309	3312	3315	3551	9641	8517	10788	134728	3667	8660	83737	3725	3726	3784	3838	3839	23633	3895	10128	8567	5604	6416	5607	5608	5609	4214	4296	9020	10746	4215	4217	6885	1326	5871	5594	1432	5595	5599	5601	9261	2011	4163	4174	4176	4528	2475	4633	10398	4638	653361	4790	4791	4792	4793	4794	64332	28512	28511	147945	7182	8439	26471	56957	5058	10914	5134	5170	5178	5202	10401	5295	5296	5585	5371	25885	84172	9533	51082	9533	5437	5441	4659	10848	5537	9055	5578	5580	5581	5588	5590	5693	5700	5701	5702	5707	5718	5719	5708	5709	9861	5713	5747	5781	5836	10399	22821	9462	5925	5966	5970	5971	117584	55312	8737	11035	26994	64320	140823	6156	6124	6128	6132	6205	6207	9252	6198	6256	9919	6500	4087	4088	6597	6598	6599	6601	6605	55512	6654	6655	9043	6714	6772	6776	7341	6850	10454	23118	257397	10010	8887	29110	9755	92610	7124	7128	8792	7132	7133	943	79155	7157	8717	7185	7186	7187	9618	7188	7189	84231	10293	10131	83696	57761	22954	26133	200081	7295	10628	7322	7323	7329	222643	8237	9099	331	7529	7531	7532	7533	10971	7534	7709	7763
PC_3618	BCR	207	1386	493	55024	581	9564	8915	596	10018	604	640	29760	673	695	151888	84433	836	840	842	867	868	6348	388372	890	894	896	898	930	933	921	971	973	974	975	1017	1019	1021	1022	51363	1147	123920	1380	1385	1398	1399	1445	1499	54205	27071	28988	1785	420	79930	1978	2002	2213	2353	2354	2308	2309	2534	2549	9846	2885	2931	2932	2969	3055	3059	10014	51564	3190	8519	3551	8517	3635	3702	3708	3709	3725	3726	7462	3932	3937	54923	4067	10892	5604	5605	6885	11184	5594	1432	5595	5596	5599	5601	9261	4690	4739	4773	4775	4790	4792	5170	118788	5293	5294	5295	5296	5305	8396	79837	8394	8395	23396	5335	5336	59338	59339	5579	5580	5581	5588	5587	5747	2185	5781	26469	5777	5788	5894	5911	2889	5921	25780	5925	5966	5970	6194	6195	6198	22800	10603	6452	6464	84174	6654	6655	26228	6772	6774	6850	8115	7006	7408	7409	7410	7454	7535
PC_3619	p38 cascade ( BMP2 signaling(through TAK1) )	1386	5606	5608	6885	5600	6300	5603	1432
PC_3620	L-Arginino-succinic acid = L-Arginine + Fumaric acid ( Citrate cycle )	435
PC_3621	D-Fructose 6-phosphate + D-Glyceraldehyde 3-phosphate = D-Erythrose 4-phosphate + D-Xylulose 5-phosphate ( Pentose phosphate cycle )	7086	8277	84076
PC_3622	VEGFR3 signaling in lymphatic endothelium	207	1277	1278	1385	1398	2324	2335	2885	3672	3673	3676	3678	3688	6416	5594	5600	1432	5595	5290	5295	112476	6195	6464	6654	7424	2277
PC_3623	fatty acid biosynthesis initiation II	2194	54995	146861
PC_3624	Uridine + Orthophosphate = Uracil + D-Ribose 1-phosphate ( Pyrimidine Nucleotides and Nucleosides metabolism )	7378
PC_3625	Succinic acid + Ubiquinone = Fumaric acid + Ubiquinol ( Citrate cycle )	6389	6390
PC_3626	Citric acid = cis-Aconitic acid + H2O ( Citrate cycle )	48	50
PC_3627	spermidine biosynthesis I	262	6723
PC_3628	LKB1 signaling events	84335	84446	9024	51719	11140	1385	200186	1509	2099	2118	7430	2932	3320	4133	4137	2011	57787	64223	2475	4609	5578	5664	57521	2810	102724428	23235	23387	4089	6604	6794	114790	51765	92335	55437	7157	7248	7249	7529	7531	7532	7533	10971	7534
PC_3629	NADP+ + 5,6-Dihydro-uracil = NADPH + Uracil ( Pyrimidine Nucleotides and Nucleosides metabolism )	1806
PC_3630	(S)-2,3-Epoxy-squalene = Lanosterol ( Steroids metabolism )	4047
PC_3631	IL-1 signaling pathway (through p38 cascade) ( IL-1 signaling pathway (through p38 cascade) )	3552	3553	3554	3556	3654	51135	6885	4615	10454	23118	54472	7189	7334	387522
PC_3632	Calcineurin activation signaling ( CD4 T cell receptor signaling )	5530	5532	5533	5534
PC_3633	Growth hormone signaling pathway(JAK2 STAT5) ( Growth hormone signaling(JAK2 STAT5) )	2688	2690	3717	5781	8651	8835	9021	6776	6777
PC_3634	BMP Signalling Pathway	650	6497	4089	7321	7323	9765
PC_3635	ATP + UMP = ADP + UDP ( Pyrimidine Nucleotides and Nucleosides metabolism )	51727
PC_3636	fatty acid alpha-oxidation II	23205	81616	2180	2181	2182	51703	23305	26061	5264	11001
PC_3637	Signaling with Wnt (Canonical) ( Canonical Wnt signaling pathway Diagram )	607	1387	1499	2033	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	51176	4041	4040	26108	90780	4089	6597	6932	83439	6934	7088	7089	7090	7091	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484
PC_3638	IL-7 signaling pathway(JAK1 JAK3 STAT5) ( IL-7 signaling(JAK1 JAK3 STAT5) )	572	3561	3574	3575	3716	3718	5290	5291	5293	5295	5296	6776	6777
PC_3639	NGF signaling pathway ( NGF signaling pathway )	369	673	2885	3265	3845	4803	4893	4914	5335	5580	5894	6464	25759	53358	6654	6655
PC_3640	CD28 signaling ( CD4 T cell receptor signaling )	940	941	942
PC_3641	Malonyl-CoA = Acetyl-CoA + CO2 ( Pyruvate metabolism )	23417
PC_3642	Butanoyl-CoA + Acceptor = Crotonoyl-CoA + Reduced acceptor ( Butanoate metabolism )	35
PC_3643	(S)-Dihydro-orotic acid + O2 = Orotic acid + H2O2 ( Pyrimidine Nucleotides and Nucleosides metabolism )	1723
PC_3644	pyridoxal 5'-phosphate salvage pathway	8566	55163
PC_3645	alanine degradation III	2875	84706
PC_3646	Validated transcriptional targets of TAp63 isoforms	25	100	64782	581	27113	8945	91768	1026	1029	1147	9635	9249	23405	667	1959	2033	2125	355	2232	2319	1647	9518	2877	26959	3486	3551	83737	3675	3691	182	4193	4240	26155	1728	4968	64065	5347	5366	5371	5580	6273	5268	6469	6604	6667	132671	6749	7022	9540	8626	9618	7421	11059	10971
PC_3647	superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)	30	38	8435	2224	9453	3032	3156	3157	3158	3422	91734	4597	4598	10654
PC_3648	2-Oxo-glutaric acid + N2-Succinyl-L-ornithine = L-Glutamic acid + N2-Succinyl-L-glutamate 5-semialdehyde ( Arginine and Proline metabolism )	4942
PC_3649	T cell receptor signaling (PLC gamma, PKC, Ras and IKK-NF-kappaB cascade) ( CD4 T cell receptor signaling (NF-kB cascade) )	919	915	916	917	920	3113	3115	3117	3118	3119	3120	3122	3123	3125	3126	27040	3932	4790	5335	5336	5588	10125	5970	7409	7535
PC_3650	UDP-D-xylose and UDP-D-glucuronate biosynthesis	7358	80146
PC_3651	L-Alanine + Glyoxylic acid = Pyruvic acid + Glycine ( Glycolysis and Gluconeogenesis )	189	64902
PC_3652	Syndecan-4-mediated signaling events	87	8038	6352	6387	7852	1785	2147	2247	2251	2260	2335	8324	10755	3678	3688	284217	3909	4192	4318	84309	5340	5578	5580	5747	5879	387	6385	6386	7035	7057	3371	23495
PC_3653	alpha-tocopherol degradation	8529
PC_3654	C-MYC pathway	86	8312	1029	55294	2932	26959	2648	10524	4149	4609	5062	5300	5371	5515	5525	8607	10856	6502	8464	9913	6881	6883	6880	8295	7709
PC_3655	ERK cascade ( CD4 T cell receptor signaling (ERK cascade) )	369	673	5604	5605	5594	5602	5595	5599	5601	5894
PC_3656	Glypican 1 network	351	640	2247	2260	2268	2321	2534	2817	3055	284217	3932	4067	3084	5320	5621	462	9353	4087	6714	6997	7040	7043	7046	7048	7422	7525
PC_3657	triacylglycerol degradation	26090	57406	3990	3991	8513	9388	11343	5406	5408	119548	57104	80339	8228
PC_3658	N-Acetyl-D-glucosamine = N-Acetyl-D-mannosamine ( Aminosugars metabolism )	5973
PC_3659	BMP2 signaling pathway(through Smad) ( TGF-beta_BMP Diagram(MolecularVariation) )	25805	650	657	658	659	1387	2033	4086	4089	4091	4092	6774	23090
PC_3660	G alpha s GDP-GTP exchange signaling ( GPCR Adenosine A2A receptor signaling pathway )	135	2778	2784	10681	2793
PC_3661	heme biosynthesis from uroporphyrinogen-III I	1371	2235	3060	7389
PC_3662	Caspase9 activation signaling ( Fas signaling pathway )	317	842	54205
PC_3663	Wnt signaling network	10159	115908	22943	8321	11211	2535	8322	7855	8323	8324	8325	8326	3487	83999	79412	4041	4040	4920	284654	6259	50964	11197	7471	7472	7473	89780	7474	7476	7477
PC_3664	p63 transcription factor network	8626
PC_3665	Mammalian Notch signaling pathway ( Notch signaling pathway Diagram )	6868	1387	28514	2033	182	9794	84441	55534	4851	4853	4854	4855	5663	5664	3516
PC_3666	NAD+ + Phenyl-acetaldehyde + H2O = NADH + Phenyl-acetic acid ( Phenylalanine degradation )	220	218	221
PC_3667	JNK cascade ( TGF-beta signaling(through TAK1) )	3725	6416	6885	5602	5599	5601
PC_3668	Stabilization and accumulation of cytoplasmic beta-catenin (Canonical) ( Xenopus axis formation Wnt signaling pathway Diagram )	324	8312	8313	102800317	1499	1855	1856	1857	10023	23401	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	2932	4041	4040
PC_3669	L-Tetrahydro-folic acid + L-Serine = 5,10-Methylene-tetrahydro-folic acid + Glycine + H2O ( Folate metabolism )	6470	6472
PC_3670	Rap1 activation signaling (through cAMP, PKA, Cbl and C3G) ( GPCR Adenosine A2A receptor signaling pathway )	867	868	23624	1399	5578	5567	5568	5906	5908	2889	6714
PC_3671	inositol pyrophosphates biosynthesis	9807	51447	117283	253430	64768	9677	23262
PC_3672	NAD phosphorylation and dephosphorylation	51205	65220	23530	92370
PC_3673	L-Alanine + Glyoxylic acid = Pyruvic acid + Glycine ( Glycine and Serine metabolism )	189	64902
PC_3674	p38 cascade ( Toll-like receptor signaling pathway (p38 cascade) )	1386	5604	5605	5606	6416	5607	5608	5609	6885	5600	6300	5603	1432
PC_3675	thio-molybdenum cofactor biosynthesis	55034
PC_3676	IGF1 signaling pathway ( IGF1 signaling pathway )	369	673	2885	3265	3479	3480	3484	3485	3486	3487	3488	3489	3667	3818	3845	4893	5290	5291	5293	5295	5296	5894	6464	25759	53358	6654	6655
PC_3677	calcium transport I	487	488	489	27032	9914
PC_3678	Signaling without Wnt (Mammal) ( Mammalian Wnt signaling pathway Diagram )	51176	6932	83439	6934	7088	7089	7090	7091
PC_3679	Negative regulation of gene expression ( Insulin receptor signaling )	207	208	10000	2308	2309	4303
PC_3680	TPO signaling pathway(JAK2 STAT3) ( TPO signaling(JAK2 STAT3) )	3717	4352	6774	7066
PC_3681	PRPP biosynthesis I	5631	221823	5634
PC_3682	2-Oxo-glutaric acid + L-Leucine = L-Glutamic acid + 4-Methyl-2-oxo-pentanoic acid ( Valine,Leucine and Isoleucine degradation )	586	587
PC_3683	L-Serine + Pyruvic acid = Hydroxy-pyruvic acid + L-Alanine ( Glycine and Serine metabolism )	189
PC_3684	Stabilization and accumulation of cytoplasmic beta-catenin (Canonical) ( Mammalian Wnt signaling pathway Diagram )	324	8312	8313	102800317	1499	1855	1856	1857	10023	23401	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	2932	4041	4040
PC_3685	Visual signal transduction	1259	1258	2779	2782	10681	2792	6011	118142757	2979	9626	3000	2986	9227	5145	5158	5148	145226	5959	8787	388531	6010	6121	6295	9187
PC_3686	E-cadherin signaling events	999	1499	3728
PC_3687	protein citrullination	29943	11240	51702	23569	353238
PC_3688	NAD+ + 2-Hydroxy-butanoic acid = NADH + 2-Oxo-butanoic acid ( Propanoate metabolism )	3939	92483	3945	3948
PC_3689	NAD+ + (S)-3-Hydroxy-2-methyl-propanoic acid = NADH + (S)-Methyl-malonate semialdehyde ( Valine,Leucine and Isoleucine degradation )	1962	3030	3030	3028
PC_3690	ATP + D-Ribose 5-phosphate = AMP + D-5-Phospho-ribosyl 1-diphosphate ( Purine nucleotides and Nucleosides metabolism )	221823	5634
PC_3691	NAD biosynthesis II (from tryptophan)	125061	23498	8564	8942	55191	64802	23057	349565	23475	6999
PC_3692	Heterotrimeric GTP-binding protein coupled receptor signaling pathway (through_G_alpha_s,_cholera_toxin,_adenylate_cyclase_and_cAMP) ( GPCR signaling (cholera toxin) )	134	135	136	183	185	186	374	551	627	27302	9210	650	651	652	653	654	655	656	685	796	797	885	959	941	942	1081	1392	1437	1440	3576	3577	3579	1622	50846	28514	10683	54567	1812	1813	1814	1815	1816	1906	1907	1908	1950	2056	2069	356	2246	2255	2256	2258	2259	8823	8822	8817	9965	2247	26281	26291	27006	8074	2248	2249	2250	2251	2252	2253	2254	2488	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	51083	2520	2641	2662	10220	2658	9573	8200	392255	151449	2661	2668	2688	2691	2695	2778	2784	10681	2793	2796	2911	2912	2913	2914	2915	2916	2917	2918	2922	1839	3082	3439	3446	3439	3448	3449	3451	3440	3452	3441	3442	3443	3444	3445	3456	3458	3467	3479	3481	3549	3586	3589	3592	3593	3596	3600	3603	3605	3606	3552	3553	3562	3565	3567	3569	3574	3578	3623	3624	3625	3626	83729	3630	182	3714	4254	3827	3952	3972	3976	4049	100507027	2660	4693	4803	4838	4878	4852	3084	9542	10718	145957	4908	4909	5020	5154	5155	5443	5539	5617	51052	5697	6343	6469	6608	6750	6863	6866	7039	7040	7042	7043	7066	7124	8743	7200	7252	200081	7422	7423	7424	2277	7432	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484
PC_3693	4-hydroxyphenylpyruvate biosynthesis	6898
PC_3694	E-cadherin signaling in the nascent adherens junction	10006	4301	207	8907	382	760	595	998	999	1398	1495	1499	1500	2017	26999	1739	55740	8826	3682	3695	3728	27252	10787	4830	5290	5295	23396	5879	5906	5908	2889	387	6714	7074	7082	7410	10163
PC_3695	5-aminoimidazole ribonucleotide biosynthesis I	2618	5198	5471
PC_3696	NAD+ + (S)-Malic acid = NADH + Oxaloacetic acid ( Citrate cycle )	4190	4191
PC_3697	regulation of target gene expression by AP-1 ( Toll-like receptor signaling pathway (through ECSIT, MEKK1, MKKs, p38 cascade) )	1386
PC_3698	CDP-diacylglycerol biosynthesis I	51099	10554	10555	56894	56895	55326	11200	57678	150763	84803	137964	2820	253558	10162	254531	154141	129642	79143
PC_3699	NAD salvage pathway II	51205	5167	5169	64802	23057	349565	54981	27231	115024	4907	83594	92370
PC_3700	IL-13 signaling pathway(JAK1 TYK2 STAT6) ( IL-13 signaling(JAK1 TYK2 STAT6) )	3596	3597	3598	3565	3566	3667	8660	3716	6778	7297
PC_3701	RAC1 signaling pathway	10006	10152	10097	10096	394	396	10095	10109	10094	10093	10092	1386	10458	9564	55845	999	1072	1398	1495	1499	1535	1536	26999	8826	128239	3725	3984	5606	6416	5608	5609	4214	4296	1432	5599	5601	653361	4688	10787	27035	10811	124056	5058	5062	8394	8395	23396	5330	5879	29127	6774	6776	8936	10163
PC_3702	AKT(PKB)-TOR signaling ( Insulin receptor signaling )	207	208	10000	1973	1974	1977	1978	1981	8672	2475	5728	6009	6194	6198	7249
PC_3703	superpathway of serine and glycine biosynthesis I	26227	29968	5723	6470	6472
PC_3704	ATP + dUDP = ADP + dUTP ( Pyrimidine Nucleotides and Nucleosides metabolism )	4830	4831	4832	4833	8382	10201	29922
PC_3705	Negative regulation of (G alpha s GDP-GTP exchange signaling) ( GPCR signaling (cholera toxin) )	2778	5996	6001	8786	6002	6003	10636	6004	26575	64407	10287	5997	8601	5998	5999	8490	9628	6000	85397	8787
PC_3706	Netrin-mediated signaling events	116986	9564	815	998	1612	1630	1793	9844	2534	4131	5604	5605	5594	5595	4651	4690	9423	5058	5290	5295	5306	5335	5747	5879	387	6714	7204	90249	219699	8633	8976	7525
PC_3707	Glypican 3 network	652	22943	2252	5045	2719	5599	5601	5727	6469
PC_3708	2-Oxo-glutaric acid + L-Phenylalanine = L-Glutamic acid + Phenyl-pyruvic acid ( Phenylalanine degradation )	2805	2806
PC_3709	triacylglycerol biosynthesis	51099	10554	10555	56894	56895	55326	8694	84649	57678	150763	84803	137964	253558	10162	254531	154141	129642	79143	116255	346606	8611	8612	8613	196051	64748	79948	9890
PC_3710	p38 cascade ( Toll-like receptor signaling pathway (through ECSIT, MEKK1, MKKs, p38 cascade) )	1386	5604	5605	5606	6416	5607	5608	5609	4214	5600	6300	5603	1432
PC_3711	GMCSF-mediated signaling events	6347	1154	1437	1438	1439	2353	9846	2885	3265	3551	3635	3394	3717	3845	4067	5604	5605	5594	5595	4893	5008	5290	5295	5292	5578	5567	5568	5781	5894	6464	6654	6772	6773	6774	6776	6777	6850	7534
PC_3712	2-Oxo-glutaric acid + L-Isoleucine = L-Glutamic acid + (R)-2-Oxo-3-methyl-pentanoic acid ( Valine,Leucine and Isoleucine degradation )	586	587
PC_3713	NAD+ + (S)-3-Hydroxy-butanoyl-CoA = NADH + Acetoacetyl-CoA ( Lysine degradation )	1892	1962	3030
PC_3714	Notch secretory pathway ( Notch signaling pathway Diagram )	5045	4851	4853	4854	4855
PC_3715	1,25-dihydroxyvitamin D3 biosynthesis	1594	120227	5447
PC_3716	serine biosynthesis	26227	29968	5723
PC_3717	phospholipases	100137047	729330	8399	81579	5319	5320	26279	30814	64600	50487	5321	100137049	8605	283748	123745	255189	5322	8398	11145	151056	23236	5330	5331	5332	5333	113026	84812	51196	5335	5336	23007	9651	89869	5337	5338	23646	122618	201164	50640
PC_3718	L-Alanine + 2-Oxo-glutaric acid = Pyruvic acid + L-Glutamic acid ( Glycolysis and Gluconeogenesis )	2875	84706
PC_3719	BMP receptor signaling	197	25805	650	652	654	655	657	658	659	9350	8646	91851	58190	10106	10217	10468	26585	2932	148738	6885	5594	9241	8021	5494	5499	23645	56963	285704	6497	4086	4089	4090	4091	4092	4093	57154	64750	25928	10454	23118	331	9765
PC_3720	taurine biosynthesis	1036	51380
PC_3721	SnoN degradation signaling ( TGF-beta_super_family_signaling_pathway(canonical) )	5682	5683	5684	5685	5686	5687	5688	5689	5699	5690	5691	5692	5693	5694	5695	5696	5698	5700	5701	5702	5704	5705	5707	5716	5717	5718	5719	5708	5709	5710	5711	9861	5713	5714	5715	6498	4087	64750
PC_3722	NAD+ + (S)-Lactic acid = NADH + Pyruvic acid ( Glycolysis and Gluconeogenesis )	3939	92483	3945	3948
PC_3723	Beta1 integrin cell surface interactions	929	975	1301	1302	80781	1277	1278	1280	1281	1282	1284	1285	1286	1287	1288	1289	1290	1291	1292	1293	256076	131873	1294	1464	2162	2200	2243	2244	2266	2335	93185	3672	8515	22801	3673	3675	3676	3678	3655	3679	8516	3680	3685	3688	58494	284217	3908	3909	3910	3911	3912	3915	3914	3915	3918	4192	4811	255743	5328	5329	6696	7045	7052	7057	7058	3371	7412	7422	7448
PC_3724	ATP + dAMP = ADP + dADP ( Purine nucleotides and Nucleosides metabolism )	203	204	205	26289
PC_3725	GDP-glucose biosynthesis	2645	80201	5236	55276	5239
PC_3726	E2F transcription factor network	317	472	672	840	23468	890	896	898	9134	993	990	983	1017	1026	1027	1029	1031	1050	4502	8824	23491	283848	221223	1387	1719	1869	1870	1871	1874	1875	1876	144455	79733	2033	26959	3065	3090	2648	8850	9587	4170	4172	4605	4609	4998	5328	5422	10419	5729	5902	5925	5928	5932	5933	5934	6240	6241	23429	5054	23411	6595	6667	6822	7027	7029	7030	7083	11073	7161	10155	8295	7298	8409	8936	7515	7528
PC_3727	Citric acid = Isocitric acid ( Citrate cycle )	48	50
PC_3728	Heterotrimeric GPCR signaling pathway (through G alpha q, PLC beta and ERK cascade) ( GPCR signaling (G alpha q) )	134	135	136	183	185	186	369	374	551	627	27302	9210	650	651	652	653	654	655	656	673	685	796	797	885	959	941	942	1081	1392	1437	1440	3576	3577	3579	1622	50846	28514	10683	54567	1812	1813	1814	1815	1816	1906	1907	1908	1950	2056	2069	356	2246	2255	2256	2258	2259	8823	8822	8817	9965	2247	26281	26291	27006	8074	2248	2249	2250	2251	2252	2253	2254	2488	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	51083	2520	2641	2662	10220	2658	9573	8200	392255	151449	2661	2668	2688	2691	2695	2776	2784	10681	2793	2796	2911	2912	2913	2914	2915	2916	2917	2918	2922	1839	3082	3439	3446	3439	3448	3449	3451	3440	3452	3441	3442	3443	3444	3445	3456	3458	3467	3479	3481	3549	3586	3589	3592	3593	3596	3600	3603	3605	3606	3552	3553	3562	3565	3567	3569	3574	3578	3623	3624	3625	3626	83729	3630	182	3714	4254	3827	3952	3972	3976	4049	100507027	2660	4693	4803	4838	4878	4852	3084	9542	10718	145957	4908	4909	5020	5154	5155	5443	5539	5578	5579	5580	5581	5582	5584	5588	5590	5617	51052	5697	5894	6343	6469	6608	6750	6863	6866	7039	7040	7042	7043	7066	7124	8743	7200	7252	200081	7422	7423	7424	2277	7432	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484
PC_3729	B-Raf activation signaling ( GPCR Adenosine A2A receptor signaling pathway )	673	5906	5908
PC_3730	Negative regulation of (transcription by R-smad	3065	3066	8841	9759	10014	10013	51564	55869	9734	6497	6498	4086	4087	4088	4089	4090	4093	7088	7089	7090	7091
PC_3731	PDGF signaling pathway (Mammal) ( PDGF signaling pathway )	9459	998	1398	2885	3265	3845	9020	4690	4893	5058	5154	5155	5156	5159	5290	5291	5293	5295	5296	5781	5894	5921	6464	25759	53358	6654	6655	6776	6777
PC_3732	IL-4 signaling pathway(JAK1 JAK3 STAT6) ( IL-4 signaling(JAK1 JAK3 STAT6) )	3561	3565	3566	3716	3718	5777	6778
PC_3733	p38 cascade ( Toll-like receptor signaling pathway (p38 cascade) )	1386	5608	6885	5600	6300	5603	1432
PC_3734	fatty acid beta-oxidation III (unsaturated, odd number)	1632	10455	1962
PC_3735	Pyruvate metabolism ( Pyruvate metabolism )	31	32	55902	97	98	3029	84264
PC_3736	FGF8 signaling pathway(Mouse) ( FGF signaling pathway )	369	673	2002	2004	2005	2078	2113	2114	2119	2120	2313	10818	10817	3265	3845	4893	5894	6654	6655	6688
PC_3737	IL-10 signaling pathway(JAK1 TYK2 STAT3) ( IL-10 signaling(JAK1 TYK2 STAT3) )	3586	3587	3588	3716	6774	7297
PC_3738	epoxysqualene biosynthesis	2222	6713
PC_3739	NAD+ + D-Sorbitol = NADH + D-Fructose ( Fructose and Mannose metabolism )	6652
PC_3740	AKT(PKB)-Bad signaling ( Insulin receptor signaling (Mammal) )	207	208	10000	572	2810	7529	7531	7532	7533	10971	7534
PC_3741	Gene expression of IL2 by AP-1 ( CD4 T cell receptor signaling (JNK cascade) )	2353	2354	8061	2355	3725
PC_3742	(S)-3-Hydroxy-3-methyl-glutaryl-CoA = Acetyl-CoA + Acetoacetic acid ( Valine,Leucine and Isoleucine degradation )	3155
PC_3743	Phospholipase C gamma signaling ( CD4 T cell receptor signaling )	3702	3708	3710	5335	5336
PC_3744	UDP-D-glucose + D-Galactose 1-phosphate = D-Glucose 1-phosphate + UDP-D-galactose ( Galactose metabolism )	2592
PC_3745	ethanol degradation IV	84532	55902	79611	217	224	847	7306
PC_3746	Signaling events mediated by Stem cell factor receptor (c-Kit)	207	572	596	867	1387	1399	420	2056	2057	2241	2309	2549	9402	2887	2885	2932	3265	3717	3815	4254	4067	5604	5605	11184	5595	5599	4145	4286	5170	5287	5290	5295	112476	5728	5781	5777	5800	5894	6198	10603	10019	6464	6591	8651	6654	161742	200734	26228	6772	6774	6776	7006	7409
PC_3747	Heterotrimeric GPCR signaling pathway (through glutamate, G alpha q and PLC beta) ( GPCR GroupI metabotropic glutamate receptor signaling pathway )	369	673	2776	2784	10681	2793	2911	2915	5578	5579	5580	5581	5582	5584	5588	5590	5894
PC_3748	spermine biosynthesis	262	6611
PC_3749	(S)-Dihydro-orotic acid + H2O = N-Carbamoyl-L-aspartic acid ( Pyrimidine Nucleotides and Nucleosides metabolism )	1677
PC_3750	G alpha s GDP-GTP exchange signaling ( GPCR signaling (cholera toxin) )	134	135	136	185	186	3577	3579	1812	1813	1814	1815	1816	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	2778	2784	10681	2793	2911	2912	2913	2914	2915	2916	2917	2918	6608
PC_3751	D-Glucosamine 6-phosphate + H2O = D-Fructose 6-phosphate + NH3 ( Fructose and Mannose metabolism )	10007
PC_3752	PAR4-mediated thrombin signaling events	2147	2151	9002	2767	10672	9630	2769	2776	2782	54331	4633	5330	387	6093	9475
PC_3753	NADPH + Cholesterol + O2 = NADP+ + 7-Hydroxy-cholesterol + H2O ( Steroids metabolism )	1581
PC_3754	D-Glucose 6-phosphate = D-Fructose 6-phosphate ( Fructose and Mannose metabolism )	2821
PC_3755	BMP signaling in Drosophila (dorsal midline) ( BMP signaling in Drosophila )	1387	2033	9794	84441	55534	6597	7490
PC_3756	Heterotrimeric GPCR signaling pathway (through Dopamine and G alpha s) ( GPCR Dopamine D1like receptor signaling pathway )	775	776	778	779	781	782	783	784	785	786	10369	10368	27092	27091	59283	59283	1020	1385	1812	1816	2778	2784	10681	2793	2902	2903	2904	2905	2906	5501	5518	5519	5521	5522	5523	28227	5525	5526	5527	5528	5529	5578	5567	5568	5786
PC_3757	Canonical Wnt signaling pathway	324	8312	857	53944	1499	8452	1855	1856	1857	7855	2869	2931	2932	59349	4040	85409	55361	8395	5525	8498	89780
PC_3758	Downstream signaling in naïve CD8+ T cells	567	673	801	801	801	919	915	916	917	925	926	1958	1961	2002	8320	356	2353	8061	3002	3105	3265	3439	3446	3439	3448	3449	3451	3440	3452	3441	3442	3443	3444	3445	3454	3455	3458	3558	3559	3560	3561	3725	3726	3845	5604	5605	5594	5595	5599	5601	4772	4773	4775	4893	5290	5551	5578	5579	5581	5588	5778	5894	6775	7124	8784	7293	3604
PC_3759	UTP + D-Glucose 1-phosphate = Pyrophosphate + UDP-D-glucose ( Glycolysis and Gluconeogenesis )	7360
PC_3760	beta-alanine degradation I	18	4329
PC_3761	NAD+ + L-Glutamic acid + H2O = NADH + 2-Oxo-glutaric acid + NH3 ( Glutamic acid and Glutamine metabolism )	2746	2747
PC_3762	Heterotrimeric GPCR signaling pathway (through Adenosine G alpha s) ( GPCR Adenosine A2A receptor signaling pathway )	135	1385	2778	2784	10681	2793	5578	5567	5568
PC_3763	RXR and RAR heterodimerization with other nuclear receptor	19	596	84498	8930	8648	9612	7376	10062	9971	3164	5465	5467	5468	5914	5915	5916	6198	6256	6257	6258	6720	7040	7067	7068	7124	7421
PC_3764	Neurotrophic factor-mediated Trk receptor signaling	25	2532	9743	627	595	998	1398	1399	9093	1759	1793	6993	30844	9844	55179	10818	10817	2549	9846	10755	2885	3265	57498	3845	9500	5604	5594	5595	4145	23263	23327	4803	4804	4893	4908	4909	4914	4915	4916	5290	5295	5335	5584	5590	5781	5879	5906	5908	2889	5921	5923	10287	387	391	6016	6014	6464	25759	53358	6654	8878	6774	7074
PC_3765	Raf activation signaling (through Grb2 and Sos) ( B cell receptor signaling )	369	673	2885	3265	3845	4893	5894	6654	6655
PC_3766	Beta catenin degradation signaling (Drosophila) ( Drosophila Wingless/Wnt signaling pathway Diagram )	8454
PC_3767	D-Glucosamine 6-phosphate + H2O = D-Fructose 6-phosphate + NH3 ( Aminosugars metabolism )	10007
PC_3768	NAD+ + CoA + (S)-Methyl-malonate semialdehyde => NADH + Propanoyl-CoA + CO2 ( Propanoate metabolism )	4329
PC_3769	D-Glucose 6-phosphate = D-Fructose 6-phosphate ( Glycolysis and Gluconeogenesis )	2821
PC_3770	NADH + 1,3-Bisphospho-D-glyceric acid = NAD+ + D-Glyceraldehyde 3-phosphate + Orthophosphate ( Glycolysis and Gluconeogenesis )	2597	26330
PC_3771	Canonical Wnt signaling pathway ( Canonical Wnt signaling pathway Diagram )	375790	25776	960	1499	56998	22943	27123	27122	27121	2487	2817	2239	3339	83999	79412	51176	4041	4040	6885	51701	6382	6383	9672	6385	2810	6423	6424	6932	83439	6934	11197	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484	7529	7531	7532	7533	10971	7534
PC_3772	PLK2 and PLK4 events	10769	10733
PC_3773	Acetyl-CoA + Dihydro-lipoamide = CoA + 6-S-Acetyl-dihydro-lipoamide ( Butanoate metabolism )	1737	8050
PC_3774	p38 cascade ( TGF-beta signaling(through TAK1) )	1386	5606	5608	6885	5600	6300	5603	1432
PC_3775	ATP + dIDP = ADP + dITP ( Purine nucleotides and Nucleosides metabolism )	4830	4831	4832	4833	8382	10201	29922
PC_3776	Nephrin/Neph1 signaling in the kidney podocyte	207	409	572	23607	2151	2534	2885	3725	55243	6416	5602	5599	5601	4690	8440	4868	7827	50855	5290	5291	5295	5335	5584	5590	5879	7082	7225	8976
PC_3777	CD28 signaling ( CD4 T cell receptor signaling (JNK cascade) )	940	941	942
PC_3778	AKT(PKB) activation signaling ( PDGF signaling pathway )	207	208	10000	5170	5290	5291	5293
PC_3779	3-phosphoinositide biosynthesis	10423	9896	55361	55300	5297	5298	5286	5287	5288	5289	5290	5291	5293	5294	5295	5296	8503	30849	23533	146850	200576	8396	8394	8395	23396	138429	22908
PC_3780	D-Ribose 1-phosphate = D-Ribose 5-phosphate ( Pentose phosphate cycle )	5236
PC_3781	VEGF signaling pathway ( VEGF signaling pathway )	90	91	92	93	94	207	208	10000	238	269	369	572	657	658	659	673	695	815	816	817	818	902	8317	983	1017	1018	1019	1020	1021	1022	1024	1025	1147	1445	1452	1453	102800317	53944	1455	1456	1956	2260	2263	2261	2264	2321	2324	2534	2674	156	157	2868	2869	2870	131890	2931	2932	3480	3551	9641	8517	3643	3654	3656	51135	3702	3716	3717	3718	3791	3815	3932	4058	5604	5605	5606	6416	5607	5608	5609	4214	4294	4296	7786	9175	9020	10746	84451	4215	4217	6885	1326	4293	5871	8491	5594	5602	5600	6300	5603	1432	5595	5598	5599	5601	9261	7867	8550	4233	8569	4331	4342	2475	4804	51701	4914	5058	5062	10298	106821730	106821730	5156	5159	5170	5290	5291	5293	5295	5335	5336	5347	1263	5562	5563	5564	5565	5578	5567	5568	5571	51422	53632	5573	5575	5576	5577	5578	5579	5580	5581	5582	5584	5588	5590	5592	5593	5747	2185	5894	8737	8767	11035	6195	6196	6197	27330	6198	6199	6259	9047	6714	6850	7006	7046	7048	7297	7422	7423	7424	2277	7465	7535
PC_3782	AKT(PKB)-Bad signaling ( IL-7 signaling(JAK1 JAK3 STAT5) )	90	91	92	93	94	207	208	10000	238	269	369	572	657	658	659	673	695	815	816	817	818	902	8317	983	1017	1018	1019	1020	1021	1022	1024	1025	1147	1445	1452	1453	102800317	53944	1455	1456	1956	2260	2263	2261	2264	2321	2324	2534	2674	156	157	2868	2869	2870	131890	2931	2932	3480	3551	9641	8517	3643	3654	3656	51135	3702	3716	3717	3718	3791	3815	3932	4058	5604	5605	5606	6416	5607	5608	5609	4214	4294	4296	7786	9175	9020	10746	84451	4215	4217	6885	1326	4293	5871	8491	5594	5602	5600	6300	5603	1432	5595	5598	5599	5601	9261	7867	8550	4233	8569	4331	4342	2475	4804	51701	4914	5058	5062	10298	106821730	106821730	5156	5159	5170	5347	1263	5562	5563	5564	5565	5578	5567	5568	5571	51422	53632	5573	5575	5576	5577	5578	5579	5580	5581	5582	5584	5588	5590	5592	5593	5747	2185	5894	8737	8767	11035	6195	6196	6197	27330	6198	6199	6259	6714	6850	7006	7046	7048	7297	7465	10971	7535
PC_3783	Stabilization and accumulation of cytoplasmic beta-catenin (Canonical) ( Drosophila Wingless/Wnt signaling pathway Diagram )	324	8312	8313	102800317	1499	1855	1856	1857	10023	23401	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	2932	4041	4040
PC_3784	HIV-1 Nef	317	9530	596	637	330	835	836	839	840	841	842	919	8837	1147	8738	54205	1616	8772	355	356	5609	9020	4217	5599	4790	4792	5970	8737	7124	7132	8717	7185	7186
PC_3785	glycogen degradation III	178	2548	8972	5236	55276	5239	5834	5836	5837
PC_3786	UDP-N-acetyl-D-galactosamine biosynthesis II	2582	2645	10007	132789	64841	2821	80201	5238	6675
PC_3787	sulfate activation for sulfonation	9061	9060
PC_3788	sucrose degradation V (mammalian)	226	229	130589	3795	6476	7167
PC_3789	Wnt secretory pathway (Canonical) ( Drosophila Wingless/Wnt signaling pathway Diagram )	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484
PC_3790	L-Arginino-succinic acid = L-Arginine + Fumaric acid ( Arginine and Proline metabolism )	435
PC_3791	Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling	9564	1398	11330	1511	1793	1956	1991	2243	2244	2266	2335	2357	2358	2359	2822	3082	3675	3678	3684	3685	3688	3689	3690	3693	9622	4035	4321	4322	4314	4318	4691	80310	5159	5328	5329	5340	5879	5054	6714	7040	7436	7448
PC_3792	tRNA charging	16	57505	833	79587	1615	55157	124454	2058	10667	2193	10056	2617	3035	23438	3376	55699	3735	51520	23395	4141	92935	4677	79731	25973	2058	5917	57038	6301	54938	6897	80222	123283	7407	7407	7453	10352	8565	51067
PC_3793	Succinyl-CoA + Dihydro-lipoamide = CoA + S-Succinyl-dihydro-lipoamide ( Citrate cycle )	1743
PC_3794	NAD+ + 3,4-Dihydroxy-phenyl-ethyleneglycol = NADH + 3,4-Dihydroxy-mandelaldehyde ( Tyrosine metabolism )	124	125	126	127	128	130	131	137872
PC_3795	Toll-like receptor signaling pathway (through JNK cascade)(Canonical) ( Toll-like receptor signaling pathway (through JNK cascade) )	929	3654	51135	3929	23643	6885	4615	10454	23118	7099	54472	7189	7334	387522
PC_3796	Negative regulation of gene expression ( Insulin receptor signaling (Mammal) )	207	208	10000	2308	2309	4303
PC_3797	IL2-mediated signaling events	596	1017	1154	9046	2353	2534	9846	2885	3265	3458	22806	3558	3559	3560	3561	3667	8660	3716	3718	3725	3845	3932	5604	5605	5594	5600	1432	5595	5599	5601	9261	4609	4893	5290	5295	5579	5581	2185	5781	5894	5921	387	6464	8651	8835	9021	6654	8027	10254	6772	6774	6776	6777	6850
PC_3798	GDP-mannose biosynthesis	29926	29925	2821	4351	5372	5373
PC_3799	L-dopachrome biosynthesis	7299
PC_3800	IL-7	207	572	868	1213	2308	2309	2534	2931	2932	3561	3574	3575	3667	8660	3716	3718	5604	5605	5594	5595	5295	2185	6464	8027	6772	6774	6776	6777
PC_3801	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	10423	55361	55300	5297	5298	5305	8396	79837	8394	8395	23396	138429	23236	5330	5331	5332	5333	113026	84812	51196	5335	5336	23007	9651	89869
PC_3802	Propanoyl-CoA + Acceptor = Propenoyl-CoA + Reduced acceptor ( Propanoate metabolism )	84129	34
PC_3803	JNK cascade ( IL-1 signaling pathway (through JNK cascade) )	3725	5609	6885	5599
PC_3804	Gene expression by FOXO ( Insulin receptor signaling )	2308	2309	4303
PC_3805	guanine and guanosine salvage I	3251	4860
PC_3806	glutamine biosynthesis I	2752
PC_3807	NAD+ + (S)-Malic acid = NADH + Pyruvic acid + CO2 ( Glycolysis and Gluconeogenesis )	4199	10873
PC_3808	NAD+ + (R)-Lactic acid = NADH + Pyruvic acid ( Glycolysis and Gluconeogenesis )	197257
PC_3809	FOXA transcription factor networks	3169	3170	3171
PC_3810	NAD+ + L-Glutamic acid + H2O = NADH + 2-Oxo-glutaric acid + NH3 ( Arginine and Proline metabolism )	2746	2747
PC_3811	Alpha6 beta4 integrin-ligand interactions	3655	3691	284217	3908	3909	3911	3912	3915	3914	3915	3918
PC_3812	(S)-3-Hydroxy-butanoyl-CoA = Crotonoyl-CoA + H2O ( Butanoate metabolism )	1892	1962	3030
PC_3813	ceramide biosynthesis	123099	2531	10558	9517	55304
PC_3814	Propanoyl-CoA + Acceptor = Propenoyl-CoA + Reduced acceptor ( Valine,Leucine and Isoleucine degradation )	84129	34
PC_3815	Polo-like kinase signaling events in the cell cycle	5347	10769	1263	10733
PC_3816	Inositol phosphate metabolism ( Inositol phosphate metabolism )	3612	3613	3628	3631	8821	3632	3633	3636	253430	51477	3706	3707	55586	4952	5297	5286	5289	5290	5291	5293	5294	23533	5305	8396	79837	8394	8395	23396	23236	5330	5331	5332	5333	113026	84812	51196	5335	5336	89869	5728	8867	8871
PC_3817	CoA + ATP + Succinic acid = Succinyl-CoA + ADP + Orthophosphate ( Citrate cycle )	8803
PC_3818	IL-1_signaling(through_IKK-NFkB_cascade)(canonical) ( IL-1 signaling pathway (through NF-kappaB) )	3552	3553	3554	3556	3654	51135	6885	4615	10454	23118	7099	54472	7189	7334	387522
PC_3819	regulation of target gene expression by AP-1 ( IL-1 signaling pathway (through JNK cascade) )	3725	4790	5970
PC_3820	ATP + dTMP = ADP + dTDP ( Pyrimidine Nucleotides and Nucleosides metabolism )	1841
PC_3821	AKT(PKB) activation signaling ( PDGF signaling pathway )	207	208	10000	5170	5290	5291	5293
PC_3822	Class I PI3K signaling events mediated by Akt	207	208	10000	572	598	842	1026	1027	1147	2308	2309	4303	2931	2932	3320	3836	4217	79109	64223	2475	5170	5578	5591	5894	253260	2810	6517	6714	9882	7529	7531	7532	7533	10971	7534
PC_3823	Beta catenin degradation signaling (Mammal) ( Mammalian Wnt signaling pathway Diagram )	324	8312	8313	8945	1499	8454	2932	6500
PC_3824	NAD+ + 3,4-Dihydroxy-mandelaldehyde + H2O = NADH + 3,4-Dihydroxy-mandelic acid ( Tyrosine metabolism )	220	218	221
PC_3825	IL4-mediated signaling events	57379	207	246	383	598	604	867	6356	6361	10344	959	972	1051	1277	1278	9046	1959	2113	2208	2242	2885	2971	3159	3586	3597	3598	3561	3565	3566	3567	3635	3662	3667	8660	3690	3716	3717	3718	4049	1432	2475	4602	4603	4988	54625	5284	5290	5295	5777	84666	6198	6403	6464	8651	9021	9655	6667	6688	6776	6777	6778	7033	7070
PC_3826	Insulin receptor signaling ( Insulin receptor signaling )	369	673	1977	1978	2280	2885	2932	3265	3630	3643	3667	8660	8471	3845	2475	4893	5290	5291	5293	5295	5296	5518	5519	5521	5522	5523	28227	5525	5526	5527	5528	5529	5562	5563	5564	5565	5571	51422	53632	5786	5894	2810	6464	25759	53358	6517	6654	6655	7249	7529	7531	7532	7533	10971	7534
PC_3827	sphingomyelin metabolism	339221	142891	259230	166929	6609	6610	55512	55627
PC_3828	Gli processing signaling ( Hedgehog signaling pathway )	8945	1026	1027	1028	1029	1030	1031	1032	8454	2737	2932	5578	5567	5568	6500
PC_3829	NADH repair	2597	55739	128240
PC_3830	Regulation of Androgen receptor activity	10513	367	10498	1050	1387	3301	1958	10919	2033	2316	2308	2624	2932	3065	51564	10481	3320	3725	8850	10524	11143	3817	3818	6416	5608	1432	5599	4193	8648	10499	190	7181	7182	2908	5152	5585	5451	10399	25898	5966	6256	6257	6258	29843	23411	6595	6599	6605	25803	6714	6736	7113	8805	83637
PC_3831	serotonin degradation	125	130	217	224	4128	4129	6817	6799	445329	445329	7365	10720
PC_3832	G alpha q GDP-GTP exchange signaling ( GPCR GroupI metabotropic glutamate receptor signaling pathway )	2776	2784	10681	2793	2911	2915
PC_3833	BMP signaling in Drosophila ( BMP signaling in Drosophila )	1387	2033	9794	84441	55534	6597	7490
PC_3834	CDC42 signaling events	10097	10096	324	396	9459	8874	10095	10109	10094	10093	10092	1386	10458	9564	673	867	998	8476	999	1072	1495	1499	81624	1739	55740	2059	23265	2151	2932	388585	3265	8826	128239	3725	3984	3985	5606	6416	5608	5609	4214	4296	5594	1432	5595	5599	5601	2475	4633	5058	5062	10298	50855	5080	5290	5295	5337	8611	5581	5590	5879	5894	5923	6198	4735	6714	7074	10188	7410	8976	7525
PC_3835	Prostaglandin and Leukotriene metabolism ( Prostaglandin and Leukotriene metabolism )	8644	239	246	247	240	873	874	8529	4051	2678	2687	91227	27306	4048	4056	5730	9536	80142	5740	5742	5743	6916
PC_3836	Nicotinate D-ribonucleotide + ATP = Deamido-NAD+ + Pyrophosphate ( Nicotinate and Nicotinamide metabolism )	64802	23057
PC_3837	Aurora B signaling	6790	9212	6795	332	699	23468	55143	1058	8452	1674	7813	3020	3020	3619	10112	9493	11004	90293	55958	4638	9918	64151	23397	4691	10403	4869	54888	5037	5501	5528	5684	29127	5921	387	1731	151648	10592	10051	3925	6867	7431
PC_3838	dTMP de novo biosynthesis	1719	6470	6472	7298
PC_3839	Caspase8 activation signaling ( TNFR1 signaling pathway )	841	8772
PC_3840	XMP + Pyrophosphate = Xanthine + D-5-Phospho-ribosyl 1-diphosphate ( Purine nucleotides and Nucleosides metabolism )	3251
PC_3841	SHP2 signaling	4301	284	2909	627	1950	1956	2263	2261	10818	10817	2549	9846	2770	2773	2885	3265	3458	3459	3479	3480	3558	3559	3560	3561	3569	3570	3572	3667	3716	3717	3718	3791	3845	3932	8543	5604	5605	4803	4846	4893	4908	4909	4914	4915	4916	55824	5155	5159	5290	5295	5578	5781	5894	387	6383	6464	6654	6772	7010	7422
PC_3842	asparagine degradation I	374569	80150
PC_3843	Notch secretory pathway (Mammal) ( Notch signaling pathway Diagram )	5045	4851
PC_3844	IL23-mediated signaling events	242	6347	916	920	2919	4283	3458	3593	3594	3605	112744	3606	8809	8807	29949	3553	3558	51561	149233	11009	3569	3675	3717	4353	4790	4792	4843	5290	5295	5970	9021	6772	6774	6775	6776	7124	7297
PC_3845	ERK cascade ( GPCR GroupI metabotropic glutamate receptor signaling pathway )	369	673	5604	5605	5594	5595	5894
PC_3846	putrescine degradation III	219	217	218	224	221	4128	4129	6303	112483
PC_3847	gluconeogenesis I	226	229	669	2023	2026	2027	2203	8789	2597	26330	2821	4190	4191	4199	4200	10873	5105	5223	5224	5230	5232	1462
PC_3848	Inosine + Orthophosphate = Hypoxanthine + D-Ribose 1-phosphate ( Purine nucleotides and Nucleosides metabolism )	4860
PC_3849	FAS (CD95) signaling pathway	207	637	329	330	695	843	836	841	8837	1147	1213	7430	8772	23017	355	356	3551	8517	5608	5609	4214	5602	5600	1432	5599	5601	5170	5290	5291	5295	5783	5981	8737	6609	6714	6850
PC_3850	NADP+ + 5,6-Dihydro-thymine = NADPH + Thymine ( Pyrimidine Nucleotides and Nucleosides metabolism )	1806
PC_3851	lactose degradation III	2720	112937
PC_3852	PKA activation signaling ( GPCR signaling (cholera toxin) )	107	55811	108	109	196883	111	112	113	114	115	2778	5578	5567	5568	5573	5575	5576	5577
PC_3853	Beta2 integrin cell surface interactions	718	3491	959	2159	50848	2212	2243	2244	2266	2811	3383	3384	3385	3386	3681	3683	3684	3687	3689	83700	3827	5327	5328	5329	5624	10417	7045	7070	7412
PC_3854	anandamide degradation	2166	158584
PC_3855	JNK cascade ( TNFR1 signaling pathway )	83737	6416	5609	4217	5602	5599	5601
PC_3856	D-Glycerate 2-phosphate = D-Glycerate 3-phosphate ( Glycolysis and Gluconeogenesis )	669	5223	5224
PC_3857	Ceramide signaling pathway	9131	207	427	572	9530	581	596	637	330	841	1147	8738	1509	54205	1950	1965	5610	8772	3479	8844	8567	5604	5605	6416	4214	9448	5594	5595	5599	4609	4790	4792	8439	5074	5154	5580	5590	8575	5894	5925	5970	8737	6609	55512	56848	7124	7132	8717	7186
PC_3858	EPO signaling pathway	596	598	695	867	1399	2056	2057	2549	2885	3265	3635	8660	3717	4067	1432	5599	4790	5295	5335	5336	5781	5777	5906	2889	10019	6464	9021	6654	6772	6776	6777	7006	7410
PC_3859	GMP + Pyrophosphate = Guanine + D-5-Phospho-ribosyl 1-diphosphate ( Purine nucleotides and Nucleosides metabolism )	3251
PC_3860	ATP + dGDP = ADP + dGTP ( Purine nucleotides and Nucleosides metabolism )	4830	4831	4832	4833	8382	10201	29922
PC_3861	TCR signaling in naïve CD4+ T cells	207	8915	84433	867	919	940	915	916	917	920	941	942	998	1147	1445	28988	2316	2533	2534	9846	9402	2885	3122	3123	3265	3551	8517	3635	3702	3845	27040	3932	3937	10892	9020	1326	11184	4690	4893	84876	55824	5170	5290	5335	5578	5579	5581	5588	5728	5781	5777	5788	5906	10125	10235	83593	6452	6464	84174	6654	6786	27347	7189	55503	7409	7454	7535
PC_3862	Regulation of Ras family activation	801	801	801	816	153090	2885	3265	3845	3956	3958	4763	4893	51196	5578	5579	5581	5590	112476	27342	5921	5922	10156	8437	5923	5924	10125	10235	25780	115727	9610	6237	6654	6655	8831
PC_3863	2-Oxo-glutaric acid + L-Aspartic acid = L-Glutamic acid + Oxaloacetic acid ( Alanine,Aspartic acid and Asparagine metabolism )	2805	2806
PC_3864	Hedgehog	207	409	91653	891	1024	50937	1387	1499	50846	1859	2619	2735	2736	2737	156	55733	64399	3549	55582	374654	8930	9968	9439	10001	7101	5578	5727	8643	51715	10284	6383	6469	25942	6497	4086	6608	27148	51684	7531
PC_3865	adenine and adenosine salvage III	100	113179	3251	4860
PC_3866	ErbB receptor signaling network	374	685	1950	1956	2064	2065	2066	2069	1839	3320	3084	9542	10718	145957	7039
PC_3867	NAD+ + 3-Methyl-imidazole acetaldehyde + H2O = NADH + 3-Methyl-imidazole-acetic acid ( Histidine degradation )	220	218	221
PC_3868	NAD+ + Dihydro-lipoamide = NADH + Lipoamide ( Pyruvate metabolism )	1738
PC_3869	ATP + D-Ribose 5-phosphate = AMP + D-5-Phospho-ribosyl 1-diphosphate ( Pentose phosphate cycle )	221823	5634
PC_3870	Heterotrimeric GPCR signaling pathway (through G alpha s ACs Epac BRaf and ERKcascade) ( GPCR signaling (G alpha s, Epac and ERK) )	107	55811	108	109	196883	111	112	113	114	115	134	135	136	183	185	186	374	551	627	27302	9210	650	651	652	653	654	655	656	685	796	797	885	959	941	942	1081	1392	1437	1440	3576	3577	3579	1622	50846	28514	10683	54567	1812	1813	1814	1815	1816	1906	1907	1908	1950	2056	2069	356	2246	2255	2256	2258	2259	8823	8822	8817	9965	2247	26281	26291	27006	8074	2248	2249	2250	2251	2252	2253	2254	2488	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	51083	2520	2641	2662	10220	2658	9573	8200	392255	151449	2661	2668	2688	2691	2695	2778	2784	10681	2793	2796	2911	2912	2913	2914	2915	2916	2917	2918	2922	1839	3082	3439	3446	3439	3448	3449	3451	3440	3452	3441	3442	3443	3444	3445	3456	3458	3467	3479	3481	3549	3586	3589	3592	3593	3596	3600	3603	3605	3606	3552	3553	3562	3565	3567	3569	3574	3578	3623	3624	3625	3626	83729	3630	182	3714	4254	3827	3952	3972	3976	4049	100507027	2660	4693	4803	4838	4878	4852	3084	9542	10718	145957	4908	4909	5020	5154	5155	5443	5539	5617	51052	5697	6343	6469	6608	6750	6863	6866	7039	7040	7042	7043	7066	7124	8743	7200	7252	200081	7422	7423	7424	2277	7432	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484
PC_3871	NAD+ + 4-Hydroxy-phenyl-acetaldehyde + H2O = NADH + 4-Hydroxy-phenyl-acetic acid ( Tyrosine metabolism )	220	218	221
PC_3872	tryptophan degradation X (mammalian, via tryptamine)	10327	224	1644	4128	4129
PC_3873	Succinic acid + Ubiquinone = Fumaric acid + Ubiquinol ( Tyrosine metabolism )	6389	6390
PC_3874	3-phosphoinositide degradation	3631	8821	3633	3635	23203	22876	27124	51763	3636	64419	8897	4952	90809	55529	23203	5728	114971	22908	8867	8871	93492
PC_3875	PDGFR-beta signaling pathway	10006	25	59	81	10097	10096	4301	116985	2909	396	10095	10109	10094	10093	10092	10458	9564	640	673	55845	867	1398	1445	2017	26999	1785	9732	420	5610	2002	2059	2268	2353	2534	2549	2887	2885	3055	3265	8826	3685	3690	3717	3725	3727	3845	8844	3932	4035	4067	5604	5605	6416	5609	5594	5602	5595	5599	5601	4609	93649	4690	8440	10787	4893	55824	5058	5155	5159	5290	5291	5294	5295	146850	5300	5321	5335	5515	5518	5521	5578	5580	5581	5728	5770	5781	5771	5795	5867	5868	5879	5894	5906	5908	2889	5921	387	6197	1901	2810	6464	6494	6503	9368	9351	6654	8877	6714	6722	6772	6774	6776	6777	6876	9712	7410	10163	8976	7525	7529	7531	7532	7533	10971	7534
PC_3876	ATP + ADP = ADP + ATP ( Purine nucleotides and Nucleosides metabolism )	4830	4831	4832	4833	8382	10201	29922
PC_3877	TNF receptor signaling pathway	6868	9530	329	330	841	857	1147	1540	8772	3551	8517	8567	5606	5609	4214	4215	4217	6885	5871	8491	9448	11183	4790	203447	8439	5584	5590	10399	5970	117584	8737	6609	6610	8878	6772	10454	23118	7124	7128	7132	7133	23043	8717	7185	7186	7295
PC_3878	Positive regulation of (Transcription of SOCS by STAT dimer) in JAK STAT pathway ( JAK-STAT pathway and regulation pathway Diagram )	90	91	92	93	94	207	208	10000	238	269	369	657	658	659	673	695	815	816	817	818	902	8317	983	1017	1018	1019	1020	1021	1022	1024	1025	1147	1445	1452	1453	102800317	53944	1455	1456	1956	2260	2263	2261	2264	2321	2324	2534	2674	156	157	2868	2869	2870	131890	2931	2932	3480	3551	9641	8517	3643	3654	3656	51135	3702	3716	3717	3718	3791	3815	3932	4058	5604	5605	5606	6416	5607	5608	5609	4214	4294	4296	7786	9175	9020	10746	84451	4215	4217	6885	1326	4293	5871	8491	5594	5602	5600	6300	5603	1432	5595	5598	5599	5601	9261	7867	8550	4233	8569	4331	4342	2475	4804	51701	4914	5058	5062	10298	106821730	106821730	5156	5159	5170	5347	1263	5562	5563	5564	5565	5578	5567	5568	5571	51422	53632	5573	5575	5576	5577	5578	5579	5580	5581	5582	5584	5588	5590	5592	5593	5747	2185	5894	8737	8767	11035	6195	6196	6197	27330	6198	6199	6259	6714	6772	6773	6774	6775	6776	6777	6778	6850	7006	7046	7048	7297	7465	7535
PC_3879	2-oxobutanoate degradation I	593	594	1629	1738	84693	4594	5095	5096
PC_3880	CXCR4-mediated signaling events	207	407	409	572	9564	640	919	915	916	917	920	998	1072	1398	1445	6387	7852	1759	2268	2308	2534	10672	2770	2771	2773	2775	2781	2782	54331	156	2870	3055	9146	3122	3123	3635	83737	3717	3932	3984	4067	79109	64223	4318	2475	55824	5058	5170	5290	5291	5294	5295	146850	23236	5330	5331	5590	5747	2185	5781	5777	5788	5829	5879	10399	5899	5908	5911	5996	387	388	389	253260	6714	54434	6772	6773	6774	6776	6777	29979	7409	27183	9525	7525
PC_3881	2-Methyl-propanoyl-CoA + Acceptor = 2-Methylprop-2-enoyl-CoA + Reduced acceptor ( Valine,Leucine and Isoleucine degradation )	35
PC_3882	(R)-Methyl-malonyl-CoA = (S)-Methyl-malonyl-CoA ( Propanoate metabolism )	84693
PC_3883	ceramide degradation	56624
PC_3884	L-Glutamine + D-Fructose 6-phosphate = L-Glutamic acid + D-Glucosamine 6-phosphate ( Fructose and Mannose metabolism )	2673	9945
PC_3885	Insulin receptor signaling (Mammal) ( Insulin receptor signaling (Mammal) )	207	84335	208	10000	369	673	1977	1978	2280	23770	2885	2932	3265	3630	3643	3667	8660	8471	3845	64223	2475	4893	5290	5291	5293	5295	5296	5518	5519	5521	5522	5523	28227	5525	5526	5527	5528	5529	5562	5563	5564	5565	5571	51422	53632	5786	5894	57521	2810	6654	6655	7249	7529	7531	7532	7533	10971	7534
PC_3886	JNK cascade ( CD4 T cell receptor signaling )	2353	2354	8061	2355	3725	5604	5605	5602	5599	5601
PC_3887	dopamine degradation	224	1312	4128	4129	6817	6799	445329	445329
PC_3888	pyruvate fermentation to lactate	3939	160287	92483	3945	3948
PC_3889	Negative regulation of heterotrimeric GPCR signaling pathway (through G alpha s) ( GPCR signaling (G alpha s, PKA and ERK) )	107	55811	108	109	196883	111	112	113	114	115	2770	2771
PC_3890	Stabilization and accumulation of cytoplasmic beta-catenin (Canonical) ( Canonical Wnt signaling pathway Diagram )	324	8312	8313	102800317	1499	1855	1856	1857	10023	23401	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	2932	4041	4040
PC_3891	acetate conversion to acetyl-CoA	84532	55902	79611
PC_3892	ATP + D-Ribose 5-phosphate = AMP + D-5-Phospho-ribosyl 1-diphosphate ( Pyrimidine Nucleotides and Nucleosides metabolism )	221823	5634
PC_3893	Toll-like receptor signaling pathway (p38 cascade) ( Toll-like receptor signaling pathway (p38 cascade) )	929	3654	51135	3929	23643	6885	4615	10454	23118	7099	54472	7189	7334	387522
PC_3894	Negative feedback regulation of FGF8 signaling by Sprouty2 (Mouse) ( FGF signaling pathway )	6654	6655
PC_3895	ERK cascade ( GPCR Adenosine A2A receptor signaling pathway )	673	5604	5605	5594	5595
PC_3896	NF-kB signaling ( IL-1 signaling pathway (through NF-kappaB) )	8945	1147	8454	3551	8517	6885	4790	4792	4793	4794	5970	6500
PC_3897	LPA receptor mediated events	107	108	109	196883	111	112	113	114	115	147	207	9138	9564	836	1398	3576	1956	2353	2549	2767	2768	10672	9630	2769	2770	2771	2773	2775	2776	2781	2782	54331	2932	1839	3265	3725	1902	9170	23566	2846	4067	4137	4313	4318	4790	4792	5291	5295	5331	5335	5338	5580	5581	5587	112476	5747	2185	5829	5879	5970	387	9351	6714	7074	7205
PC_3898	D-Fructose 1,6-bisphosphate = Dihydroxy-acetone phosphate + D-Glyceraldehyde 3-phosphate ( Pentose phosphate cycle )	226	229	230
PC_3899	ATP + dCDP = ADP + dCTP ( Pyrimidine Nucleotides and Nucleosides metabolism )	4830	4831	4832	4833	8382	10201	29922
PC_3900	Fas signaling pathway ( Fas signaling pathway )	581	637	841	54205	1616	8772	355	356	6416	5609	4217	5602	5599	5601	2810	7529	7531	7532	7533	10971	7534
PC_3901	PLC beta signaling ( GPCR signaling (G alpha q) )	2776	23236	5330	5331	5332
PC_3902	NADP+ + D-Sorbitol = NADPH + D-Glucose ( Fructose and Mannose metabolism )	231
PC_3903	3-Hydroxy-isopentyl-CoA = 3-Methylbut-2-enoyl-CoA + H2O ( Valine,Leucine and Isoleucine degradation )	1892	1962	3030
PC_3904	glutamate dependent acid resistance	2571	2572
PC_3905	Negative regulation of (Dimerization of STAT) in JAK STAT pathway ( JAK-STAT pathway and regulation pathway Diagram )	5781	6776	6777
PC_3906	Nicotinamide D-ribonucleotide + ATP = NAD+ + Pyrophosphate ( Nicotinate and Nicotinamide metabolism )	64802	23057
PC_3907	Notch degradation signaling (Mammal) ( Notch signaling pathway Diagram )	55294	4851	4853	4854	4855
PC_3908	Retinoic acid receptors-mediated signaling	207	902	983	1022	1387	2033	3065	8841	8850	5594	1432	5595	5599	4331	8648	10499	8202	9612	8204	5578	5578	5582	5914	5915	5916	9256	6256	6257	6258	7421
PC_3909	(S)-3-Hydroxy-3-methyl-glutaryl-CoA = 3-Methyl-glutaconyl-CoA + H2O ( Valine,Leucine and Isoleucine degradation )	549
PC_3910	alanine biosynthesis II	2875	84706
PC_3911	pentose phosphate pathway	2539	9563	5226	25796	6120	22934	6888	7086	8277	84076
PC_3912	MAP kinase cascade	7529
PC_3913	TCR signaling in naïve CD8+ T cells	207	567	8915	84433	867	919	940	915	916	917	941	942	925	926	1147	1445	2534	9402	2885	3105	3265	3551	8517	3845	27040	3932	3937	10892	9020	1326	4893	84876	55824	5170	5290	5335	5551	5578	5579	5581	5588	5777	5788	5906	10125	10235	83593	6464	6654	6786	7189	55503	7409	7535
PC_3914	Signaling without Wnt (Canonical) ( C. elegans endoderm induction Wnt signaling pathway Diagram )	51176	6932	83439	6934	7088	7089	7090	7091
PC_3915	UDP-N-acetyl-D-galactosamine biosynthesis I	2582
PC_3916	B-Raf activation signaling ( GPCR signaling (G alpha s, PKA and ERK) )	673	5906	5908
PC_3917	D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis	253430	3705	9562
PC_3918	AMP + Pyrophosphate = Adenine + D-5-Phospho-ribosyl 1-diphosphate ( Purine nucleotides and Nucleosides metabolism )	353
PC_3919	Wnt secretory pathway (Canonical) ( Mammalian Wnt signaling pathway Diagram )	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484
PC_3920	Signaling with Wnt (Canonical) ( Xenopus axis formation Wnt signaling pathway Diagram )	607	1387	1499	2033	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	51176	4041	4040	26108	90780	4089	6597	6932	83439	6934	7088	7089	7090	7091	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484
PC_3921	L-serine degradation	10993	113675
PC_3922	G alpha i GDP-GTP exchange signaling ( GPCR signaling (pertussis toxin) )	134	135	136	185	186	3577	3579	1812	1813	1814	1815	1816	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	2770	2771	2784	10681	2793	2911	2912	2913	2914	2915	2916	2917	2918	6608
PC_3923	ATP + L-Glutamic acid + NH3 = ADP + L-Glutamine + Orthophosphate ( Glutamic acid and Glutamine metabolism )	2752
PC_3924	Pyruvic acid + Enzyme N6-(lipoyl)lysine = [dihydrolipoyllysine-residue acetyltransferase] S-acetyldihydrolipoyllysine + CO2 ( Pyruvate metabolism )	5160	5161	5162
PC_3925	Caspase3 activation signaling ( Fas signaling pathway )	836	841
PC_3926	geranylgeranyldiphosphate biosynthesis	9453
PC_3927	ATP + GDP = ADP + GTP ( Purine nucleotides and Nucleosides metabolism )	4830	4831	4832	4833	8382	10201	29922
PC_3928	IL8-mediated signaling events	3576
PC_3929	GTP + L-Fucose 1-phosphate = GDP-L-fucose + Pyrophosphate ( Fructose and Mannose metabolism )	8790
PC_3930	Sumoylation by RanBP2 regulates transcriptional repression	3065	9759	4193	9972	23225	8021	23636	8554	9063	5901	5903	5905	7341	7329	7514
PC_3931	methylglyoxal degradation III	231	57016	1571
PC_3932	ATP + dTDP = ADP + dTTP ( Pyrimidine Nucleotides and Nucleosides metabolism )	4830	4831	4832	4833	8382	10201	29922
PC_3933	PLK3 signaling events	472	898	995	11200	1263	7157
PC_3934	Histidine degradation ( Histidine degradation )	216	8854	219	217	224	501	223	26	314	8639	84735	3034	3035	23438	3067	3176	4128	4129
PC_3935	Propanoate metabolism ( Propanoate metabolism )	55902	5095	5096
PC_3936	Phospholipase C gamma signaling ( B cell receptor signaling )	3708	3710	5336
PC_3937	glycine biosynthesis I	6470	6472
PC_3938	Circadian rhythm pathway	406	390502	8553	1111	9575	1407	1408	102800317	8553	3162	4841	4862	9572	5187	8864	8914	11091
PC_3939	NAD+ + CoA + (S)-Methyl-malonate semialdehyde => NADH + Propanoyl-CoA + CO2 ( Valine,Leucine and Isoleucine degradation )	4329
PC_3940	L-Alanine + Glyoxylic acid = Pyruvic acid + Glycine ( Alanine,Aspartic acid and Asparagine metabolism )	189	64902
PC_3941	Canonical Wnt signaling pathway ( Xenopus axis formation Wnt signaling pathway Diagram )	375790	25776	960	1499	56998	22943	27123	27122	27121	2487	2817	2239	3339	83999	79412	51176	4041	4040	6885	51701	6382	6383	9672	6385	2810	6423	6424	6932	83439	6934	11197	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484	7529	7531	7532	7533	10971	7534
PC_3942	Signaling without Hh ( Hedgehog signaling pathway )	2735	2736	2737	5727	8643	6608	51684
PC_3943	L-carnitine biosynthesis	223	8424	55217
PC_3944	(S)-reticuline biosynthesis II	7299
PC_3945	ERK cascade ( B cell receptor signaling )	369	673	5604	5605	5594	5595	5894
PC_3946	Beta catenin degradation signaling (Canonical) ( Mammalian Wnt signaling pathway Diagram )	324	8312	8313	8945	1499	8454	2932	6500
PC_3947	(S)-Malic acid = Fumaric acid + H2O ( Tyrosine metabolism )	2271
PC_3948	tRNA splicing	83707	116461	80746	79042	283989
PC_3949	ATM pathway	25	84142	472	637	641	672	993	995	11200	114769	1487	64421	2177	3014	10524	9656	4193	4361	4683	5884	10111	5883	5932	9025	8243	9126	7014	7156	7158	10155	7334	51720	7518	7529
PC_3950	L-Tetrahydro-folic acid + L-Serine = 5,10-Methylene-tetrahydro-folic acid + Glycine + H2O ( Glycine and Serine metabolism )	6470	6472
PC_3951	sorbitol degradation I	6652
PC_3952	Regulation of RhoA activity	29	11214	116985	64411	9743	2909	393	394	395	23779	64333	396	397	398	9138	9639	55160	9826	23365	22899	9828	23370	9181	115557	64283	50650	7984	613	1027	1671	8655	1894	10160	4168	23263	4650	6530	25791	84033	4983	55200	5910	387	57522	7204	7409	7410	10451
PC_3953	methylmalonyl pathway	84693	4594	5095	5096
PC_3954	HIF-1-alpha transcription factor network	5243	9429	133	207	226	405	8553	79365	664	768	10370	10987	1356	1385	1387	6387	7852	1906	54583	112399	2022	2023	2033	2056	2113	2235	2353	5045	2624	2645	51564	3091	3098	3099	3162	3172	3398	3484	3689	3725	3939	3952	4170	8648	10499	10397	4843	4869	4907	5209	5211	5230	5236	5315	123	6095	5054	6513	6515	4088	4089	6667	7015	7018	7033	7037	7422
PC_3955	glutaryl-CoA degradation	30	38	8435	2639	3032
PC_3956	Adenylate cyclase inactivation signaling ( GPCR signaling (G alpha i) )	107	55811	108	109	196883	111	112	113	114	115	2770	2771
PC_3957	AKT(PKB) activation signaling ( Insulin receptor signaling (D. melanogaster) )	5170
PC_3958	NAD+ + Dihydro-lipoylprotein = NADH + Lipoylprotein ( Glycine and Serine metabolism )	1738
PC_3959	AKT(PKB)-GSK3beta signaling ( Insulin receptor signaling )	207	208	10000	2932	2997	2998
PC_3960	Signaling with Wnt (Mammal) ( Mammalian Wnt signaling pathway Diagram )	607	1387	1499	2033	8321	11211	2535	8326	8322	7855	8323	8324	8325	8326	51176	4041	4040	26108	90780	4089	6597	6932	83439	6934	7088	7089	7090	7091	7471	80326	7480	7481	51384	7472	7482	7473	89780	54361	7474	81029	7475	7476	7477	7478	7479	7483	7484
PC_3961	D-Sedoheptulose 7-phosphate + D-Glyceraldehyde 3-phosphate = D-Ribose 5-phosphate + D-Xylulose 5-phosphate ( Pentose phosphate cycle )	7086	8277	84076
PC_3962	PAR1-mediated thrombin signaling events	11214	396	9138	408	1759	1785	2147	2149	2151	2767	2768	10672	9630	2769	2770	2771	2773	2775	2776	2781	2782	54331	157	4633	4846	5290	5295	5585	23236	5330	5331	5578	5579	5580	5582	387	6093	9475	6642	6643	7225	7408	7791
PC_3963	UDP-D-glucose = UDP-D-galactose ( Galactose metabolism )	2582
PC_3964	p53 pathway	25	207	472	390502	890	900	1017	1029	1111	11200	114769	1387	1434	1452	1453	102800317	53944	1455	1456	1616	8445	1877	2033	80204	2932	28996	10075	8850	10524	84148	387893	1432	5599	5601	4193	4194	4738	5300	8493	10848	5515	5580	10419	5786	11186	25898	6135	9349	6125	80854	6502	56950	7157	63970	10155	91875	7321	7874	7528
PC_3965	GDP-L-fucose biosynthesis II (from L-fucose)	197258	8790
PC_3966	NAD+ + L-2-Amino-adipate 6-semialdehyde + H2O = NADH + L-2-Amino-adipic acid ( Lysine degradation )	60496
PC_3967	glycine degradation (creatine biosynthesis)	2593	2628
PC_3968	regulation of target gene expression by AP-1 ( Toll-like receptor signaling pathway (through JNK cascade) )	3725
PC_3969	LPA4-mediated signaling events	107	108	109	196883	111	112	113	114	115	1385	2774	2778	2846	5578	5581	9252
PC_3970	Cellular roles of Anthrax toxin	84168	118429	801	801	801	834	1667	1667	2099	5045	3606	3553	5604	5605	5606	6416	5608	5609	5594	5595	22861	2908	5241	7124	7412
PC_3971	ATP + CDP = ADP + CTP ( Pyrimidine Nucleotides and Nucleosides metabolism )	4830	4831	4832	4833	8382	10201	29922
